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ABSTRACT 
The Ryri gene encodes the skeletal muscle sarcoplasmic reticulum calcium release channel, also 
known as the ryanodine receptor. The RYRI gene has been extensively characterised in humans and 
pigs. The gene is large (-100-200 Kbp) and is transcribed into a —15,000 nt mRNA that encodes a 
500 kDalton transmembrane protein of —5,000 amino acids. Mutations in the human and pig RYR] 
genes are thought to be responsible for inherited diseases, specifically malignant .hyperthermia 
(humans and pigs) and Central Core Disease (humans). Malignant hyperthermia (MH) is a potentially 
lethal hereditary disorder of skeletal muscle that may be triggered by inhalational anaesthetics and 
depolarising muscle relaxants. A specific nucleotide change (C—>T) at position 1843 in the cDNA is 
responsible for MJ-1 susceptibility in pigs and in some susceptible humans. The mutation in pigs is 
also associated with reduced levels of body fat. It remains to be demonstrated whether the C1 843T 
mutation is responsible for both phenotypes in the pig. Although the evidence for RYR] mutations 
causing susceptibility to malignant hyperthermia is reasonably convincing, the evidence for RYR] 
mutations causing Central Core Disease is less so. Characterising and manipulating the Ryrl gene in 
a mammalian model (e.g. mice) could help the understanding of the function of this gene. In this 
present study, experiments were carried out a) to characterise the mouse skeletal muscle ryanodine 
receptor (Ryrl) gene cDNA, b) to construct a contiguous map of the murine Ryrl gene and c) to 
evaluate the phenotype of the Ryrl knockout transgenic mice and to develop a mouse model, which 
carries a homologue of the C1843T mutation, associated with MH in pigs and some humans. 
The murine Ryrl cDNA has been characterised by cDNA cloning and sequence analysis. Murine 
Ryrl exon-specific RT-PCR primers were designed and used to generate Ryrl cDNA fragments from 
skeletal muscle total RNA of the mouse strain 129. The cloned RT-PCR products are overlapping and 
yield about 15 kb cDNA sequence. The cDNA sequence has higher sequence similarity with 
mammalian sequences than other vertebrate and invertebrate ryanodine receptor gene(s). A 
contiguous map of the Ryrl gene has been constructed by DNA fingerprint analysis and STS 
mapping. Large fragment genomic clones containing murine Ryrl sequences have been isolated from 
two libraries - a Bacterial Artificial Chromosome (BAC) library and P1-derived artificial 
chromosome (PAC) library. Of the 33 clones isolated, 4 were from the BAC and 29 were from the 
PAC library. The BACs form two contiguous fragments separated by a gap. The relationships among 
the. BACs were confirmed by DNA fingerprinting using human RYR] cDNA fragments. This 
experiment also confirms the isolated clones are skeletal muscle ryanodine receptor isoform (Ryrl) 
specific. Sequence information from these BAC genomic clones and cDNA sequence information 
from this study has been used to develop STS markers. A contiguous map of the clones and flanking 
sequences has been established by STS analysis in BAC/PAC clones, which together span about 495 
kb. The presence of all tested STS markers in two single PACs indicates that the murine Ryrl gene is 
about 150 kb. To create a mouse model for pig MH, five attempts have been made to introduce the 
C1843 T  mutation by homologous recombination into an HPRT disrupted Ryrl gene in ES cells, but 
all were unsuccessful. In order to understand the failed attempts at gene replacement, the targeting 
vector construct containing 4.7 kb genomic DNA with the point mutation was sequenced and 
confirmed by comparing the sequence with the murine cDNA sequence. The exon sequences of the 
construct were found to be more than 80% and 100% identical (except the point mutation) to those of 
the mammalian and murine Ryrl cDNA sequences respectively. To evaluate second round gene 
targeting efficiency, another gene replacement experiment has been performed using the construct 
with a new selectable marker (neomycin). This experiment yielded three positive homologous 
recombinants clones from 1 x 107 electroporated cells. This targeting frequency is very low compared 
to the first round gene knockout (62%) using the same length of target homology sequence. To 
confirm whether the targeting event occurred in the non-targeted allele gene targeting has been 
performed and selection for neomycin expression applied. In 280 clones examined neither the wild 
allele or knockout allele had been replaced, rather the neo gene had been integrated at random. 
In the longer term, the information obtained from the present cDNA sequence, Ryrl clones isolated 
(129 strain) and gene targeting experiments in the Ryrl locus can be used to develop new targeting 
strategies and constructs to create and test mouse models for MH and CCD mutations in human. 
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All genes are constantly subject to the risk of mutation. Mutations are caused by 
errors made during DNA replication and recombination, by DNA-damaging agents/ 
chemicals, by chemical instability within the DNA, and even by errors made by 
DNA repair mechanisms themselves. Many of the mutations represent single-base 
substitutions such as transitions, which are changes form one purine to the other 
(A-G) or from one pyrimidine to the other (C<->T), and transversions, which are 
changes from purine to pyrimidine (A-+T or A->C or G—*C or G-->T) or pyrimidine 
to purine (T-+A or T—G or C—*G or C—*A). Other mutations arise from insertions 
or deletions that range from a single base pair to large DNA fragments, from 
inversion, or from translocations. If the mutant gene product is defective in any 
serious way and is disadvantageous for survival, the mutant gene will be removed 
from the population by natural selection. The 'mutant' organism will either die 
prematurely or produce fewer progeny than its unmutated contemporaries. In the 
case of protein-coding genes, even significant changes in the DNA sequence may not 
affect the functional product because of the degeneracy of the genetic code, but the 
changes will generate one or more alleles and polymorphism within the gene 
sequence. Allelic variation has been useful for identifying, isolating and mapping 
genes in the genome (Watson et al., 1987). 
1.1. Finding genes 
Genes can be identified by functional or positional cloning or by the positional 
candidate approach. In functional cloning, genes are isolated based on information 
regarding metabolic defects protein products (e.g. amino acid sequence) or function. 
Antibodies specific to the protein product or the ability of the gene product to act as 
a selectable marker can also be used in functional cloning. For example, the genes 
responsible for the inherited disorders phenylketonuria and sickle cell anaemia were 
identified based on fundamental information about the basic biochemical defect, 
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without reference to chromosomal map position (Ballabio, 1993; Collins, 1992; 
1995). 
In positional cloning, genes are identified and isolated based on knowledge of their 
genetic/physical location in the genome, and usually with little useful information 
regarding gene function. The initial information on location may include visible 
cytogenetic rearrangements or deletions in the chromosome, and/or segregation and 
linkage analyses in families and pedigrees with the genetic disease. For example, 
many of the X-linked disease genes have been isolated by the positional cloning 
approach exploiting the haploid status of the X chromosome in males. The wide 
availability of patients with deletions and translocations involving the X 
chromosome has allowed precise localisation of the gene or the disease locus. For 
example, the X-linked Chronic granulomatous, Fragile X, Kailmann syndrome and 
Glycerol kinase deficiency disease genes in human have been identified using 
positional cloning (for reviews see: Ballabio, 1993; Collins, 1992; 1995). 
Chromosomal rearrangements and linkage analyses can occasionally lead directly to 
the disease gene. However, the challenge in positional cloning often concerns 
moving from a linked marker to the disease gene and the mutation. The classic 
example of positional cloning of a human disease gene that illustrates this approach 
concerns Cystic Fibrosis (Kerem et al., 1989; Riordan et al., 1989; Rommens et al., 
1989a; 1989b). Once the complete sequence of the human genome is known 
positional cloning will become more like the positional candidate gene approach 
described below. 
The positional candidate approach combines information on function and position. 
This approach does not require isolation of a new gene but relies on available 
information from previously isolated gene(s). First the disease gene or locus is 
assigned to a chromosomal region by linkage mapping. The literature and genome 
databases are then surveyed for genes already known to map to this chromosomal 
region and that might explain the disease phenotype (Ballabio, 1993; Collins, 1992; 
1995). For example, Marfan syndrome and the fibrillin gene have been mapped first 
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to chromosome region 15q in human. The mutated fibrillin gene was then found to 
be a candidate gene for Marfan syndrome (review by Collins, 1992). 
The skeletal muscle ryanodine receptor gene (RYR]) which is associated with 
Malignant hyperthermia (MH) in some humans and with the Porcine Stress 
Syndrome (PSS) in pigs has been identified as a candidate gene for these disorders 
using the combined information on function and position, and with the mutation 
detection approach. 
This thesis focuses on attempts to create a mouse model for the porcine MH mutation 
(Chapter 5). The murine skeletal muscle ryanodine receptor (Ryrl) isoform was 
characterised at the cDNA (Chapter 3) and genomic (Chapter 4) level to provide the 
basic molecular information for manipulation of this gene. 
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1.2. Ryanodine receptor 
The (skeletal muscle) ryanodine receptor is a key component of the calcium release 
channel in the sarcoplasmic reticulum. The term 'ryanodine receptor' is somewhat 
misleading as the binding of the plant alkaloid - ryanodine - to the protein is a 
laboratory rather than a physiological phenomenon. 
1.2.1. Nomenclature 
The symbol Ryr is used to denote the ryanodine receptor(s). There are three 
isoforms, denoted with the symbols Ryrl, Ryr2, and Ryr3 with each encoded by a 
separate gene. When referring to genes, loci, mRNA/cDNA the symbol is shown in 
italics (e.g. Ryrl). When referring to the protein, plain text is used (e.g. Ryr2). 
Genetic nomenclature for humans and farm animals such as pigs uses symbols in 
which all characters are in capitals (e.g. RYR1) whereas for mice only the first letter 
is capitalised (e.g. Ryrl). When referring to ryanodine receptors (protein) in general 
terms rather than a specific isoform I have used Ryr. When referring to the 
corresponding gene(s) I have used the mouse nomenclature - Ryr in general terms, or 
Ryrl, Ryr2 for specifics. For specific references to the genes in pigs and humans I 
have used the accepted nomenclature for those species. 
1.3. Ryanodine receptor genes 
The first eDNA clones encoding a ryanodine receptor were isolated by functional 
cloning (Takeshima et al., 1989; Zorzato et al., 1990). The ryanodine receptor was 
first identified by the binding of the plant alkaloid to sarcoplasmic reticulum. The 
binding of ryanodine was used in the partial purification of the protein. Knowledge 
of the protein (partial amino acid sequence) and antibodies raised against the protein 




The rabbit skeletal muscle sarcoplasmic reticulum (SR) ryanodine receptor protein 
(Ryrl) was isolated from junctional face membrane (JFM) fraction using its binding 
affinity for the plant alkaloid ryanodine. Two oligodeoxyribonucleotides (oligos) 
were designed on the basis of the partial amino acid sequence of this purified protein 
(Leberer et al., 1989; Takeshima et al., 1989). These oligos were 5' end labelled and 
used as probes to screen a cDNA library derived from rabbit skeletal muscle 
poly(A) RNA. The initial clone thus isolated was used to probe for adjacent cDNA 
sequences. This procedure was repeated successively to isolate the full length of the 
cDNA for the skeletal muscle rabbit ryanodine receptor (Ryrl) gene. The 5' end 
cDNA was also used to isolate -jl 5 kb genomic DNA clone from a lambda Charon 
4A library (Takeshima et al., 1989). 
Zorzato et al. (1990) also isolated rabbit Ryrl specific cDNA clones from a cDNA 
expression library constructed from rabbit fast-twitch psoas muscle poly(A) RNA. 
The library was screened first with a primary polyclonal antibody specific for the 
Ca 2+  release channel protein. The positive clones were confirmed using a second 
antibody raised against the purified 30 S-ryanodine receptor. By this approach two 
partial cDNA clones were isolated and their restriction digested fragments have been 
used to isolate a full length calcium release channel cDNA from a neonatal rabbit 
skeletal muscle cDNA library (Zorzato et al., 1990). 
The full length (15.23 kb) rabbit Ryrl cDNA encodes a protein of 5,037 (Takeshima 
et al., 1989)! 5,032 (Zorzato et al., 1990) amino acids with a molecular mass of 
565.22 kDa. Two discrepancies have been observed between these amino acid 
sequences. The sequence -Ala-Gly-Asp-Ala-Gln- reported by Takeshima et al. 
(1989) as 3481-3485 residues is not found in the sequence reported by Zorzato et al. 
(1990). Residue 2015 has been recorded as Glu by Takeshima et al. (1989) but Asp 
is in the sequence published by Zorzato et al. (1990). The Asp for Glu replacement 
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found at position 2015 is conservative and could represent allelic variants. The 
stretch of five amino acids (3481-3485) in the sequence of Takeshima et al., (1989), 
but absent from the sequence reported by Zorzato et al., (1990), is likely to be due to 
the alternative splicing of a 15 bp exon region, as found in human RYRJ cDNA 
(Zhang et al., 1993). Analysis of this region in RYRJ transcripts by PCR 
demonstrate that coexistence of two distinct RYR transcripts in RNA from both adult 
slow- and fast —twitch rabbit skeletal muscle and thus unambiguously demonstrates 
that rabbit skeletal muscle contains at least two types of R YR] transcripts (Zorzato et 
al., 1994). 
The cardiac ryanodine receptor or -Ca 2+ release channel (Ryr2) has been purified in 
the form of a '-30 S complex, with a molecular mass of 400 kDa (Anderson et al., 
1989). A cDNA expression library constructed from rabbit cardiac muscle poly(A) 
RNA was screened with monoclonal antibodies (raised against the purified cardiac 
ryanodine receptor) to isolate cDNAs encoding the cardiac ryanodine receptor 
isoform (Ryr2). The cDNA, 16,532 base pair in length, encodes a protein of 4,969 
amino acids with a molecular mass of 564.711 kDa. The deduced amino acid 
sequence is 66% similar to that of the skeletal muscle ryanodine receptor (Otsu et al., 
1990). Partial sequence for human Ryr2 isoform showed 89% nucleotide identity 
and 95% predicted amino acid similarity with the rabbit Ryr2 isofonn (Martin et al., 
1998). Although Ryr2 is the main isoform found in cardiac muscle it is also found in 
brain. The sequences used by Martin et al. (1998) for these comparisons were 
derived from RYR2 eDNA prepared from human hippocampus and cerebellum. 
A single polypeptide for the rabbit Ryr3 isoform has been isolated from rabbit 
diaphragm using Ryr3 specific antibodies. As estimated by SDS-PAGE Ryr3 has 
been shown to be slightly, larger than the Ryrl isoform (Murayama and Ogawa, 
1996; 1997). But the molecular mass of the rabbit Ryr3 protein is estimated to be 
552 kDa from its predicted amino acid sequence (Hakamata et al., 1992), which is a 
slightly smaller mass than that of the rabbit Ryrl protein (565 kDa) (Takeshima et 
al., 1989; Zorzato etal., 1990). 
1.3.1 .2.Human 
The rabbit Ryrl cDNA probe has been used to isolate human RYR] calcium release 
channel cDNA from a foetal psoas muscle cDNA library. A series of six linear 
cDNA clones were isolated from the library and the 5' end was identified using a 
primer extension procedure. The gaps between the clones were isolated from a 
chromosome 19 specific library (MacLennan et al., 1989; Zorzato et al., 1990). The 
full length human RYRJ cDNA (15.24 kb) encodes a protein of 5,032 amino acids 
with a molecular mass of 563.58 kDa. This deduced molecular mass is considerably 
larger than that of the purified protein i.e., 485.0 kDa (MacLennan et al., 1989). 
A physical map composed of overlapping cloned fragments representing a 
contiguous DNA sequence (contig) spanning more than 800 kb has been established 
for the region containing the human RYR] gene (Rouquier et al., 1993; 1994). 
Rouquier et al. (1993) used three cosmid libraries derived from a Chinese hamster-
human hybrid cell line (5HL9-5B) that contains a single human chromosome 19 to 
isolate RYRJ genomic clones. Cosmid clones have been contig mapped on the basis 
of fingerprinting analysis and the gap between these contigs has been covered by a 
Yeast Artificial Chromosome (YAC) clone. A Bacterial Artificial Chromosome 
(BAC) clone spanning the 3' end has also been isolated using RYR] specific cosmid 
probes. This BAC clone closed the gap between two of the previously characterised 
cosmid contigs (Rouquier et al., 1993) and was used to resolve some errors in the 
cosmid contigs (Rouquier et al., 1994). 
To determine the fine structural organisation of the 158 kb human skeletal muscle 
RYR] gene containing 106 exons, Phillips et al. (1996) isolated cosmid clones from a 
human chromosome 19 genomic DNA library (LL 1 9NLO 1). The positive cosmids 
were subcloned and probed with the full-length cDNA (Zorzato et al., 1990). The 
positive subclones were sequenced in order to define the precise intronlexon 
boundaries. The upstream regulatory sequences were identified by alignment of 
cDNA and genomic sequences. Unidentified exon regions were PCR amplified and 
sequenced (Phillips et al., 1996). 
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Human RYR3 isoform cDNAs have been isolated from human brain cDNA library 
using the rabbit Ryr3 cDNA clone as a probe. Partial (Martin et al., 1998) and 
complete (Nakashima et al., 1997) nucleotide sequence of the human RYR3 cDNA 
has been determined by sequence analysis of nine overlapping clones. The deduced 
amino acid sequence is 4,866 amino acid long with a calculated molecular mass of 
551.046 kDa. The amino acid sequence is 96%, 69% and 67% similar to the 
sequences of the rabbit Ryr3, Ryr2 and Ryrl isoforms respectively (Nakashima et 
al., 1997). 
1.3.1 .3.Pig 
The porcine skeletal muscle RYRJ eDNA (15.25 kb) which encodes a protein of 
5034 amino acids has been cloned and sequenced for three pig breeds (Fujii et al., 
1991; Harbitz et al., 1990; 1992). Fujii et al. (1991) constructed skeletal muscle 
cDNA libraries from halothane-sensitive Pietrain and halothane-resistant Yorkshire 
pigs. These libraries were screened with human RYRJ cDNA probes. Comparative 
analysis of the RYR] eDNA sequences showed that the halothane-sensitive Pietrain 
breed has a pyrimidine transition point mutation (C—*T) at nucleotide position 1843 
that changes the amino acid at position 615 from Arginine to Cysteine. 
Norwegian Landrace pig RYR] cDNA clones have been isolated using rabbit cDNA 
clones as probes. In the Norwegian Landrace pig breed the CIT point mutation has 
been observed at nucleotide 1840 (Harbitz et al., 1992). The eDNA sequence 
reported by Harbitz et al. (1992) lacks the start codon. Therefore, nucleotide 1840 in 
this sequence (Harbitz et al., 1992; EMBL accession number: X62880) corresponds 
to nucleotide 1843 (as numbered from the start codon) in the sequence reported by 
Fujii et al. (1991) (EMBL accession number: M91452). Both Fujii et al. (1991) and 
Harbitz et al. (1992) agree that the polymorphic amino acid is residue 615. 
Other polymorphisms within the pig RYRJ gene are discussed below (1.8.1.4) in the 
context of malignant hyperthermia. 
The deduced amino acid sequences of the RYR1 proteins from human, pig and rabbit 
were found to be very similar (nearly 97% identity) and a total of 4810 amino acids 
are conserved in all three species. Totals of 155, 152 and 153 amino acid differences 
were found between the human/porcine, porcine/rabbit and human/rabbit sequences 
respectively (Harbitz et al., 1992). A major difference was found between the 
human and rabbit proteins in an acidic region of the protein (Zorzato et al., 1990). 
The 5' end region of the porcine gene spanning 19 kb (Brenig and Brem, 1992) and 
about 80 kb (Leeb et al., 1993) has been isolated from a German Landrace pig 
genomic library using an RT-PCR product corresponding to amino acids 2490-3330 
region as a probe. The clones were subcloned, sequenced and compared with 
porcine cDNA sequences in order to identify the intron/exon boundaries. Partial 
sequence information for the 19 kb clone covering the 5 '-flanking region shows that 
it contains about 2.5 kb of coding sequence and 10 exons (Brenig and Brem, 1992). 
The genomic sequence has also been determined for a 15.5 kb genomic sequence 
with 18 exons corresponding to coding region 4624-7929 (Leeb et al., 1993), and 3 
cosmid contigs spanning 72.7 kb genomic sequence including exons 1 to 71 coding 
for 3538 amino acids (Wen et al., 1996). 
1 .3.1.4.Mouse 
Partial cDNAs corresponding to the 3'-ends of the Ryrl, Ryr2 and Ryr3 genes have 
been isolated from a mouse skeletal muscle and brain cDNA library using a human 
RYR3 cDNA (Giannini et al., 1995) and a rabbit Ryrl cDNA as probes (Takeshima 
et al., 1995). Genomic clones with limited coverage of the 5'-end of the mouse Ryrl 
gene have been isolated (Takeshima et al., 1994a; Moore et al., 1998). Therefore, at 
the start of my project there were only limited molecular clones for Ryrl available 
for studies in this important laboratory / experimental animal (i.e mouse). 
1.3.1 .5.Avian 
In chicken only two isoforms of ryanodine receptors, namely a and 3, homologues to 
mammalian Ryrl and Ryr3 respectively, have been identified. As yet, there is no 
evidence for the presence of an avian homologue of the third mammalian isoform 
Ryr2. The a and 0 isoforms were isolated from a chicken skeletal muscle cDNA 
library using cDNA fragments corresponding to the 3' end of mouse, mink and 
human Ryr3 cDNAs as probes. The 3' end of the chicken RYRJ cDNA and full 
length of the RYR3 isoform have been cloned and sequenced (Ottini et al., 1996). 
Sequence (74 bp) homologous to exon 17 of the porcine RYRJ has also been cloned 
from the white Italian goose (Anser anser) using porcine sequence primers (Gronek 
et al., 1999). 
The chicken 15.089 kb RYR3 cDNA encodes 4,869 amino acids, corresponding to a 
protein with a molecular mass of 552.445 kDa. The predicted amino acid sequence 
shows 89.9% identity to mammalian Ryr3 and 85.6% to frog Ryr3. The 3' end of the 
cDNA for the RYRJ isoform (2011 bp) showed 79.1 and 75.2% identity with 
mammalian and frog Ryrl nucleotide sequences (Ottini et al., 1996). 
1.3.1 .6.Frog 
Two groups of cDNAs, which encode ryanodine receptor of bullfrog (Rana 
catesbeiana), have been cloned and sequenced from frog muscle cDNA library using 
a porcine cDNA 3' end as the initial probe. Like avians, frog also has only a and 3 
isoforms that are homologous to the mammalian Ryrl and Ryr3 isoforms 
respectively. The 17.067 kb a isoform has an alternative splicing site in the C-
terminal (amino acids 3,847-3.855) to produce proteins of 5,037/5,031 amino acids 
with molecular masses of 571.262 kDa and 570.607 kDa respectively. This isoform 
has about 80% amino acid sequence similarity with the mammalian Ryrl isoform. 
The -isoform cDNA (16.038 kb) encodes a protein of 4,868 amino acids with a 
molecular mass of 553.029 kDa. The amino acid sequence has 86% similarity to the 
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mammalian Ryr3 isoform. About 69% similarity has been observed between frog a 
and 3 isoforms (Oyamada et al., 1994) 
1.3. 1.7.Fish 
A cDNA encoding the Ryrl isoform in fish (Blue marlin i.e., Mnigricans) has been 
cloned from muscle cDNA and specific primer extension libraries using DNA and 
antibody as probes. The 16.313 kb eDNA encodes a protein of 5,081 amino acid 
with a calculated molecular mass of 576.302 kDa. The fish protein sequence is 
longer than the other vertebrate Ryrl sequences, which is largely accounted for by 
two insertions, one of 30 amino acids from amino acid 1,851-1,880 and one of 25 
amino acids from amino acids 1,926-1,950. It has higher amino acid sequence 
similarity to frog Ryrl (77%) than to human and rabbit Ryrl respectively (72% and 
73%) (Franck et al., 1998). 
1.3.2. Invertebrates 
1.3.2.1 .Nematode 
The molecular mass of the Caenorhabditjs elegans (C.elegans) Ryr protein has been 
reported as 576 kDa molecular mass, which is bigger than the mammalian receptors 
(Sakube et al., 1997). cDNA clones were isolated by screening a cDNA library with 
a rabbit Ryrl cDNA fragment. The longest cDNA clone was sequenced and the 
deduced amino acid sequence has been shown to be about 45 to 49% similar to the 
C-terminal tenth of mammalian ryanodine receptors. The cDNA clones were used to 
isolate genomics clones for the C.elegans Ryrl gene that was shown to consist of 46 
exons encoding 5071 amino acid residues. The deduced amino acid sequence of the 
C. elegans RYR protein is 47%, 42% and 40% similar to Drosophila Ryr, rabbit 
Ryr2 cardiac isofonn and rabbit Ryrl skeletal isoform proteins, respectively (Sakube 
et al., 1997). 
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1.3.2.2.Fruit fly 
A 25.68 kb mammalian ryanodine receptor homologue has been identified in a 
Drosophila melanogaster genomic DNA library. Protein-coding sequence predicted 
by computer analysis and sequence determined through partial cDNA cloning 
showed the presence of 26 exons with evidence of alternative splicing. Ryr 
expression in embryos suggests that the gene can produce an niRNA of 16 kb 
(Takeshima et al., 1994b). 
1.4. Cytogenetic map location 
The ryanodine receptor genes have been mapped in several species by linkage 
analysis or physical mapping techniques including in situ hybridisation to 
chromosomes and the analysis of somatic cell hybrids. 
The pig RYR] (the skeletal muscle calcium release channel, CRC) was mapped to 
chromosome 6 by in situ hybridisation and analysis of somatic cell hybrids (Harbitz 
et al., 1990). The grain distribution on chromosomes localised RYR] to the 
chromosomal region 6p11-q21 (Harbitz et al., 1990) (figure 1.1). The map location 
has been defined more precisely in later experiments by radioactive in situ 
hybridisation (SSC6cen-q21; Yang et al., 1992) and then by fluorescence in situ 
hybridization (SSC6q12; Chowdhary et al., 1992a). Long-range restriction map 
studies suggest that the minimal distance between the porcine glucose phosphate 
isomerase (GPI) and RYR] (CRC) loci would be at least 500 kb (Frengen and 
Davies, 1995). The pig RYR] locus has also been mapped to chromosome 6 by 
linkage analysis (for example: Rohrer et al., 1994; 1997; Archibald et al., 1995; 
Raszek et al., 1995; Marklund et al., 1996; Grimm et al., 1997). Other linkage 
studies concerning RYRJ and malignant hyperthermia are discussed later. 
Analysis of human-rodent somatic cell hybrids with a human RYR] cDNA probe was 
used to map the human RYRJ gene to the long arm of chromosome 19. When 
additional hybrids carrying deletions or translocations in chromosome 19 were 
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examined the RYR] gene was localised to 1 9q 13.1 (figure 1.1) (MacKenzie et al., 
1990). The position and orientation of the RYRJ gene within this region was 
established by fluorescence in situ hybridisation (FISH) with RYR] cDNA (Trask et 
al., 1993) and YAC clones (Rouquier et al., 1993). Trinucleotide repeat (D19S190) 
and dinucleotide repeat markers (D19S47, D19S75 and D19S191) in the RYRJ region 
have been ordered in human/hamster somatic cell hybrids containing fragments of 
human chromosome 19. These markers are in the following order 19cen-D19S75-
D19S191-Ryrl-(D19S47, D19S190) -19ter (Iles et al., 1992). These markers were 
also used for linkage mapping studies. Further linkage mapping is discussed below 
in the context of malignant hyperthermia. 
In mouse, the Ryrl locus has been mapped by multipoint linkage analysis in a Mus 
domesticus/Mus spretus interspecific backcross using rabbit 3' end Ryrl cDNA, 
Atpa-2 and Ckmm probes. This study mapped the Ryrl to chromosome 7 and 
ordered the genes as: cen-Pkcc-D1 
(Cavanna et al., 1990). The cytogenetic map locations of the three mouse Ryr genes 
has been established through in situ hybridisation using partial cDNA probes specific 
for Ryrl, Ryr2 and Ryr3 (Mattei et al., 1994). These partial cDNA clones specific 
for the different Ryr isoforms were isolated from a murine brain cDNA library using 
human Ryr3 cDNA as probe (Mattei et al., 1994) and confirmed by sequencing 
(Giannini et al., 1995). The murine Ryrl gene was mapped to the 7A2 - 7132 region 
(figure 1.1). 
In cattle, Chowdhary et al. (1 992b) localised the RYR] gene on chromosome 1 8q23-
q26 through in situ hybridisation with a porcine RYRJ cDNA probe. Synteny 
mapping studies using porcine CRC (RYRJ) and GPI probes in a bovine-murine 
somatic cell hybrid panel showed that these two genes are closely linked (Miller et 
al., 1992). The position of the RYRJ locus on the horse chromosomes has been 
established using a porcine RYRJ cDNA (Chowdhary et al., 1992b) and horse BAC 
clone as probes (Godard et al., 1998) for in situ and fluorescence in situ 










Figure 1.1: Ryrl locus on mammalian chromosome 
MMU 7 Mouse chromosome 7 
HSA19 Human chromosome 19 
SSC 6 Pig chromosome 6 
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The pig cardiac ryanodine receptor gene (RYR2) has been mapped on the 
chromosome 14q22-q23 using a YAC containing part of the RYR2 locus as a probe 
for in situ hybridisation to metaphase chromosomes (Leeb et al., 1995). This map 
location has been further confirmed by PCR analysis in a rodent-porcine somatic cell 
hybrid panel (Leeb et al., 1995). The somatic cell hybrid analyses also showed that 
RYR2 and the D-amino acid oxidase gene (DAO) are syntenic (Leeb etal., 1995) 
The human RYR2 locus has been mapped to chromosome 1q42.1-q43 using rabbit 
Ryr2 cDNA fragments as probes for FISH to human metaphase chromosome spreads 
(Otsu et al., 1993). The mouse Ryr2 gene has been mapped to the 13A1-13A2 
region (Mattei et al., 1994). 
The human RYR3 gene has been mapped using RYR3 specific genomic fragments 
amplified by PCR as probes for in situ hybridization. The RYR3 gene was mapped to 
chromosome 15q14-q15 (Sorrentino et al., 1993). The mouse Ryr3 gene has been 
mapped to the 2E5-2F3 region (Mattei etal., 1994). 
The Ryrl locus in mouse chromosome 7A2-7B2 is homologous to human 
chromosome 19q13.1 (MacKenzie et al., 1990; Trask etal., 1993), pig chromosome 
6q1.2->21 (Harbitz et al., 1990), horse chromosome lOpiS (Chowdhary et al., 
1992b; Godard et al., 1998) and cattle chromosome 18q23-q24 (Chowdhary et al., 
1992b) cytogenetic regions. Mouse Ryr2 region (13A1-13A2) is homologous to 
human chromosome 1q42.1-q43 (Otsu et al., 1993) and porcine 14q22-q23 (Leeb et 
al., 1995). The Ryr3 region of mouse chromosome 2 2E5-2F3 is homologous to 
human 1 Sql 4-q 15 (Sorretino et al., 1993). These regions of homology are well 
known regions of conserved synteny between these species. The mouse 
chromosome 7, human chromosome 19 and pig chromosome 6 regions of conserved 
synteny have been studied for many years. 
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1.5. Expression 
Three isoforms of ryanodine receptor proteins have been identified and named Ryrl, 
Ryr2 and Ryr3. The isoforms differ in size (molecular mass) and in their patterns of 
expression. The expression and distribution in different cells/tissues have been 
examined by presence of mRNA and or the ryanodine receptor protein itself (Otsu et 
al., 1990; Arai et al., 1992; Giannini et al., 1995), Western analysis and 
immunoreactivity with anti-Ryr antibodies (Chen et al., 1993; Murayama and 
Ogawa, 1996; Buck etal., 1997; DiJulio etal., 1997; Tong etal., 1997; Querfurth et 
al., 1998), RT-PCR and by monitoring of 4,4-difluoro-1,3,5,7-tetramethyl-4bora 
3,4-diaza-s-indacene-3 -prop ionic acid succinimidyl ester (BODIPY)-ryanodine 
fluorescence (Zhang et al., 1997) and by in situ hybridisation (Rosemblit et al., 
1999). 
High level expression of the skeletal muscle isoform (Ryrl) in both fast- and slow-
twitch muscle and also in the oesophagus and testis has been observed. However, 
lower expression was also found in spleen, diaphragm, oesophagus, thigh muscles 
and Purkinje cells in the cerebellum. The Ryr2 gene is expressed mainly in cardiac 
muscle but also at lower levels in myocytes, lung and pancreatic acinar cells. The 
Ryr3 gene is expressed in the brain hippocampus, caudate nucleus and amygdala at 
high level and it appears to be widely transcribed in the cerebrum, cerebellum, 
uterus, vas deferens, skeletal muscle, lung, oesophagus, spleen, gut, kidney, stomach, 
submaxillary gland, thymus, testis, adrenal gland and ovary (Otsu et al., 1990; Arai 
et al., 1992; Giannini et al., 1995; Murayama and Ogawa, 1996; Nakashima et al., 
1997; Murayama and Ogawa, 1997; Martin et al., 1998; Leite et al., 1999). The 
presence of Ryr3 protein has also been identified in the microsomal membrane 
during cell differentiation and differentiated skeletal muscle cells (Tarroni et al., 
1997). The expression is independent of cell fusion and myotube formation (Tarroni 
et al., 1997). RYR3 expression has also been found in diaphragm muscle (Conti et 
al., 1996) and parotid acinar cells (DiJulio etal., 1997). 
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The Ryrl and Ryr2 genes are also expressed in, gut, kidney, stomach, submaxillary 
gland, thymus, adrenal gland and ovary. In the testis germ cells, expression of Ryrl 
and Ryr3 has been observed, and all three isoforms in the cerebrum and in the 
cerebellum (Otsu et al., 1990; Arai et al., 1992; Giannini et al., 1995). Alternative 
splice variants of Ryr3 mRNA have been found in brain and peripheral tissues. 
These splice variants might generate potential heterogeneity in the function of Ryr3 
in different tissues (Marziali et al., 1996; Murayama and Ogawa, 1997). 
During mouse development, expression of the Ryr2 gene has been found at day 8.5 
in the heart tube and it continues to be expressed at high level in cardiac tissues. 
Ryrl gene expression has been detected at day 9.5 in the myotome and later at high 
levels in developing skeletal muscles. As discussed below, (see section 1.6) other 
proteins are involved in calcium release channels. For example, Inositol 1,4,5-
triphosphate receptor (IP3R)-induced Ca 2+  regulation and expression has been found 
as early as day 5.5 in the inner cell mass. Through day 12.5, high level IP3R 
expression has been found in most organs/tissues and then its expression becomes 
tissue specific with the highest levels in the central nervous system (Rosemblit et al., 
1999). Ryrl and Ryr2 expression in skeletal and cardiac muscles increases 
significantly during the first few days after birth and reaches a steady state in the 
adult, whereas IP3R mRNA levels decline after birth (Marks, 1992; Tarroni et al., 
1997). Also, the presence of high levels of cardiac/slow-twitch isoforms of Ca 2+_ 
ATPase and calsequestrin has been observed in foetal stages but these were 
gradually replaced by fast-twitch isoforms in adult muscle (Arai et al., 1992). 
Although there are differences in molecular weight, function and expression among 
the three Ryr subtypes, all the isoforms release calcium from intracellular storage 
following cellular stimulation. 
17 
1.6. Ryr protein 
A sarcoplasmic reticulum (SR) calcium release channel (CRC) protein has high 
binding affinity to a plant alkaloid, ryanodine. Optimal ryanodine binding to skeletal 
muscle sarcoplasmic reticulum membranes is dependent on a number of factors such 
as Ca 2+ concentration, ionic strength, pH and temperature (DiJulio et al., 1997). 
CRC appears to be the only cellular site of ryanodine binding, and is referred to as 
the ryanodine receptor protein (Ryr). Binding affinity to [3H]-ryanodine, [(3-
cholamidopropyl) dimethylammonio] -1- propane-sulfonate (CHAPS) and 
polyclonal and monoclonal antibodies (Chen et al., 1993) have been used to isolate 
and to characterise a heavy SR ryanodine receptor protein with a molecular mass of 
about 400-500 kDa from the 30 S sarcoplasmic reticulum (SR) (DiJulio et al., 1997; 
Needleman and Hamilton, 1997; Du et al., 1998). Ryanodine receptor proteins have 
been isolated from human, rabbit, pig, rat and frog (Anderson et al., 1989; 
Takeshima et al., 1989; Zorzato et al., 1990; Harbitz et al., 1992; Lai et al., 1992; 
Delbono and Chu, 1995; Richter etal., 1997). 
The Ryr molecule consists of two main regions: a C-terminal channel region and a 
large amino-terminal in the cytoplasmic region that constitutes the foot structure 
spanning the junctional gap between the sarcoplasmic reticulum and the transverse 
tubule. The first 4000 amino acids which are hydrophilic are likely to form a 
cytoplasmic domain (Zorzato et al., 1990). The cytoplasmic region preceding the 
first transmembrane segment contains candidate binding sites for modulators of the 
calcium-release channel (Takeshima et al., 1989). The transmembrane region has 
four highly hydrophobic segments in its C-terminal tenth. Each hydrophobic 
segment, comprising about 20 amino-acid residues, represents transmembrane a-
helices. (Takeshima et al., 1989). Another model suggests that the transmembrane 
domain consists of 10 helices, four in the N-terminal quarter and six in the C-
terminal quarter of the protein (MacLennan and Toyofuku, 1992). Electron 
microscopy studies of the three dimensional structures of skeletal muscle calcium 
release channels have shown that Ryrl has 10 or more transmembrane domains 
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(Radermacher et al., 1994) but a study with antibodies showed better agreement with 
a four transmembrane model (Leeb and Brenig, 1998). 
Marks et al. (1989) reported the isolation and characterization of the rabbit skeletal 
muscle junctional channel complex (JCC). As noted by the authors, the JCC is 
identical to the ryanodine receptor. The three dimensional structure of the calcium 
channel/JCC has been examined by electron microscopy (Wagenknecht et al., 1989). 
It showed that the two faces of the JCC which associate with the junctional face 
membrane of the terminal cisternae of sarcoplasmic reticulum and the transverse 
tubule are distinct from one another (Wagenknecht etal., 1989). 
Sequence analysis of Ryr proteins has shown that the cytoplasmic C-terminal region 
is highly conserved. In order to study the importance of the C-terminal region Gao et 
al. (1997) made a series of cDNA constructs in which parts of the coding sequences 
were deleted. The expression of the constructs was examined in human embryonic 
kidney cells. The results showed that the most 15 C-terminal amino-acids are 
important for the expression of a functional Ryr complex (Gao et al., 1997). These 
amino acids appear to be essential for correct assembly of a skeletal muscle Ryr that 
can bind ryanodine and display stable calcium channel activity. 
Although the amino acid sequence of rabbit cardiac muscle sarcoplasmic reticulum 
isoform (Ryr2) shares only 66% similarity with that of the skeletal muscle isoform 
(Ryrl), the predicted secondary structures and hydropathicity plots show that these 
two isoforms exhibit the same topology in both transmembrane and cytoplasmic 
domains (Otsu etal., 1990). 
1.7. Function 
The function of the ryanodine receptors has been studied following genetic 
manipulation of cell lines and mice. The methods for genetic manipulation in mice 
are discussed later. 
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In order to study the functions of ryanodine receptor genes, the mouse Ryrl 
(Takeshima et al., 1994a; Moore et al., 1998) and Ryr3 genes (Takeshima et al., 
1996) have been disrupted by gene knock-out. The Ryrl gene has been knocked-out 
in exon 2 (Takeshima et al., 1994a) and exon 10 (Moore et al., 1998) by inserting a 
neomycin marker gene into the gene(s). The Ryr3 gene has been knocked-out in Ji 
ES cells using homologous replacement vectors, which replace either exon 1 or exon 
2 of Ryr3 with the neomycin resistance gene (Takeshima etal., 1996). 
Mice that are homozygous for the Ryrl exon 2 knock-out die perinatally and show 
gross abnormalities of skeletal muscle (Takeshima et al., 1994a). Mice with only 
one copy of the disrupted gene are normal. The mouse Ryrl gene has also been 
disrupted by inserting an HPRT mini-gene into exon 17 (Hitchin et al., unpublished 
data). I have examined the phenotypes of transgenic mice with the Ryrl exon 17 
knock-out as part of the research for this thesis. The exon 10 knock-out of Ryrl has 
been maintained in cell lines rather than as transgenic mice (Moore etal., 1998). 
Antibodies raised against Ryrl, Ryr2 and Ryr3 have been used to find the presence 
of ryanodine receptors in wild type and homozygous Ryrl knock-out mice. The anti-
Ryrl antibody only bound to membranes from wild type mice. No detectable 
immunoreactivity towards the anti-Ryr2 or Ryr3 antibodies was detected in skeletal 
muscles from wild-type or Ryrl knock-out mice (Buck etal., 1997). 
Transgenic mice with a targeted mutation in either exon 2 or exon 10 of the Ryrl 
gene (Takeshima et al., 1994a; Moore et al., 1998) have triad junctions lacking the 
feet structure (dyspedic) in skeletal muscle (Takekura et al., 1995; Protasi et al., 
1998) which is essential for both muscular maturation and E-C coupling. This 
function of Ryrl cannot be substituted by other subtypes of the receptors (Takeshima 
et al., 1994a). Dyspedic skeletal muscle cells, which do not express Ryrl, lack E-C 
coupling and also have about a 30 fold reduction in L-type Ca 2+ current density 
(Fleig et al., 1996; Nakai et al., 1996). There appears to be reciprocal signalling 
between the RYR1 isoform and the dihydropyridine receptor (DHPR) isoforms 
(Nakai et al., 1997). The Ca2  release activity of Ryrl is controlled by the DHPR 
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and the Ca 2+ channel activity of the DHPR is controlled by Ryrl. But DHPR does 
not showed any interaction with the Ryr2 and Ryr3 isoforms (Nakai et al., 1997). 
In order to study the signalling between DHPR and Ryrl Nakai et al. (1998) 
constructed a series of chimeric Ryrl/Ryr2 cDNAs and expressed them in dyspedic 
myotubes that lack endogenous Ryrl. The results showed that Ryrl residues (2,659-
3,720) are able to enhance only Ca 2+  channel function, whereas, the 1,635-2636 
region of Ryrl mediates both E-C coupling and enhanced Ca 2+ channel function 
(Nakai et al., 1998). Leong and MacLennan, (1998) also demonstrated through 
experiments with Ryrl, Ryr2 chimeric cDNAs, that the amino acids in the region 
1076-1112 play a role in interactions between the Ca 2+ release channel of skeletal 
muscle Ryrl and the loop linking domains II and III of the skeletal muscle L-type 
Ca 2+  channel DHPR. The skeletal muscle DHPR al residue amino acids 720-765 
(domains II and III) are responsible for the bi-directional coupling with Ryrl 
(Grabner et al., 1999). 
Although neither Ryr2 nor Ryr3 can mediate E-C coupling of the skeletal muscle 
type, in the mutant mice lacking Ryrl, both Ryr2 and Ryr3 are capable of residual 
calcium release in the skeletal muscle. Disruption of the Ryrl gene results in 
complete loss of E-C coupling in skeletal muscle (Takeshima et al., 1994a) but Ryr3 
provides calcium induced calcium release (Takeshima et al., 1995). Mice with the 
Ryr3 knock-out do not have any abnormality in E-C coupling (Takeshima et al., 
1996). Yamazawa et al. (1996) showed that the E-C coupling could not be restored 
by Ryr2 in cultured skeletal muscle cells lacking Ryrl. Mice lacking both Ryrl and 
Ryr3 were created by mating transgenic mice in which either the Ryrl or Ryr3 gene 
had been mutated. The double mutants died perinatally and had the same appearance 
as the homozygous Ryrl knock-out mice but show greater muscle degeneration. 
Loss of E-C coupling and muscular degeneration has been observed together in mice 
lacking both Ryrl and Ryr3 isoforms. Triadic junctions without feet structures are 
found in transgenic mice lacking Ryrl and a few triadic junctions with feet 
structures, presumably composed of Ryr3. In the double (Ryrl, Ryr3) knock-out 
mice triadic junctions are found, but without feet structures (Ikemoto et al., 1997). 
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The results suggest that molecular components other than ryanodine receptors are 
responsible for the triad formation (Ikemoto et al., 1997). These experiments show 
that the ryanodine receptor subtypes have complex functions and are not completely 
interchangeable. 
As noted earlier, Ryr3 expression has been observed in the skeletal muscle cells 
(Conti et al., 1996; DiJulio et al., 1997; Tarroni et al., 1997). In addition, Ryr3 
expression has also been found in mice lacking the Ryrl isoform. More recently, 
Flucher et al. (1999) have studied the localization of Ryrl and Ryr3 in skeletal 
muscle fibres. Ryr3 was found together with the DHPR in the triadic junction 
between the t-tubules and the sarcoplasmic reticulum. During development, Ryr3 
expression declined rapidly in some fibres whereas other fibres maintained 
expression of Ryr3 into adulthood. The localisation of the Ryr3 in skeletal muscle 
triads, together with Ryrl, is consistent with an accessory function of Ryr3 in 
skeletal muscle E-C coupling (Flucher etal., 1999). 
The nematode C. elegans has a single gene (at the unc-68 locus) encoding a 
ryanodine receptor. The morphological and behavioural phenotypes observed in 
unc-68 null mutants suggest that intracellular calcium release is not essential for E-C 
coupling (Maryon et al., 1998). 
Immunoblot analysis of frog skeletal muscle calcium release channel protein using 
polyclonal antibodies raised against rat Ryr isoforms showed that it has two distinct 
Ryr isoforms homologous to the mammalian skeletal and cardiac isoforms (Lai et al., 
1992). Ogawa et al. (1999) demonstrated functional differences in the skeletal 
muscle Ca 2+  release channels between rabbit and frog using properties of Ca 2+  
induced Ca 2+  release activity and [3H]ryanodine binding activities. They showed that 
rabbit Ryr has higher Ca 2+  affinity, higher acidity in the presence of Ca 2+ alone with 
less stimulation by adenine nucleotide and less enhancement of [3H]ryanodine 
binding by caffeine than frog. 
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1.8. Calcium regulation 
Calcium regulates a wide range of events in both muscle and non-muscle cells. 
These events include the control of metabolic pathways, mediation of endocrine 
secretion, stimuli for second messenger production, fertilisation, cell growth, 
neuronal signal transduction and muscle contraction (Wingertzahn and Ochs, 1998). 
Muscle contraction and relaxation are regulated by the myoplasmic free calcium 
concentration, which in turn is regulated by Ca 2+  binding proteins in the endoplasmic 
reticulum. Ca 2+  binding proteins such as calsequestrin and calreticulin maintain the 
free [Ca 2+]at iO to 10 M (Berridge, 1993; Szegedi et al., 1999). Calcium is 
released back into the cytosol through the inositol trisphosphate (InsP 3) receptor or 
Ryr channels (Berridge, 1993). The distribution of such InsP 3- or ryanodine-
sensitive calcium stores varies considerably from cell to cell. Some cells either have 
ryanodine-sensitive stores as in skeletal muscle or InsP3-sensitive stores, as in 
Xenopus oocytes. Calcium release through InsP 3  receptors is a unique mechanism 
for regulation of intercellular Ca 2+  levels that has been studied extensively 
(Berridge, 1993; Wingertzahn and Ochs, 1998). 
In skeletal muscle and heart the rise in cytoplasmic Ca 21 concentration is triggered 
by an electrical event, the depolarisation of the plasmalemma, which results in the 
release of calcium from the sarcoplasmic reticulum (SR) lumen (Fleischer and Inui, 
1989). Calcium is pumped into SR by the calcium pump protein, also known as the 
Ca2tATPase. Calcium ions, pumped into the lumen of the SR, are stored largely by 
the calcium-binding protein, calsequestrin. Calsequestrin is a low-affinity and high-
capacity calcium binding protein in sarcoplasmic reticulum (SR). The mouse cardiac 
and skeletal muscle calsequestrin genes have been cloned and their expression 
studied (Park et al., 1998a). Calsequestrin has been found to be associated with the 
ryanodine receptor and other proteins in a Ca 2+-dependentmanner (Zhang et al., 
1997). 
In skeletal muscle, the signal for Ca 2+ release is initiated at the neuro-muscular 
junction. 	An action potential then spreads over the plasma membrane and 
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transversely into the fibre via the T-tubules. The signal is then transferred across the 
triad junction, and Ca2  is released from the terminal cisternae. The process is 
referred to as electro-mechanical coupling or depolarisation-induced Ca 2 release 
(Fleischer and Inui, 1989). In striated muscle, ryanodine receptor (Ryrl, the calcium 
release channel in the sarcoplasmic reticulum), dihydropyridine receptor (DHPR, the 
voltage-gated L-type calcium channel in the transverse tube) and SR Ca 2tATPase 
(SERCA, the calcium pump in the SR) proteins mediate excitation-contraction 
coupling (E-C coupling). Contraction is preceded by a massive release of stored 
Ca 2+  through Ryr channels, which open in response to activation of voltage gated 
Ca2  channels through the established interactions of actin, myosin and troponin 
(Catterall, 1991). These E-C coupling proteins expressed differently in the skeletal 
and cardiac muscles and DHPR could play an important role in Ca 2+ metabolism 
during early stages of differentiation (Park etal., 1998b). 
The calcium-release channel is activated by several compounds, including Ca 2 at 
micromolar concentrations, ATP, adenine nucleotides, caffeine, halothane, ryanodine 
at nanomolar concentrations and also sulthydryl reagents (glutathione, NO and NO 
adducts), cyclic adenosine diphosphoribose (cADPR) and poly-S-Nitrosylation. Ryr 
channel activity is inactivated by Mg 2+  and Ca 2+  at millimolar concentrations, 
ryanodine at micromolar concentrations and ruthenium (Fleischer and Inui, 1989; 
Sonnleitner et al., 1998; Xu et al., 1998a). The effects of different ions have been 
examined in competition studies and at least three mechanisms have been proposed 
to explain the results (Meissner et al., 1997). These mechanisms include, 
competitive binding of Mg 2+  and monovalent cations to the Ca 2 activation sites, 
binding of divalent cations to the Ca2  inactivation sites and binding of anions to the 
specific anion regulatory sites. Several proteins are also reported to interact with the 
Ca2  release channel including aldolase, glyceraldehyde-3 -phosphate dehydrogenase, 
triadin, calmodulin, immunophilins (FK506 binding proteins), protein kinases and 
phosphatases (Needleman and Hamilton, 1997; Xu et al., 1998b). In addition, some 
exogenous factors like ryanoids, toxins, xanthines, anthraquinones, phenol 
derivatives, adenosine and purinergic agonists and antagonists, NO donors, oxidizing 
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reagents, dantrolene, local anaesthetics and polycationic reagents are also found to 
affect Ryr function (Xu et al., 1998b). 
A comparative study of the functional properties of the Ryr3 in normal and knock-
out mice identified a novel ryanodine-sensitive channel, with properties distinct from 
those of Ryrl channels. This lipid bilayer channel is always associated with the 
presence of the Ryr3 isoform. The novel channel, like the Ryrl channel, is sensitive 
to the cADPR, inactive at nanomolar Ca 2+ concentration in the presence of 1 mlvi 
ATP, but opens only by increasing Ca 2+  to micromolar levels and is not inhibited at 
higher Ca2 concentrations (Sonnleitner et al., 1998). 
1.9. Malignant hyperthermia 
Malignant hyperthermia (MH) is a pharmacogenetic disease with an autosomal 
dominant pattern of inheritance in humans (McCarthy et al., 1990; Fagerlund et al., 
1997). MH crises occur when susceptible individuals are exposed to commonly used 
anaesthetics such as halothane, or depolarising skeletal muscle relaxants (e.g. 
succinylcholine). An MH crisis is characterised by a rapid increase in body 
temperature, acidosis, hypoxia, skeletal muscle rigidity, accompanied by hyper-
metabolism, high fever and cellular ion imbalances. If the crisis is not diagnosed 
immediately and treated with the drug dantrolene, the patient may die within minutes 
from ventricular fibrillation, within hours from pulmonary edema or coagulopathy, 
or within days from neurological damage or obstructive renal failure (Deufel et al., 
1992; MacLennan and Phillips, 1992). 
Malignant hyperthermia in humans was first reported in 1960. The incidence of MH 
episodes was about one in 15,000 in children and about one in 50,000 in adult 
exposed to anaesthetics (MacLennan, 1992). MH susceptibility can be diagnosed, by 
an in vitro caffeine-halothane contracture test. It requires a biopsy of viable muscle 
for in vitro measurements of halothane or caffeine induced tension in muscle strips. 
The biopsied muscle fibres are attached to a force-displacement transducer and then 
exposed to incremental doses of caffeine, to single or incremental doses of halothane, 
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or to incremental doses of caffeine in the presence of halothane (MacLennan, 1992). 
In the European method, individuals whose fibres undergo contractures exceeding 
the threshold with both halothane and caffeine are considered to be MH-susceptible 
(MHS). Those patients whose fibres undergo contractures exceeding the threshold 
with either halothane or caffeine, but not both, are diagnosed as MH-equivocal 
(MHE) and those patients whose fibres behave normally are MH-negative (MHN). 
This test gives a specificity of 93.6% (EMHG, 1984; Ording et al., 1997). In the 
North American method, individuals whose fibres undergo contractures exceeding 
the threshold with either halothane or caffeine are considered to be MHS (Larach 
1989; MacLennan and Phillips, 1992). 
A homologous phenotype to anaesthetic-induced ME1 has been observed in pigs. It 
can be triggered by stress, induced by handling the animal, transport, high 
temperatures and disturbance of the animal before slaughter, and is a manifestation 
of the porcine stress syndrome (PSS) (Archibald, 1991). In pigs the gene responsible 
for the porcine stress syndrome and for halothane-induced malignant hyperthermia is 
referred to as the halothane gene (HAL). In pigs, in contrast to humans, 
susceptibility to halothane-induced malignant hyperthermia exhibits a recessive 
mode of inheritance. For example, in the halothane challenge test, the heterozygous 
carriers (HAL") fail to respond. Homozygous susceptible pigs (HAL) respond to 
stress or exposure to halothane in the same way as human MH carriers (i.e. 
heterozygotes) respond to anaesthetics (Louis et al., 1990). The reaction of a 
susceptible pig appears to be more rapid than that of a susceptible human. There is 
no convincing evidence of stress-induced malignant hyperthermia in humans. 
The difference in the mode of inheritance between humans and pigs indicates that the 
rest of the genome also has an influence on the malignant hyperthermia phenotype. 
The difference in the mode of inheritance and the reaction times may also suggest 
that the two species have different sensitivity thresholds to abnormal calcium levels 
in muscle. As discussed below, only one mutation causal for ME! is found in the pig 
RYR] gene, but several different RYR] mutations are associated with MH 
susceptibility in humans. 
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Traditionally, PSS animals have been diagnosed on the basis of their susceptibility to 
halothane through a halothane challenge test, which will induce signs typical of a 
malignant hyperthermia reaction such as muscle rigidity, tachycardia, ventricular 
arrhythmia, mottled cyanosis and fever in animals homozygous for the susceptible 
HAL allele (n/n). Homozygous n/n (halothane reactor) animals produce poorer meat 
quality, with a higher frequency of pale, soft, exudative (PSE) meat or watery pork, 
than halothane non-reactors (N/N or N/n). These detrimental effects of the gene on 
meat quality were first reported in 1953. The susceptible allele HAL" is also 
associated with reduced levels of fat and increased lean content. The stress 
susceptible allele (HALe) could have been eliminated by selective breeding using the 
halothane challenge test and progeny testing. But selection for high feed efficiency, 
superior muscling and low fat content led to most genetically superior pig lines and 
breeds showing increasing frequencies of PSS (Louis et al., 1990; Archibald, 1991; 
MacLennan, 1992). 
The halothane challenge test fails to distinguish between homozygous normal pigs 
(HALW) and carriers (HAL'). A DNA test for the causal mutation would solve this 
problem. Therefore, in the 1980s several groups started searches for the HAL gene 
(Archibald, 1986). The RYRJ gene was identified as the HAL gene by a combination 
of positional candidate gene cloning, physiological candidate gene cloning, 
comparative gene mapping and good luck. 
1.9.1. Role of the ryanodine receptor in Malignant Hyperthermia (Mu) 
1.9.1.1 .Physiological approaches 
As muscle is the site of the phenotypic defects associated with MH this genetic 
disorder is classified as a myopathy. 
Ca 2+  is an important regulator of muscle contraction, relaxation and energy 
metabolism. In halothane sensitive pigs increased calcium has been observed in the 
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skeletal muscle cytoplasm. This abnormality in Ca 2+  regulation is believed to be the 
primary reason for MH (Louis et al., 1990). Cytosolic calcium concentration is 
regulated by intracellular signalling pathways (Berridge, 1993). In skeletal muscle, 
there are essentially three membrane systems that regulate cytoplasmic calcium - the 
plasma membrane, mitochondria and the sarcoplamic reticulum. No abnormalities 
have been found in muscle contractile proteins. Louis et al. (1990) argue that as 
halothane and dantrolene have no effect on calcium regulation by the plasma 
membrane in normal or MH muscle, changes in this membrane are unlikely to be 
responsible for MH. Several groups have studied mitochondrial systems in MH and 
normal pigs and humans. Louis et al. (1990) concluded that although mitchonciria 
may contribute to MH they are unlikely to be the site of the primary defect. The 
sarcoplasmic reticulum and associated transverse tubule components are suspected to 
be the site of primary defect in MH (Louis et al., 1990). 
Differences in calcium-induced Ca 2+  release have been found between normal and 
MHS (malignant hyperthermia susceptible) muscle. For example, in muscle fibres 
from an MH patient the calcium-induced Ca 2+ release mechanism was shown to be 
more sensitive to calcium than in fibres from normal muscle (Endo et al., 1983). 
Calcium-induced calcium release and halothane-induced calcium release in pigs 
sensitive to halothane (MHS) (Ohnishi et al., 1983) and human MRS sarcoplasmic 
reticulum (SR) showed a significantly higher sensitivity to calcium and the 
maximum rate of Ca2  release than that in normal muscles (Endo et al., 1983). No 
difference has been observed in Ca 2  uptake by the SR or the properties of the 
contractile proteins between the MHS patients and normal human muscles (Endo et 
al., 1983). Mickelson et al. (1988) found no differences in Ca 2+-ATPase activity, 
calsequestrin content and calcium accumulation in SR vesicles isolated from MHS 
and normal pigs. MHS SR releases more calcium than normal SR when exposed to a 
variety of concentrations of ATP, Mg 2 , or caffeine and produces elevated twitch 
force in MHS muscles (Mickelson et al., 1988). These differences could be due to 
abnormal regulation of SR calcium release in vivo resulting in an increased 
sarcoplasmic Ca 2+  level during a twitch and increased tension production. These 
differences have been observed both in isolated heavy SR membranes and intact 
muscle bundles. As the ryanodine receptor has a key role in Ca 2 release from the 
sarcoplasmic reticulum variation in the RYR 1 protein could be the cause of the 
differences observed. Therefore, the RYR] is a candidate gene for MH. 
1.9.1 .2.Linkage mapping and positional candidate gene approaches 
Genetic or linkage mapping is based on establishing the relationships among 
recombination events between markers (phenotypic, genotypic, morphological, 
biochemical and DNA). The HAL gene was assigned to a linkage group comprising 
biochemical markers glucose phosphate isomerase (GPI), the H and S blood groups 
(EAH, EAS or S(A-O), the erythrocyte-6-phosphogluconate dehydrogenase (PGD) 
and alpha- 1B-glycoprotein(AJBG)] in the order S(A-O)-GPI, HAL-EAH-AJBG-PGD 
(for a review see - Archibald and Imlah, 1985). The HAL locus was subsequently 
mapped to chromosome 6 through in situ hybridization assignments for the two 
linked markers GPI and PGD (Davies et al., 1988; Yerle et al., 1990a; 1990b). 
DNA-based markers in the pig GPI gene were developed for prediction of pig HAL 
genotypes by linkage analysis (Davies et al., 1988). The pig GPI gene could have 
been used as a starting point for the positional cloning of the HAL gene. 
In humans, GPI maps to chromosome 19q 13.1. As pig MH was considered to be 
homologous to human MH, McCarthy et al. (1990) tested Irish MH pedigrees for 
linkage to chromosome 19 markers. These results supported the assumption that MH 
in humans and pigs were genetic diseases with similar underlying causes. As 
discussed below, MH in humans has multiple causes, including some where the gene 
responsible is not linked to chromosome 19 (see 1.8.1.5). Therefore, as studies of 
pig MH were to play a key part in understanding this inherited disease it was 
fortunate that the Irish pedigrees had the chromosome 19 associated form of MH. 
MH was shown to have linkage to markers from the GPI region of chromosome 19 
with a peak lod score of 5.65 for theta = 0 with the cyotochrome P540 gene (CYP2A) 
in one family (McCarthy et al., 1990). The multi point linkage analysis of the 
chromosome 19q12-13.2 region showed the distance between D19S9 and APOC2 to 
be 20 cM and that they are flanking the MH region (McCarthy et al., 1990). 
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1.9.1.3 Ryanodine receptor gene is a candidate for the MHS gene 
The human ryanodine receptor (RYR]) gene was mapped to chromosome 19q13.1 by 
MacKenzie et al. (1990) using a human RYR1 eDNA clone (Zorzato et al., 1990) to 
probe DNA from a somatic cell hybrid panel. A major inherited disease of muscle - 
Myotonic Dystrophy (MD) - had previously been mapped to the long arm of 
chromosome 19. Therefore, MacKenzie et al. (1990) tested a restriction fragment 
length polymorphism (RFLP) marker for the RYRJ gene for linkage to the myotonic 
dystrophy locus. The Ryrl locus was sub-localised on 1 9q 13.1 and mapped near the 
MD susceptibility locus in the following order: 19qcen-Ryr-D19S8-D19S16-
D1 9S3 7-APOC2-CKMM-MD-pE WRB 1-1 9qter (MacKenzie et al., 1990). Several 
recombinants between RYR1 and MD excluded RYRJ as the gene responsible for 
MD. The authors speculated that as the RYRJ region in humans shows homology to 
the region in pigs containing the HAL gene, RYR] could be a candidate for the 
malignant hyperthermia gene. 
Linkage studies were performed in MH families with DNA markers in the RYRJ 
gene. Susceptibility to MH was shown to co-segregate with the RYR1 markers with 
a lod score of 4.20 at a linkage distance of zero cM (MacLennan et al., 1990). 
Therefore, MacLannan et al. (1990) identified the ryanodine receptor as a strong 
candidate for malignant hyperthermia. 
MacLennan and his colleagues compared full length ryanodine receptor cDNA 
sequences from Canadian MR-susceptible Pietrain and MH negative (MHN) 
Yorkshire pigs and found 18 single nucleotide polymorphisms (Fujii et al., 1991). 
One of the polymorphisms, a replacement of C with T at nucleotide 1843, alters the 
amino acid sequence from Arg to Cys at position 615 (Arginine in MFIN and 
Cysteine in MHS). This substitution also destroys a recognition site for the HinPI 
restriction endonuclease and creates a HgiAI site (Fujii etal., 1991). 
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In humans, an equivalent to the pig Arg6 1 5Cys has been found in some MH patients. 
The mutation is know as the Arg 614 Cys mutation and results from a C  840T 
mutation (Gillard et al., 1991; Moroni et al., 1995). Other mutations in the human 
RYR] gene have been found in other MH pedigrees (Gillard et al., 1992; Zhang et 
al., 1993; Phillips et al., 1994; Quane et al., 1993; 1994a; 1994b; 1997; Keating et 
al., 1997; Lynch et al., 1997; Manning et al., 1998a; 1998b). The alteration 
(Cl 840T) of the sequence deletes an RsaI site, other mutations cause loss or gain of 
restriction sites in many cases (table 1.1). These mutations have been identified 
through comparative SSCP analysis of MH patients' cDNA with that of normal 
individuals, followed by sequence comparison. These mutations and restriction site 
changes are listed in the table 1.1. These mutations are used to diagnosis MR 
inheritance in the family pedigrees (Fagerlund et al., 1994; 1995; 1996; Beyer and 
Varsanyi, 1997; Monsieurs et al., 1998). 
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CTC TGC CTG 35 Cys 35 Cys CTC CGC CTG Cys—.Arg Acil gain 48/25+23 MR Lynch etal., 1997 GTC CGC GTT 163 Arg 163 Arg GTC TGC GTT Arg—Cys BstUI loss 32+44/76 CCD I MH Quane etal., 1993; 
Quane et al., 1994a 
ACA CTG TGG 198 Leu 197 Leu ACA CTA TGG None AIwNI loss 5 1+39/90 
Fagerlund et al., 1994 
Gillard etal., 1992 
37 common 
GAG GGG GGA 248 Gly 248 Gly GAG AGG GGA Gly—*Arg MspI loss 19+69/86 MH Gillard etal., 1992; 
TAC GGG GAG 341 Gly 341 Gly TAC AGG GAG Gly—Arg SSCP analysis MH 
Alestrom etal., 1995 
Quane etal., 1994a 
341 Gly 341 Gly Gly—+Arg MspI gain 86/19+67 MH Alestrom etal., 1995 TAT GCC GCT 359 Ala 359 Ala TAT GCT GCT None Acil loss 91+18/110 Gillard etal., 1992 ATG ATC CAC 403 Ile 403 Ile ATG ATG CAC Ile—*Met MboI loss 29+63/92 CCD / MR Quane et al., 1993 CTG CGC AAC 471 Arg 470 Arg CTG TGC AAC Arg—*Cys HinPI loss 154/110+44 Gillard etal., 1992 
60 common CTC TAT GAA 522 Tyr 522 Tyr CTC TCT GAA Tyr—.Ser None SSCP analysis MR Quane etal., 1994b GAT CGG CTG 552 Arg 552 Arg GAT TGG CTG Arg—.Trp Sau3A loss 26+211/237 MR Keating etal., 1997 GCC TCA TCT 556 Ser 555 Ser GCC TCG TCT None None Gillard etal., 1992 GTA CGC TCC 614 Arg 614 Arg GTA TGC TCC Arg—+Cys RsaI loss 33+41/74 CCD/MH Gillard etal., 1991; 
GTA CGC TCC 614 Arg 614 Arg GTA CGT TCC Arg—*Leu SSCP analysis MR 
Quane et al., 1994a 
Quane etal., 1997 TGC CCT GTG 762 Pro 762 Pro TGC CCC GTG None None Zhang et at., 1993 CAG ACA ACA 981 Thr 980 Thr CAG ACG ACA None None Gillard etal., 1992 CAC AAC GTG 993 Asn 993 Asn CAC AAT GTG None MaeIII and Zhang etal., 1993 
Afihil loss 






















ATC CGC TCG 2162 Arg 2163 Arg ATO TGC TOG Arg—.Cys SSCP analysis MH Manning etal., 1998b ATC CGC TCG 2162 Arg 2163 Arg ATC CAC TOG Arg—*His SSCP analysis MH Manning etal., 1998b ATC GTG CAG 2167 Val 2168 Val ATO ATG CAG Val—+Met SSCP analysis ME Manning et al., 1998b GAG ACG GTC 2205 Thr 2206 Thr GAG ATG GTC Thr—Met SSCP analysis MIT Manning etal., 1998b CCC GCC OTG 2366 Ala 2366 Ala CCC GOT CTG None Acil loss and Manning etal., 1998a 
Avail gain 
OTO GGA OGO 2433 Gly 2433 Gly OTC AGA OGC Gly—+Arg AIwNI gain 55/27+28 MH Keating et al., 1994 OTO GGA OGO 2433 Gly 2433 Gly OTC AGA CGC Gly --- *Arg Ddel I gain 298/268+35 MH Phillips etal., 1994 
2434 Gly 2434 Gly GIy—Arg AlwNI gain 128/28+100 MN Richter etal., 1997 GGA OGC TGT 2434 Arg 2434 Arg GGA CAC TGT Arg—*His HgaI loss 115+95 /210 CCD / MB Zhang etal., 1993 OTC OGO TOO 2457 Arg 2458 Arg OTO TGO TOO Arg—Cys Acil loss 28+14+12/40+14 MH Manning etal., 1998a CTO OGO TOO 2457 Arg 2458 Arg OTC CAC TOO Arg-4Nis SSCP analyis MN Manning etal., 1998a AAG GCG TOO 2499 Ala 2499 Ala AAG GOA TOO None Fold loss 33+27+50 / 33+77 Gillard etal., 1992 CGT GTG TAT 2508 Val 2507 Val OGT GTA TAT None None Gillard etal., 1992 OAG CAC OTG 2620 His 2620 His OAG CAT OTG None Gillard etal., 1992 TTG OGO OGO 2623 Arg 2623 Arg TTG OGT OGO None Hinpl loss 37+25/62 Gillard et al., 1992 COO AOG GGC 2658 Thr 2658 Thr 000 ACA GGO None BsaJI loss 46+86/136 Gil!ard etal., 1992 GOC ATT GCC 2705 Ile 2704 Ile GOC ATC GCC None Gillard etal., 1992 GTG GAT GOT 2729 Asp 2729 Asp GTG GAC GOT None Fold loss 38+106/149 Gillard etal., 1992 
91 common 
GGA GAG AAC 2778 Glu 2778 Glu GGA GAA AAO None Gillard etal., 1992 OTT AGT GOT 2862 Ser 2862 Ser OTT AGC GOT None HinPI gain 205/50+153 Gillard etal., 1992 GOC OCA GOT Pro 3061 3060 Pro None PvuII loss and Gillard etal., 1992 
MspI gain 
AAC OTO ACC Leu 3229 3229 Leu StyI gain 223/130+89 Gillard etal., 1992 
Table 1.1: 	RYR1 mutations identified in MHS and CCD families. The positions of amino acids residues are referred to by reference to the 
human RYR1 cDNA seqeuence EMBL accession no: J05200. 
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1.9.1 .4.Further linkage and mutation analyses 
As discussed above (see section 1.2.1.3), Fujii et al. (1991) found 18 nucleotide 
differences (nucleotide positions 276, 1843, 1878, 3942, 4332, 4365, 6538, 7563, 
7809, 8811, 9063, 9456, 9471, 9822, 9982, 11121, 12171, 13878) between the RYR1 
cDNA sequences for a Canadian Pietrain HAL and a Yorkshire HALNN pigs. Of 
these mutations or polymorphisms seventeen are silent mutations. Only one 
mutation, at nucleotide position 1843, causes a change in the sequence of the protein 
changing the amino acid at position 615 from Arginine to Cysteine. Harbitz et al. 
(1992) compared the cDNA sequence from a Norwegian Landrace HALNN pig to 
these previously published sequences. At five of the single nucleotide polymorphism 
(SNP) sites identified by Fujii et al. (1991) the Norwegian Landrace pig had the 
Yorkshire allele and at eleven of the SNP sites the Pietrain allele. For some regions 
of the cDNA Harbitz et al. (1992) sequenced two or more cDNA clones and 
identified seven single nucleotide polymorphisms two of which corresponded to 
nucleotide differences observed between the Pietrain and Yorkshire sequences of 
Fujii et al. (1991). In the Norwegian Landrace pig breed the CIT point mutation was 
reported for nucleotide 1840 (Harbitz et al., 1992). As noted earlier, the cDNA 
sequence reported by Harbitz et al. (1992) lacks the start codon. Therefore, 
nucleotide 1840 in this sequence (Harbitz et al., 1992; EMBL accession number: 
X62880) corresponds to nucleotide 1843 (as numbered from the start codon) in the 
sequence reported by Fujii et al. (1991) (EMBL accession number: M91452). Both 
Fujii et al. (1991) and Harbitz et al. (1992) agree that the polymorphic amino acid is 
residue 615. These observations support the hypothesis that the C1843T mutation in 
the RYR] gene is a causal mutation in porcine MH (Harbitz et al., 1992). However, 
one C to G sequence variation at nucleotide 6274 has been detected which 
potentially replaces Pro 2092  (German Landrace) with Ala (Norwegian Landrace) 
(Leeb etal., 1993). 
The C  843T point mutation alters the restriction endonuclease site pattern in the PSS 
animals. These mutations can be identified through RFLP (Fagerlund et al., 1992), 
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PCR-RFLP (Fujii et al., 1991; Gillard et al., 1992; Kuryl and Kossakowska, 1994), 
PCR-SSCP techniques (Nakajima et al., 1996; Keating et al., 1997) and, 
mutagenically separated PCR (MS-PCR) (Lockley et al., 1996) and ELISA tests 
(Truett et al., 1998). These techniques facilitate the unambiguous identification of 
all three HAL (or RYR]) genotypes-N/N, N/n, n/n. These methods are rapid, accurate 
and non-invasive, and eliminate the 5% diagnostic error associated with the 
halothane challenge test in pigs (Otsu et al., 1991). More recently, microassays for 
the functional of calcium release channels in skeletal muscle homogenates have been 
developed as a diagnostic test for susceptibility to MH in pigs (O'Brien and Li, 
1997). 
Other polymorphisms observed within the porcine RYR1 gene include a 
microsatellite (Bolt etal., 1993) and a GIC single nucleotide polymorphism in intron 
38 (Brenig and Leeb, 1996). The GIC transversion polymorphism in intron 38, at 
nucleotide position 18875, co-segregates with the C1843T point mutation in exon 17. 
In these families the GIG genotypes are MHS, GIC are heterozygous and the C/C are 
homozygous MT-iN (Brenig and Leeb, 1996). 
Linkage studies with the C1843T RYR1 point mutation and GPI and PGD markers in 
Canadian and British Landrace strains found that the 1843T allele co-segregated with 
HAL and supported the hypothesis that C1 843T is the causal mutation for porcine 
MH (Fujii et al., 1991; Otsu et al., 1991). This hypothesis has been confirmed in 
Hampshire, Duroc, Landrace, Yorkshire breeds (Houde et al., 1993) and native pig 
breeds (Bikovacka mangulica and Moravka) (Sarac et al., 1997). Linkage analyses 
with the RYRJ marker and the markers for the GPI, PGD, PGM, A1BG, P11, P12, 
HPX, TFloci (Houde etal., 1993; Sarac etal., 1997) confirm that RYR1 and HAL are 
both linked to GPI and PGD, thus providing some support for the identity of HAL 
and RYRI. RFLP studies on the MHS and normal pigs has showed the RFLP 
markers for the RYRJ gene (CRC 1/CRC3) are linked to the A1BG locus and confirm 
the assignment to chromosome 6 (Mariani etal., 1992). 
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Many different mutations have been observed in the human RYR] gene as 
summarised in Table 1.1. [A more up-to-date summary of the RYR] mutations and 
polymorphisms has been published since I submitted this thesis for examination 
(McCarthy etal., 2000).] Some of these mutations have been found to be associated 
with susceptibility to M}T and others have been found to be associated with a 
different genetic disease - Central Core Disease (CCD) (Quane et al., 1993). CCD 
can also be regarded as a myopathy. 
The frequency of the C  840T mutation in humans with the MHS phenotype has been 
estimated as 5 to 10% (Deufel et al., 1995). Together the Argl63Cys, Gly248Arg, 
Gly34lArg, Ile4O3Met, Tyr522Ser, Gly2433Arg, and Arg2434His account for 
approximately 10% of MHS cases in Caucasian populations (Quane et al., 1997). 
Fletcher et al. (1995) found that only of MH-positive subjects had the C1840T 
mutation and a further 1% the C487T mutation that is also associated with CCD. 
The absence of these mutations in the controls confirms the association with 
MH/CCD but also indicates that there may be other genetic causes of MH (Fletcher 
et al., 1995). The frequencies of these disease-associated mutations differ between 
populations. Less than 3% of the UK population have the C1 840T mutation 
associated with MH (Hall-Curran et al., 1993). About 1% of Swedish families with 
MHS have the G1021A mutation (Fagerlund et al., 1996). In contrast, in the North 
American population no G1O21A mutation has been observed (Stewart et al., 1998) 
and in addition this mutation does not co-segregate with MH and CCD in some 
British families (Adeokun etal., 1997). 
These mutations are thought to lead to an increased caffeine and halothane 
sensitivity in the individuals. The role of MH mutations in Ca 2+ regulation has been 
studied in COS-7 cells transfected with a rabbit Ryrl cDNA carrying a Cys for Arg 
at position 615, corresponding to position 614 in humans, (Treves et al., 1994), and 
also in human embryonic kidney (HEK-293) cells, transfected with rabbit Ryrl 
cDNAs each carrying a different mutation (n=15) (Tong etal., 1997). [3H]ryanodine 
binding affinity has been examined in human skeletal muscle specimens having 
G1y2434 to Arg mutation (Richter et al., 1997) and cells derived from MH-negative 
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and MH-susceptible patients carrying Arg 163 to Cys mutation (Censier et al., 1998). 
The results from these studies showed that the mutant receptors are more sensitive to 
low concentrations of caffeine and halothane than the wild type receptors. MH-
susceptible individuals exhibit a half-maximal halothane concentration causing an 
increase in intracellular Ca 2+ concentration, which is twofold lower than that of cells 
derived from MH-negative individuals. These results suggest that the RYRJ 
mutations are responsible for the abnormal regulation of Ca 2 observed in muscle of 
MHS individuals, especially when challenged with halothane or caffeine. 
As in vertebrates, functional defects associated with the Ryr gene have been 
observed in invertebrates. In C.elegans a single Ryr gene has been found in the unc-
68 locus (Sakube et al., 1997). unc-68 is required in body-wall muscle cells for 
normal motility and is also expressed in most muscle cells. A null mutation in the 
gene causes loss of function in the pharyngeal and body-wall muscle cells and a 
reduction in growth rate and brood size, defective pharyngeal pumping (feeding) and 
abnormal vacuoles in the terminal bulb of the pharynx (Maryon et al., 1998). 
1.9.1.5.Lack of RYRJ and MH linkage 
Although MHS and RYRJ mutations show linkage in pigs and many human families, 
MHS is not linked to RYR1 in all human MH pedigrees. Linkage studies in Swedish 
MH families (Fagerlund et al., 1992) and in three other unrelated families (Levitt et 
al., 1991) using RFLP-based markers have shown that markers from 19q12-13.3 do 
not co-segregate with MHS. Three recombinants or crossovers have also been 
observed in some Bavarian MH families between RYR] and the Mif locus (Deufel et 
al., 1992). In two MHS families chromosome 19 markers (D19S190 and D19S47 
immediately distal to RYR1) showed lod scores below -2 in a multi point analysis 
(lies et al., 1992). These studies suggest that MHS is clinically heterogeneous and 
that RYR] is not the only candidate gene with respect to MH in man. 
It has been proposed that there is a second locus for MH (MJ-1S2) on chromosome 
17q1 1.2-q24 (Levitt et al., 1992). lies et al. (1993) mapped the candidate genes 
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(CACNLBJ, CACNLG) encoding the human skeletal muscle L-type voltage-
dependent calcium channel (DHPR) 01 and y subunits respectively to this region of 
chromosome 17. But as they found no evidence of linkage to MH they excluded 
these genes as candidates for MHS2. However, there was no evidence to support the 
localization of MJ-1S2 on chromosome 17 in their families. Similarly, Sudbrak et al. 
(1993) excluded the genes encoding the muscle L-type voltage-dependent calcium 
channel (DHPR) al 01 and y  subunits (CACNLJA3 on chromosome lq, CACNLB1, 
CACNLG) and the sodium channel (SCN4A) gene as candidates for susceptibility to 
malignant hyperthermia. Again, in their families they found no evidence for an 
MHS2 locus on chromosome 17 (Sudbrak et al., 1993). Complete co-segregation of 
MHS with the marker D7S849 adjacent to the gene for the a2/6 sub unit of the 
DHPR receptor (CACNLA2) on chromosome 7q has been found in one MH pedigree 
(Iles et al., 1994). Linkage between MHS and chromosome 3q13.1 has been found 
in some European pedigrees (Sudbrak et al., 1995) and with the site of a candidate 
gene, DHPR receptor al-subunit (CACNLJA3) on chromosome lq with lod score of 
4.38 (Robinson et al., 1997; Monnier et al., 1997). A further MHS locus has been 
mapped to chromosome 5p (Robinson et al., 1997). Although the evidence from 
some MH pedigrees is inconclusive there appears to be more than one gene 
responsible for susceptibility to MR. More recently, it has been reported that the 
Ca 2+  release channel of skeletal muscle links with the II and III domains of the 
skeletal muscle L-type Ca 2+  channel DHPR. These DHPR II and III domains and the 
Ryr channel are involved in bi-directional coupling and calcium release in the 
skeletal muscle (Grabner et al., 1999). These findings may explain the reason for 
heterogeneity in the MH families. 
1.9.1 .6.Other traits associated with MIH or HAL or Ryrl 
In some families MH is also associated with Chronic myopathy and Central Core 
Disease (CCD) (Zhang et al., 1993; Quane et al., 1993). These diseases map to the 
same region of chromosome 19q12-13.2 (Deufel et al., 1992). Multipoint linkage 
analysis showed that the CCD locus maps to chromosome 1 9q 13.1, flanked on the 
proximal side by D19S191/D19S28 and distally by D19S47 (Schwemmle et al., 
1993). Recombination between MHS markers and CCD suggest that these are 
discrete loci (Fargerlund et al., 1996). 
The MHS genotype with respect to the point mutation at position 1843 of the RYRJ 
gene has some advantage in pig breeds. In Pietrain, the recessive HAL n  allele is 
associated with lean, heavily muscled pigs and low fat meat. Similar observations 
have been made in RYRJ mutation studies with respect to meat quality in six 
different breed groups (Rempel et al., 1995; Murrary and Johnson, 1998). In 
contrast, no significant effect of the C1 843T mutation was found on fatness and 
carcass composition (Garcia-Macias et al., 1996) or slaughter weight (Larzul et al., 
1997). 
The observed associations between HAL (RYRJ) genotypes and leanness could be 
caused by the RYR] disease mutation or by variation at another closely linked gene. 
For example, known linked genes include APOE (apolipoprotein E) and the 
transforming growth factor beta 1 gene (TGFBJ) gene which have effects on 
myogenesis and adipogenesis, and the hormone sensitive lipase (LIPE) gene which 
has an affect on body fat content as noted by Otsu et al. (1991). Studies on German 
Landrace and Pietrain breeds showed that MH genotypes influence secondary 
changes in lipid composition. The MRS animals had lower quantities of lipid, but 
the quantity was also influenced by breed and sex. In general, meat from females 
has more fat than meat from males (Hartmann et al., 1997). Dual-energy x-ray 
absorptiometry (DXA) analysis in different growth periods showed that for pigs at 
30, 60 and 90 kg, NN pigs have more fat and less lean than the nn pigs, while the Nn 
pigs were intermediate with respect to both fat and lean percentages (Mitchell and 
Scholz, 1997; Lahucky et al., 1997). The nn genotype shows a 6% increase in 
carcass lean weight (Larzul et al., 1997). Hence there are some advantages 
associated with the HAL locus and the MH point mutation in the calcium release 
channel gene may provide an advantage in lean meat production. 
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1.10. 	Genetic manipulation 
Reverse genetics involves altering the genotype of an individual and then observing 
the resulting phenotype. Altering the genotype of an individual is achieved by 
mutagenesis with varying degrees of precision. Chemicals or radiation can be used 
for mutagenesis in mammals. Since the 1980s DNA or gene transfer technology has 
been used for altering the genotypes in mice and other animals. The resulting 
animals are termed transgenic. 
Transgenic technology and reverse genetics has been used since the 1980's, to 
develop an understanding of gene regulation, tumour development, immunological 
specificity, molecular genetics of development and other biological processes of 
fundamental interest. Transgenic mice have also played a role in examinations of the 
feasibility of the industrial production of human therapeutic drugs by domesticated 
animals and in the creation of transgenic strains that act as biomedical models for 
various human genetic diseases. Transgenic mice can be created by a) retroviral 
vectors that infect the cells of an early stage embryo prior to implantation into a 
receptive female; or b) microinjection of DNA into the enlarged sperm nucleus (the 
male pronucleues) of a fertilised egg or c) introduction of genetically engineered 
embryonic stem (ES) cells into an early stage developing embryo prior to 
implantation into a receptive female. 
Retroviral vectors are an effective means of integrating a transgene into the genome 
of a recipient cell. However, they can only transfer about 8 kb of DNA, which, 
because of the size constraint, may lack essential adjacent sequences for regulating 
the expression of the transgene. There is a further major drawback of the use of 
retroviral vectors. Although these vectors are designed to be replication defective, 
the genome of the retroviral strain (helper virus) that is needed to create large 
quantities of the vector DNA can be integrated into the same nucleus as the 
transgene. Despite special precautions, helper strain retroviruses could be produced 
by the transgenic organism. Consequently, for applications in which either a 
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commercial product is to be synthesised by the transgenic organism or the transgenic 
organism is to be used as food, it is absolutely necessary that there be no retroviral 
contamination. 
1.10.1. Microinjection 
In mammals, after entry of the sperm into the egg, the sperm nucleus (male 
pronucleus) and female nucleus exist separately till nuclear fusion. As the male 
pronucleus tends to be larger than the female pronucleus it is generally the target into 
which DNA is microinjected. After inoculation, eggs are implanted microsurgically 
into a foster mother, who has been made pseudopregnant by being mated to a 
vasectomized male. The foster mother will deliver pups derived from the inoculated 
eggs. The transgenic animal can be identified through Southern blot hybridisation or 
by PCR assay. A transgenic mouse can be mated to another mouse to determine if 
the transgene is in the germ line of the founder animal. At best, about 5% of 
inoculated eggs develop into live transgenic animals (Watson etal., 1987). 
The DNA injected into a mouse zygote male pronucleus frequently concatamerizes 
into multicopy (head-to-tail, head-to-head or tail-to-tail) blocks prior to integration. 
Furthermore, with the microinjection method, the integration site of the DNA is 
random. The insertion site can strongly influence the expression of the integrated 
DNA (Bronson et al., 1996). In some individuals, the transgene may not be 
expressed because of the site of integration, and in others the copy number may lead 
to over- or under expression. Such abnormal levels of gene expression may disrupt 
the normal physiology of the animal and not all of the transgenic pups will have the 
appropriate characteristics (Bradley and Liu, 1996). Normally, only gain of function 
mutations are feasible and the endogenous gene expression cannot be manipulated, 
although it is possible to make dominant negative modifications of multimeric 
proteins (Herskowitz, 1987). An antisense RNA approach, in which the transcription 
of the transgene generates antisense RNA, has been used successfully in a few cases 
to inhibit expression of the corresponding endogenous gene (Katsuki etal., 1988). 
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1.10.2. Gene targeting 
Gene targeting describes the process of precise alteration of the genome through 
homologous recombination between genomic DNA sequences and the introduced 
DNA fragments. With this system, it is possible to introduce a functional gene at a 
specific site within a gene(s) (Stacey et al., 1994; Abuin and Bradley, 1996) and its 
also possible to generate a loss of function (knock-out) allele of the gene of interest 
(Takeshima et al., 1996). As such homologous recombination events are extremely 
rare it is necessary to perform the gene targeting step in cells that can be grown in 
vitro. Specialised cells that retain the ability to develop into a wide range of tissues 
need to be used for gene targeting so that the manipulated cells can contribute to a 
developing transgenic animal. Embryo-stem (ES) cells represent the necessary 
specialised pluripotent cell type. Following gene targeting in vitro, the genetically 
engineered cells can be selected and multiplied in cell culture. The homologous 
recombinants can be identified by hybridisation (Southern blot) or PCR analysis of 
DNA isolated from the ES cells that survive the selection regime (Picard, 1994; Lay 
et al., 1998). 
Totipotent ES cells retain the capability of differentiation into all other cell types, 
including germ line cells. The manipulated ES cells are introduced into blastocysts 
and can contribute to the formation of chimaeric animals. In some cases the 
transgene fails to transmit through the germline. The failure of germline 
transmission may due to aneuploidy, rather than loss of totipotency, in ES cells 
(Longo et al., 1997). With gene targeting and homologous recombination the 
randomness of integration that is inherent with the DNA microinjection and 
retroviral vector systems is avoided. Gene targeting has also been used to modify the 
genomes of plants (Ow and Medberry, 1995; Thykjaer et al., 1997), insects (Yamao 
etal., 1999) and protozoans (Papadopoulou and Dumas, 1997). 
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1.10.2.1 Embryonic stem cells 
The limitations of microinj ection technology have been overcome for research in the 
mouse by the availability of mouse embryonic stem (ES) cells. Such ES cells have 
not been isolated for other species. ES cells are derived from the blastocyst stage of 
the developing mouse embryo (Evans and Kaufman, 1981; Martin, 1981). In in vitro 
culture, ES cells can be propagated and genetically engineered without altering their 
pluripotency. Most mouse strains are not permissive for ES cell isolation. Indeed, 
almost all ES cell lines currently in use have been obtained from the 129 mouse 
strain and from a very few other inbred mouse strains such as C57BL16 and BALB/c. 
In exceptional cases ES cells have been developed from mouse strains previously 
considered to be non-permissive for ES cell isolation e.g. CBA/Ca. It has been 
suggested that genetic background strongly influences the efficiency of developing 
ES cell lines from other species (McWhir et al., 1996; Brook and Gardner, 1997; 
Muller, 1999). 
Hypoxanthine phosphoribosyl transferase (HPRT) deficient ES cell lines E14TG2a 
(Hooper et al., 1987), HM-1 (Magin et al., 1992) and E14.1TG3B1 (Tsuda et al., 
1997) derived from 129 mice have advantages over wild type ES cell lines for gene 
targeting experiments. In the mouse the X-chromosome-linked HPRT gene, which is 
33 kb long and contains nine exons (Melton et al., 1984), encodes the enzyme 
hypoxanthine phosphoribosyl transferase that is involved in the purine salvage 
pathway (Selfridge etal., 1992). HPRT catalyses the addition of purines to the sugar 
intermediate glutamine phosphoribosylpyrophosphate (PRPP) in wild-type cells. 
Either in the absence of purine in the medium or when HPRT is not functional, the 
cells are forced to use the alternative de novo purine synthesis pathway. This purine 
synthesis pathway can be used as the basis of selection both for and against HPRT 
expression in cultured cells. In mouse the HPRT gene is non-essential in normal 
culture media and in the whole animal. In contrast, in humans HPRT deficiency 
causes the neurological disorder Lesch Nyhan syndrome (Ansell et al., 1991; 
Selfridge et al., 1992). In HAT medium, aminopterin inhibits the enzyme 
dihydrofolate reductase, which blocks purine ribonucleotide biosynthesis in HPRT- 
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defective cells and thus kills the cells. On the other hand, loss of HPRT activity 
confers resistance to a toxic purine analogue 6-thioguanine (6-TG). Thus, in male 
ES cells only a single copy of the gene needs to be inactivated in order to generate a 
selectable phenotype. 
The HPRT-deficient male ES cell line HM-1, has been shown to yield a very high 
degree of germ line contribution, characteristic of early passage ES cells, with a gene 
targeting frequency characteristic of a more established line which is losing its 
ability for germ line contribution. In addition to conventional marker genes used in 
established ES cell lines, the HM-1 line permits the use of an HPRT mini-gene 
(Selfridge et al., 1992; Magin et al., 1992) selectable marker. More importantly, as 
HPRT can be selected for and against, two-step gene targeting procedures can be 
carried out in HM-1 cells using the HPRT mini-gene as the sole selectable marker 
(Magin et al., 1992; Selfridge et al., 1992). One potential disadvantage of using the 
HPRT gene as the selectable marker for gene targeting is that the HPRT mini-gene 
has been shown to be expressed at different levels in different target loci. This study 
suggests that the expression of the introduced marker gene could be affected by gene 
methylation (Melton etal., 1997). 
1.10.2.2 Genetic recombination 
Foreign DNA can be introduced into the ES cells by calcium phosphate/DNA 
precipitation, microinjection, protoplast fusion, lipofection, viral vectors (Russell and 
Hirata, 1998; Tsuzuki and Rancourt, 1998; Yamano et al., 1999) and electroporation. 
Electroporation is the most commonly used technique for introducing DNA into ES 
cells. Although it is not particularly efficient and requires some apparatus, the 
procedure is simple, fast and useful for most cell lines. The technique involves the 
exposure of cells to a pulsed electric field. This shock presumably creates pores in 
the cell membrane, thus allowing dissolved DNA to be taken up by the cells. 
In eukaryotic organisms, homologous recombination takes place during meiosis, 
mitotic cell growth and DNA repair. Homologous recombination can occur between 
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any pair of homologous DNA sequences. In general, this mechanism is responsible 
for the introduction of foreign DNA fragments into the mammalian genome by gene 
targeting. 
Many vectors have been developed for the cloning of large segments of mammalian 
DNA, i.e., cosmids, bacteriophage P1, PACs, BACs (Yang et al., 1997) and YACs 
(Peterson, 1997; Peterson et al., 1997). Large nucleic acid fragments can be also be 
created by long-range PCR methods (Randolph et al., 1996) or manipulated as 
double stranded RNA (Montgomery et al., 1998) or RNA/DNA chimeric 
oligonuclotides (Lai and Lien, 1999). Targeting constructs carry a segment of DNA 
homologous to the target site, including, where desired, a genetic alteration to be 
introduced into the genome. Two different configurations of vectors have been used 
to target the locus of interest namely; insertion and replacement vectors (figure 1.2). 
Insertion vectors are linearised through a double-stand break within the region of 
homology. A single crossover event resulting in the insertion of the entire construct 
into the target locus leads to duplication of the region of homology. Replacement 
vectors are co-linear with the endogenous target gene and require the equivalent of a 
double crossover event between the vector and target for the desired change to be 
incorporated into the genome (Capecchi, 1989; Mansour, 1990b). 
Although the introduced foreign DNA vector is designed to integrate within a 
specific chromosomal location in the ES cell genome, some cells will have DNA 
integrated at non-target sites (random integration); in other cells, integration will 
occur at the target site (homologous integration). Moreover, in most of the ES cells, 
the input DNA will not be integrated at all. Absolute (targeting) frequency is the 
ratio between the number of homologous (targeted) recombinants and the total 
number of cells exposed to the transfection procedure. Effective targeting frequency 
can be defined as the proportion of homologous recombinants in the total number of 
transformed cells (homologous and random integrants). Finally, the enriched 
frequency is expressed as the ratio between true homologous recombinants and total 
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Figure 1.2: Gene targeting in the murine HPRT locus. Disruption of HPRT by 
gene targeting with (A) a sequence replacement targeting vector or (B) a sequence 
insertion targeting vector. Vectors of both classes contain HPRT sequences 
interrupted in the eighth exon with the neomycin gene (Capecehi, 1989). 
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Several factors, such as, degree of sequence variation between the vector and the 
chromosome (Hasty et al., 1991a; Riele et al., 1992), the length of the homologous 
DNA sequence region (Hasty et al., 1991b; Zhang et al., 1994), ES cell cycle rates 
(Udy et al., 1997) affect gene targeting frequency. As a result considerable variation 
has been observed between the success of different gene targeting experiments. In 
addition, genetic variation in 129 inbred strains (Simpson et al., 1997) and mixed 
genetic background with SvJ strains (Threadgill et al., 1997) can also have a 
negative impact on gene targeting. 
To enrich for the cells with DNA integrated at the target site, a procedure called 
positive-negative selection can be used. This strategy uses positive selection for 
cells that have vector DNA integrated anywhere in their genome and negative 
selection against the vector DNA sequence that is integrated at non target sites. In 
the targeting vector the positive selectable marker, such as the neomycin-resistance 
gene (neo) (Gondo et al., 1994; Hone et al., 1995; Skryabin and Schmauss, 1997) or 
HPRT mini-gene (Stacey et al., 1994) expression cassettes, are placed within the 
region of homology with the target locus. The negative selectable marker, such as 
the simplex virus thymidine kinease (HSV-tk) gene, is placed outside the region of 
homology or in the vector back bone (see figures 2.6A and 5.1). When homologous 
recombination occurs between the regions of homology in the targeting construct and 
the target locus the positive selectable marker is introduced to the target locus and 
the negative selectable marker is excluded. In addition promoterless and 
polyadenylation trap strategies have also been used to enrich for homologous 
integration. The expression of Green fluorescent protein (GFP) in targeted cells can 
also be used to identify homologous recombinants (Li et al., 1998) 
In positive selection, for example, the drug G418 is used for the gene targeting 
construct having neomycin resistance for homologous recombination and those cells 
in which random integration has occurred will retain the HSV-tk gene and thus, will 
be specifically eliminated by negative selection with the antiviral agent gancyclovir 
(GANC) (Tzimagiorgis et al., 1996) 
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The promoterless strategy uses vectors in which the positively selectable marker 
lacks its own promoter, but its expression is activated from the target gene promoter 
following homologous integration. Vectors of this type are therefore restricted to 
genes that are transcriptionally active in the target cells. The positively selectable 
cassette is usually cloned in frame with the endogenous translated product, creating a 
fusion gene. 
Polyadenylation trap targeting vectors are designed to use the transcription 
terminationlpolyadenylation signals of the target gene to generate a stable hybrid 
transcript, consisting of elements from both the target gene and the positive selection 
cassette. This type of positive selection should work for most genes, irrespective of 
their level of expression in the transfected cells. 
For example, to study the biological role of ryanodine receptor genes in Ca 2+  
signalling, mice lacking Ryrl (Takeshima etal., 1994a; Moore etal., 1998) and Ryr3 
(Takeshima et al., 1996) have been developed by gene knock-out. The Ryrl gene 
has been knocked-out in exon 2 (Takeshima et al., 1994a) and exon 10 (Moore etal., 
1998) using the neomycin marker gene at the site of homology. The Ryr3 gene has 
been knocked-out in Ji ES cells using a homologous replacement vector, which 
replaces the endogenous Ryr3 promotor and exon 1 with the neomycin resistance 
gene (Takeshima et al., 1996). 
Although the above strategies are capable of creating transgenic mice with a 
disrupted or knocked-out gene allowing the gene function to be studied, sometimes it 
is necessary to introduce multiple, distinct and precise mutations into the locus of 
interest. Several methods, such as a tag-and-exchange (Askew et al., 1993) or 
double-replacement (Stacey etal., 1994; Wu et al., 1994), plug and socket (Detloffet 
al., 1994), Hit and run vectors (Hasty et al., 1991c) or in and out (Valancius and 
Smithies, 1991; Toth et al., 1996), replacement and excision (Hone et al., 1995) 
have been reported to be useful to introduce subtle mutations into mouse genes (see 
review by Muller, 1999). 
In addition, conditional gene targeting approaches based on the Cre/loxp system have 
a major advantage for modification of tissue specific gene expression in mice (Orban 
et al., 1992; Araki et al., 1995; Kolb et al., 1999). Cre-mediated DNA 
recombination has been demonstrated in the zygote stage using loxP—neo--loxP 
cassette (Lakso etal., 1996) 
As a result of homologous recombination, several hundred mutants (Brandon et al., 
1995a; 1995b; 1995c) have been generated. Details of some of these transgenic mice 
are also recorded on the Internet (Sikorski and Peters, 1997; http://tbase.jax.org ). 
Most of these targeting experiments have been designed to inactivate genes (knock-
out), thus enabling the study of their function and regulation, creating animal models 
for human genetic diseases (reviewed by Melton, 1990; Searle etal., 1994; Erickson, 
1996; Porter and Dallman, 1997; Anagnostopoulos, 1999), to analyse the function of 
housekeeping and developmental genes (Melton, 1994), to study gene regulation, to 
manipulate the expression of genes by targeting changes to their control sequences 
(Shastry, 1998) and to ensure both the repeatability and pattern of transgene 
expression by directing transgenes to chosen sites in the genome (Stacey et al., 
1994). The ability to correct mutant genes offers enormous possibilities in medical 
research as an alternative to current methods of gene therapy (reviewed by Yanez 
and Porter, 1998; Lai and Lien, 1999) and transplantation (Mannon and Coffman, 
1999). Application of this technology in livestock species to increase output or 
produce therapeutic proteins would undoubtedly be of commercial value. To date, 
the use of gene targeting to create modified animals has been limited to the mouse, 
since this is the only species from which ES-like cells have shown the ability to 
contribute to the germ line. However, combined progress in enhancing targeting 
efficiency in somatic cells and the new nuclear transfer technologies (Wilmut et al., 
1997; Schnieke et al., 1997) should allow the generation of targeted animals from 
other species in the medium term. 
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1.11 Present study 
1.11.1 Aim and objectives 
The aims of my project are to characterise the mouse ryanodine receptor gene and to 
manipulate the gene in order to examine the phenotypes associated with specific 
mutations. A mouse model, in which the Ryrl gene was disrupted in the malignant 
hyperthermia target exon by the insertion of an HPRT mini-gene, was available from 
previous studies. The specific project objectives are: 
to characterise the mouse skeletal muscle ryanodine receptor (Ryrl) gene 
to develop a mouse model, which carries a homologue of the C1 843T mutation, 
associated with MH in pigs and some human forms of MH. 
to evaluate the phenotype of the Ryrl knock-out transgenic mice. 
1.11.2 Experimental approach 
1.11.2.1 Characterising the murine Ryrl gene 
The mouse Ryrl gene could be characterised by cloning and analysis of the cDNA 
and building a contig map of genomic clones covering the entire murine Ryrl locus. 
1.11.2.1.1 cDNA cloning 
The skeletal muscle ryanodine receptor cDNA has been reported to be approx 15 to 
16 kb in vertebrates. The Ryrl gene had previously been cloned from a skeletal 
muscle cDNA library using specific and random primed reverse transcription, and 
screened with heterologous probes or poly- and monoclonal antibodies (Leberer et 
al., 1989; Takeshima et al., 1989; Zorzato et al., 1990) (see chapter 1.2.1). These 
approaches are laborious and time-consuming. As an alternative, RT-PCR is more 
sensitive and versatile, it can be used to determine the presence or absence of a 
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specific transcript, to estimate expression levels and to clone cDNA products without 
constructing and screening a cDNA library. 
The primary requirements for this technique were, murine Ryrl specific primers, 
suitable enzyme system to amplify the cDNA fragments from skeletal muscle total 
mRNA and a vector system to clone the amplified products. 
1.11.2.1.2 Isolation ofgenomic clones 
Bacteriophage ?. and cosmid vector systems are commonly in use to clone large 
DNA fragments for eukaryotic physical mapping and chromosome walking. These 
libraries have cloning capacities of up to 24 kb and 45 kb respectively (Cai et al., 
1995). Yeast artificial chromosome (YAC) vectors and Bacterial Artificial 
Chromosome (BAC) vectors are in use for chromosome mapping. 
Although YACs are capable of carrying more than one megabase of insert DNA and 
are used for large-scale physical mapping of genes (Rouquier et al., 1993), the 
cloned inserts are often chimeric. Moreover, isolation of pure insert DNA can be 
difficult. 
BAC libraries are based on the Eschericha co/i single-copy plasmid F factor and are 
capable of carrying insert DNA fragments of more than 300kb in size. BAC clones 
are generally nonchimeric and the insert DNA can be isolated by a standard 
procedure used for plasmid and cosmid DNA purification (Woo et al., 1994). 
Overlapping BACs are excellent tools for chromosome walking, and for the 
generation of contigs used in physical mapping (Rouquier et al., 1994). 
All cloning systems mentioned above had been used to isolate Ryrl genomic clones 
from pig and human. The contig maps showed that the genomic locus is about 200 
kb. If the mouse Ryrl locus were as compact as human and pig Ryrl locus, it would 




1. 11.2.2 Manipulation of the Ryrl locus 
The evidence that the 'halothane' mutation (C1843T) in the pig RYR1 gene causes 
susceptibility to malignant hyperthermia and reduced levels of body fat is derived 
from association studies and segregation analyses. In order to prove that the mutant 
is causal in the disease and/or with respect to reduced levels of body fat, it is 
necessary to carry out experiments to create the mutant de novo and monitor the 
consequences i.e. a reverse genetics approach. At present such experiments are not 
possible in pigs. As an alternative, creating a homologous point mutation in the 
mouse Ryrl model would allow the impact of this mutation to be studied 
experimentally. 
Murine embryonic stem (ES) cells retain their pluripotency in in vitro cell culture. 
When they are reintroduced into a host embryo, they can develop normally and 
contribute to all tissues in the resulting chimeric animal, including, most importantly, 
the germ line. My project was designed to use this resource to create specific 
mutations and study their effects in whole animals. 
By integration of a selectable marker into the gene of interest a null, knock-out or 
loss of function mutation may be created. The selectable marker can be inserted 
using either an insertion or replacement vector. The creation of a specific mutation 
in the endogenous gene will require either a single or double replacement strategy. 
Gene replacement is potentially a very powerful technique to generate animal models 
of human genetic diseases (see review Melton, 1990). It is useful to study regulation 
of gene expression, protein structure and function (Stacey et al., 1994). 
Introducing point mutations using double replacement is based on tag selection 
cassettes for which both positive and negative selection can be applied in ES cells, 
such as HPRT. Homologous integration of this cassette into the target locus is 
positively selected (tag step). In a second round of gene targeting (exchange step), a 
precise alteration (point mutation) is introduced into the tagged locus, resulting in 
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displacement of HPRT. The advantages of the two-step double targeting strategy 
are: ability to replace the target gene with any of the sequences constructed in the 
replacement vector; including subtle mutations, deletions, insertions, human 
homologues, or totally non-homologous fragments at the replacement step. This 
double replacement strategy has been used to replace the mouse a-lactalbumin gene 
with its human homologue (Stacey et al., 1994) and p53 gene with the lacZ gene 
(Gondo et al., 1994). This double replacement approach is illustrated in figures 5.1 
and 5.2. 
The biological role of ryanodine receptor genes in Ca 2+  signalling has been studied 
extensively in mice in which the Ryrl (Takeshima et al., 1994a; Moore et al., 1998) 
or Ryr3 genes (Takeshima et al., 1996) have been disrupted by a knock-out 
approach. The Ryrl gene has been knocked- out in exon 1 (Takeshima et al., 1994a) 
and exon 10 (Moore et al., 1998) and the Ryr3 gene has been disrupted by 
replacement of the endogenous Ryr3 promotor and exon 1 (Takeshima et al., 1996) 
with a neomycin marker gene. The RYRJ mutations implicated in susceptibility to 
MH (pigs and humans) or CCD (humans) are subtle point mutations rather than 
major disruptions or deletions. Therefore, mice, in which the Ryrl gene has been 
knocked-out, are unlikely to be useful models for studies of MH or CCD. One of the 
aims of my research project was to develop mice carrying specific point mutations in 
the Ryrl gene as models for MH. In order to produce such mice it would be 
necessary to replace the tag step (HPRT mini-gene inserted in to Ryrl) from an 
earlier project with the C1843T mutation associated with pig MH. As a long term 
aim, the information obtained from the present study and the clones isolated can be 
used to manipulate the Ryrl locus. 
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Chapter 2 
2. Materials and methods 
2.1. Bacterial culture 
2.1.1. Bacterial culture for plasm id isolation 
Bacterial colonies were cultured overnight in 10 ml Luria-Bertani (LB) medium (5 g 
NaCl; 10 g Bacto tryptone; 5 g yeast extract per 1000 ml) with required antibiotic 
(table 2.1) and used for mini-preparations of plasmid DNA. For maxi-preparations 
of plasmid DNA, 0.25 ml of overnight grown pre-culture was inoculated into 250 ml 
of LB medium with antibiotic. The bacterial cells were cultured overnight at 37 °C 









pUC18 2.6 Ampicillin 100 
pBluescript II (SK) 2.9 Ampicillin 100 
pGEM - T 3.0 Ampicillin 100 
pPoly III 2.1 Ampicillin 100 
pBR322 4.3 Tetracycline 50 
pBeIoBAC 11 7.4 Chloramphenicol 12.5 
pPAC4 19.5 Kanamycin 25 
Table 2.1: 	Plasmid vectors used for DNA fragment cloning and DNA 
proliferation 
2.1.2. Preparation of agar plates 
Sterile LB bottom agar (10 g tryptone; 5 g yeast extract; 5 g NaCl; 15 g bacto agar 
per 1000 ml) was cooled to 40-45 °C, mixed with the required antibiotic, X-gal and 
IPTG and poured into sterile petri dishes of the appropriate size and left at room 
temperature for a few minutes to set. Once the agar had set the plates were placed in 
a 37 °C oven (Jouan), upside down, with the lids half off, for about 60 min to allow 
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excess moisture to evaporate. Plates were stored at 4 °C up to 2 weeks until 
required or used immediately (X-gal, IPTG mixed plates were used to select 
recombinant bacteria through blue/white screening). 
2.2. Plasmid DNA isolation 
2.2.1. Mini-preparation ofplasmid DNA 
	
2.2.1.1. 	Using the alkaline lysis method 
The alkaline lysis method (Sambrook et al., 1989) was used for small-scale isolation 
of plasmid DNA. The 1.5 ml overnight culture was centrifuged at 10,000 x g for 1 
mm (Biofuge primo rotor pp  3/97 #7594 at room temparature/20 °C unless 
mentioned otherwise) and the supernatant was removed. The cell pellet was 
resuspended in 100 pd of resuspension buffer (50 mM Tris-HC1, pH 7.5; 10 mm 
EDTA; 100 p.g/ml RNAase A) followed by 200 JLil of fresh lysis buffer (0.2 M 
NaOH; 0.1% SDS), mixed and incubated on ice for 10 mm. Then, 150 .tl of chilled 
3.0 M potassium acetate (600 ml 5 M potassium acetate; 115 ml glacial acetic acid; 
285 ml distilled water made up to 1000 ml) was added, the tube vortexed and 
incubated on ice for 10 mm, after which it was centrifuged at 10,000 x g for 10 mm. 
The supernatant was transferred into a new tube, 1.0 ml of ethanol was added and the 
tube was inverted several times (to precipitate the plasmid DNA) and then 
centrifuged for 15 min at 10,000 x g. The DNA pellet was washed with 70% ethanol, 
air-dried and dissolved in 50 j.il of TE buffer (10 mM Tris-HC1, pH 8.0; 1.0 mM 
EDTA). 
2.2.1.2. 	Using the WizardTM mini-preps DNA purification 
system 
The WizardTM mini-preps DNA purification system (Promega) was used to isolate 
plasmid DNA for sequencing. The overnight culture (1.5 ml) was centrifuged at 
10,000 x g for 1.0 min and the supernatant was removed. The cell pellet was 
resuspended in 100 .tl of resuspension buffer (50 mM Tris-HC1, pH 7.5; 10 mM 
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EDTA; 100 p.g/ml RNAase A). The cells were lysed by the addition of 100 pJ of cell 
lysis buffer (0.2 M NaOH; 0.1% SDS), mixed and incubated on ice for 10 mm. 
Then, 100 p1 of chilled neutralisation solution (1.32 M potassium acetate, pH 4.8) 
was added, the tube vortexed and incubated on ice to precipitate the proteins and 
chromosomal DNA. After 10 min the tube was centrifuged (10,000 x g for 10 mm). 
The supernatant was transferred into a new tube, mixed with 1.0 ml of Wi zardTM 
mini-prep DNA purification resin and poured into a 3 ml syringe fitted on a 
WizardTM mini-column. The solution was gently passed through the column under 
vacuum and the column was washed with 2 ml of column wash buffer (200 mM 
NaCl; 20 mM Tris-HC1, pH 7.5; 5 mM EDTA; 55% ethanol) to remove all 
contaminants. The syringe was removed and the column was placed on a 1.5 ml 
microfuge tube and centrifuged at 10,000 x g for 1 min to remove traces of wash 
solution. The column was transferred to a new microfuge tube; 60 j.tl of autoclaved 
distilled water was added and kept at room temperature for 5-10 min to dissolve the 
plasmid DNA. The plasmid DNA was eluted by centrifugation (10,000 x g for 1 
mm) and stored at —20 T. 
2.2.2. Maxi-preparation ofplasmid DNA 
Large scale preparation of plasmid DNA was carried out using a Qiagen plasmid 
maxi kit. Qiagen plasmid purification protocols are based on a modified alkaline 
lysis procedure, followed by binding of plasmid DNA to Qiagen anion exchange 
resin under appropriate low salt and pH conditions. RNA, proteins, dyes and low 
molecular weight impurities are removed by a medium salt wash. Plasmid DNA is 
eluted in a high salt buffer concentrated and desalted by isopropanol precipitation. 
Bacterial cells from the clone of interest, grown in 250 ml LB medium with required 
antibiotic were harvested by centrifugation at 6,000 x g for 15 min at 4 °C (Sorvall 
F16/250) and the pellet washed in STE (0.1 M Tris-HC1, pH 8.0; 1.0 mM EDTA; 0.1 
M NaCl). The cells were resuspended in 25 ml of resuspension buffer, P1 (50 mM 
Tris-HC1, pH 8.0; 10 mM EDTA; 100 .ig/ml RNAase A), and incubated for 10 min at 
room temperature. 50 ml of lysis buffer, P2 (200 mM NaOH; 1.0% SDS) was added 
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and mixed gently to lyse the cells. After 10 min incubation at room temperature, 35 
ml of pre-cooled buffer, P3 (3.0 M potassium acetate, pH 5.5) was added and 
incubated on ice for 30 mm. The clear lysate was separated by centrifugation 
(20,000 x g for 30 min at 4 °C) and the supernatant was collected in a fresh tube. 
A QIAGEN tip-500 column was pre-washed and equilibrated with 10 ml of QBI 
buffer (750 mM NaCl; 50 mM MOPS, pH 7.0; 15% Triton X-100) before adding the 
supernatant to the column. After filtration of the supernatant the column was washed 
twice with 30 ml of buffer QC (1.0 M NaCl; 50 mM MOPS, pH 7.0; 15% ethanol). 
The plasmid DNA was eluted with 12 ml of elution buffer, QF (1.25 MNaC1; 50 m 
Tris-HC1, pH 8.5; 15% ethanol). The plasmid DNA elutate was precipitated with 0.7 
volume of isopropanol and pelleted by centrifugation (15,000 x g for 30 min at 4 °C) 
(Sorvall SS-34). The pellet was washed with 70% alcohol, air-dried and dissolved in 
1.0 ml of TE and stored at —20 °C. The concentration of the DNA samples was 
quantified by taking into account, that on absorbance of 1 at 260 nm corresponds to 
50 tg /ml DNA. 
2.3. Genomic DNA isolation 
High molecular weight genomic DNA was isolated from the mouse (Mus musculus, 
129sv strain) tail, liver tissue and Embryonic Stem (ES) cells. 
2.3.1. From mouse tissues (tail and liver) 
2.3.1.1. 	Sample preparation 
Tail biopsies (approximately 1-2 cm) taken from five week old mice were incubated 
overnight at 37 °C in 0.75 ml tail lysis buffer (10 mM Tris-HC1, pH 7.9; 1.0 mM 
EDTA, pH 8.0; 0.3 M Sodium acetate; 0.1% SDS; 200 mg/ml Proteinase K). The 
small animal unit provided the digested tail samples. The tissue residue and the hairs 
were removed by centrifugation (6,000 x g for 5 mm) and the clear lysate (0.5 ml) 
was used for DNA extraction. 
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A method modified from Laird et al. (1991) was used to isolate DNA from liver 
tissue. Freshly dissected liver tissue (1.0 g) was homogenised in 10 ml of tissue lysis 
buffer (100 mM Tris-HC1, pH 8.5; 5.0 mM EDTA; 0.2% SDS; 200 mM NaCl; 200 
mg/ml proteinase K) on ice and then incubated overnight in a shaking incubator at 55 
T. The undigested tissue residues were removed by centrifugation (6,000 x g for 5 
mm) and the clear lysate (7.0 ml) was used for DNA extraction. 
2.3.1.2. 	DNA extraction 
The cell lysates from proteinase K digested tail or liver tissue was mixed with equal 
volumes of phenol: chloroform: i soamyl alcohol (25:24:1) and centrifuged (15,000 x g 
for 10 mm). The aqueous phase was transferred into a fresh tube, mixed with an 
equal volume of chloroform:isoamyl alcohol (24:1) and centrifuged (15,000 x g for 
10 mm). To the aqueous phase, one-tenth volume of 3.0 M sodium acetate and 
double the volume of chilled ethanol was added and mixed gently. The precipitated 
DNA was hooked out with a sterile loop and washed with 70% (v/v) ethanol, air-
dried, dissolved in TE and stored at 4 T. 
2.3.2. From Embryonic Stem (ES) cells 
A Puregene DNA isolation kit (Gentra Systems, Inc.) was used to isolate genomic 
DNA from ES cells. Confluent stage ES cells in 25 cm  flasks were washed twice 
with phosphate buffered saline (PBS) to remove dead cells. 3.0 ml of cell lysis 
solution (Tris; EDTA; SDS) was added, swirled in a shaker to cover the plate and 
lyse the cultured cells that adhered to the culture plate/flask. To the lysate, 3 .tl of 
100 tg/ml RNAase A solution was added, mixed and incubated at 37 °C for 60 mm. 
One ml protein precipitation solution (ammonium acetate) was added, mixed well to 
precipitate the proteins, and then centrifuged (15,000 x g for 10 mm). The 
supernatant was transferred into a fresh tube and 3.0 ml of isopropanol was added, 
mixed gently by inverting the tube to precipitate DNA, and centrifuged (15,000 x g 
for 10 mm). The DNA pellet was washed twice with 70% (v/v) ethanol, air-dried, 
dissolved in TB and stored at 4 T. 
2.4. DNA analysis 
2,4.1. Restriction digestion 
The restriction enzymes used in this study were purchased either from New England 
Biolabs (NEB) or Boehringer Mannheim unless mentioned otherwise. Genomic and 
plasmid DNAs were digested according to the manufacturers' instructions except that 
4-6 fold excess enzyme was used in each digestion. Digestions were carried out at a 
final concentration of 0.1 to 0.5 j.tg/pi DNA with not more than 10% (v/v) enzyme in 
the solution. After the required incubation time at the optimal digestion temperature, 
10 mM EDTA was added to stop endonuclease activity, and the enzyme was then 
heat inactivated at 65 °C for 15 mm. 
2.4.2. Electrophoresis 
The digested or undigested DNA samples or PCR products were diluted in 6 x 
loading buffer (0.25% bromophenol blue; 0.25% xylene cyanol; 30% glycerol) to 
give a final concentration of 1 x buffer to load on an agarose gel, to separate, identify 
and purify DNA fragments by size. When an electric field is applied across the gel, 
DNA, which is negatively charged at neutral pH, migrates towards the anode. The 
electrophoretic mobility of linear DNA depends on the length of the DNA and the gel 
concentration. Conventional horizontal agarose gel electrophoresis was used to 
separate DNA fragments up to 20 kb in size. DNA molecules longer than 20 kb are 
poorly resolved by standard agarose gel electrophoresis. These longer molecules are 
resolved by using pulsed-field gel electrophoresis (PFGE) and DNA fragments from 
5 to 200 kb in size were separated in this study. 
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2.4.2.1. 	Conventional horizontal agarose gel electrophoresis 
The 1 x TAE buffer (40 mM Tris; 40 mM Acetate; 1.0 mM EDTA, pH 8.0) was used 
to prepare agarose gels (0.8 to 2.0% (w/v)) and an electrophoresis buffer. The 
agarose (BDH) was melted by microwaving in the buffer until it became a clear, 
transparent solution. The melted agarose solution was cooled to 50-55 °C and 
poured into a mold. After the gel was completely set, the comb and tape was 
removed, placed in the electrophoresis tank and covered with electrophoresis buffer. 
Then, the DNA- gel-loading buffer mix was loaded into the wells and 
electrophoresed for up to 18 hrs at 60 V/cm, after which, the gel was stained with 
ethidum bromide (0.5 p.g/ml), visualised on an UV-transillumunator and 
photographed. For short electrophoresis runs the ethidium bromide (0.5 j.xg/ml) was 
added to the melted agarose prior to casting the gel. 
2.4.2.2. 	Pulsed-field gel electrophoresis (PFGE) 
Large DNA fragments were resolved by a clamped homogenous electric field 
(CHEF)-DR-III-PFGE system (Bio-Rad). By altering the electric field between the 
spatially distinct pairs of electrodes, the high molecular weight DNA molecules are 
able to reorient and migrate at different speeds through the pores in an agarose gel. 
The size of the high molecular weight DNA molecules determines how quickly they 
can be reoriented when the electric field changes and thus how quickly they can 
migrate through the gel. 
The DNA samples were electrophoresed through a 1.0% (w/v) pulsed-field certified 
agarose gel (Bio-Rad) in 0.5 x TBE (45 mM Tris; 45 mM borate, 1.0 mM EDTA, pH 
8.3) at 14 T. Electrophoresis was carried out for up to 18 h at 6 V/cm field strength 
at an angle of 120 ° with a time ramp from initial to final switch intervals of 5 s and 
15 s, respectively. After electrophoresis the gels were stained with ethidum bromide 
(0.5 [tg/ml) for 20 min in 0.5 x TBE buffer, visualised on an UV-transilluminator and 
photographed. 
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2.5. Southern analysis 
2.5.1. Southern blotting 
Southern blotting refers to the transfer of DNA from an electrophoresis gel to a nylon 
membrane support, so that the immobilised DNA can be examined for the presence 
of specific sequences or sequence similarities (Southern, 1975). The DNA transfer is 
achieved by capillary flow of liquid through the gel to the membrane. The DNA is 
fixed to the membrane by heat or UV crosslinking. 
The DNA in gels was depurinated by soaking the gels with gentle agitation in 0.25 M 
HC1 until the bromophenol blue dye turned to yellow, then rinsed in distilled water. 
The gels were then soaked in denaturing solution (1.5 M NaCl; 0.5 M NaOH) for 45 
min with gentle agitation. Gels were rinsed with distilled water before soaking in 
neutralisation solution (1.0 M Tris-HC1, pH 7.4; 1.5 M NaCl) for 30 min with gentle 
agitation. The neutralisation solution was then changed and gels soaked for another 
15 mm. A nylon membrane (Hybond-NTM, Amersham) and three sheets of 
Whatmann 3 mm paper were cut to the size of gels to be blotted. A Pyrex dish 
containing 20 x SSC (3 M NaCl; 0.3 M sodium citrate) was set up with a glass plate 
over the top with two sheets of Whatmann 3.0 mm paper acting as a wick into the 20 
x SSC solution. Gels were then placed on the Whatmann papers over the dish. The 
membrane was prewetted in distilled water and placed on top of gels using millipore 
forceps. Any visible air bubbles were smoothed out with a glass pipette. The 
Whatmann papers cut to the same size as the gel were individually wetted in distilled 
water and placed on gels in the same manner as the membrane. Gels were 
surrounded with Saran wrap and a stack of absorbent paper towels was placed on 
top. A glass plate was then placed over the towels and a 0.75-1 kg weight was placed 
on top. The DNA was transferred overnight. After blotting, positions of the wells 
were marked and nylon membranes were neutralised in 0.5 M Tris pH 7.0 for 5 mm 
and rinsed with 2 x SSC pH 7.0, followed by baking at 80 °C for 2 hours. 
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2.5.1.1. 	Alkali blotting 
Pulsed-field electrophoresis gels were destained and the DNA was nicked by 
exposure to UV light (60 in Joules). The nicked DNA was denatured in alkali buffer 
(0.4 N NaOH; 1.5 M NaCl) for 15 mm, then transferred to nylon membranes 
(Hybond-NTM, Amersham) by capillary blotting using alkali buffer. After 36 h, 
blots were dismantled, and the nylon membranes were neutralised in 0.5 M Tris pH 
7.0 for 5 min and rinsed with 2 x SSC pH 7.0, then baked at 80 °C for 2 hours. 
2.5.2. Radiolabelling DNA probes 
2.5.2.1. 	Preparation of radiolabelled DNA probes 
Labelling with [cc 32P] dCTP was based on the use of random sequence 
hexanucleotides to prime DNA synthesis on denatured template DNA at numerous 
sites (Feinberg and Vogeistein, 1983; 1984). The primer-template complex is a 
substrate for the Klenow fragment of DNA polymerase I. By substituting a 
radiolabelled nucleotide for a non-radioactive equivalent in the reaction mixture, 
newly synthesised DNA is made radioactive. Very small amounts of input DNA can 
be labelled enabling very high specific activity probes to be produced with relatively 
small quantities of added nucleotides. These radioactively labelled fragments can 
then be used as sensitive hybridisation probes (Southern, 1975). 
A Rediprime DNA labelling system (Amersham) was used to label the DNA probes. 
This system uses an exonuclease-free Klenow enzyme. The absence of 5'-3' 
exonuclease activity associated with the DNA polymerase I ensures the labelled 
nucleotides incorporated by the polymerase are not subsequently removed as 
monophosphates. So, the amount of newly synthesised DNA often exceeds the 
amount of input DNA. 
In each labelling reaction -P25-50 ng DNA probe was radiolabelled using 
{ct32P]dCTP. Radiolabelling reactions were performed in total volumes of 50 pl. 
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The template (25-50 ng DNA in 45 .tl of distilled water) was denatured for 10 mm 
in a boiling water bath and immediately chilled on ice for 3-5 mm. The denatured 
DNA solution (45 tl) was centrifuged briefly to bring the contents to the bottom of 
the tube and added into a rediprime labelling mix (a buffered solution of dATP, 
dGTP, dTTP; exonuclease free Kienow enzyme; random primers-9 mers containing 
blue dye). The tube was gently flicked until the blue colour was evenly distributed 
and then centrifuged briefly. Five p.1 (50 p.Ci) of Redivue [cc 32P]dCTP (Amersham) 
was added, the contents were mixed by gentle pipetting up and down a few times, 
centrifuged briefly and incubated at 37 °C in a water bath for 20 mm. The reaction 
was stopped by adding 5 j.il of 0.2 M EDTA. 
	
2.5.2.2. 	Purifying [a32P] dCTP labelled DNA probes 
Prepacked NICK-Sephadex G-50 DNA grade columns (Pharmacia) were used to 
separate labelled probes from unincorporated [a 32P]dCTP-labelled nucleotides. The 
column was equilibrated and the labelled probes were separated using TE buffer (pH 
7.5) as the running solution. First the column was equilibrated with 4 ml of TE 
buffer. The radiolabelled probe (50 p.1) was added to the column. After the probe 
had completely entered into the column, the sample was eluted twice with 400 p.1 of 
TE buffer. Eluates were collected in separate tubes. In this separation, the 
unincorporated [a 32P]dCTP-labelled nucleotides are retained in the Sephadex G-50 
column and the labelled probe eluted with the second 400 p.1 of elution buffer. An 
aliquot (2 p.1) of purified sample (the second eluate) was used for calculating the 
specific activity of the probe. 
2.5.2.3. 	Quantifying [a32P]dCTP-labelled DNA probes 
The following method was utilised to assay the incorporated [a 32P] dCTP's from 
labelled and purified DNA probes. 2 p.1 of the DNA probe from the second 400 p.1 
eluate and 2 p.1 of elution buffer (TE) were spotted onto separate filters. Each filter 
was placed in a 20 ml scintillation vial and the mean specific activity was measured 
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for 1 min using a liquid scintillation counter (Wallac 1410, Pharmacia). If the 
incorporation was satisfactory (1x10 6 total counts/mm), the DNA probe was 
denatured by adding one-tenth volume (40 pA) of 2.0 M NaOH and used for 
hybridisation. If the incorporation was unsatisfactory, a fresh DNA probe was 
prepared. 
2.5.3. Hybridisation and autoradiography 
In hybridisation experiments denatured single stranded radiolabelled DNA probes 
anneal to the complementary DNA fragment(s) immobilised on the membrane. The 
stability of the hybridisation depends on the extent of base pairing to the target 
sequence. The non-specifically bound and unbound probes on the membranes were 
removed by washing the membranes from high to low salt concentration solutions 
(low to high stringency). 
Pre-hybridisation of membranes (Southern and Northern blots) was performed in 
revolving glass cylinders using 30 ml of hybridisation solution (0.5 M Na2HPO4; 
7.0% SDS; 1.0 mM EDTA) at 65 T. After a minimum of 60 min pre-hybridisation, 
the radioactive denatured probe was added to the hybridisation solution and 
hybridised overnight at 65 T. The membranes were first washed twice in a solution 
containing 2 x SSC and 0.1% SDS at 65 °C for 20 min each, then in 1.0 x SSC and 
0.1% SDS (65 °C for 20 mm) and final wash in 0.1% SSC and 0.1% SDS (65 °C for 
15 mm). The membranes were rinsed in 2 x SSC at room temp to remove the SDS, 
the excess dripping solution was removed by placing the membranes on 3 mm filter 
paper and covered with Saran wrap to keep the membranes moist. Membranes were 
placed on X-ray film (AGFA; CURIX RP1) between intensifying screens in 
autoradiography cassettes and kept at -80 °C for 2 h to a week. X-ray films were 
developed automatically using X-Ograph compact x 2. If necessary, the membranes 
were stripped by placing them in boiling 0.1% SDS and then allowed to cool to room 
temperature. The membranes were removed and exposed to X-ray film to confirm 
that stripping of the probe had been successful before being hybridised with a 
different probe. 
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2.6. Polymerase Chain Reaction (PCR) 
The thermostable Taq DNA polymerase (Eckert and Kunkel, 1990) was used for 
DNA amplification. PCR analysis was used for rapid screening of the 
presence/absence of the target allele in mice and in ES cell line genomic DNA, to 
screen the mouse BAC library, to generate the Ryrl probes for mouse PAC library 
screening and Southern blot analysis. 
2.6.1. Primer design 
Fragments of the Ryrl gene were amplified using primers designed from known 
murine sequences. The sequence information was either extracted from the EMBL 
DNA sequence database or generated during this study. Primer0.5 (Whitehead 
Institute for Biomedical Research, 199 1) was used to design suitable primer pairs. 
2.62. PCR conditions 
Target fragments were amplified in a total reaction volume of 20 jtl, including 20 
pmol of each primer, 1.5 MM M902, 0.2 mM dNTPs and 0.5 U Taq DNA 
polymerase in a final concentration of 1 x PCR buffer (Boerhringer Mannheim). The 
cycling reaction was preceded by 5 min denaturation at 95 °C and terminated with a 
final extension at 72 °C for 5 mm. Each cycle consisted of 1 min at 94 °C, 1 min at 
the appropriate annealing temperature, and 1 min at 72 °C for primer extension. 
Reactions were carried out for 35 cycles in a Perkin-Elmer Gene Amp-9600 thermal 
cycler. The PCR products were separated by electrophoresis through an 1.0-2.0% 
agarose gel in 1 x TAE buffer with ethidium bromide (0.5 .tgIml) and visualised on a 
UV- transilluminator. 
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2.7. Manipulation of recombinant plasmid DNA 
2.7.1. PurjfIcation ofDNA fragments from agarose gels 
QIAEX II agarose gel extraction kit (QIAGEN) was used to isolate and purify DNA 
fragments from agarose gels. This method is based on the solubilization of agarose 
with sodium perchiorate, followed by selective adsorption of DNA onto the QIAEX 
II particles. The DNA fragments were used in subcloning and probe preparation for 
Southern and Northern blotting procedures. 
The digested DNA fragment or PCR amplified product was size fractionated on 0.8-
1.5% agarose gel buffered in 1 x TAE. The region of gel containing the required 
DNA fragments was carefully cut out under long wave (366 nm) UV light. The 
excised gel slice was transferred into a 1.5 ml microfuge tube. The weight of the 
slice was determined and 3 volumes (300 iii) of solubilisation buffer, QX1 was added 
to one gel volume (100 mg). 30 tl of homogeneous solution of QIAEX II was added 
to 2-10 jtg of DNA fragment and incubated at 50 °C in a water bath for 10-15 mm. 
To dissolve the agarose gel and keep the QIAEX II in suspension, the solution was 
mixed by inverting the tubes for a few seconds every 2-3 mm. Then, the sample was 
centrifuged (10,000 x g for 1 mm) to pellet the QIAEX II containing the bound 
DNA. The pellet was resuspended in 0.5 ml of QX1 buffer and centrifuged (10,000 
x g for 1 mm) to remove traces of agarose. The QIAEX II bound DNA fragments 
were washed twice with 0.5 ml of wash buffer PE by resuspension and centrifugation 
(10,000 x g for 1 mm). The wash buffer was removed, air-dried and the DNA was 
dissolved in 50 j.tl of TE buffer. After 5-10 min the tube was centrifuged (10,000 x g 
for 1 mm) to pellet the QIAEX II and the purified DNA solution was transferred into 
a clean microfuge tube and stored at —20 T. 
2.7.2. Blunt-ending of PCR products 
The PCR and Reverse Transcriptase coupled PCR (RT-PCR) products generated by 
Taq and Tfl DNA polymerase have a 5' A overhang due to the terminal transferase 
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activity of these enzymes (Clark, 1988). The 5' A overhangs were blunt-ended using 
Klenow enzyme. A 16 tl sample of the purified PCR product was added to 2 .il of 
T4 DNA ligation buffer, 5 U (1 .tl) of Kienow enzyme and 1 tl of 4.0 mM dNTPs. 
The reaction mix was incubated at 37 °C for 30 minutes and used for DNA ligation. 
2.7.3. Shrimp Alkaline Phosphate (ShAP) treatment 
Linearised plasmid pBluescript II (SK) and pUC 19 DNA was dephosphorylated 
using Shrimp alkaline phosphatase (ShAP) instead of the calf alkaline phosphatase, 
as the Shrimp enzyme is more easily inactivated after the reaction is complete. 1.0 
pg of plasmid was digested with the required restriction enzyme and 2.5 units of 
ShAP were added to the enzyme digest reaction for the final 30 mm (the enzyme will 
work in most restriction buffers). The reaction was stopped by adding 10 MM EDTA 
and the enzyme was completely and irreversibly inactivated by heating at 65 °C for 
15 mm. After inactivation the solution was cooled to room temperature and DNA 
was extracted with, phenol: chloroform: isoamyl alcohol (25:24:1) and 
chloroform:isoamyl alcohol (25:1). The plasmid DNA was ethanol precipitated in 
the presence of one-tenth volume of 3.0 M sodium acetate and centrifuged (15,000 x 
g for 10 mm). The DNA pellet was washed with 70% (v/v) ethanol, air-dried, 
dissolved in TE and stored at - 20 T. 
2.7.4. DNA ligation 
A Rapid DNA ligation kit (Boehringer) was used to ligate DNA fragments into 
plasmid vectors (Table 2.1). For each ligation 50 ng of vector was used in a total 
volume of 20 p.1. A series of reactions was set up with molar vector:insert ratios from 
1:1 to 1:5. Two vector controls were used, one with ligase, and one without ligase. 1 
p.1(50 nglp.1) vector DNA and 7 p.1(50-250 p.g) insert DNA was diluted with 2 p.1 of 
5 x DNA dilution buffer to a total volume of 10 p.1. 10 p.! of 2 x T4 DNA ligation 
buffer was added to a final concentration of 1 x and mixed. To the mix 1 p.! of T4 
DNA ligase (5 U/p.!) was added mixed and incubated for 30 min at room 
temperature. After ligation an aliquot of ligation mix was used for transformation. 
2.7.5. Transformation of E. coil DH5a cells with plasm id DNA 
E.coli DH5a competent cells (GIBCO BRL) were thawed on ice and gently mixed 
using a micro pipette tip. 2.5 p.l of ligated plasmid DNA was added to 1 x 10 7 (50 p.1) 
cells (final concentration of not more than 5% ligation mix) and placed on ice. After 
45 mm, the cells were heat-shocked for 45 s at 42 °C and replaced on ice for 2-5 mm. 
500 tl LB medium (without antibiotic) was added and incubated at 37 °C for 60 mm. 
100-150 p.1 of culture was spread onto a LB agar plate containing the required 
selective antibiotic (Table 2.1), X-gal and IPTG. The plates were incubated 
overnight at 37 °C for colony formation, and recombinant clones were selected 
through blue/white screening. 
2.8. Isolation of large genomic clones from murine genomic DNA libraries 
2.8.1. From BA  library 
	
2.8.1.1. 	Primers for BAC screening 
Fragments of the Ryrl gene were amplified using primers designed from known 
murine sequences. The primers for exon 1 (Takeshima et al., 1994a), exon 17 
(unpublished) and the 3' untranslated region (Takeshima et al., 1995) of the murine 
sequence were used to screen the mouse BAC library. The relevant EMBL accession 
numbers for the source sequences are D21798, X95655 and D38216 respectively. 
The primers are listed in the table 3.1. 
2.8.1.2. 	BAC library screening 
The commercially available mouse BAC library was supplied by Research Genetics 
Inc. USA. In this library mouse genomic DNA was cloned into the Hindlil site of 
the pBe1oBAC11 vector (figure 2.1). The library consists of 221,184 clones, 
organised in 72 superpools and provides —7.37-fold genome coverage. Each super 
pool represents 8 plate pools. Each plate pool was made by pooling the DNA from 
the 384 colonies stored in individual wells of a single 384-well microplate. The 
superpools and plate pools were supplied as purified DNA preparations. Specific 
plates were requested from Research Genetics after preliminary screening of the 
superpools and plate pools. A schematic representation of BAC screening is shown 
in figure 2.2. The selected plates were initially screened by colony-PCR 
amplification using the appropriate primer pairs. 
The supplied master plates were replica plated into 60 t1 of LB with 12.5 p.g/ml 
chloramphenicol with and without 15% glycerol and incubated at 37 °C for 24 h. 
The glycerol plate was stored at - 80 °C and the other plate at 4 T. The plate stored 
at 4 °C was used for colony screening. 
Five jil culture from each well of a 384 well plate was transferred to a well in a 96-
well microtitre plate containing 200 tl of 0.1% DEPC treated water. Culture aliquots 
corresponding to 4 different clones in the master plate were pooled in each well in 
the 96-well plate. 4 tl of colony mix was used for direct PCR amplification in a 
total volume of 20 l reaction. The four clones from the positive were directly 
screened from the 384 well plate. 
Selected BACs were plated on LB agar medium with 12.5 .ig/ml of chioramphenicol 
for single colony isolation. Single colonies were selected randomly, cultured and 
confirmed by PCR amplification. The DNA from confirmed positive BACs was then 
prepared. 
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Figure 2.2: Schematic representation of the organisation of the mouse BAC 
library 
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2.8.2. From PAC library 
	
2.8.2.1. 	Probes for PAC library screening 
Murine Ryrl-specific, exon 1, exon 17, exon 64 and the 3' untranslated region PCR 
products and the 3' end human RYR] eDNA (RYR] cDNA clones were kindly 
provided by Dr. David MacLennan, Toronto, Canada) were used as probes to screen 
a 21-mouse PAC library obtained from the Roswell Park Cancer Institute (RPCI). 
2.8.2.2. 	PAC library screening 
The Roswell Park Cancer Institute-mouse PAC library (The RPCI-21 mouse PAC 
library) was used to isolate murine Ryrl positive PAC clones. Female mouse spleen 
genomic DNA has been cloned into the BamHI site of the pPAC4 vector (figure 2.3). 
The library represents the equivalent of approximately 11.6-fold the mouse genome. 
The library has been arrayed into 384 well microtiter dishes and then grided on 22 x 
22 cm nylon high density hybridisation filters for screening by hybridisation. Each 
hybridisation membrane represents 27,650 distinct mouse PAC clones, stamped in 
duplicate (55,300 colonies in total). On each membrane there are 48 x 48 boxes of 
12 clones. Each box has a 5 x 5 array of the 12 clones spotted twice (12 duplicated 
clones with the middle spot empty). The possible twelve orientations of duplicate 
spots are shown in figure 2.4. These orientation patterns were used to identify 
hybridised clones on the autorad as intense dark patches. The library membranes 
were obtained from Resource Center/Primary Database (RZPD), Berlin (URL = 
http://www.rzpd.de ) from whom specific clones (clones by xly-co-ordination) were 
requested after preliminary screening of the high density hybridisation filters. A 
schematic representation of PAC screening is shown in figure 2.4. Requested clones 
were supplied as an agar stab. The stabbed PACs were plated on LB agar medium 
with 25 .tg/ml of kanamycin for single colony isolation. A single colony from each 
plate was cultured and PAC plasmid DNA was prepared. 
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Figure 2.3: PAC vector pPAC4. 
(http://bacpac.med.buffalo.edu/ppac4eniarged.htm)  
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Figure 2.4: A schematic representation of PAC membrane screening and 12 
possible orientations of duplicated spots. 
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2.8.2.3. 	Scoring PAC clone xly-co-ordination 
Probe hybridised positive clones were identified by clone orientation patterns in the 
5 x 5 box array and the xly-co-ordination possession was calculated as per the 
suppliers instructions using the formula, 
x = 5(X-I)+x' 
y = 5(Y-l)+y' 
Where: 
5 = 5 x 5 array 
X,Y= co-ordinates of the blocks on the filter 
x',y'= co-ordinates of each clone with in the 5 x 5 array 
x,y = final co-ordinates of desirable clones 
For example, observation of pattern 12 in the circled array in figure 2.4 was 
calculated as follows 
Arrangement of clones in an array 	 5 
Co-ordinates of the block on the filter 	 X = 5; 	Y = 3 
Co-ordinates of each clone within the block 	x'l = 3; 	y'l = 1 
x'2=5; 	y'2=2 
Applied into the formula: 
xl =5(5-1)+3=23 
yl =5(3-1)+1 = 11 
x2 = 5(5-1)+5 = 25 
y2 = 5(3-1)+2 = 12 
so, the co-ordinates of the resulted clones are x  = 23, y  = 11 and x2= 25, y2= 12. 
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2.8.3. BAC/PACplasmidDNA preparation 
Selected single BAC and PAC colonies were pre-cultured overnight in 10 ml LB 
medium with chioramphenicol (12.5 j.tg/ml) and kanamycin (25 p.g/ml) respectively. 
0.25 ml of overnight grown pre-culture was inoculated into 250 ml of LB medium 
with respective antibiotic and incubated overnight at 37 °C in a shaking incubator at 
200 rpm. Qiagen plasmid maxi kit was used to isolate plasmids from BAC and PAC 
clones. The clone, grown in 250 ml LB medium was harvested, the cells were lysed 
with buffer P1, P2 and P3. The clear lysate was separated by centrifugation and 
purified through a QIAGEN tip-500 column. The column bound plasmid DNA was 
eluted with 12 ml of elution buffer QF pre heated to 50 °C and precipitated with 0.7 
volume of isopropanol. The pellet was washed with 70% (v/v) alcohol, air dried and 
dissolved in TE, quantified and stored at —20 T. 
2.8.4. Isolation of BA C left and right ends 
The Hindill restriction site was used as a cloning site in the BAC library clones. The 
generation of right and left end fragment of the BAC clones exploited the presence of 
unique/single restriction enzyme sites on either side of the cloning site (Hindill) on 
the vector pBe1oBAC11 (Wang et al., 1997). The right and left end fragments can be 
isolated by plasmid end rescue and inverse polymerase chain reaction (IPCR) 
techniques respectively (Woo et al., 1994; Garge, 1996). A schematic representation 
of BAC end isolation is shown in figure 2.5. 
For end isolation, separate aliquots of 1 g BAC DNA were completely digested 
with BamHJ, EcoRJ, KpnI, Sad, Smal and SphI for 4 h at 37'C. The digested 
products were phenol: chloroform: isoamyl alcohol (25:24:1) extracted, precipitated 
with one tenth volume of 3.0 M sodium acetate and double the volume of chilled 
ethanol, and centrifuged (15,000 x g for 30 mm). The pellet was washed with 70% 
(v/v) alcohol, air-dried and dissolved in 20 tl of TE buffer. 2 j.tl of purified DNA 
was self ligated in a total volume of 50 .tl with 1 U of 14 DNA ligase in 1.0 mM ATP 
buffer at 12 °C overnight. 
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Figure 2.5: 	Schematic diagram of the generation of the right and left end isolation 
using plasmid rescue (right end) and IPCR (left end) techniques in BAC 
pBeloBACl 1 vector (Wang et al., 1997) were the insert has BamHI restriction sites 
(Woo et al., 1994; Garge, 1996 1) . 
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2.8.4.1. 	Plasmid end rescue 
For right end isolation, 5 tl of ligated DNA was transformed into E.coli DH5ct 
competent cells (Gibco-BRL). Positive transformants were selected on LB agar 
plates containing 12.5 jig/ml chloramphenicol. Plasmid DNA was extracted from 
positive clones. The right end fragments were verified by digestion with selected 
enzyme and selected enzyme plus Hindlil to release the insert. The digested 
fragments were separated on a 1% (w/v) agarose gel in 1 x TAE buffer containing 
ethidium bromide (0.5 tg/ml) and visualised on a UV-transilluminator. 
As an alternative, clones were PCR amplified using M13 forward and BAC 4 
primers (table 4.3; figure 2.5) and the products size fractionated by agarose gel 
electrophoresis. 
2.8.4.2. 	Inverse Polymerase Chain Reaction (IPCR) 
For left end isolation, 1 jil of ligated product was PCR amplified using BAC 1, BAC 
2 primers (table 4.3; figure 2.5). To verify the left ends, the insert PCR products 
were digested with selected enzyme and selected enzyme plus Hindlil. The digested 
PCR products were separated on a 1% agarose gel in 1 x TAE buffer containing 
ethidium bromide (0.5 .tg/ml) and visualised on a UV-transilluminator. 
2.9. RNA isolation and analysis 
All glassware and solutions used for RNA work were treated with diethyl 
pyrocarbonate (1.0% DEPC) and pipettes and the working surface were cleaned with 
RNAsezap (Ambion) to destroy ribonucleases. Gloves were changed frequently. 
The Ultraspec RNA isolation system (Biotecx) was used to isolate total RNA from 
mouse tissues and cultured ES cell lines. Tissues (0.5-1.5 g) were frozen in liquid 
nitrogen immediately after dissection from the animal. Frozen tissue (0.1-0.5 g) was 
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homogenised in 2 ml of Ultraspec RNA solution (Biotecx) using an ultra-
homogeniser (Ultra-turrax). 
Confluent stage ES cells in 25 cm  flask were washed with PBS to remove dead cell 
residue and 2.0 ml of Ultraspec RNA solution was added, swirled in a shaker to 
cover the plate and lyse the cultured cells that adhere to the culture plate. The cell 
homogenate lysate was transferred into a microfuge tube. 
The homogenate (from tissue and ES cells) was placed on ice for 5-10 min to 
dissociate nucleoprotein complexes. 0.2 ml of chloroform was added per ml of 
Ultraspec RNA solution, mixed vigorously and placed on ice. After 10 mm 
incubation the solution was centrifuged (10,000 x g for 15 min at 4 °C) and the 
aqueous phase (supernatant) was transferred into a fresh tube. An equal volume of 
isopropanol was added, mixed gently by inverting the tube, placed on ice for 10-15 
min to precipitate RNA and centrifuged (10,000 x g for 15 min at 4 °C). The RNA 
pellet was washed twice with 75% ethanol by vortexing and subsequent 
centrifugation (10,000 x g for 10 min at 4 °C), briefly dried, dissolved in 0.1% DEPC 
treated, autoclaved distilled water and stored in -20 T. The concentration of the 
RNA samples was quantified assuming that an absorbance of 1 at 260 nm 
corresponds to 40 tg /ml RNA. DNA- and protein-free RNA has an 260/280 nm 
absorbance ratio of approximately 1.8 —2.0. 
2.9. 1. Electrophoresis of RNA 
Messenger-RNAs (mRNA) have secondary structures. Therefore, denatured gels are 
used for RNA electrophoresis (Sambrook et al., 1989). 
Total RNA solution (10 p.g) was made up to 7 jti with 0.1% DEPC treated distilled 
water and added to 23 pl of sample buffer (15 il formamide; 5 .il 37% formaldehyde 
solution; 3 jii 10 x MOPS (0.2 M 3-[N-Morpholino] propane-suiphonic acid; 0.5 M 
sodium acetate pH 7.0; 0.01 M Na2EDTA). Samples were incubated at 65 °C water 
bath for 5 min and placed on ice for 5 min before adding 3.3 p1 of 10 x running 
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buffer (50 % glycerol; 0.1% mg/ml bromophenol blue). The samples were 
electrophoresed in denaturing 1.5% agarose gels containing 1 x MOPS buffer, 6.8 % 
formaldehyde and using 1 x MOPS as the gel tank buffer. After electrophoresis the 
gel was ethidium bromide stained (0.5 tg/m1) for 10-20 min,. destained with distilled 
water for 2 h to overnight and visualised on a UV-transilluminator and photographed. 
2.9.2. Northern blotting 
A capillary blot was set up to transfer the RNA from agarose gel to nylon membrane 
in Northern blotting, as described for Southern blotting. 20 x SSC transfer buffer 
was used to transfer RNA to nylon membranes overnight. After blotting, the 
membranes were neutralised in 0.5 M Tris-HC1, pH 7.0 for 5 mm, rinsed in 2 x SSC 
and baked at 80 °C for 2 h. 
2.10. 	Cloning of the Ryrl cDNA 
2.10.1. Reverse Transcription coupled PCR ampl?fication (RT-PCR) 
RT-PCR is a most sensitive and versatile technique. It can be used to determine the 
presence or absence of a specific transcript, to estimate expression levels and to 
clone cDNA products without constructing and screening a cDNA library. 
The Access RT-PCR system (Promega) was used to synthesise Ryrl cDNA fragments 
from total RNA, isolated from murine skeletal muscle. The optimised single buffer 
system has the advantage of enabling reverse transcription (RT) and polymerase 
chain reaction (PCR) amplification to work in a single tube. The AMV reverse 
transcriptase (AMV RT) from avian myeloblastosis virus was used to synthesise the 
first stand of cDNA and the thermostable Tfl DNA polymerase from Thermus flavus 
was used for second strand cDNA synthesis and DNA amplification. 
Target RNA fragments were reverse transcribed and amplified in a total reaction 
volume of 50 j.tl, including 10 .xl of AMV/Tfl 5 x reaction buffer, 50 pmol of each 
primer (table 3.1), required MgSO 4, 0.2 mM dNTP mix, AMV reverse transcriptase 
(5 U) and Tfl DNA polymerase (5 U). The target RNA was reverse transcribed at 48 
°C for 45 mm. Then the PCR cycling reaction was preceded by 1 min denaturation at 
95 °C and terminated with a final extension at 72 °C for 5 mm. Each cycle consisted 
of 1 min at 94 °C, 1 min at the appropriate annealing temperature, and 1 min at 72 °C 
for primer extension. Reactions were carried out for 35 cycles in Perkin-Elmer Gene 
Amp-9600 thermal cycler. The RT-PCR products were separated by electrophoresis 
through an 1.0-2.0% agarose gel in 1 x TAE buffer with ethidium bromide (0.5 
p.g/ml) and visualised on a UV- transilluminator. 
To amplify the Ryrl cDNA fragments, the reaction was optimised in different MgSO 4 
concentrations such as 1.0 mM, 1.5 mM, 2.0 mM and 2.5 mM. 
2.10.2. Cloning of RT-PCR ampl/IedRyr1 cDNA products 
A Rapid DNA ligation kit (Boehringer) was used to ligate RT-PCR fragments into the 
plasmid vectors. Blunt ended RT-PCR products were cloned into the EcoRV site of 
the pBlueskript II (SK) vector. PCR products with 'sticky-ends' were cloned into the 
pGEM-T vector (Promega). In the PCR reaction the Tfl and Taq polymerases often 
add a single deoxyadenosine, in a template-independent fashion, to the 3' ends of the 
amplified fragments (Clark, 1988). The vector pGEM-T has single 3'-T overhangs at 
the insertion site which improves the ligation of the PCR product into the plasmid. 
An aliquot (2 tl) of ligation mix was transformation into competent E.coli DH5a 
cells (1 x 106  cells in 50 .tl) and the recombinants were selected on ampicillin, X-gal, 
IPTG plates. 
2.11. 	DNA sequencing 
The ABI PRISM dye terminator cycle sequencing ready reaction kit (Applied 
Biosystems) was used for sequencing sample preparation. The prepared samples 
(plasmid, PCR products) were sequenced on an Applied Biosystems (ABI) model 
373A automated DNA sequencing system. Cycle sequencing using dye-labelled 
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terminators is a rapid and convenient method for performing enzymatic extensions 
for DNA sequencing. The major benefits are a) sequencing reaction in a single tube 
reaction. b) the same protocol is used for single, double-stranded DNA and PCR 
fragments. c) less starting template DNA is needed than with non-cycling protocols. 
d) easier sequencing of large molecules (e.g. BAC, PAC clones) and e) the enzyme 
AmpliTaq DNA polymerse, FS is a mutant form of Taq DNA polymerase which has 
no 5' to 3' exonuclease activity and f) the sequence data are captured semi-
automatically in an electronic format. 
Sequence reactions were carried out in a total volume of 20 pl. It includes 8 tl ABI 
PRISM dye terminator cycle sequencing ready reaction mix (A-dye terminator; G-
dye terminator; T-dye terminator; C-dye terminator; dITP; dATP; dCTP; dTTP; Tris-
HC1, pH 9.0; MgCl2 ; thermal stable pyrophosphatase; AmpliTaq DNA polymerase, 
FS), 5 pmol sequencing primer, 500-1000 jig template DNA (plasmidiPCR product). 
The reaction was initiated by 5 min denaturation at 95 °C and finished at 4 T. Each 
cycle consisted of 10 sec denaturation at 96 °C, 5 sec at 50 °C for primer annealing, 4 
min at 60 °C for primer extension and dye termination. The reactions were carried 
out for 25 cycles in a Perkin-Elmer Gene Amp-9600 thermal cycler. 
The PCR-Dye terminated products were precipitated in 50 tl of ethanol with 2 j.il of 
3.0 M sodium acetate and centrifuged (15,000 x g for 30 min at 4 °C). The pellet 
was washed in 70% (v/v) ethanol, air-dried and dissolved in 4 tl of loading buffer 
(deionized formamide: 50 mM EDTA, pH 8.0; 5:1). The samples were denatured for 
3 min at 94 °C and kept on ice while loading into the sequencing gel. 
2.11.1. BA  end sequencing 
The BAC ends were sequenced in a total volume of 40 jii, including 2-3 jig of 
template DNA, 50 pmol T7 or SP6 (table 4.4) sequencing primer and 16 p.1 ABI 
PRISM dye terminator cycle sequencing ready reaction mix. The cycle sequencing 
was performed as above and the products were precipitated in 100 jtl of chilled 
ethanol with 4 jtl of 3.0 M sodium acetate. 
2.11.2. Acrylamide gel preparation 
2.11.2.1. Preparation of gel plates 
The glass plates, spacers and comb were washed with alconox, rinsed with distilled 
water and air-dried. The dried plates were aligned with spacers (0.4 mm) and three 
edges of the plates sealed tightly with tape and clamped. 
2.11.2.2. Preparation of sequencing gel 
For 60 ml of gel solution, 30 g urea, 9 ml 40% acrylamide stock solution (40 g 
acrylamide; 2.105 g bis-acrylamide in 100 ml distilled water), was dissolved in 25 ml 
of water and stirred continuously for --45 min with -1 g mixed bed resin for 
deionization. The solution was poured into a 50 ml syringe attached to a 0.8 Iim 
filter (millipore). It was filtered into a conical sidearm flask containing 3 ml of 
filtered 20 x TBE (216 g Iris base; 110 g boric acid; 40 ml of 0.5 M EDTA in 1000 
ml distilled water) and degassed for 10 mm. To initiate polymerization, freshly 
prepared 10% ammonium persulphate (300 t1) and TEMED (27 jil) were added and 
gently swirled to mix. This solution was poured immediately between the plates 
without trapping air bubbles. The plates were laid horizontally and a surface former 
was inserted, clamped and left for -3 h to allow polymerization. After 
polymerization the clamps, tape and surface former were removed, the outsides of 
the plates were washed and dried. The gel plate was set-up as per the instructions for 
the Applied Biosystems (ABI) model 373A automated DNA sequencing system and 
the gels were run for 14 h at 30 mA in 1 x TBE buffer. 
	
2.12. 	Sequence analysis 
The sequence data from ABI sequence was transferred into GCG programsuite 
(Devereux et al., 1984; Womble, 2000). The subclone (pRyr2005, BAC and RT-PCR 
derived Ryrl cDNA fragments) sequence fragments were assembled using the 
STADEN package (Staden, 1996; Staden et al., 2000). All sequences were compared 
to GenBank and EMBL databases using FASTA (Pearson et al., 1997; Pearson and 
Lipman, 1988; Pearson, 2000) and BLAST (Altschul et al., 1990a; 1990b; 1997; 
Pearson, 2000) search. The Ryrl sequence similarity sequences were used to 
develop primers. 
2.13. 	Culture and manipulation of murine Embryonic Stem (ES) cells 
2.13.1. Culture Media for ES cells 
2.13.1.1. Complete medium 
The complete medium was used as non-selective medium for murine ES cells. The 
medium was prepared as follows: 28 ml of foetal calf serum, 28 ml of new-born calf 
serum, 5.6 ml of non-essential aminoacids (100 x), 5.6 ml of 200 MM L-glutamine, 
1.1 ml of 3-mercaptoethanol, 280 jil of leukaemia inhibitory factor (LIF) medium 
and 5.6 ml penicillin (10 mg/ml) were mixed in a sterile 100 ml glass bottle and 
filtered through 0.22 j.tm filter (Millipore) into a fresh bottle of 500 ml Glasgow 
minimum essential medium (Sigma). The medium was stored at 4 °C and used 
within 2-3 weeks. The medium was always prewarmed to 37 °C prior to being used 
to feed cells. 
A number of serum batches were tested for cloning efficiency and their ability to 
support undifferentiated ES cell proliferation by Ms. Ray Ansell. 
2.13.1.2. Selective media for gene targeted ES cells 
Medium containing G418 (300 G418 .tgIml) was used to select cell clones 
expressing the neomycin resistance gene. 
HAT (Hypoxanthine-Thymidine-Aminopterin) medium was used to select cells 
expressing the HPRT gene. The media contain complete media with final 
concentration of 1 x HAT solution (100 x HAT solution = 272.2 mg hypoxanthine; 
48.4 mg thymidine; 4.0 ml of 2.2 mg/ml M-aminopterin in 200 ml of distilled water. 
6-TG medium was used to select cell clones against HPRT gene function. The 
medium contains complete medium with a final concentration of 10 jiM (1.67 p.g/ml) 
of 6-TG. 
2.13.2. Culture of embryonic stem cells 
2.13.2.1. Embryonic stem cell lines 
The knock-out Ryrl cell lines Ryrl 7 (+1-) and Ryr24 (+1-) were used in this study. 
The cells were expanded for a few passages and frozen again in several aliquots in 
liquid nitrogen until needed. 
2.13.2.2. Thawing of ES cells 
The vial of frozen cells was quickly removed from liquid nitrogen, liquid nitrogen 
was allowed to escape from the vial, which was then transferred to a water bath at 37 
°C and agitated until the contents had thawed. The contents of the tube were added 
to 5 ml of the appropriate medium in a centrifuge tube. The cells were pelleted by 
centrifugation (1,000 x g for 5 mm) and resuspended in 5 ml of fresh medium. The 
cell suspension was plated onto a gelatinised (0.1 % gelatine) 25 cm 2 flask and 
incubated at 37 °C in the 5% CO2 incubator (LEEC). 
2.13.2.3. Passage of ES cells 
When the cells were 80-90% confluent, media were changed, and 2 hours later cells 
were passaged. After 2 hours medium was removed, the cells were washed with 
phosphate buffered saline (ready to use Ca 2 and Mg 2+  -free PBS tablets were 
dissolved and autoclaved in distilled water). ES cells were then harvested from the 
flask by aspirating the cells in 1.0 ml trypsin -EGTA (TEG) solution (100 ml 2.5% 
trypsin; 0.4 g EGTA; 0.1 g PVA; 6.3 g NaCl; 0.12 g Na2HPO4; 0.216 g KH2PO4; 
0.333 g KC1; 0.9 g D-glucose; 2.7 g tris; 0.9 ml 1% phenol red in 1000 ml). The 
trypsinized cells were centrifuged in 10 ml medium for 5 min at 1,000 x g, the 
medium was removed and the cell pellet was resuspended in fresh medium. The cell 
suspension was reseeded onto a next size flask (25 cm  to 75 cm 2,  75 cm2 to 150 cm) 
and cultured. The passage number was increased with each trypsinisation. 
2.13.2.4. Freezing of ES cells 
The ES cells harvested from a 25 cm  flask were resupended in 1.0 ml of culture 
medium and placed on ice. To this, 1.0 ml of 2 x freezing mix (60% required 
medium; 20% DMSO; 20% fetal calf serum) was added and mixed gently by 
pipetting. The mixture was dispensed in 1.0 ml aliquots into pre-cooled screw cap 
tubes, placed inside a polystyrene box and left in a —70 °C freezer to cool slowly. 
The tubes were transferred to liquid nitrogen after a few days. 
2.13.3. Gene targeting vectors 
2.13.3.1. Construction of vector pRyr2006 
The gene targeting vector pRyr2006 was similar to vector pRyr2005 (figure 2.6). 
pRyr2005 vector was constructed previously by Dr E. Hitchin and used for first 
round targeting of the mouse Ryrl gene. A 2.45 kb SmaI-EcoRV fragment 
containing the MT-neomycin (neo) expression cassette from plasmid pBT/MT neo 
(RI) version 2 was subcloned into the Smal site in exon 17 of the Ryr] gene fragment 
in plasmid pRyr2005, such that the Ryrl gene and neo expression cassette were in 
S. 
the same transcriptional orientation. This targeting vector has 4.7 kb of Ryr] gene 
sequence distributed as two arms of homology, 1.4 kb and 3.3 kb in length, flanking 
the neo gene. 
2.13.4. Electroporation 
Electroporation was performed with, (i) cells without DNA, to assess the number of 
surviving cells after electroporation and the toxic effect of DNA, if any, (ii) 
Replacement experiment with a neo gene (vector pRyr2006), to assess the frequency 
of gene targeting efficiency and (iii) gene targeting with replacement vector 
pRyr2005, to introduce C 1843 mutation in the Ryrl exon 17 region. 
Cells (1 x 107  ) and linearized targeting vector DNA (250 tg) were resuspended in 1 
x HBS, mixed to final volume of 0.8 ml and placed into a 0.4 cm electrode gap micro 
electroporation chamber. The electroporation was performed with a single pulse at 
800V and 3.0 tF. Electroporated cells and DNA were incubated for 10 min at room 
temperature. The cells were then diluted in 100 ml of non-selective culture medium 
and 10 ml aliquots were plated onto 0.1% gelatinised tissue culture plates. 
2.13.4.1. Preparation of gene targeting vector DNA for 
electroporation 
The replacement vectors pRyr2005 and pRyr2006 (250 tg) were linearized with NotI 
restriction endonuclease, which is present in the pPolyIII vector backbone. To 
ensure complete digestion, the linearized vectors were compared with uncut vectors 
on a 1.0% agarose gel electrophoresis. Completely digested vector DNA was 
phenol-chloroform extracted and ethanol precipitated with one tenth volume of 3 M 
sodium acetate and centrifuged (10,000 x g for 10 mm). The pellet was washed with 
70% ethanol, air-dried and resuspended in 200 p1 of HEPES buffered saline (HBS = 
20mM HEPES, pH 7.05; 137 mM NaCl; 5 mM KC1; 0.7 mM Na2HPO4 ; 6 mM D-
glucose). 1 p1 of resuspended DNA was checked by agarose gel electrophoresis to 
confirm complete resuspension. 
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Figure 2.6: Maps of the replacement vectors used for gene targeting. 
pRyrlO13 targ4ting constructs; used in first round gene targeting to introduce PGK-HPRT mini gene into the Smal site of the 
Ryrl locus. 
pRyr2005 targd. construct; to introduce C  843T mutation point mutation into the Ryrl locus 
pRyr2006 target construct ; used to test second round gene targeting efficiency 
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Figure 2.6: Maps of the replacement vectors used for gene targeting 
2.13.4.2. Preparation of ES cells for electroporation 
ES cells that were 80-90% confluent were refed and 2 hours later harvested. The 
harvested cell pellet was resuspended in 20 ml of fresh medium. Total cell number 
was calculated from an aliquot of the cell suspension using a hemocyto meter (depth 
0.1 mm, 1/400 mm 2) cell counter, (Weber England). An aliquot of 1 x 10 7 cells was 
transferred to a fresh tube and centrifuged (1,000 x g for 5 mm). The medium was 
removed and the cell pellet was resuspended in 600 ti of 1 x HBS. 
2.13.5. Isolation of G418, 6-TG resistant cell clones 
To test the targeting efficiency, a gene replacement experiment with a neo gene was 
carried out using the replacement vector pRyr2006. The pRyr2006 was linearized at 
the NotI site in the plasmid backbone and 250 g DNA was electroporated into the 
Ryrl 7 (+1-) ES cell line. The random integration events were determined by selection 
for MT-Neo expression in G418 and the homologous recombinant clones were 
selected against PGK-HPRT mini-gene function in 6-TG selection. 
To isolate G418, 6-TG resistant (G418R ,  6TGR) cell clones, pRyr2006 DNA was 
electroporated into the Ryrl7 (+1-) cell line. The electroporated cells were diluted 10 
fold in 100-ml complete medium and 10-ml aliquots (106 cells/plate) were plated 
onto a gelatinised 9 cm diameter tissue culture plates. After 24 h in non-selective 
medium, to evaluate the number of cells surviving after electroporation, one plate 
was giemsa stained and compared with a plate from the cell electroporated without 
DNA. Other plates were selected initially in G418 (300 jg/ml) to determine the 
transformation efficiency and random integration of MT-neo expression cassette into 
the genome. After 15 days selection in G418, one of the 9 plates was stained and the 
G418 resistant colonies were counted. 6-TG (10 tM = 1.67 jig/ml) was added to 
other plates and the G418, 6-TG selection was continued for another 6 days. All 
G418 R  6-TG' ES cell clones were picked, trypsinized and expanded in G418, 6-TG 
medium. Genomic DNA from cell clones was used for analysis. 
2.13.6. Selection of C1843Tpoint mutation replaced ES cell clones 
The replacement vector pRyr2005 has been used to introduce C  843T point mutation 
in the Ryrl exon 17 region by homologous recombination. The replacement vector 
pRyr2005 was linearized at the Nod site in the plasmid backbone and electroporated 
into the Ryrl7 (+1-) cell line. The homologous recombinants were selected against 
HPRT gene function in 6-TO medium. Two methods were used to isolate 6TGR  ES 
cell clones from the electroporated cells. In the first method, an aliquot of 0.5 x 107 
electroporated cells was diluted 10 fold in 100-ml HT medium and 10 ml aliquots 
(2.5 x 105 cells/plate) were plated onto a 0.1% gelatinised 9 cm diameter plates. 
After 8 days in HT medium, 6-TO (10 jim = 1.67 tgImi) was added and the selection 
was continued for 18 days. 
In the second method, an aliquot of 0.5x 107  electroporated cells was seeded onto a 
0.1% gelatinised 175 cm  flask. After 8 days in HT medium, the cells were 
trypsinized, counted and reseeded onto a 0.1% gelatine-coated 9 cm plates at a 
concentration of 1.5 x 10 4, 1.5 x 105 and 1.5 x 106  cells/plate. 6-TO was added to the 
medium and selection was maintained for 10 days. All 6TGR  ES cells clones from 
method (i) and (ii) were picked trypsinized and expanded in 6-TO medium. 
Oenomic DNA from the selected ES cell clones was used for analysis. 
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Chapter 3 
3. Molecular cloning and sequence analysis of the murine Ryrl 
cDNA 
3.1. Introduction 
Messenger RNA (mRNA) is synthesised on a DNA template by the process of 
transcription. The synthesised RNA is complementary to the template strand of 
DNA. Most eukaryotic mRNAs have a sequence of poly-adenylic acid at the 3' end 
called a poly-A tail. Reverse transcriptase can be used with an oligo-dT primer to 
synthesise DNA from mRNA. In general, short chains of oligo-dT are mixed with 
the mRNA; they hybridise to the poly-A tail to provide a primer for the action of the 
enzyme reverse transcriptase to synthesise a single-stranded eDNA chain, often with 
a 5' end hairpin loop turn. This loop structure serves as a primer for the synthesis of 
a complementary DNA strand. In this procedure, the information in mRNA is copied 
into complementary DNA (cDNA). The resulting double-stranded cDNA can then 
be inserted into a vector system to construct a cDNA library. From the library, 
cDNA derived from specific gene(s) can be isolated by screening the library using 
DNA, oligodeoxyribonucleotides, or antibodies as probes. Despite the development 
of numerous cDNA cloning strategies, obtaining full-length cDNA from low 
abundance and/or long mRNAs remains a formidable task. As an alternative, 
transcripts from gene(s) expressed at low levels can be cloned using RT-PCR based 
on the strategy described by Frohman et al. (1988). 
Full-length skeletal muscle ryanodine receptor cDNAs specific for rabbit (Takeshima 
et al., 1989; Zorzato et al., 1990), human (MacLennan et al., 1989; Zorzato et al., 
1990), pig (Fujii et al., 1991; Harbitz et al., 1990; 1992; Leeb et al., 1993), frog 
(Oyamada et al., 1994), fish (Franck et al., 1998), C.elegans (Sakube et al., 1997), 
D.melanogaster (Takeshima et al., 1994b) have been isolated from cDNA libraries 
using antibodies, oligonucleotides, homologous and heterologus DNA as probes. 
Only partial cDNAs corresponding to the 3' end of Ryrl, Ryr2 and Ryr3 have been 
isolated from mouse skeletal muscle and brain cDNA libraries using a human RYR3 
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cDNA (Giannini et al., 1995) and rabbit Ryrl cDNA as probes (Takeshima et al., 
1995). The isolation and characterisation of cDNAs corresponding to the entire 
murine Ryrl mRNA would provide valuable information for the development of 
mouse models and mutation analysis for MH and CCD. 
This chapter describes the cloning, sequencing, contig mapping and comparative 
analysis of the murine Ryrl cDNA and deduced amino acids derived from the 
cDNA. The approach takes advantage of the principles of the RT-PCR system. RT-
PCR fragments were cloned and sequenced. Overlapping cDNA fragments 




The three isoforms of ryanodine receptor proteins differ in size (molecular mass) and 
in their patterns of expression. High level expression of the skeletal muscle isoform 
(Ryrl) has been observed in both fast- and slow-twitch muscles and also in the 
oesophagus and testes (Otsu et al., 1990; Giannini et al., 1995; Nakashima et al., 
1997; Martin etal., 1998; Leite etal., 1999). ES cell lines currently in use have been 
obtained from the mouse strains 129 and from a very few other inbred mouse strains 
such as C57BL/6 and BALB/c (McWhir et al., 1996; Brook and Gardner, 1997; 
Muller, 1999). In order to clone the skeletal muscle specific (Ryrl) isoform, total 
RNA was isolated from adult 129 mice skeletal muscle and used as the template for 
RT-PCR reactions. The resulting products from the mRNA are isogenic for 129 
mice and could be very useful for gene targeting related experiments. 
3.2.2. RT-PCR primers 
Fragments of the Ryrl cDNA were amplified using primers designed from known 
murine Ryrl sequences. The sequence information for the primers RyrRNAO 1 and 
RyrRNA07 (see table 3.1) were extracted from the EMBL database DNA sequence 
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D21798 (Takeshima et al., 1994a) and X83932 (Giannini et al., 1995) respectively. 
EcoRV digested BAC 548L24 fragments were sub cloned to develop a gene 
replacement vector (not used in this study). The sub clone end sequences showed 
sequence similarity to the human RYRJ exons 25, 36 and 54. The exon 25 sequence 
was used to develop primers RyrRNA13 and RyrRNA 14, the exon 36 sequence was 
used to develop a primer RyrRNA15, and the exon 54 was used to design a primer 
RyrRNA 18. The BAC 548_1,24 right end sequence showed similarity to human 
RYR] exon 64 region (figure 4.3) and was used to develop primer RyrRNA 19. 
Other exon specific primers were designed either from exons in the vector pRyr2005 
sequence (figure 5.5) or sequence from RT-PCR generated fragments. The primer 
sequences are listed in table 3.1. 
3.2.3. Amplification and cloning of murine Ryrl cDNA 
Rapid amplification of cDNA ends (RACE) is a widely used technique for 
characterising 3' regions of mRNAs (Frohman et al., 1988; Bespalova et al., 1998). 
The procedure consists of two rounds of amplification. The first round of 
amplification is a synthesis of first (-) cDNA strand complementary to the mRNA 
using a common 3' end oligo (dT) 17 primer, and the second round involves 
amplification of the target fragment using general and gene specific primers and the 
first (-) cDNA strand as template. To synthesise cDNA for the murine Ryrl 3' end, 
total RNA from skeletal muscle was reverse transcribed in the first step using a 
common 35-base oligo with (dT) 17 residues (RyrRNA 08). In the second step, the 
gene-specific primer (RyrRNA 07) anneals with a first (-) cDNA strand product and 
was extended to generate a complementary second (+) strand. The double stranded 
3' end cDNA fragment was amplified by PCR using general (3') (RyrRNA 08a) and 
gene-specific (RyrRNA 07) primers (table 3.1). As Bespalova et al. (1998) 
suggested, RT-PCR was carried out with different general/specific primer 
concentrations (50150 pmol; 30/50 pmol; 10150 pmol). Successful amplification was 
achieved with a ratio of 1:5 (10150 pmol) of the general primer (RyrRNA 08a) to the 
gene specific primer RyrRNA 07 (figure 3.1). 








Ryr RNA 01 AGT TTT TGC GGA GGA TGA TGA AG EMBL: D21798 1.0 48 60 1.80 
Ryr RNA 02 TGC ACA CAC AGA GTG AAC ACA GC pRyr2005 
Ryr RNA 03 GAA TCT TGG AAA GAG ATT GTG AAC C pRyr2005 1.0 48 60 0.57 
Ryr RNA 04 CCC ATT CAA AGC CGT AAG AAT AG pRyr2005 
Ryr RNA 12 GTG GGC TCC ATT TCT GAC AGC T pRyr2005 1.5 48 60 1.26 
Ryr RNA 13 CTC CTG TGG TGA CTG CTT CGA A BAC548_L24 
Ryr RNA 14 TTC CGG GCA GAG AAG TCC TAT G BAC 548 L24 1.5 48 60 2.73 
Ryr RNA 15 GTG AAG GCT TTC ATG AGG AGG C BAC 548_L24 
Ryr RNA 37 TAC AGA TGT GCC ACC TCC TGG A cDNA 5 1.5 48 60 3.33 
Ryr RNA 38 TGT AGC CTT CTC GGG GGT CAT A cDNA7 
Ryr RNA 18 GTC TTT GAA GGC CAT GAT TGC C BAC548j 24 1.0 48 60 1.03 
Ryr RNA 19 TTC CAC ATA GGG GTT CCT GGT G BAC 548_L24 
Ryr RNA 29 AGA AGA TGG TGG AGA ACC TGC G cDNA 7 1.5 48 60 1.90 
Ryr RNA 3O CTA TGT CAT CCT CCC CTG GTG G cDNA4 
Ryr RNA 38 TGT AGC CTT CTC GGG GGT CAT A cDNA 8 1.5 48 60 1.70 
Ryr RNA 28 TCA TCA CCC TCT ACC TCC TCG C cDNA4 
Ryr RNA O7 CAG AGA GTG AAA TTC TTG AAC TAC TTG TCG EMBL:X83932 1.0 48 60 1.66 
Ryr RNA O8 CCA GTG AGC AGA GTG ACG AGG ACT CGA GCT CAA GCT (dT)17 Poly Atail 
Ryr RNA O8a TGA GCA GAG TGA CGA GGA CTC G Ryr RNA O8 
Table 3.1: 	Primers used for RT-PCR reactions to generate murine Ryrl cDNA fragments. 
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Figure 3.1: 3' Rapid amplification of cDNA end (RACE). 
Effect of varying the concentration of the general primer in the PCR 
following RT. In the series of RT-PCRs, the general primer RyrRNA 
08a was used in combination with the specific primer RyrRNA 07 at 
concentrations of 50150 pmol (A), 30/50 pmol (B), and 10150 pmol (C) 
to amplify murine Ryrl 3' end. Water (lane 1) and genomic DNA 
(lane 2) were used as negative controls and total RNA isolated from 
skeletal muscle (lane 3) as templates for RT-PCR. PCR products were 
separated in a 1% agarose gel followed by ethidium bromide staining. 
To amplify other RT-PCR fragments, gene-specific forward and reverse primers 
were used (table 3.1). In reverse transcription, the reverse primer anneals with the 
mRNA and produces the cDNA first (-) strand. The cDNA second (+) strand 
synthesis was carried out with the forward primer. In subsequent PCR cycles the 
forward and reverse primers use the double-stranded cDNA fragment as a template. 
The RT-PCR conditions were standardised with different Mg 2 concentrations 
(figure 3.2). Genomic DNA was used as a control to check for DNA contamination 
in the RNA and to identify the true cDNA product in the PCR products (figure 3.3). 
Amplified RT-PCR products were size separated by electrophoresis. The eDNA 
fragments were gel purified and cloned either into the EcoRV site of the plasmid 
pBluescript II (SK) or the vector pGEM-T. The primers, cDNA fragment size and 
cloned vectors are listed in the table 3.2. 
3.2.4. Sequencing and contiguous map of Ryrl cDNA fragments 
To determine the murine Ryrl cDNA fragment sequence, the cloned eDNA 
fragments were subcloned and sequenced. The recombinant vector (vector with 
cDNA fragment) was completely digested with Sau3A and A/uI, or HaeIII for sub 
cloning. The resulting DNA fragments were ligated into the BamHI and SmaI 
restriction sites in the pBlueskript II (SK) vector respectively. Some clone(s) were 
also partially digested with CviJI, and fragments in the 0.4 to 0.6 kb size range were 
gel purified and ligated into the SmaI site of the pBlueskript 11 (SK) vector. From the 
resulting white clones DNA was isolated and sequenced in an ABI 373A automated 
sequencer using M- 13 forward and reverse primers. The sequences were assembled 
using the STADEN package, (Staden, 1996; Staden et al., 2000). Gaps in the 
sequence were bridged using a primer walking procedure. 
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Primer Name RT-PCR Product Size 
in kb 
Homologous to human 
RYR1 exon region 
Product name Plasmid vector used 
to clone the product 
Ryr RNA 01 Vs Ryr RNA 02 1.80 1 - 17 cDNA1 pBluescript II (SK) 
Ryr RNA O3VsRyr RNA O4 0.57 14-18 cDNA2 pGEM—T 
Ryr RNA 12 Vs Ryr RNA 13 1.26 18-25 cDNA3 pBluescnpt II (SK) 
Ryr RNA 14 Vs Ryr RNA 15 2.73 25-36 cDNA5 pGEM - T 
Ryr RNA 37 Vs Ryr RNA 38 3.33 (2.7+0.63) 36 - 55 cDNA6 pBluescript 11 (SK) 
Ryr RNA 18 Vs Ryr RNA 19 1.03 54 - 64 cDNA7 pBluescript II (SK) 
Ryr RNA 29VsRyr RNA 3O 1.90 63-77 cDNA8 pGEM—T 
Ryr RNA 38 Vs Ryr RNA 28 1.70 76-91 cDNA9 pGEM - T 
Ryr RNA O7VsRyr RNA O8 1.66 94-3'end cDNA4 pGEM—T 
Ryr RNA 08a 
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Figure 3.2: Effects of MgSO 4 concentration on RT-PCR 
amplification. 
RT-PCR reactions were performed using various concentrations of 
MgSO4 to determine optimal conditions for specific product 
amplification. The products of amplification of a 1.26 kb target 
murine Ryrl cDNA fragment (cDNA 3) using RyrRNA 12 and 
RyrRNA 13 primers are shown above. The reaction products were 







Figure 3.3: Amplification of RNA specific RT-PCR products. 
RT-PCR reactions were performed using water and genomic DNA as 
negative control templates to determine cDNA fragments and DNA 
contamination in the template RNA. Amplification of a 0.57 kb target 
murine Ryrl cDNA using RyrRNA 03 and RyrRNA 04 primers from 
RNA, and a 1.8 kb product from genomic DNA are shown above. The 
reaction products were analysed by agarose gel electrophoresis 
followed by ethidium bromide staining. 
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Sequence data from the nine RT-PCR fragments were contig mapped using the 
STADEN package sequence assembly programme. Overlapping RT-PCR fragment 
contigs are shown in figure 3.4. The 5' cDNA contig provides a length of 12,730 bp 
sequence. The contig was further extended 40 bp 5' upstream by adding exon 1 and 
2 sequence extracted from the published data (EMBL accession number D21798; 
Takeshima et al., 1994a) and assembled with the RT-PCR fragment cDNA 1. The 
sequence data are shown in Annex - 1. 
The fragment cDNA 6 was amplified using primers RyrRNA 37 (5') and RyrRNA 
38 (3'). Sequence analysis of the data from cloned eDNA 6 revealed the presence of 
some sequence (0.63 kb) between the RyrRNA 38 sequence and the cloning site in 
the vector. This additional sequence did not show sequence similarity to RYR] 
mRNA or genomic sequences. Therefore, I concluded that as the additional 
sequence was outside the sequence defined by the RyrRNA 37 and 38 primers it 
represented a cloning artefact. When this artefact sequence was removed an 
overlapping contig between the RT-PCR fragments cDNA 6 and cDNA 7 could be 
established. The overlap between the cDNA 7 and edited cDNA 6 sequences 
provided further evidence that the deleted sequence was an artefact. 
The forward primer RyrRNA 29 (located on the cDNA 7 fragment) and the reverse 
primer RyrRNA 30 (located on the cDNA 4, i.e., 3' end fragment) were designed to 
amplify the gap between the eDNA fragments cDNA 7 and cDNA 4. In RT-PCR 
amplification, these primers amplified a 1.90 kb fragment and extended the contig 5' 
downstream, but did not join the fragments cDNA 7 and cDNA 4. In order to bridge 
the gap another set of primers (RyrRNA 39 and RyrRNA 28) were designed and 
used to amplify total mRNA. The RT-PCR product extends further the sequence 5' 
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Figure 3.4 Schematic diagram of RT-PCR fragments to compile mouse Ryrl cDNA contigs. 
The protein coding region of murine Ryrl eDNA is indicated by an open box, the dotted line in the box indicates an un-
cloned Ryrl region and the 3' - untranslated region is indicated by double lines. RT-PCR fragments are identified by 
numbers on top of the lines and their respective sizes determined by sequencing are indicated by side of the lines. RT-PCR 
ends homologous to human exons are indicated on the top line. The thick black line labelled as "a" indicates exon sequence 
extracted from EMBL database accession number D21798 (Takeshima et al., 1994a). 
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In the sequence assembly, nucleotide mismatches were found between the primer 
RyrRNA 30 and the overlapping cDNA sequence from fragment cDNA 9 (sequence 
matches are shown in bold). Thus, although the primer RyrRNA 30 had been 
designed specifically for the target region in eDNA 4 it acted as a random primer in 
the reverse transcription of the Ryrl mRNA molecule. 
Ryr RNA 30 (primer) 
	
5' CTA TGT CAT CCT CCC CTG GTG G 
3' 
Ryrl cDNA sequence 
	
5' TTG CCC GCC CTC CTC CAG GTG G 
3' , 
A 1.6 kb length 3' end fragment (Annex —2) of the Ryrl cDNA fragment (cDNA 4) 
was cloned using RACE approach. The sequence showed 100% sequence identity to 
murine 3' end sequences in the EMBL DNA database (EMBL accession no: 
X83932; Giannini et al., 1995 and EMBL accession no: D38216; Takeshima et al., 
1995). The 3 '-untranslated region, beginning after the TGA termination codon, was 
85 bp long and a typical polyadenylation signal AATAAA was located 17 base 
upstream of the polyadenylation site. These features are identical to the murine Ryrl 
3' untranslated sequence region reported by Takeshima et al. (1995). 
3.2.5. DeducedAmino acids 
The amino acid sequences were deduced from the murine Ryrl contig sequences 
using the translation programme in the GCG package. The murine Ryrl eDNA 
nucleotide and deduced amino acid sequences for 5' and 3' end are shown in the 
Annex - 1 and Annex - 2 respectively. The 5' end cDNA contig sequence encodes 
4,256 amino acids and the 3' end contig encodes 490 amino acids. 
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Human 100 91.3 	91.1 82.7 55.7 59.3 70.8 64.8 45.4 45.9 46.4 43.3 37.0 45.7 64.6 
Pig 100 90.9 82.9 50.2 59.0 71.6 61.5 45.5 46.1 45.8 43.3 37.3 45.6 64.8 
Rabbit 100 83.0 49.7 59.0 72.7 61.7 45.6 45.8 46.2 43.3 37.3 46.2 66.0 
Mouse 100 72.7 71.3 48.0 65.8 49.8 49.9 45.1 48.2 48.6 52.2 64.5 
Frog 100 50.4 64.6 41.2 65.7 65.9 66.5 66.1 65.6 42.2 62.3 
Fish 100 65.4 61.5 63.9 64.1 65.7 63.9 47.9 43.1 62.0 
ri Human 100 74.9 46.0 46.5 46.0 42.5 43.7 47.3 69.8 
Rabbit 100 65.4 65.9 66.3 66.7 46.3 42.4 56.8 
Human 100 91.7 90.6 38.4 38.8 41.5 58.9 
Rabbit 100 89.4 41.9 38.8 42.3 58.8 
Mink 100 75.4 74.8 42.0 60.1 
Chicken 100 39.5 39.7 58.5 
Frog 100 40.2 59.8 
C.elegan 100 57.9 
I)rosophila 100 
Table 3.3: 	Pairwise nucleotide sequence identity among Ryr isoforms. 
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Ryr 1 Ryr2 Ryr3 Ryr 
Isoforml Species 
Cz 
o - - - - - 
0 
L) 
Human 100 96 	96 90 77 73 63 64 63 63 63 63 64 37 5 
Pig 100 96 90 78 74 64 64 64 64 64 64 64 37 5 
-: Rabbit 100 90 78 74 64 64 64 63 63 63 64 37 5 
Mouse 100 75 71 62 62 62 62 62 62 62 37 5 
Frog 100 78 65 65 65 65 65 65 66 37 5 
Fish 100 63 63 63 62 63 63 63 36 5 
c' Human 100 98 67 67 67 67 67 39 5 
Rabbit 100 67 67 67 67 67 39 5 
Human ioo 96 95 87 86 37 5 
Rabbit 100 95 86 85 37 5 
Mink 100 86 85 37 5 
Chicken 100 85 37 5 
Frog 100 37 5 
C.elegan 100 6 
Drosophila 100 
Table 3.4: 	Pairwise amino acid sequence identity among Ryr isoforms. 
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3.2.6 Homology searches 
	
3.2.6.1. 	Nucleotide sequence 
The EMBL and GenBank databases were searched with murine Ryrl cDNA 
sequence using FASTA and BLAST (Pearson and Lipman, 1988; Altschul et al., 
1990a; 1990b; Pearson et al., 1997; Pearson, 2000). The sequence search reveals 
that the murine Ryrl sequence has more sequence similarity with mammalian Ryrl 
sequences than with those of other species and other isoforms (Ryr2 and Ryr3). To 
calculate sequence identity among published Ryr sequences, pairwise alignments 
were made using the GAP programme in GCG (Smith and Waterman, 1981). The 
overall nucleotide sequence identities among the murine Ryrl and published 
sequences are given in table 3.3. 
3.2.6.2. 	Amino acid sequence 
Multiple alignment was made using the pileup programme (Feng and Doolittle, 
1987; Higgins and Sharp, 1989) with the deduced murine amino acid sequence and 
the published Ryr sequences. The multiple alignments are shown in Annex - 3. 
From the multiple alignment data, the overall amino acid sequence identities between 
the murine Ryrl and published sequences were calculated and are summarised in 
table 3.4. The deduced murine Ryrl amino acid sequence shares more sequence 
identity with the mammalian RYR1 (90%) and is 75% and 71% identical to frog and 
fish Ryrl amino acid sequences, respectively. Pairwise comparisons with Ryr2 and 
Ryr3 sequences from mammals and bird (chicken, Ryr3) showed 62% sequence 
identity. 
The Ca 2+  release channel is modulated by four physiologically relevant molecules: 
2+ 	2+ Ca , Mg , ATP and calmodulin (Zorzato et el., 1990). In the Ryr protein, Ca 2+  
calmodulin-dependent protein kinase and adenine nucleotide binding sites have been 
identified with the use of putative modulatory sites for glutamate-rich region, 
RXXS/T regions and GXGXXG regions respectively (Otsu et al., 1990; Zorzato et 
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el., 1990; Nakashima et al., 1997; Franck et al., 1998). The presence of these sites 
was determined for the deduced amino acid sequences from murine Ryrl 5' and 3' 
end contigs and other published Ryrl amino acid sequences. The locations of these 
sites in the amino acid sequences were predicted using the localpattern programme 
in GCG package. 
A search of the deduced amino acids from murine Ryrl amino acid sequence (5' and 
3' end contigs) revealed a total of 17 sites for RXXSIT sequence, 5 sites for 
GXGXXG and one site for gluamate-rich region (see Annex - 3). Of the 17 sites for 
RXXSIT 13 sites are conserved in the mammalian (human, pig, rabbit and mouse) 
sequences. Another 3 sites are conserved in the mammalian Ryrl sequence with one 
exception (either human or pig or rabbit) for each site and 3 sites were found to be 
conserved in vertebrate Ryrl sequences (human, pig, rabbit, mouse, frog and fish). 
One site (at amino acid position 2174 - 2177) was found to be unique to murine 
Ryrl sequence. 
Of the 5 putative nucleotide binding sequence sites (GXGXXG) found in the murine 
Ryrl deduced amino acid sequence (from 5' and 3' end contigs), 4 were found to be 
conserved in vertebrate Ryrl sequences and one site was found to be conserved only 
in the mammalian Ryrl sequences. 
A single glutamate-rich region corresponding to a putative ça 2 binding site region 
in the murine sequence was observed between residues 1875 - 1925. This region is 
conserved in all vertebrates except the fish Ryrl sequence. The glutamate-rich site 
in the fish Ryrl amino acid sequence shows a positional shift in the multiple 
alignment. The predicted sites are marked in Annex - 3. 
Sequence data are available for different Ryr isoforms in a variety of species. I 
examined the evolutionary relationship amongst these Ryr isoforms. The multiple 
amino acid sequence alignment was analysed using the graphical phylogenetics 
package Phylo_Win (Galtier et al., 1996). The murine Ryrl deduced amino acid 
sequence clustered closely with the other mammalian Ryrl isoforms. The murine 
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Ryrl sequence was found to be more closely related to Ryrl sequences from frog 
and fish than to Ryr2 or Ryr3 sequences in other mammals (figure 3.5). The results 
from the phylogenetic analyses are in close agreement with the earlier analysis by 
Franck et al. (1998). 
3.2.6.3. Homologous regions for human MH and CCD mutations 
In humans, mutations in the RYRJ gene have been identified through analysis of MH 
pedigrees (Gillard et al., 1992; Keating et al., 1997; Lynch et al., 1997; Manning et 
al., 1998; Phillips et al., 1994; Quane et al., 1993; 1994a; 1994b; 1997; Zhang et al., 
1993). The alteration (C1840T) of the RYR] cDNA sequence deletes a RsaI site. 
Other mutations cause loss or gain of restriction sites in many cases (table 1.1). 
These mutations have been identified through comparison of cDNA prepared from 
affected and normal individuals. The mutations and restriction site changes are listed 
in the table 1.1. These mutations are used to diagnosis MH inheritance in the family 
pedigrees (Fagerlund etal., 1994; 1995; 1996; Beyer and Varsanyi, 1997; Monsieurs 
etal., 1998). 
The mouse sequences homologous to the regions containing the human MH and 
CCD mutations were examined in the murine Ryrl cDNA sequence. To identify the 
homologous regions in the murine sequence, mutant amino acid positions were 
located on the human RYRJ cDNA sequence (EMBL: j05200.em_hu4) and then the 
homologous regions were identified through pairwise alignment between human and 
mouse amino acid sequences. The nucleotide homologous regions were summarised 
in the table 3.5. The amino acids homologous to those mutated in human MH, CCD 
RYR 1 protein are marked in Annex —3. 
17Jl_ 0 . 061 Chicken Ryr3  
( 1 oo) L 
Frog Ryr3 
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C. elegan Ryr 
Figure 3.5: 	Phylogenetic tree of Ryr isoforms based on protein sequence data. 
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Table 3.5: 	Murine sequence homologous regions to RYR1 mutations identified in MH and CCD families. 












Amino acid position in 
mouse 
CTC TGC CTG 35Cys CTC CGC CTG Cys—*Arg MH GTT GTG TCT 37Cys 
GTC CGC GTT 163 Arg GTC TGC GTT Arg - Cys CCD / MH GTT CGA GTT 165 Arg 
ACA CTG TGG 198 Leu ACA CTA TGG None ACT CTG TGG 200 Leu 
GAG GGG GGA 248 Gly GAG AGG GGA Gly - Arg MH GAG GGA GGG 250 Gly 
TAC GGG GAG 341 Gly TAC AGG GAG Gly - Arg MH TAT GGA GAG 343 Gly 
TAT GCC GCT 359 Ala TAT GCT GCT None TAT GCT GCC 361 Ala 
ATG ATC CAC 403 lie ATG ATG CAC lie -> Met CCD / MI-I ATG ATA TAC 405 lie 
CTG CGC AAC 471 Arg CTG TGC AAC Arg - Cys CTG CGC AAC 473 Arg 
CTC TAT GAA 522 Tyr CTC TCT GAA Tyr - Ser MH CTC TAT GAA 524 Tyr 
GAT CGG CTG 552 Arg GAT TGG CTG Arg—Trp MH GAC CGT CTG 554 Arg 
GCC TCA TCT 556 Ser GCC TCG TCT None GCC TCA TCT 558 Ser 
GTA CGC TCC 614 Arg GTA TGC TCC Arg—*Cys CCD/MH GTA CGC TCC 616 Arg 
GTA CGC TCC 614 Arg GTA CGT TCC Arg—*Leu MH GTA CGC TCC 616 Arg 
TGC CCT GTG 762 Pro TGC CCC GTG None TGC CCC GTG 764 Pro 
CAG ACA ACA 981 Thr CAG ACG ACA None CAG ACA ACT 983 Thr 
CAC AAC GTG 993 Asn CAC AAT GTG None CAC AAT GCT 995 Asn 
ATG ATC GAC 1152 lie ATG ATT GAC None ATG ATT GAT 1154 lie 
CTG CCA GCT 1786 Pro CTG CTA GCT Pro - Leu CTG CCA GCT 1789 Pro 
TTC AAA GAT 2012 Lys TTC AAG GAT None TTC AAA AAT 2014 Lys 
CTG GGC AGC 2059 Gly CTG TGC AGC Gly - Cys CTG GGA AGC 2061 Giy 
ATC CGC TCG 2162 Arg ATC TGC TCG Arg 	Cys MH ATC CGC TCA 2164 Arg 
ATC CGC TCG 2162 Arg ATC CAC TCG Arg—* His MH ATC CGC TCA 2164 Arg 
ATC GTG CAG 2167 Val ATC ATG CAG Val -+ Met MI-I ATT GTG CAG 2169 Val 
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Amino acid position in 
mouse 
GAG ACG GTC 2205 Thr GAG ATG GTC Thr —> Met MIFf GAA ACA GTC 2206 Thr 
CCC GCC CTG 2366 Ala CCC GCT CTG None CCT GCC CTG 2367 Ala 
CTC GGA CGC 2433 Gly CTC AGA CGC Gly -* Arg MH CTA GGA CGC 2434 Gly 
GGA CGC TGT 2434 Arg GGA CAC TGT Arg — His CCD / MH GGA CGC TGT 2435 Arg 
CTC CGC TCC 2457 Arg CTC TGC TCC Arg -4 Cys MH CTT CGG TCC 2458 Arg 
CTC CGC TCC 2457 Arg CTC CAC TCC Arg -* His MH CTT CGG TCC 2458 Arg 
AAG GCG TCC 2499 Ala AAG GCA TCC None AAG GCA TCC 2500 Ala 
CGT GTG TAT 2508 Val CGT GTA TAT None CGA GTG TAT 2509 Val 
CAG CAC CTG 2620 His CAG CAT CTG None CAG CAC CTG 2621 His 
TTC; CGC CGC 2623 Arg TTG CGT CGC None CTT CGA CGC 2624 Arg 
CCC ACG GGC 2658 Tlij CCC AA GGC None CCC ACA GGC 2659 Thr 
GCC ATT GCC 2705 Ile GCC ATC GCC None GCC ATC GCG 2706 Ile 
GTG GAT GCT 2729 Asp GTG GAC GCT None GTG GAC GCT 2730 Asp 
GGA GAG AAC 2778 Glu GGA GAA AAC None GGT GAG AAC 2779 Glu 
CTT AGT GCT 2862 Ser CTT AGC GCT None CTC AGC GTG 2863 Ser 
Table 3.5: 	Murine sequence homologous regions to RYR] mutations identified in MET and CCD families. Human RYR] eDNA 
sequence referred its EMBL accession no as j05200.em_hu4 
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3.3. Discussion 
This chapter described the cloning and sequencing of murine Ryrl cDNAs. The 
resulting DNA sequence and predicted amino acid sequences have been examined. 
The 5 'and 3' cDNA contigs of 12.73 kb and 1.61 kb respectively provide almost 
complete coverage of the Ryrl transcript. The sequences were derived from nine 
RT-PCR fragments and were assembled using the STADEN package. The amino 
acid sequence of the encoded (Ryrl) protein was deduced from the cDNA sequence. 
Although the RT-PCR primers were designed from Ryrl exon sequence information 
to anneal to specific sites in the murine Ryr] mRNA, in reverse transcription two 
primers (RyrRNA 30, RyrRNA 28) gave unexpected products as a result of priming 
at other sites. However the products were murine Ryrl specific but smaller than the 
expected product size. In both cases the unexpected priming occurred with the 
reverse primer i.e. the primer used to prime the reverse transcriptase reaction. The 
annealing temperature used for the reverse transcriptase reaction is 48 °C. As RNA-
DNA hybrids are more stable than DNA-DNA hybrids it is possible that reverse 
transcription can be primed by relatively short DNA-RNA hybrids. The requirement 
for sequence matches is at the 3' end of the primer. For primer Ryr RNA 30 shown 
above, there is a high level of sequence matching between the 3'-end of the primer 
and the sequence at the unexpected priming site, with the last five bases matching 
perfectly. In reverse transcription, these reverse primers might anneal with specific 
or random sites on the mRNA and produce cDNA first (-) strands. The cDNA 
second (+) strand synthesis was carried out with a Ryrl specific forward primer. 
Synthesis of a second (+) strand cDNA is only possible if the reverse transcription 
occurs from a Ryrl mRNA template. It appears that in addition to the specific site, 
the reverse primer annealed to a non-specific site on the Ryrl mRNA and produced a 
smaller product. In subsequent PCR cycles the forward and reverse primers used the 
double-stranded cDNA fragment as a template. Amplification of the smaller product 
might be advantageous in subsequent PCR cycles. 
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The relationship between the different Ryr isoforms cloned from different species has 
been analysed. Amino acid comparison among all Ryr isoforms indicates that the 
Drosophila Ryr gene is distinct from the three isoforms present in the vertebrates 
(5% identity). However, the Drosophila Ryr nucleotide sequence showed about 56 - 
65% nucleotide identity at 3' end region of all Ryr isoforms, which suggests that all 
three isoforms evolved from a common ancestor. The nucleotide sequences of the 
Ryr isoforms showed more variation within the species than the (deduced) encoded 
amino acid sequences. For example, the human RYR1 cDNA showed 70.8% and 
45.4% nucleotide sequence identity with RYR2 and RYR3 nucleotide sequences, 
respectively (table 3.3). The deduced human RYR1 amino acid sequence showed 
63% identity to both RYR2 and RYR3 amino acid sequences (table 3.4). 
The murine Ryrl cDNA sequence (5' and 3' end contigs) shared 83% sequence 
identity with mammalian sequences (human, pig and rabbit), and 72% and 71% with 
frog and fish Ryrl cDNA sequences respectively. The deduced murine Ryrl amino 
acid sequence shares greater sequence identity with the mammalian RYR1 (90%), 
and shares 75% and 71% identity with frog and fish Ryrl amino acid sequences, 
respectively. Comparisons between the human RYR1 amino acid sequence and the 
deduced amino acid sequences from the 5' and 3' end contigs revealed that the 
uncloned gap between the two contigs amount to about 891 bps of cDNA sequence 
and encode 297 amino acids. 
The Ca 2+  release channel is modulated by four physiologically relevant molecules: 
Ca 2+'  Mg2 , ATP and calmodulin (Zorzato et al., 1990). Putative Ca 2+'  calmodulin-
dependent protein kinase and adenine nucleotide binding sites have been identified in 
the Ryr protein as glutamate-rich regions, RXXS/T regions and GXGXXG regions 
respectively (Otsu et al., 1990; Zorzato et al., 1990; Nakashima et al., 1997; Franck 
et al., 1998). The presence of these putative binding sites was examined in the 
deduced amino acid sequences from murine Ryr 1 5' and 3' end contigs and other 
published Ryrl amino acid sequences. Amino acid sequences in these regions 
showed some variations. However, most of the regions are highly conserved in 
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mammalian sequences. These conserved sequences are also found in the murine 
sequence. 
Futatsugi et al. (1995) reported the presence of two alternate splicing regions in the 
mouse skeletal muscle Ryrl mRNA, homologous to rabbit Ryrl regions Ala 3481 - 
Glu 3585 (referred to as AS!) and Val 3865 - Asn 3870 (referred to as Ash). 
Searches for the homologous regions in the murine amino acid sequence revealed the 
presence of both sequences. The ASI region is present in the RT-PCR fragment 
cDNA8 and positioned at Ala 3481 - Glu 3585. Multiple alignment of the Ryrl 
sequences revealed the absence of these residues in human and pig sequences. The 
ASH region present in the RT-PCR fragment cDNA9 and positioned at Val 3867 - 
Asn 3872 is conserved in all mammals. 
Takeshima et al. (1989) predicted the secondary structure of the rabbit Ryrl protein 
from the amino acid sequence deduced from cDNA sequence. The predictions 
revealed that the molecule has four highly hydrophobic segments (referred to as Ml 
- M4) in the C terminal tenth that represent transmembrane a - helices. The murine 
amino acid sequence homologous to the four hydrophobic transmembrane domains 
predicted from the rabbit sequence are completely identical. As the murine Ryrl 
sequence is incomplete a full secondary structure prediction is not possible, but it 
would seem likely that these conserved transmembrane structures are also present in 
the mouse Ryrl protein. 
MacLennan and his colleagues compared full length ryanodine receptor cDNA 
sequences from Canadian MH-susceptible Pietrain and MH negative (M}{N) 
Yorkshire pigs and found 18 single nucleotide polymorphisms (Fujii et al., 1991). 
One of the polymorphisms, a replacement of C with T at nucleotide 1843 alters the 
amino acid sequence from Arg to Cys at position 615 (Arginine in MHN and 
Cysteine in MHS). In humans, an equivalent mutation has been found in some MH 
patients. In humans the mutation is know as the Arg 614 Cys mutation and results 
from a C1840T mutation (Gillard et al., 1991; Moroni et al., 1995). In mouse, the 
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arginine residue homologous to the pig and human was found at amino acid position 
616. This amino acid is identical in all vertebrate species (Annex - 3). 
Other mutations associated with human MH and CCD in the human RYRJ gene have 
been found through analysis of MH pedigrees (Gillard et al., 1992; Keating et al., 
1997; Lynch et al., 1997; Manning et al., 1998; Phillips et al., 1994; Quane et al., 
1993; 1994a; 1994b;1997; Zhang et al., 1993). The normal or wild type amino acid 
residues at each of the MH and CCD associated mutation sites were identified in the 
normal human Ryrl amino acid sequence and compared with the murine Ryrl amino 
acid sequence. Amino acid identity between the 'normal' human sequence and 
mouse or other sequences could suggest that these amino acids are conserved 
because they are critical to the function of the protein. Alterations to conserved and 
important residues might be expected to disrupt the protein and have an adverse 
effect on the carrier individual. The amino acid and nucleotide sequences of human 
MH/CCD mutation regions were compared with the corresponding mouse nucleotide 
and amino acid sequences. Although the nucleotide sequences were not 100% 
identical between mouse and human, in these MH/CCD mutant regions, the amino 
acid sequences were 100% identical. These amino acids are conserved in all the 
characterised mammalian Ryrl sequences. Homologues of the human (putative) 
MH/CCD mutations could be made in transgenic mice in order to study the 
relationship between the mutations and disease phenotypes. 
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Chapter 4 
4. Isolation and characterisation of the murine Ryrl genomic clones 
4.1. Introduction 
The mouse genome consists of 19 pairs of autosomes plus an X/Y pair of sex 
chromosomes. The size of the haploid mouse genome is estimated as 3 x 10 9 bp. In 
order to study genes or interesting regions of the genome it is standard practice to 
isolate genomic DNA, break it up into smaller fragments and clone the fragments in 
bacterial cells. For example, eukaryotic genomic DNA fragments are commonly 
cloned in bacteriophage lambda (X) and cosmid vector systems, having cloning 
capacities of up to 24 kb and 45 kb respectively (Lathe et al., 1987). Collections of 
many thousands of independent clones together constitute genomic libraries. But the 
relationships of the clones to one another in a genomic library are unknown. When 
the gene or region of interest is larger than the cloning capacity of the vector it is 
necessary to establish a contig map of the region. 
A contig map is a set of contiguous overlapping cloned fragments that have been 
positioned relative to one another. Where the cloned fragments are small many 
independent clones will be needed to establish a contig map. Therefore, systems that 
can be used to faithfully clone large fragments are essential for contig map 
construction in mammalian genomes. 
P1-derived artificial chromosome (PAC), Eschericha coil (E. coil) single-copy 
plasmid F factor based and bacterial artificial chromosome (BAC) vectors can be 
used to clone DNA fragments up to 300 kb (Shizuya et al., 1992; Ioannou et al., 
1994). Although yeast artificial chromosome (YAC) vectors are capable of carrying 
more than one megabase of insert DNA (Rouquier et al., 1993), the inserts are often 
chimeric and isolation of pure insert DNA can be difficult. On the other hand, both 
PACs and BACs can faithfully propagate DNA fragments of up to 300 kb and the 
insert DNA can be isolated by standard procedures used for plasmid DNA 
purification (Woo et al., 1994). Although high levels of chimeric clones are found in 
all YAC libraries, chimeric clones are not a problem in BAC and PAC libraries 
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(Shizuya et al., 1992). Thus, BAC and PAC clones are excellent tools for generation 
of contiguous (contig) physical maps and chromosomal walking (Rouquier et al., 
1994). 
Cosmid, BAC and YAC libraries have been used to build contig maps of the RYR] 
gene and for chromosome walking in human and pig. The human RYRJ gene has 
been contig mapped from 55 cosmid clones. A gap in the cosmid contig was filled 
with a 800 kb YAC (Rouquier et al., 1994) and a — 15 0 kb BAC clone (Leeb et al., 
1995). A contig of the pig RYR] gene spanning 72.7 kb has been developed from 
three overlapping phage clones (Wen et al., 1996). 
At the start of this project there was only limited genomic information and clones 
available for the Ryrl region in mice. The Ryrl genomic clones had been isolated 
from murine libraries in order to create knockout mouse models in the Ryrl exon 2 
(Takeshima et al., 1994a) and exon 10 (Moore et al., 1998) regions. Isolation of the 
entire Ryrl genomic region in cloned form would provide an excellent resource for 
the development of mouse models for mutations associated with the MH and CCD 
diseases. As the Ryr] gene is large (-150 - 200 kb) large fragment clones such as 
BAC would be useful for building such a contig map. 
In this chapter I describe isolation and contig mapping of the murine Ryrl locus. 
This approach takes advantage of BAC and PAC clones and the principles of DNA 
fingerprinting and sequence-tagged site (STS) maps using sequence specific primers. 
I used murine Ryrl specific PCR products to screen a BAC library and analysed 
them in the first phase. PAC clones were isolated to fill the gap between BAC 
contigs. Then STS primers were used to order the BAC and PAC clones. Through 
this approach, I constructed a BAC and PAC contig of more than 450 kb containing 
the entire Ryrl gene. 
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4.2. Result 
4.2.1. Analysis of a murine BAC library 
4.2.1.1. 	BAC library screening and clone isolation 
The commercially available (CITB) mouse BAC library was supplied by Research 
Genetics Inc., USA. In this library mouse genomic DNA was cloned into the Hindlil 
site of the pBe1oBAC11 vector (figure 2.1). The library consists of 221,184 clones 
that are organised in 72 super pools, and has a genome coverage of 7.37 fold. Each 
super pool represents 8 plate pools with each plate pool corresponding to a pool of 
DNA from the 384 colonies on a single plate. The super pools and plate pools were 
supplied as purified DNA. Specific plates were requested from Research Genetics 
after screening super pools and plate pools. 
The BAC library was screened using PCR amplification of the target region(s). PCR 
primers were designed from the Ryrl exon 1 (Takeshima et al., 1994a; EMBL: 
D21798), exon 17 (Hitchin, unpublished; EMBL: X95655) and the 3' untranslated 
region (UTR) (Takeshima et al., 1995; EMBL: D38216). The primer sequences, 
amplification product sizes and annealing temperatures are listed in table 4.1. Before 
screening the library, PCR conditions for each primer pair were standardised on 
genomic DNA from the 129-mouse strain. The BAC super pools (72) were screened 
first. The corresponding plate pools for the positive super pool were then screened 
by PCR. The positive individual plates were obtained form Research Genetics, USA. 
The supplied master plates were replica plated and initially screened by colony-PCR 
amplification (see section 2.8.1.2). Positive BACs were picked from the 384 well 
replica plate and plated on LB agar medium with 12.5 tg/ml of chloramphenicol in 
order to isolate single colonies. A single colony was cultured and checked again for 
the presence of the target STS by PCR 
E3 
Primer name Sequence (5'-3') Annealing 
temperature 
(°C) 




Ryrlexon 1.for GGG GGA OCT TCT CTC ATT GTG T 59 1.5 252 
Ryrlexon 1.rev GGA CCC AGA CAA AAA CGT ACC G 
Ryrlexonl7.for TGT CCT GAT TGA GAG TCC TGA GG 55 1.5 461 
Ryrl exon 17.rev CTG AGO CTG AGG TCA TGT TGG 
Ryrl 3'end.for COT CCC CCA CCT CAA GTG 55 1.5 100 
Ryrl 3'end.rev GGG GGT GTA GCA CAG GAT TT 
13RA2.for GTG CCC CTC TGG OCT CTG TA 60 1.5 199 
1E3RA2.rev AGO GGG CAG AGG GGT TTC 
Ryrl exon 64.for AGT CAC TCA AGO CTC OTT ATG 60 1.5 258 
Ryrl exon 64.rev GGA AAA GTG AGA AAA ATG GG 
Table 4.1: 	Primers used to screen BAC library to identify presence of specific PCR product in 
super pools, plate pools and individual plates. 
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Primer name Sequence (5'-3') Annealing 
temperature 
(°C) 




Ryrlexon 1.for GGG GGA CCT TCT CTC ATT GTG T 59 1.5 252 
Ryrlexonl.rev GGA CCC AGA CAA AAA CGT ACC G 
Ryrlexonl7.for TGT COT GAT TGA GAG TCC TGA GG 55 1.5 461 
Ryrl exon 17.rev CTG AGC CTG AGG TCA TGT TGG 
Ryrl 3'end.for COT CCC CCA COT CAA GTG 55 1.5 100 
Ryrl 3'end.rev GGG GGT GTA GCA CAG GAT TT 
13RA2.for GTG CCC CTC TGG OCT CTG TA 60 1.5 199 
13RA2.rev AGO GGG CAG AGG GGT TTC 
Ryrl exon 64.for AGT CAC TCA AGO CTC OTT ATG 60 1.5 258 
Ryrl exon 64.rev GGA AAA GTG AGA AAA ATG GG 
Table 4.1: 	Primers used to screen BAC library to identify presence of specific PCR product in 
super pools, plate pools and individual plates. 
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Table 4,2: 	Positive pools identified from BAC library. 
PCR screening identified pools and individual clones. Each super pool corresponds to 8 plate pools. 
- represents the presence of right size PCR products corresponding to each target region of murine Ryrl gene. 
• - represents non-positive clones either in the plate pools or plates 
4- represents false positive clones identified form the plate. 
	
Presence of PCR product to 	 Plate pool Plate 	Clone position 
no 	no in the plate 
Exoni Exon 17 3' UTR 13 Right Exon 64 
arm 
























Table 4.2: 	Positive pools identified from BAC library. 
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amplification. Then DNA samples from confirmed positive BACs were prepared. 
The results of screening the BAC library for Ryrl exon 1, exon 17 and the 3 '-UTR 
are summarised in table 4.2. 
The DNA isolated from BAC clones 548_L24, 236_13 and 421_116 was confirmed 
by PCR to contain Ryrl exon 1, exon 17 and the 3 '-UTR end respectively. In the 
BAC library, the mouse genomic DNA fragments were cloned in the HindIII site of 
the vector pBe1oBAC 11. The vector has a NotI restriction site on either side of the 
Hindlil cloning site. As NotI cuts infrequently in the mouse genome NotI digestion 
can be used to release the BAC insert DNA (figure 2.5). The BACs were digested 
with Nod restriction enzyme and digestion products were analysed by pulsed-field 
gel electrophoresis. In NotI digests, the 7.5 kb vector band (Wang et al., 1997) and 
the insert DNA fragments were observed. BAC 548_L24 and BAC 23613 showed 
insert sizes of -435 (45+90) kb and --185 (45+140) kb respectively with internal NotI 
sites. Nod digestion of BAC 421_116 yielded a single insert band of --100 kb (figure 
4.1). 
4.2.1.2. 	Generation of BAC end probes 
The right and left ends from each BAC clone were isolated by plasmid end rescue 
and inverse polymerase chain reaction respectively (see section 2.8.4). The end 
fragments were used as probes to identify the overlapping regions among the BACs. 
The BAC ends were isolated by digesting BACs separately with each of BamHI, 
EcoRI, KpnI, Sad, Smal, and SphI. The digestion products from each enzyme were 
self ligated and used for end isolation as described in the material and methods 
section (see also figure 2.5). 
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Figure 4.1: Ethidium bromide-stained BAC DNA analysed by pulsed-field gel 
electrophoresis 
DNA was digested with Nod. Separation of the digested DNA was carried out on a 
CHEF DR - III system (Bio-Rad) for 18 h at a field strength of 6 V/cm in a 1% agarose 
gel in 0.5 X TBE at 14 °C with 1200  angle and a initial and final switch intervals of 5 to 
l5sec. 
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Figure 4.2: Generating BAC ends by PCR 
(A): BA  right end generated byplasmid rescue 
PCR products labelled as "a, b and c" indicates the bands selected 
For BAC right end analysis 
a 
	
	Right end fragment after the BAC 236_13 digestion 
with BamHl 
b 	Right end fragment after the BAC 421_16 digestion 
with BamHI 
c 	Right end fragment after the BAC 548L24 digestion 
with BamHI 
(B): BA  left end generated by inverse-PCR 
PCR products labelled as "d, e and f" indicates the bands selected 
For BAC left end analysis 
d 	Left end fragment after the BAC 236_13 digestion 
with EcoRI 
e 	Left end fragment after the BAC 421_16 digestion 
with Sad 
f 	Left end fragment after the BAC 548_1-24 digestion 
with EcoRI 
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Marker HO 	BAC 236 13 	BAC 421116 BAC 5481-24 












Figure 4.2: Generating BAC ends by PCR 
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BAC end Primers Primer sequences Annealing Mg 2+ con 
Fragment size 
temperature in mM in kb 
(°C) BAG  
23613 	421 	16 548_L24 
Right M13 forward GTA AAA CGA CGG CCA GT 55 1.5 1.0 	2.5 	0.3 
BAC4 CAC TAT AGA ATA CTC AAG 
Left BAC1 CTG CAG GCA TGC AAG C 60 1.5 0.4 	1.2 	0.3 
BAC2 GTC GAC TCT AGA GGA TC 
Table 4.3: 	Primer pairs used to amplify BAG end fragments 
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For right end isolation, the ligated products were transformed into E.coli DH5ct and 
the clones were selected for chioramphenicol resistance. White colonies were 
obtained from the BamHI, Sad, and SphI digests and self-ligations. Plasmid DNA 
was prepared from white colonies and double-digested with the selected enzyme (e.g. 
BamHI) and HindilI to release the right end fragments. The digests were separated 
on agarose gels to allow selection of the smallest fragment. Unfortunately, clear 
insert fragments were not observed. This problem was solved by PCR amplification, 
using M-13 forward and BAC4 primers (figure 2.5; table 4.3). The PCR amplified 
products (figure 4.2-A) were gel purified and used as probes. 
For left end isolation, self-ligated products were directly PCR amplified using BACI 
and BAC2 primers (figure 2.5; table 4.3). The products were double-digested with 
the relevant enzyme (e.g. EcoRl) with Hindlil and then gel separated. EcoRI 
digested, self ligated fragments yielded the smallest PCR products from BAC 
543_L24 and BAC 236_13 and Sacl derived ligation for BAC 421_116 (figure 4.2-
B). These 'left end' products were gel purified and used as probes. 
4.2.1.3. 	Sequencing the end of BAC inserts directly 
BAC ends were sequenced directly to develop new sequence-tagged sites (STS) and 
PCR primers to be used in BAC/PAC analysis. This approach provides a quick and 
easy means of generating paired STS markers and gene walk probes compared to the 
BAC end isolation and sequencing approach. 
BAC and PAC ends have been direct end-sequenced using different methods (Wang 
et al., 1994; Boren et al., 1996; Boysen et al., 1997; Kelly et al., 1999). In this 
present study, BAC DNA was subjected to cycle sequencing using FS+ dye 
terminator cycle sequencing on an ABI 373A automated sequencer. The reaction 
conditions were standardised with different amounts (20 - 50 pmoles) of vector-
based primers (table 4.4) with 1-3 jig of BAC template DNA. Poor quality data with 
weak signals were observed in sequence reactions containing less than 30 pmoles of 
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primer (both in standard and longer primers) and less than 2 jig BAC template DNA. 
On the other hand, 2-3 jig BAC template DNA with 30-50 pmoles of primer yielded 
good sequence data. However, too many non-specific bases (N) were observed 
throughout sequences when the standard 16-18 mer sequencing primers were used. 
I have directly sequenced BAC insert ends from BAC 548_L24, BAC 23613 and 
BAC 421_116. The BAC right and left ends of the inserts were sequenced using 
longer SP6 and T7 primers (table 4.4) respectively, without subcloning. The insert 
end-sequences were then compared to the available sequences in the database using 
FASTA and BLAST searches. Both end sequences from the BAC 236_13 and BAC 
412116 showed poor sequence similarity with human genomic and other sequences. 
Interestingly, the sequence from BAC 548_L24 using the primer SP6 showed 
sequence similarity to human RYRJ exon 64 region and other Ryr] sequences (Sus 
scrofa, rabbit, Oryctolagus cuniculus, Rana catesbeiana) (figure 4.3) and the 
sequence using T7 primer showed similarity to many murine repeat family 
sequences. The sequences from BAC 236_13 (both ends) and BAC 548_L24 (right 
end; SP6 primer) were used to develop end STSs. 
BAC end 	Primer 	 Sequence 5' - 3' 
Right 	BAC4 CAC TAT AGA ATA CTC AAG 
SP6 GAT TAC GCC AAG CTA TTT AGG TGA CAC TAT AGA ATA C 
M-13 reverse GGA AAC AGC TAT GAC CAT G 
Left 	BAC1 CTG CAG GCA TGC AAG C 
T7 TAA TAC GAC TCA CTA TAG GGC GAA TTC GAG CTC GG 
M-13 forward GTA AAA CGA CGG CCA GT 
Table 4.4: 	Primers used to sequence BAC ends. 
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BacL2 4sp€ : 	TGGAGGACG: ACAAGTGTCTTGCTACCGAACGCTC: GCAGTAT: .TACT'T::TGGGAACCACCAGGAACCCCTATGTGGMG. 
u4E482 	: 
z54280 TGGATGACGTTCAGGTCTCTTGCTATCGAACGCTGTGCAGTATCTACTCTCTGGGAACCACCAGGAACCCTTACGTGGAAAAG.  
x15209 	: ATCC. 
a20359 . ...........ACGTCCAGGTCTCTTGCTACCGAACGCTGTGCAGTATCTACTCCCTGGGAACCACCAAGAACACTTATGTGG1JAAGCTTCGGCCA 
j05200 	ATCC.TGGACGACGTCCAGGTCTCTTGCTACCGAACGCTGTGCAGTATCTACTCCCTGGGAACCACCAAGAACACTTATGTGGAAAAGCTTCGGCCA  
m91451 : ATCC. TGGATGACGTTCAGGTCTCTTGCTATCGAACGCTGTGCAGTATCTACTCTCTGGGCCACCAGGAACCCTTACGTGGAJJGCTGCGGCCA 
m91452 	: ATCC. TGGATGACGTTCAGGTCTCTTGCTATCGAACGCTGTGCAGTATCTACTCTCTGGGCCACCAGGAACCCTTACGTGGJGCTGCGGCCA 
x62880 : ..CC.TGGATGACGTTCAGGTCTCTTGCTATCGAACGCTGTGCAGTATCTACTCTCTGGGAACCACCAGGAACCCTTACGTGGAAAAGCTGCGGCCA  
x15750 	: . TCC.TGGATGACGTGCAGGTGTCTTGCTACCGAACATTGTGCAGCATCTACTCTCTGGGGACCACCAAGAACACTTATGTGGAAAAGCTACGGCCA  
Figure 4.3: Sequence homology to BAC 548_L24 right end 
The BAC 548_L24 DNA (3j.tg) was directly right end sequenced with 37 base length SP6 primer (50 pmol) using ABI 
- Cycle sequence protocol. Sequence homology to the BAC 548_1,24 - SP6 was identified through BLAST search 
and then aligned. Red and blue sections in the sequence are intron and exon sequences respectively. Black sequences 
are cDNA sequence out side to the exon 64 region. The sequence identity with human RYRI exon 64 genomic region 
(U48482), human cDNA (J05200, A20359), pig genomic (Z54280), pig cDNA (M91451, M91452, X62880), and 
Rabbit cDNA (X15209, X15750) sequences are marked in blue. The numbers listed at the beginning of each sequence 
represent respective EMBL accession numbers for the sequences. 
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4.2.1.4. 	Construction of the Ryrl BAC contig 
To examine the overlap between the BACs, clones were tested first for the presence 
of STSs, then by fingerprinting using the human RYRJ cDNA, murine Ryrl genomic 
DNA and BAC end-fragments as probes. 
4.2.1.4.1. Sequence-tagged site (STS) analysis 
The primers initially used for BAC library screening (exon 1, exon 17 and 3'UTR) 
and BAC end-derived STSs (I3LA, 13RA2, II6RA) (see table 4.7) were used to 
amplify PCR products from the BAC clones. The BAC 548_L24 and BAC 236_13 
were both positive for exon 1, exon 17 and exon 64 (BAC 548_L24 right end STS). 
The 3' UTR region was found only in the BAC 421_116. The BAC 236_13 right-end 
STS was only found in the source clone (i.e. BAC 23613). These results suggested 
that the BAC 548_L24 and BAC 236_13 clones overlap in the 5' region and that 
there was a gap between the BAC 548_L24/BAC 236_13 and BAC 412_116 clones. 
4.2.1.4.2. Southern analysis 
The human RYRJ cDNA (Rouquier et al., 1993) and the BAC ends were used as 
probes in BAC DNA fingerprinting analysis to confirm and estimate the degree of 
similarity between the clones for contig map building. The end probes could also be 
useful to bridge/identify the gap between the clones. For fingerprinting the BACs 
were digested with EcoRI, Hindill, and NotI endonucleases, Southern blotted and 
hybridised separately with a( 32P)dCTP labelled probes. 
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Figure 4.4: Screening for overlapping BAC clones by Southern 
hybridisation 
	
(A) 	Southern hybridisation of the BAC clones with plasmid vector 
as probe 
Because of the presence of an EcoRl site on the pBeloBAC 11 
(see figure 2. 1), digestion with EcoRI produced an insert-vector 
fragment in BAC. The BAC library was constructed in the 
HindU! site. HindIlI digestion releases 7.4 kb vector without 
any insert fragment. 
(B - F) 	DNA finger printing of the BAC clones with human RYR1 
cDNA fragments 
EcoRl and Hindlil digested BACs DNA were hybridised with 
human RYR] cDNA fragments HRR6 (B), HRR5 (C), HRR4 
(D), HRR3 (E) and HRRI (F). 
The "v" indicates insert-vector (in EcoRI digest) and vector (in 
Hindul digest) band. 
The arrowheads indicate the fragments hybridised with human 
RYR] cDNA fragments. 
Lane I BAC 548_L24 
Lane 2 BAC 236_13 
Lane 3 BAC42I_116 
Lane  BAC4I2 019 
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Probe 5' -3' 
Probe size 
in kb 
EcoRI digest fragment size 
in kb 
BAC 
548_L24 	236_13 	421_116 
HindIll digest fragments size 
in kb 
BAC 
548_L24 	236_13 	421_116 
HRR6 2.5 10.5 10.5 12.1 12.1 
2.6 2.6 9 9 
1.75 1.75 4.3 4.3 
3.8 3.8 
HRR5 3.8 10.5 10.5 4.3 4.3 
5.3 5.3 3.7 3.7 
1.85 1.85 3.3 3.3 
HRR4 2.4 9.8 9.8 11 11 
6.4 6.4 





1.5 6.6 3.4 
0.7 10.3 10.3 11 
4.8 4.8 3.3 
1.1 5.1 
HRR2 2 9.6 6.5 
HRRI 0.5 13.8 9 
3.4 
0.7 13.8 9 
3 
Table 4.5: 	BAC clones hybridising with human RYRJ cDNA probes 
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Fingerprints for each BAC clone were established based on combinations of 
restriction enzyme, fragment size and probe used. The presence of the same 
fragment as defined by a combination of fragment size, restriction enzyme and probe 
hybridisation in two or more BAC clones could provide evidence of overlaps 
between the clones. Where several fragments of this type are found in common 
between two clones then the clones can be assumed to overlap. Complete EcoRI, 
Hindill and NotI digests were used for fingerprinting to identify overlaps between 
the BAC clones. The order of restriction fragments within each BAC clone using 
analysis of partial digests was not established. 
The NotI digests performed in order to estimate the size of the cloned inserts had 
revealed an internal Nod site in the BAC 23613 and BAC 548_L24 clones. 
Inspection of the sequence of the human RYRJ cDNA revealed a NotI site in a region 
corresponding to exon 25. The NotI digests of BAC clone DNA were probed with a 
2.5 kb EcoRI fragment from construct vector pRyr2005 that contains murine Ryrl 
exons 14 - 20 (see chapter 5). This probe hybridised with 140 kb and 90 kb Nod 
fragments from BAC 236_13 and BAC 548_1-24 respectively and not with the vector 
band, confirming that the insert was composed of murine DNA and contained 
sequences from the Ryrl gene. This probe (exon 14 - 20) did not hybridise to DNA 
from BAC 412116. 
The complete transcript of the human RYR] gene (15 kb) was available in the form 
of six different cDNA clones each of about 2.5 kb (Rouquier et al., 1993). These 
human RYRJ cDNA fragments and BAC end probes were used separately to probe 
EcoRI and Hindlil digested BAC DNA. Many shared DNA fragments from BAC 
548_L24 and BAC 236_13 were found with the 5' end human RYRJ cDNA probes 
(HRR6, HRR5, HRR4, HRR3) (figure 4.4-B-E/ table 4.5) and STS markers (table 
4.7). The human cDNA clones HRR6 to HRR3 corresponded to exons I to 84. 
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S 
4 	 ...' 
5' 	Mouse RvrI locus 	 I 	I 	I I 	I 
I3AC 412 019 (200 kb) 
f3AC23613(195kb) I 
BAC 548 124(135kb) I 
BAC 421 1 16 (100 kb) 
Figure 4.5: BAG contig map of the murine Ryrl gene region 
BAG contig map in the murine Ryrl region established by Southern hybridisation - base analysis and presence 
of STS markers. Genomic insert size (in kb) were determined by pulsed - field electrophoresis and are not 
scaled in the figure. The orientation (5' - 3') of the Ryrl gene region and the approximate location of the STS 
markers are on the top line. 
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This Southern hybridisation analysis confirms that the BAC 548_L24 and the BAC 
23613 are overlapping clones which harbour sequences from the 5' end. These 
genomic clones hybridise to sequences equivalent to the 5' region 11.8 kb of the 
human RYR] cDNA which corresponds to exons 1 to about 84 (Phillips et al., 1996). 
Although BAC 236_13 clone was isolated with exon 17 specific PCR primers, I 
subsequently confirmed through Southern hybridisation and BAC 236_13 end STS 
amplification, that this clone harbours exon 1 and also extends 5' upstream and 
downstream to exon 64 (table 4.8). 
The BAC 421_116 hybridised with the 3.6 kb human cDNA probe from 3' end 
(HRR1 and HRR2) but did not share any band in common with BAC 548_L24 or 
BAC 236_13 (figure 4.4-F). The BAC 23613 end STSs did not yield any PCR 
products (table 4.8) and also the BAC 421_116 right and left end probes did not 
hybridise to the other BACs (data not shown). These analyses confirmed that there is 
a gap between the BAC 548_L24/ BAC 236_13 and BAC 421_116. From these data, 
a preliminary contig map for BAC clones was constructed (figure 4.5). 
BAC fingerprinting, STSs and end-fragment hybridisation experiments failed to 
detect overlap between BAC 548_L24/ BAC 236_13 and BAC 421_116. To bridge 
the gap and extend the contig, sequence information from the "left (T7) and right 
(SP6) ends" of the BAC 236_13 and the "right end / SP6 end" of BAC 548_L24 were 
used to design PCR primers for further screening of the library. The "right end / SP6 
end" of BAC 548_L24 matches the sequence of exon 64 of the human RYR] and 
represents the 3' or right hand end of BAC 548_L24 clone shown in figure 4.5. PCR 
screening with the exon 64 primers designed from the BAC 548_L24 rightlSP6 end 
did not identify any new BAC clones (table 4.2). PCR screening of the library with 
primers designed from the "right/SP6 end" of BAC 236_13 identified nine new 
BACs. DNA from these new BACs was examined by PCR for the presence of BAC 
23613 end, exon 1, exon 17 and 3'UTR sequences. Eight of the clones were false 
positives as they were negative for the presence of the BAC 236_13 end sequence. 
Although the remaining BAC clone (BAC 412_019) was positive for the BAC 
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236_13 end sequences it did not contain Ryrl exon 1, exon 17 or the 3'UTR. 
Therefore, BAC 412_019 extends the contig 5' to the Ryrl gene (figure 4.5). The 
primers designed from the sequence of the "left (T7) end" of BAC 236_13 lacked 
specificity when used to screen the library. Thus, the further screening of the BAC 
library failed to identify any clones that bridge the gap between BAC 548_L241 BAC 
23613 and BAC 421116. As discussed later, the BAC 412_019 clone allowed me 
to locate the Ryrl locus on the cytogenetic map of the mouse genome. 
4.2.2. Analysis of murine PAC library screening 
4.2.2.1. 	PAC library screening 
As the BAC library did not appear to contain all the Ryrl sequences a 12.6 fold 
genorne coverage mouse PAC library constructed at the Roswell Park Cancer 
Institute (RPCI-2 I mouse PAC library) was screened. The library has been arrayed 
into 384 well microtiter dishes and gridded on 22x22 cm nylon high-density 
hybridisation filters for screening by probe hybridisation. Each hybridisation 
membrane represents 27,650 distinct mouse PAC clones, stamped in duplicate (see 
section 2.8.2.2). 
A total of 10 membranes covering the entire murine PAC library was screened using 
murine Ryrl-specific exon 1 (Takeshima etal., 1994a), exon 17 (unpublished), the 3' 
UTR (Takeshima et al., 1995), exon 64 (BAC 548_L24 SP6 end) PCR products and 
human RYRJ cDNA clone HRR2 as probes. Before screening the library, the probes 








Figure 4.6: PAC library screening by hybridisation 
PACs positive for the Ryrl probes were identified on the filters by duplicate clone 
hybridisation patterns. Schematic representation of the 12 possible orientation of 
duplicate clones are shown in figure 2.4. 
Example: 	RPCI —21 Mouse PAC library; Membrane ID - 109 - 7-235 
a 
Example on Hybridisation 
the figure 	orientation type 
a 	 5 
b I 
C 	 7 
d 3 
C 	 no 
Clone position on 
the membrane 
xl 	yl x2 y2 
234 23 231 24 
171 	60 171 57 
114 	103 111 104 







Non specific clone 
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A primary screening of the high-density hybridisation filters identified a total of 29 
positive PAC clones from nine membranes and one (membrane ID: 109-8-263) 
showed no hybridisation pattern. These positive PAC clones were identified based 
on the hybridisation pattern observed by autoradiography (figure 4.6). The 
individual clone identity was calculated by clone position and x,y-co-ordination on 
the membrane (see section 2.8.2.3). The 29 specific clones (clones by xly-co-
ordination) were requested from the German Human Genome Project Resource 
Centre at the Max Planck Institute for Molecular Genetics (http://www.rzpd.de ) who 
act as distributors of the RCPJ libraries. The clone positions on the membrane and 
corresponding clone names are listed in the table 4.6. The clones were supplied as 
individual agar stabs. These clones were plated on LB agar medium with 25 tg 
kanamycinlml for single colony isolation and DNA was isolated from a single colony 
culture. 
In the PAC library, the mouse genomic DNA fragments were cloned into the BamHI 
site of the vector pPAC4 by replacing a 2.7 kb vector BamHI fragment. The vector 
also has NotI restriction sites on either side of the BamHI cloning site (figure 2.3; 
http://bacpac.med.buffalo.edu/pac/ppac4.g) . The insert size of the PAC clones was 
determined by pulsed-field electrophoresis of NotI digested clone DNA. In NotI 
digestion, the 16.8 kb vector band and the insert DNA fragments were observed 
(figure 4.7). The insert sizes were calculated by comparison with the molecular 











A1-A6 	B1-B6 	C1-C6 	D1-D6 	E1-E5 
I 	I I! 	 I 
Figure 4.7: Ethidium bromide-stained PAC DNA analysed by pulsed-field gel 
electrophoresis 
DNA was digested with Non. Separation of the digested DNA was carried out on a 
CHEF DR - III system (Bio-Rad) for 18 h at a field strength of 6 V/cm in a 1% 
agarose gel in 0.5 X TBE at 14 °C with 1200  angle and a initial and final switch 
intervals of 5 to l5sec. Lanes labelled as Al - ES are lab codes for PAC clones 






Yl 	X2 	Y2 




in Noll digest 
109-5-240 21 145 21 142 RPCIP711D2O1Q2 Al -- 
16 145 16 142 RPCIP711D211Q2 A2 23+25 
11 125 11 122 RPCIP711H221Q2 A3 150 
59 116 56 116 RPCIP711I137Q2 A4 23+140 
124 215 123 212 RPCIP711F2421Q2 AS 25+97 
34 70 33 67 RPCIP711C1822Q2 A6 45+100 
180 118 177 117 RPCIP711I136OQ2 B1 -- 
175 118 172 117 RPCIP711I146OQ2 B2 -- 
109-6-211 216 225 216 222 RPCIP711DO575Q2 B3 45+95 
60 10 57 9 RPCIP711013118Q2 B4 23+80 
109-8-225 145 54 142 55 RPDIP711F2017OQ2 B5 75+95 
8 130 6 128 RPC1P711G23193Q2 B6 -- 
109-6-250 184 171 181 171 RPC1P711N12225Q2 Cl 80 
15 84 12 85 RPC1P711P22241Q2 C2 145 
125 79 122 80 RPC1P711A24242Q2 C3 45 
109-7-235 116 145 116 142 RPCIP711DO1289Q2 C4 -- 
171 60 171 57 RPCIP711E1429OQ2 CS 145 
200 116 199 119 RPC1P711109306Q2 C6 160 
114 103 111 104 RPC1P711L02325Q2 Dl 50 
234 23 231 24 RPC1P711L02326Q2 D2 50+100 
109-9-246 10 86 9 89 RPC1P711023445Q2 D3 -- 
17 158 17 156 RPC1P711A21463Q2 D4 60+80 
63 214 64 212 RPC1P711F12497Q2 D5 -- 
109-3-103 101 12 RPCIP711NO4508Q2 D6 80 
101 5 RPCIP711PO4508Q2 El -- 
90 106 89 109 RPCIP711KO7517Q2 E2 -- 
109-3-147 185 124 182 125 RPC12711H12606Q2 E3 -- 
29 177 28 179 RPCIP711M19641Q2 E4 -- 
185 50 182 49 RPC12711G12620Q2 ES -- 
Table 4.6: Clones identified from PAC high-density membrane filter screening. 
+ - represent presence of internal Noll site in the insert. 
-- - represent failure to identify insert through PFGE. 
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4.2.2.2. 	Contig construction and STS mapping 
To define the overlaps among three BACs forming the original contigs, and the 29 
PACs, all the clones were tested for the presence of several STS markers. The 
PRIMER program was used to design primers for 18 STS markers from BAC ends, 
murine Ryrl cDNA and pRyr2005 insert sequences. The STSs were verified by PCR 
analysis with mouse 129 strain genomic DNA as the template (figure 4.9). A total of 
12 STSs generated a single PCR product (table 4.7). Presence of these STSs 
provided the basis for ordering the BAG and PAC clones for the Ryrl region and 
determining the overlaps between clones. Table 4.9 summarises the STS analyses 
and the schematic representation of the STSs content was shown in the figure 4.9. 
The STS density over the intervals covered in BAGs and PACs is every 5-10 exons, 
which is suitable for ordering the clones. Of 29 PAC clones identified in the 
membrane screening, 7 appeared to be false positives for STS markers. Of the 22 
positive clones, 3 PAC clones contained all the STS markers and can be assumed to 
cover the full length of the Ryrl gene and 4 contained only 2 of the STS markers. 






Ryrl exon 1.for GGG GGA CCT TCT CTC ATT GTG T 
Ryrl exon I.rev GGA CCC AGA CAA AAA CGT ACC G 
Ryrl exon 17.for TGT CCT GAT TGA GAG TCC TGA GG 
Ryrl exon 17. rev CTG AGC CTG AGG TCA TGT TGG 
Ryrl 3'end.for CCT CCC CCA CCT CAA GTG 
Ryrl 3'end.rev GGG GGT GTA GCA CAG GAT TT 
I3LA.for TCA CAA CAA AAC AGG AGG AGG 
I3LA.rev ATG GAT TCT GGT TGA TAC AGG G 
13RA2.for GTG CCC CTC TGG CCT CTG TA 
13RA2.rev AGC GGG CAG AGG GGT TTC 
I16RA.for AGT AAG GTG ACT TAG GCG GCC A 
I16RA.rev CTG GCT TTG GGA GTG TTT GCT T 
Ryrlexon64.for AGT CAC TCA AGC CTC CTT ATG 
Ryrl exon64.rev GGA AAA GTG AGA AAA ATG GG 
Ryrl exon5/6.for GCC CTT TGA CGT GGG ATT ACA G 
Ryrl exon5/6.rev AGG TCA TCC CCA ACT CGA ACC T 
Ryrl exonl2/13.for CAC CAG GAA GGT CAC ATG GAT G 
Ryr/exonl2/13.rev TTC CCG CTG AAG CTA TCG AGA C 
Ryr RNA 22 CCC ATC AAA GAG TAT CGC AGG G 
Ryr RNA 23 TGT CTC CCC TGA CAT CTG CAA G 
Ryr RNA 33 CAG ATG CTG ATG CCT GTC TCG T 
Ryr RNA 34 GAG GTC GTA GTA GCC TGC TCG C 
Ryr RNA 4O CAA CAG CGT GGA GGA GAT GTG T 
Ryr RNA 41 TTG TTC ACG ATG ATT CGG AGG A 
Annealing Mg 2+  con Product 
temperature in mM size 
(°C) (kb) 
59 1.5 0.252 
55 1.5 0.461 
55 1.5 0.100 
55 1.5 0.151 
60 1.5 0.199 
59 1.5 0.150 
60 1.5 0.258 
60 1.5 0.5 
60 1.5 0.6 
60 1.5 2.0 
60 1.5 1.8 
60 1.5 0.4 
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Figure 4.8: PCR products for STS primers 
PCR products were amplified from 129 mouse genomic DNA 




0 ° r. N 
\0 
' H 
BAC548L24 L24 - + + + + + + + - - - - 
BAC23613 13 + + + + + + + + + - - - 
BAC421116 116- - - - - - - - - - + + 
BAC412 019 019 + - - - - - - - - - - - 
RPCIP711D201Q2 Al - - - - - - - - - - - - 
RPCIP711D211Q2 A2 - - - - - - - - - - - - 
RPCIP711H221Q2 A3 - - - - - - - - - - - + 
RPCIP711I137Q2 A4 + + + + + + + + + + + - 
RPCIP711F2421Q2 A5 - + + + + + + + + + + - 
RPCIP711C1822Q2 A6 - + + + + + + + + + + - 
RPCIP711I136OQ2 Bl - - - - - - - - - - - - 
RPCIP711I146OQ2 B2 - - - - - - - + + - - - 
RPCIP711DO575Q2 B3 - + + + + + + + + + - - 
RPCIP711013118Q2 B4 - + + + + + + + + + - - 
RPDIP711F2017OQ2 B5 - + + + + + + + + + - - 
RPC1P711G23193Q2 B6 - - - - - - - - - - - - 
RPC1P711N12225Q2 Cl - + + + + + + + + + - - 
RPC1P711P22241Q2 C2 - - - + + - - - + - + - 
RPC1P711A24242Q2 C3 - - - + + - - - - - - - 
RPCIP711DO1289Q2 C4 - - - - - - - - - - - - 
RPCIP711E1429OQ2 C5 - - - + + - - + + + + - 
RPC1P711109306Q2 C6 - - - + + - - + + + + - 
RPC1P711L02325Q2 Dl - - - + - - - + + - - - 
RPC1P711L02326Q2 D2 - + + + + + + + + + - - 
RPC1P711023445Q2 D3 - - - - - - - - - - - - 
RPC1P711A21463Q2 D4 + + + + + + + + + + - - 
RPC1P711F12497Q2 D5 + + + + + + - + + + - - 
RPCIP711NO4508Q2 D6 - + - - - - - + + + - - 
RPCIP711PO4508Q2 El - - - - - - - + + - - - 
RPCIP711KO7517Q2 E2 + + - + + - - - - - - - 
RPCIP711H12606Q2 E3 - + + + + + + + + + + - 
RPCIP711M19641Q2 E4 - - - - - - - + + - - - 
RPCIP711G1262OQ2 E5 - - - - - - - - - - - - 
Table 4.8: 	STS content in BAC and PAC clones. 
Clones were tested for murine Ryrl gene, STS and BAC end 
sequences by PCR. 
+ 	indicates the presence of the markers in the clone 
- indicates the absence of the markers in the clone 
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- BAC 412 019 (-200 kb) 
RPCIP7IIK075I7Q2 
- RPCIIP7 1 1A24242Q2 (45 kb) 
__ BAC 548 L 24 (135 kb) 
- RPCIP7I 1T1460Q2 
- RPC1P711P04508Q2 
- RPCIP7I1MI9641Q2 
BAC 23613 (195 kb) 
RPCIP71 1L02325Q2 (50 kb) 
RPCIP7 1 1N04508Q2 
RPC[P711A21463Q2 (140 kb) 
RPCTP7I 1F12497Q2 
RPCIP711D0575Q2 (140 kb) 
RPCIP7I1013118Q2 (103 kb) 
RPCIP711F2OI7OQ2(l7Okb) 
RPCIP7I 1N12225Q2 (80kb) 
RPCIP71 1L02326Q2 (150 kb) 
RPC1P711P22241Q2(145kb) 
RPCIP711E1429OQ2(145kb) 
RPCIP71 1109306Q2 (160 kb) 
RPCIP7IIF242IQ2 (122 kb) 
RPCIIP7I1C1822Q2 (145 kb) 
RPCIP71 1H12606Q2 
RPCIP71 11137Q2 (163 kb) 
BAC 421 116(100kb) 
RPCIP711H221Q2 (150 kb) 
Figure 4.9: BAC and PAC contig map of the murine Ryrl gene region. 
Schematic representation of the STS content of 4 BAC and 22 PAC clones spanning 
the murine Ryrl region. Clone identity and their respective genomic insert size (in 
kb) determined by pulsed - field electrophoresis are indicated beside the solid lines. 
The line length is not scaled. The STSs are shown in order (5' - 3') on the top line. 
A double cross line (II) shows negative for STS. 
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4.3. Discussion 
I have described the isolation and identification of clones spanning a contiguous 
length of about 450 kb, which cover the entire length of the murine Ryrl genomic 
locus. The map has been verified using two independent methods: 1) BAC 
fingerprinting confirmed overlaps between the BACs, 2) STS analysis further refined 
the location of each clone. In addition the cytogenetic location of the BAC 412_019 
(Korenberg et al., 1999) confirms the chromosomal location of the contig. 
I used commercially available BAC and PAC libraries that had been supplied in the 
form of DNA pools and high-density filters respectively. The BAC library was 
screened by PCR with murine Ryrl specific primers. Murine and human RYRJ 
specific probes were used to screen high-density filters of PAC clones by 
hybridisation. Four BACs and 22 PACs were selected for contig assembly. 
I found the one step high-density filter screening method was much quicker and 
easier than PCR analysis of DNA superpools, plate pools and individual colonies. 
The hybridisation approach requires only one screening step to identify positive 
clones. Filter hybridisation and single film exposure was sufficient to detect the 
positive PACs. In contrast, PCR analysis of DNA pools of clones requires successive 
rounds of screening to identify positive clones. 
The BAC library that I screened is estimated to provide about 7.37 fold genome 
coverage. Nevertheless, some sequences were not found. The gap between BAC 
548_L24IBAC 236_13 and BAC 412_116 region was identified in the BAC contig 
map. The absence from the BAC library of clones covering this gap may be a chance 
event or an indication that this sequence cannot be cloned in the BAC cloning 
system. This gap illustrates the importance of using alternative cloning resources for 
physical mapping. The failure to identify a BAC clone to bridge the gap could also 
be explained by the fact that the copy of the BAC library available at Roslin was two 
years old and the DNA pools had been used many times to screen for other genes. 
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Subsequent freezing and thawing of the library pools might have caused some DNA 
degradation. This problem was overcome by the identification of PAC clones that 
span the gap between the BAC contigs. 
I isolated BAC insert right and left ends by plasmid end rescue and inverse 
polymerase chain reaction techniques respectively to generate BAC end probes for 
chromosome walking. Direct sequencing of BAC insert ends suggests that insert end 
isolation is not required. The direct end sequence can be successfully used to design 
new STS markers that can be used for chromosomal walking. I found direct 
sequencing quicker and more effective for determining the nature of the clone end 
sequence(s) i.e. either the sequence is repetitive in the genome, homologous to a 
published sequence in the database or 'novel'. For example, the BAC 548_1,24 
insert right end sequence is similar to the human RYR] exon 64 sequence. This 
information indirectly confirmed that the clone I had isolated was murine Ryrl 
specific and was used to develop exon specific STS markers. The end sequences of 
some clones matched mouse repetitive sequences. Nevertheless, by careful choice of 
primers it is possible to develop unique STS markers from these end sequences. 
BAC DNA fingerprinting using human RYRJ cDNA probes, the human RYRJ exon 
64 homologous region identified through the BAC 548_L24 end, and amplification 
of PCR products derived from murine Ryrl cDNA specific STS primers confirmed 
that the isolated BAC and PAC clones are derived from the murine skeletal muscle 
ryanodine receptor isoform (Ryrl) locus and not from the Ryr2 or Ryr3 loci. 
In earlier work using a Ryrl cDNA the Ryrl locus has been mapped to the murine 
chromosome 7A2-B2 region (Leeb et al., 1995). By chance one of the random 
mouse BAC clones selected for mapping by Korenberg et al. (1999) was BAC 
412019. Korenberg et al. (1999) mapped the BAC 412019 to the murine 
chromosome 7A2-A3 region using FISH and R banding. In the present work I 
mapped the BAC 412_019 to the region flanking the Ryrl gene through an overlap 
between BAC 412_019 and BAC 236_13 (table 4.8; figure 4.5). Therefore, the 
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mouse Ryrl locus can be assigned to chromosome 7A2-A3. My data could now be 
integrated into the efforts to map and sequence the mouse genome. 
I found the use of BAC and PAC clones in map construction to be efficient and fast. 
The larger size and stability of inserts, the ease of clone DNA preparation, the ability 
to sequence ends of inserts directly to make STS, are all advantages of using BACs 
and PACs for contig construction. 
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Chapter 5 
5. Murine Ryrl locus - gene targeting 
5.1. Introduction 
Gene targeting is a powerful tool for generating mice with specific mutations as a 
means to study gene function and the resulting impact of mutations on disease. The 
first step in this procedure is targeting of the genome in embryonic stem (ES) cells. 
The simplest type of mutation that can be made with this technology is a 'knock-out' 
in which the target gene is disrupted by insertion or deletion of sequences. Creating 
point mutations is more difficult. Introducing point mutations using double 
replacement is based on tag selection cassettes for which both positive and negative 
selections can be applied in ES cell culture. Homologous integration of the marker 
cassette into the target locus can be positively selected (tag step). In a second round 
of gene targeting (exchange step), a precise alteration (point mutation) will be made 
into the tagged locus, resulting in displacement of the marker cassette. The 
advantages of the two-step double targeting strategy include the possibility of 
replacing the target gene with any of the sequences constructed in the replacement 
vector including subtle mutations, deletions, insertions, human homologues, or 
totally non-homologous fragments at the replacement step. The double replacement 
strategy has been used to replace the mouse a-lactalbumin gene with its human 
homologue (Stacey et al., 1994) and the p53 gene with the lacZ gene (Gondo et al., 
1994). 
In order to study the function of ryanodine genes, the mouse Ryrl (Takashima et al., 
1994a; Moore et al., 1998) and Ryr3 genes (Takashima et al., 1996) have been 
disrupted or knocked-out. The Ryrl gene has been knocked-out in exon 2 
(Takashima et al., 1994a) and exon 10 (Moore et al., 1998) by inserting a neomycin 
marker gene into the gene. The Ryr3 gene has been knocked-out in Ji cells using 
homologous replacement vectors, which replaced either the exon 1 or exon 2 of Ryr3 
with the neomycin resistance gene (Takashima et al., 1996). Studies on the Ryrl 
gene in mice with human MH and CCD mutations are still in their infancy. 
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This chapter describes a double replacement gene targeting approach in the HPRT 
deficient ES cell line HM-1 (Magin et al., 1992) to introduce a point mutation 
(C--+T) in exon 17 of the Ryrl gene. The point mutation that I have attempted to 
create is a mouse homologue of the RYR] C1843T mutation responsible for 
malignant hyperthermia in pigs. This procedure uses a HPRT selectable marker and 
the ability to select both for and against HPRT expression (Magin et al., 1992; 
Selfridge et al., 1992). In the first step, to inactivate the target gene (Ryrl), a HPRT 
mini-gene was inserted into exon 17 in the Ryrl gene. Mutated cells were isolated 
by selection for HPRT expression with HAT (hypoxanthine/aminopterin/thymidine). 
In the second targeting step the HPRT mini-gene and some of the surrounding Ryrl 
sequences are replaced with Ryrl sequences containing the desired point mutation. 
In the second round of targeting selection is for loss of the HPRT marker using the 
purine analogue 6-thioguanine (6-TG). Despite several attempts the introduction of 
the point mutation was not achieved. Starting from the knock-out cells generated in 
the first targeting step, a series of experiments were carried out in order to find 
reasons for the failure in second round gene replacement. 
5.2. Results 
5.2.1. First round gene targeting 
The disruption of the Ryrl gene by insertion of a HPRT mini-gene into exon 17 had 
been completed earlier by Dr. Ed Hitchin (Hitchin et al., unpublished). Thus, 
although I did not create the knock-out mice I am providing details here as the 
disrupted Ryr] gene represents the target locus for my experiments. 
Briefly, first round gene targeting in a HPRT deficient HM- 1 cell line was performed 
using a replacement vector pRyrlO13 (figure 2.6 A). The pRyr1013 vector contains 
1.4 kb upstream (short arm) of murine Ryrl sequences, a PGK-HPRT mini-gene 
expression cassette inserted into the SmaI site in Ryrl exon 17 in the opposite 
transcriptional orientation to the Ryrl gene, 3.3 kb downstream (long arm) of murine 
Ryrl sequence and a herpes simplex virus thymidine kinease (HSV tk) gene (see 
figure 2.6 A). 
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Homologous recombination of the gene targeting vector pRyrlO13 with one of the 
Ryrl alleles in the mouse embryonic stem cells results in insertion of the 2.7 kb 
PGK-HPRT mini-gene into exon 17, but exclusion of the thymidine kinase gene 
(figure 5.1). Expression of the HPRT mini-gene is controlled by its own promoter 
(PGK) in the ES cells. The thymidine kinase gene would only be integrated and 
expressed in ES cells where insertion of the targeting vector is random because 
homologous recombination results in its loss. Therefore, by using HAT to select for 
cells that contain a functional HPRT mini-gene and by using gancyclovir (GANC) to 
select against cells that contain a functional HSV-tk gene, Dr. Hitchin enriched for 
cells in which the homologous targeting event occurred. 
A very high proportion (62%) of ES cells that survived the double selection were 
shown to be true homologous recombinants (Hitchin et al., unpublished data). The 
resultant Ryrl knock-out cells (Ryr17 and Ryr24) were used to create chimeric 
mice following blastocyst injection. Germline transmission of the mutation was 
achieved and lines of mice carrying the knock-out Ryrl (Ryr1') allele were 
established. 
I developed PCR-based tests for monitoring the transmission of the (Ryr]) allele in 
mouse lines. As mice homozygous for the (RyrF) allele die shortly before or after 
birth (see section 5.2.6) it was necessary to maintain the (Ryrf 1 ') allele in 
heterozygotes. In collaboration with Dr. Margaret McClenaghan I analysed the 
phenotypes of the Ryrl knock-out mice (see section 5.2.7). 
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Figure 5.1: First round gen targeting to introduce the PGK-HPRT mini-gene into the Smal site of the Ryrl locus 
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Ryrl wild type locus 
Structure of thepRyr 1013 targeted Ryrl allele after homologous recombination 
• PGK promoter 
I-TPRT mini-ge4e 
TK 
PCR primer binding site, to test integration of the pRyr1013 construct into the Ryrl locus by homologous recombination 
	
. 	Transcriptional rientation of the marker genes 
= Plasmid 
Construct Ryrl enomic DNA 
Wild type Ryrl Ilocus 
1.8 	Numbers reresnts DNA fragment sizes in kilobases 






E 	B 	EEHXTKXN 
	
5 , I I II]n.uin.uiI 	13' x >< _<_ 
Bg 	Xb E H RS 	E 	B 	EEH 	X 
I I 	I 	I I I I II I 
	
F'] 
Bg Xb E H R V PGK-HPRT 
	
E 	B 	EEH 	X 
5 , 
	
3 , 	C 
2005 plus p 	1.8 _____ KHPRT3 
Figure 5.1: First round gene targeting to introduce the PGK-HPRT mini-gene into the Smal site of the Ryrl locus 
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5.2.2. Second round gene targeting 
Second round gene targeting was performed in the knock-out cell line (Ryrl7) 
cells) generated from the first targeting step using a replacement vector pRyr2005 
(figure 5.2 D). In this second round of gene targeting, the construct exchanges the 
HPRT mini-gene present in the Ryrl exon 17 region and precisely introduces the 
C1 843T point mutation into the exon 17, resulting in displacement of HPRT mini-
gene expression cassette (figure 5.2 F). 
5.2.2.1. 	Second round gene targeting vector and scheme of targeting 
The replacement vector pRyr2005 (constructed by Dr. Ed Hitchin) contains 4.7 kb 
murine Ryrl sequence with the C1843T point mutation in the Ryrl exon 17 (figure 
2.6 B). The regions of homology in this vector are identical to the regions of 
homology in the original knock-out vector (pRyr1013). 
Depending upon the site of crossover, homologous recombination of the gene 
targeting vector pRyr2005 with the RyrF allele could result in insertion of C  843T 
point mutation into exon 17 (figure 5.2) and lead to loss HPRT mini-gene. If the 
upstream cross-over event occurs between the point mutation and the Smal site into 
which the HPRT mini-gene was inserted then the point mutation would not be 
introduced into the locus. But as the point mutation is located very close (38 bp) to 
the SmaI site in exon 17 into which the HPRT mini-gene has been inserted this 
outcome seems unlikely. Loss of HPRT activity confers resistance to a toxic purine 
analogue 6-thioguanine (6-TG). Non targeted Ryrl knock-out alleles should 
continue to express the HPRT mini-gene and should be eliminated in the 6-TG 
medium. As Stacey et al. (1994) suggested, 6-TG resistant clones were expected to 
arise in three possible ways: (i) persistence of untargeted HM-1 cells from the first 
round targeting; (ii) cells that had spontaneously lost HPRT function (e.g., 
methylation or mutation); and (iii) loss of the HPRT mini-gene by replacement with 
C1843T mutation. 
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Figure 5.2: Second round gene targeting to introduce C1843T point mutation into the Ryrl locus 
Replacement vctor pRyr2005 targeting construct 
Knock-out Ryrl allele in Ryr 17 +1- 
 cell clone 
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Figure 5.2: Second round gene targeting to introduce C1843T point mutation into the Ryrl locus 
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5.2.2.2. 	Attempts to introduce the C1843T mutation into the Ryrl7 +1- 
cell line 
The introduction of the C1843T mutation in the Ryr17 cell line by homologous 
replacement would result in the targeted cells losing their HPRT function (i.e a 
change from HPRT to HPRr). An immediate change in the selection system 
(media) from selection for HPRT cell function (HAT medium) to selection against 
HPRT cell function (6-TG) could lead to loss of targeted cells because of the 
presence of irreversibly bounded aminopterin in the targeted cells. It has been 
recommended that growing cells in the HT (hypoxanthine and thymidine) medium 
allows time for the synthesis of new folate reductase enzyme and degradation of 
aminopterin in the cells before selection for loss of HPRT function. The targeted 
cells were expected to be resistant to 6-TG, but they would be sensitive to the 
transfer of tGMP (thio-guanine monophosphate) (Fujimoto et al., 1971) from non-
targeted cells (Ryrl 7' cells) by metabolic cooperation. This metabolic cooperation 
was termed "kiss of death" by Fujimoto et al. (1971). The 'kiss of death' requires 
close contact between the cells and it has been shown that it does not occur at low 
cell density (see Hooper and Subak-Sharpe, 1981; Hooper, 1985 for reviews on this 
topic). 
The replacement vector pRyr2005 was linearised at the NotI site in the plasmid 
backbone. The DNA was electroporated into the Ryr17' cell line at passage 13. 
Two methods were used to isolate 6-TG resistant (6TGR)  ES cell clones. In the first 
method, the electroporated cells were plated at a concentration of 1 x 10 6-cells/plate 
and cultured for 8 days in HT medium. The medium was replaced with medium 
containing 6-TG (1.67 j.tglml) and selection applied for 18 days. No cells survived. 
Thus, this selection did not yield any 6TGR  colonies. 
In the second method, half of the electroporated (0.5 x 10) cells were cultured in a 
175-cm2 flask for 8 days in HT medium, trypsinized and reseeded at different cell 
concentrations (1.5 x 106,  1.5 x 105 , 1.5 x 1O). After 10 days in 6-TG selection eight 
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6-TG' ES cell clones were isolated from plates that had been re-seeded at 1.5 x 105 
cells/plate. During subsequent expansion of these eight clones one clone 
differentiated and thus had probably lost the essential pluripotent property of ES 
cells. Only three ES cell clones survived 6-TG selection on the plates re-seeded at 
1.5 x 106  cells/plate. The non-differentiated ES cell clones were expanded; DNA 
was isolated from an aliquot of cells and used for PCR analysis. 
PCR-RFLP banding patterns were used to identify homologous recombinants in the 
ES cell clones. The C1843T point mutation in exon 17 leads to the loss of an RsaI 
site in the targeted allele. To screen for C1843T mutants / homologous 
recombinants, the Ryrl exon 17 region was PCR amplified using normal Ryrl exon 
17 forward and reverse primers (table 5.1). Following PCR amplification the PCR 
products were restriction digested with RsaI endonuclease and separated by gel 
electrophoresis (figure 5.3). 
RsaI digestion of the 0.46-kb PCR product should produce 0.16-kb and 0.3-kb 
fragments in the normal but not the mutant allele (figure 5.3). All ten 6-TG' 
resistant clones showed the normal-type Ryrl allele pattern. DNA from these clones 
were also positive for the presence of the HPRT mini-gene as determined by PCR 
using the KHPRT1 and KHPRT2 primers (table 5.1). As Stacey et al. (1994) 
suggested, formation of 6TGR  clones may be due to functional loss of the HPRT 
mini-gene either by spontaneous mutation or methylation. For example, Tsuda et al. 
(1997) reported a frequency of 0.4 per 106  6-TG' clones in a control experiment with 
untreated E14.1 cells. Thus, spontaneous loss of (HPRT) function mutations cause a 
background problem for the second round targeting strategy. 
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Primer Name Primer sequence (5' - 3') Annealing 
temperature 
(°C)  




KHPRT1 CAG TCC CAG CGT CGT GAT TAG 55 1.5 0.40 
KHPRT2 TTC AAC AAT CAA GAC ATT CTT TCC AG 
Exonl7forward TGT CCT GAT TGA GAG TCC TGA GG 55 1.5 0.46 
Exonl7reverse CTG AGC CTG AGG TCA TGT TGG 
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Figure 5.3: PCR analysis of gene targeted clones. 
Detection of the gene targeted clones by analysis of the presence or 
absence of an RsaI site in the 0.46 kb PCR fragment generated by 
using exon 17 forward and reverse primers (table 5.1). The C to T 
substitution by homologous recombination results loss of RsaI site in 
the 0.46 kb PCR product. Cleavage of the 0.46 kb fragment generates 
0.3 and 0.16 kb fragments. Lane 2, 4, 6, 8, 10, and 12 are undigested 
PCR products. Lane 3, 5, 7, 9, 11, and 13 are PCR products digested 
with RsaI restriction enzyme. 
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Five attempts have been made to introduce the C1843T mutation by homologous 
recombination into the knock-out cells (Ryrl7 line) generated in the first targeting 
step. All five attempts were unsuccessful. The targeting construct and knocked-out 
locus were analysed in an attempt to understand the reasons for failure to introduce 
the point mutation. 
5.2.3. Sequence characterisation of the pRyr2 005 targeting vector 
I determined the complete sequence of the second round targeting vector (pRyr2005) 
in order to check that it had been assembled correctly. Sub clones for sequencing 
were generated from Sau3A and A/uI complete digests with the resulting DNA 
fragments ligated into the BamHI and SmaI restriction sites of pUC18 vector 
respectively. Fragments for subcloning were also generated from partial CviJI 
digests (figure 5.4). CviJT fragments of about 0.4 to 0.6 kb fragments were isolated 
after size fractionation in agarose gels and ligated into the Smal site of the pUC 18 
vector. DNA was isolated from subclones and sequenced following a cycle 
sequencing procedure (Materials and Methods, section 2.11) using M-13 forward, M-
13 reverse primers and primer walking primers and an ABI 373A automated 
sequencer. 
The sequences were assembled using the STADEN package (Staden, 1996; Staden et 
al., 2000). The FASTA and BLAST programs (Pearson and Lipman, 1988; Altschul 
et al., 1990a; 1990b; Pearson et al., 1997; Pearson, 2000) were used to compare the 
sequences with published sequences held in the EMBL DNA sequence database and 
with my sequence data for the murine Ryrl cDNA. 
The sequence data are presented in figure 5.5. Sequence analysis of these data 
revealed that the construct has 4.7 kb murine Ryrl sequence from intron 13 to intron 
20. The exons were identified by comparison to the pig genomic RYR] sequence 
(EMBL accession number: Z49778, Brening and Brem, 1992; Schmoelzl et al., 
1996; Wen et al., 1996). The exon sequences of the construct were found to be more 
than 80% identical to those of the pig skeletal muscle ryanodine receptor gene and 
164 
100% identical to murine Ryrl sequence, except for the C1 843T mutation in exon 17 
(figure 5.6), Sequences homologous to porcine exons 14 - 20 were found in the 
correct order and orientation in the sequence of pRyr2005. The presence of the 
restriction sites used in the construction of pRyr2005 was also confirmed. The 
sequence analysis confirmed that in exon 17 a thymidine nucleotide had been 
substituted for the wild-type cytosine at the location corresponding to the porcine 
C 1843T mutation. Introduction of the C—*T mutation causes the loss of a RsaI site 
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Figure 5.4: Partial digestion of pRyr2005 DNA with CviJI restriction enzyme 
PRyr2005 DNA (1.0 .tg) was digested with various concentrations 
(0.2 U — lane 1; 0.4 U —lane 2; 0.6 U - lane 3; 0.8 U —lane 4; 1.0 U - 
lane 5) of CviJI restriction enzyme at 37 °C for 1 hour and inactivated 
at 65 °C for 15 mm. The digested products were electrophoresed on a 
1% agarose gel. The 0.4 - 0.6 kb fragments (lane 3) were pooled for 
subcloning. 
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Figure 5.5: Genornic sequence of the replacement vector pRyr20005. 
Key 	Location/Qualifiers 
V 	mune 5' up stream sequence outside the construct 
pRyr2005 was from the BAC 548_L24 by direct sequencing 
GAATTC 	Restriction sites used for vector construction 
\(i(iG(iA1GCT 	murine exon sequence 
GCAGAGGTTA 	murine intron sequence 
TGTA[ GC' - I'C'(' 	CI 843T mutation 
Sequence length 	4723 bp 
Ito 119 	5' up stream sequence outside 
the construct pRyr2005 
120 to 4723 Replacement vector pRyr2005 insert sequence 
Exon(s) 	 773 —908; 	989-1084; 1167-1285; 




51 I'TGCGGTATA TGTGTGTGTC3 
101 	CPc'PT TTGCTG AATTCTGGAG GCAGAGGTTA AGTAGATCTC 
151 TATGAGTTTA AAACCACCTT GGTCTACAGC CAGCCAAGGC TACATAGTGA 
201 GACAACAAGA GGAAAAPAC ATTAAAATGT CAGAGGGGAG AGGGTGAPAA 
251 TAGATCTCTT ATTATTTTTT AAAAGACTTA TTTATTTTAT GTATGTGAGT 
301 GCACTATAGC TGTCTTCGGG CACACCAGAA GAGGGCATCG GATCTCATTA 
351 CAGATGGTTG TGAGCCACCA CGTGGTTGCT GGGAATTGAA CTCAGCACCT 
401 CTGGAAGACC ACTCAGTGCT CTTAACCACT GAGCCATCTC TCCAGCCCCC 
451 TCTTATTTAT TATTAAGTGG TAPAAGTGAA CTGCTCCAAG TGTGCCCAGG 
501 AGTGGGGTGC CTGGAAATGA GTAAAATGGA GAGGAAACGG CAGATCACAG 
551 AGGCACAAAT TCAGCCTAAT GTTAGCAAGG ACATATTCTA GTGGAGGTTG 
601 AGGCAAAGGG CACATGAACA GGTTTGATGA GTCAAGGAGA GGAAGGCAAT 
651 ACACCTGGAG ACACAGAGCT AAGAAGCTT GGTGACCTCT GGGGACACAA 
701 CCATTACCTA GGAAATCTAG CAAAGGCTAG GCCCGAGACT CCTGCTGTAA 
751 AACCTTCATT TCTTCACCCC AGGGGATGCT CTCCCTGGTC CTGAATTGCA 
801 TTGACCGCCT CAACGTCTAC ACCACCGCTG CCCACTTTGC CGAGTTTGCG 
851 GGAGAGGAGG CAGCTGAATC TTGGAAAGAG ATTGTGAACC TGCTCTATGA 
901 ACTTCTAGGT AAGGGGACCC AGAGCTAACT TCCCCGAGGG CACCCAGATG 
951 CCCTGTCCTA ATAGATCTGA CTCTCGTGCC CCCTGCAGCC TCTCTGATCC 
1001 GTGGCPATCG CACCAACTGT GCGCTCTTCT CCACP.AACTT GGATTGGCTG 
1051 GTCAGCAAGC TGGACCGTCT GGAGGCCTCA TCTGGTAGGA GAACCCAGGA 
1101 TAGGGGGATG GGAAAGTTGG GGAGGAAAGG TTATCCCACC TCACCTGTCC 
1151 TGTGGGTACC CGGCAGGCAT CCTGGAGGTG TTGTACTGTG TCCTGATTGA 
1201 GAGTCCTGAG GTGCTGAACA TCATCCAGGA GAACCACATC AAGTCTATCA 
1251 TCTCCCTCTT AGACAAGCAT GGGCGGAATC ACAAGGTTGG CCCTGCATCC 
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1301 CTGACCCCTC CCCAGATCCC AGACGCACCT GCCGCTGCCT CGAATGTGCT 
1351 GGGATTAAAG GCGTGTGCAA CCACGCCTGG CTAACCTCAG GCTGCCCCTT 
1401 GACCTCTGAA CTTGACTTCC AGGTCCTGGA TGTGCTGTGT TCACTCTGTG 
1451 TGTGCAATGG TGTGGCTGTA TGCTCCAACC AGGACCTCAT CACCGAGAAC 
1501 TTGCTCCCGG GCCGAGAACT TCTGCTGCAG ACAAACCTCA TCAACTATGT 
1551 CACCAGGTGT GGCTCTTAPC CCCAACCTGG AACCCAACAT GACCTCAGGC 
1601 TCAGAGCCTC TCAATCCTCC CCCTGACCCA GGGACTCCAA CACAAGGGAT 
1651 GTCTCTTTCC CATCTOCTTG TCCAGGAGAG TCTCTTGTCC CCCGGCTCAT 
1701 GCTTGGTCCC TTATTCTTTC TTCTCTCTGG GTCTTGGTTT TGCCCCTGTC 
1751 TCTTCCTTCT TTCCTGTGTT TCCTCTTTCT CTTTGCCTGT TTCTGTCTGT 
1801 CTCTCTTCCA GTTCCTTCTT CCTGGCTATC GCTCATACTT TCTCTTTATC 
1851 TCTTCAPAG AATGTTTTAT GTATGTGTGC ATGCGTGTGT ATATCTGTGT 
1901 ATTACTTGCC AGCCTGATGC CCACGGAGGA TAAAGATCAC ATTCCCTGAA 
1951 ACTGGAGTTA CAGTTGGACG TGAGCCTCCA ACTGAGTGCT GAGAATCGAA 
2001 CCCAGGTCCT CTGCAAGAGC AGCCAGTGTC CTTACCCTCT GAGCCACCTC 
2051 TCCAGCCCCT CTCTCTTTAC CTTTTGATGT CTGTGTGTCT CTCTGTCTTT 
2101 CCTTCCTCTC TCTGGCTCTC CTCTCCATCT CTCCTGTCCT GTTTCCCCTG 
2151 CAGCATCCGC CCCAACATCT TTGTGGGCCG AGCAGAGGGC TCCACGCAGT 
2201 ATGGCAAATG GTACTTTGAG GTGATGGTGG ATGAGGTGGC TCCATTTCTG 
2251 ACAGCTCAGG CCACCCACCT GAGGGTGGGC TGGGCCCTCA GCGAGGGCTA 
2301 CAGCCCCTAC CCCGGAGGCG GCGAGGGCTG GGGCGGCAAC GGGGTCGGCG 
2351 ATGATCTCTA TTCTTACGGC TTTGATGGGC TGCATCTTTG GACAGGTATC 
2401 TATACCCTTC CAGGGGACTC TTACCCCTGA CCATTGACCC CAGAGTCCCC 
2451 AAGATTCTGA CGGCACACCT TAGGGTTTAA GAATCCTGAC CCCCTTACCT 
2501 CTCACCTGAC CCTAACTGTA GAACTTTCAG AATCTTGAAC TTCACCTGTT 
2551 TCCTCATATC CTACGAGGGT GATCCCAGGA GACTGCCCAA ATGTTATGAC 
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2601 CTCTGACCTT TGGTTTACGA TCTCAGAGTT CTCAGAATTC AAGCTCTATG 
2651 AAGATCAATA TCTTACTGTA TATATCCCAG GAGCCTTAGT TTTAGGATAA 
2701 CCCATGAGAA TCTTTGCTCA CACACACTCT AATATTGGGC CCCCACAGGA 
2751 TGTCTTAATA GCCACAACTT GTGGCAATAC TATTGCTTTT GTGGGACCTT 
2801 TGACCTTTGA CACTGGTGAC TTGTTGTAGG GCATGTGGCA CGCCCAGTGA 
2851 CTTCTCCGGG ACAACACCTC TTGGCCCCGG AGGATGTGGT CAGCTGCTGC 
2901 CTGGACCTCA GCGTCCCGTC CATCTCCTTT CGTATCAACG GCTGCCCCGT 
2951 GCAGGGTGTC TTTGAATCCT TCAACCTCGA TGGGCTCTTC TTCCCTGTCG 
3001 TGAGCTTCTC GGCTGGTATC PJ\GTGAGGAT CCACCCCTGT CCCACTGTCC 
3051 GTCCCCAATC AGAAGCCATA CCCCTAGAGG GCAGGGAAAG AGAAGCCTGC 
3101 TTTACAACTG ATTGGTGGCC AGTTGTGGTC ACACGAAGGG CTATGTGACC 
3151 TCAGTGTGTG ACCCTCGTGG TCTCTGATTC CTATGTCTGT CCAGGGACCT 
3201 CCAAGTAACT CTAGAATTTC ACGATGCTT TTTAATGACT CCAAACTCTC 
3251 GCAGAGATGT CTCAATGGCC CAAGACCATT CCAATGACCT GCAGTGACCC 
3301 CAGkCTTTTT CAPTGACTTT AGCATTTGAT AGTGATCTAA GATCATGTTC 
3351 GACACCCCAG TGGTCCCAGA GTCCCCGTGA TGGTCTAATG AGCTCAGACT 
3401 TGCCCAGTGA CT000TGTCA CCTGTGTACT CCACGTCCTT TCTGAGCACT 
3451 CTCAACCCTA TGGATTCCCA TTCCATGGAA ATCTTGCTTA TTTTTTTAAT 
3501 GATCGTAGAA TTGAAGTGAC TCCTAAATGA CTTTTGTGGT AGTCAGGGAG 
3551 ACAGAGCCAA GGCTGCTTGG GATCCTCATA GTCCTCTAGA AGAGTGGTTC 
3601 TCAAACCTGC GTAATGCTGC GGCCCTGTAA AACAGCTCCT CATGTTATCG 
3651 TGACACCCCC CCCCCCCAGC TGTAAAATTA TTTTTGTTGC TACTTCAAAA 
3701 ATGTATTTT GCTACTATTC AGATTATAA TGTATTTTCT GATGAGTCAC 
3751 GTGACCCCAA AGGCTGTTGT GACCCACAGG TTGAGAAGTA AAGCCTTAGA 
3801 ACATTGCACT GACCCCAGAG TTGCTCACAT ACCCCCCACT AACTGAGAGC 
3851 TCTTTCCTTC ATCCCCACCC TCCTCCTCCA GAGTGCGCTT CCTCCTTGGT 
170 
3901 GGCCGCCATG GTGAATTTPJ GTTCCTGCCC CCACCTGGCT ATGCTCCATG 
3951 CCATGAAGCT GTGCTCCCTC GGGAGCGGCT CCATCTCCAA CCCATCAAAG 
4001 AGTATCGCAG GGAGGGGCCT CGGGGGCCCC ACCTGGTGGG CCCCAGTCGC 
4051 TGCCTCTCAC ATCTGGACTT TGTACCCTGT CCTGTGGACA CCATCCAAGT 
4101 ACCACCAGCT CTGCAAGGGT TTTCTTTCCT CTAAACATTT AAAGAAAAAA 
4151 TTGTCTTGGC TTCTATTGCT AAGGATAAAA ACACTGAACT GAAAAGCAGC 
4201 TTGGGGAGAA AAGGCTTTAT TGCAGCTTGT ATTTCTACAT CAGAGTCCAT 
4251 CAGTAAGGGA AGTCAGCGCA GGACTTCAAG CAAGGAATTT AGAGACTGGG 
4301 GGCGTGGCTC AGTGGTAGAG CCCCTGCCTA GAATCTTCCA GTGAGGGGCT 
4351 GGGGGCGTGG CTCAGTGGTA GAGCCCCTGC CTAGAATCCC CCAGTGAGGG 
4401 GCTGGGGGCG TGGCTCAGTG GTAGAGCCCC TGCCTAGAAT CCCCCCAGTG 
4451 AGGGACTGGG GGTGTGGCTC AATAGTAGAG CCCCTGCCTA GAATCCCCCA 
4501 GTGAAGGGCT CAGGGCATGG CTCAGTAGCA TATGGCAATT GCCTGATGTG 
4551 TACGAAGTTC TGGGTTCCAG TCTCACAGTG TGTGTAGAAC TCTTAGTCAG 
4601 ATTCATATCA CCCTCTTCAT AAAACGATGA AGGACAGAAT TCAACTGCTG 
4651 GTTCAGCCAG TTTTTTTTTC TGACAGTTT TCTGGATCTG ACTCTAGCTC 
4701 TGGTTGGATG GGGCTGGAAG CTT 
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Figure 5.6: Identification of intron - exon boundaries in the pRyr2005 
insert sequence 
cDNA 	Sequence information from murine 5' end Ryrl 
cDNA contig 
2005 	pRyr2005 sequence (figure 5.5) 




cDNT 	1447 GGGATGCTCTCCCTGGTCCTGAATTGCATTGACCGCCTCAACGTCTACACCACCGCTG 1504 
111111111 	111111111111111111111111111111 	II 	11111 	liii 
2005 : 773 	GGGATGCTCTCCCTGGTCCTGAATTGCATTGACCGCCTCAACGTCTACACcAccGCTG 830 
cDNA 1505 CCCACTTTGCCGAGTTTGCGGGAGAGGAGGCAGCTGATCTTGGjGAGATTGTGcC 1564 
III 	I 	111111111111 	11111111111 	11111 	I 	Ii 	11111111111111111 
2005 831 CCCACTTTGCCGAGTTTGCGGGAGAGGAGGCAGCTGATCTTGGGAGATTGTGcc 890 
cDNA : 1565 TGCTCTATGAACTTCTAG 1582 
11111111 	II 	111111 
2005 	891 TGCTCTATGAACTTCTAG 908 
Exon 15 
cDNA : 1583 CCTCTCTGATCCGTGGCAATCGCACCACTGTGCGCTCTTCTCCACAAACTTGGATTG 1640 
liii 	11111111111 	III 	1111111111 	liii 	liii 	1111111 	till 	I II 
2005 : 989 	CCTCTCTGATCCGTGGCAATCGCACCAACTGTGCGCTCTTCTCCACAAACTTGGATTG 1046 
cDNA 1641 GCTGGTCAGCAAGCTGGACCGTCTGGAGGCCTCATCTG 1678 
liii 	1111111 	liii 	liii 	111111111111111111 
2005 	1047 GCTGGTCAGCAAGCTGGACCGTCTGGAGGCCTCATCTG 1084 
Exon 16 
cDNA 1679 GCATCCTGGAGGTGTTGTACTGTGTCCTGATTGAGAGTCCTGAGGTGCTGAACATCjvrC 1737 
III 	11111111111 	It 	111111111111111111111 	11111111111111111111 
2005 	1167 GCATCCTGGAGGTGTTGTACTGTGTCCTGATTGAGAGTCCTGAGGTGCTGAACATCATC 1225 
cDNA 1738 CAGGAGAACCACATCAAGTCTATCATCTCCCTCTTAGACAAGCATGGGCGGAATCACAAG 1797 
1111111111111111111111! 	111111 	till! 	111111111111! 	1111111111 	II 
2005 1226 CAGGAGAACCACATCAAGTCTATCATCTCCCTCTTAGAcAGCATGGGCGGAATCACAAG 1285 
Exon 17 
cDNA 1798 GTCCTGGATGTGCTGTGTTCACTCTGTGTGTGCAATGGTGTGGCTGTACGCTCCAACC 1855 
11111111111111111111111! 	111111111111111111111111 	111111111 
2005 	1423 GTCCTGGATGTGCTGTGTTCACTCTGTGTGTGCAATGGTGTGGCTGTATGCTCCAACC 1480 
CDNA 1856 AGGACCTCATCACCGAGAACTTGCTCCCGGGCCGAGAACTTCTGCTGCAGACCCTCA 1915 
1111 	liii! 	liii 	1111111! 	liii! 	1111111111111111111111111111111111 
2005 1481 AGGACCTCATCACCGAGAACTTGCTCCCGGGCCGAGAACTTCTGCTGCAGACjccTcA 1540 
cDNA 1916 TCAACTATGTCACCAG 1931 
IIIIIIIIIIIIIIII 
2005 	1541 TCAACTATGTCACCAG 1556 
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Exon 18 
cDNA 1932 CATCCGCCCCAACATCTTTGTGGGCCGAGCAGAGGGCTCCACGCAGTATGGCAAATG 1988 
2005 : 	2154 
I 	111111 	11111111 	I 	111111 	II 	liii 	I 	II 	1111111111 
CATCCGCCCCAACATCTTTGTGGGCCGAGCAGAGGGCTCCACGCAGTATGGCAAATG 2210 
cDNA : 	1989 GTACTTTGAGGTGATGGTGGATGAGGTGGCTCCATTTCTGACAGCTCAGGCCACCCACCT 2048 
2005 : 	2211 
11111111111111 	I 	II 	I 	111111111 	II 	I 	11111 	I 	111111111111 
GTACTTTGAGGTGATGGTGGATGAGGTGGCTCCATTTCTGACAGCTCAGGCCACCCACCT 2270 
cDNA : 2049 GAGGGTGGGCTGGGCCCTCAGCGAGGGCTACAGCCCCTACCCCGGAGGCGGCGAGGGCTG 2108 
	
111111 	11111111111111111111 	11111111111 	11111111 	11111111 
2005 2271 GAGGGTGGGCTGGGCCCTCAGCGAGGGCTPCAGCCCCTACCCCGGAGGCGGCGAGGGCTG 2330 
cDNA 2109 GGGCGGCAACGGGGTCGGCGATGATCTCTATTCTTACGGCTTTGATGGGCTGCATCTTTG 2168 
II 	1111111 	I IlIl 	II 	1111111111111111 	III 	II 	II 	11111 	III 
2005 2331 GGGCGGCAACGGGGTCGGCGATGATCTCTATTCTTACGGCTTTGATGGGCTGCATCTTTG 2390 
cDNA 	2169 GACAG 2173 
11111 
2005 : 2391 GACAG 2395 
Exon 19 
cDNA : 2174 	GGCATGTGGCACGCCCAGTGACTTCTCCGGGACAACACCTCTTGGCCCCGGAGGATGT 2231 
I 	11111 	liii 	liii 	11111111 	111111111 	I 	III 	1111111 	I 	II 
2005 2830 GGCATGTGGCACGCCCAGTGACTTCTCCGGGACAACACCTCTTGGCCCCGGAGGATGT 2887 
cDNA : 2232 GGTCAGCTGCTGCCTGGACCTCAGCGTCCCGTCCATCTCCTTTCGTATCAACGGCTGCCC 2291 
1111111 	I 	1111111111111 	liii 	I 	111111111111 	111111 	111111 
2005 2888 GGTCAGCTGCTGCCTGGACCTCAGCGTCCCGTCCATCTCCTTTCGTATCAACGGCTGCCC 2947 
cDNA 2292 CGTGCAGGGTGTCTTTGAATCCTTCAACCTCGATGGGCTCTTCTTCCCTGTCGTGAGCTT 2351 
III 	I 	liii 	I 	liii 	1111111111 	111111111 	I 	I 	III 	II 	I 	II 	I 
2005 : 2948 CGTGCAGGGTGTCTTTGAATCCTTCAACCTCGATGGGCTCTTCTTCCCTGTCGTGAGCTT 3007 
cDNA : 2352 CTCGGCTGGTATCAA 2366 
111111111111111 
2005 	3008 CTCGGCTGGTATCAA 3022 
Exon 20 
cDNA 2367 AGTGCGCTTCCTCCTTGGTGGCCGCCATGGTGAATTTAAGTTCCTGCCCCCACCTGGCTA 2426 
2005 : 	3882 
111111 	liii 	11111111111111111 	IlL 	11111111111111 	I 	1111111 
AGTGCGCTTCCTCCTTGGTGGCCGCCATGGTGAATTTAAGTTCCTGCCCCCACCTGGCTA 3941 
cDNA : 	2427 TGCTCCATGCCATGAAGCTGTGCTCCCTCGGGAGCGGCTCCATCTCCAACCCATCAAAGA 2486 
2005 : 	3942 
III 	11111111 	11111111 	1111111 	liii 	IlL 	I 	11111 	111111111111 
TGCTCCATGCCATGAAGCTGTGCTCCCTCGGGAGCGGCTCCATCTCCAACCCATCAAAGA 4001 
cDNA 2487 GTATCGCAGGGAGGGGCCTCGGGGGCCCCACCTGGTGGGCCCCAGTCGCTGCCTCTCACA 2546 
III 	1111111111111111111111111111 	111111 	I 11111111111111111 
2005 	4002 GTATCGCAGGGAGGGGCCTCGGGGGCCCCACCTGGTGGGCCCCAGTCGCTGCCTCTCACA 4061 
cDNA : 2547 TCTGGACTTTGTACCCTGTCCTGTGGACACCATCCA 2582 
II 	1111111 	I 	It 	II 	II 	Illi 	11111 
2005 : 4062 TCTGGACTTTGTACCCTGTCCTGTGGACACCATCCA 4097 
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5.2.4. Insertion of a neo gene into the murine Ryr] locus by homologous 
recombination 
There are some known technical difficulties with the double replacement strategy as 
discussed below. In order to test whether the exon disrupted by the insertion of the 
I-IPRT mini-gene could be successfully modified or replaced in a second round 
targeting event I made a new targeting construct with a neo gene. This targeting 
experiment is summarised in figure 5.7. 
I constructed a new replacement vector pRyr2006. The pRyr2005 vector was 
digested with Smal for which there is a single recognition site in pRyr2005 (in exon 
17 of the Ryrl sequences). This is the same Smal site into which the HPRT mini-
gene had been inserted in the original knock-out vector. An MT-Neomycin 
expression cassette was excised from pBT/MT-Neo (Selfridge et al., 1992) by 
digestion with EcoRV and Smal. The gel purified neo cassette was inserted into 
Smal cleaved pRyr2005. The orientation of the neo cassette was determined from 
analysis of PstI, BamHI, KpnI and Smal digests. A clone (pRyr2006), in which the 
MT-Neomycin expression cassette had been inserted into exon 17 in the same 
transcriptional orientation as the Ryrl gene, was selected for the targeting 
experiments. This targeting vector has 4.7 kb of Ryrl gene sequence distributed as 
two arms of homology; 1.4 kb and 3.3 kb in length flanking the neo gene (figure 2.6 
C). 
To isolate cells in which the neomycin cassette had replaced the HPRT mini-gene in 
exon 17 of the disrupted Ryrl allele, cells were selected for neomycin resistance and 
against the HPRT mini-gene function. In cells that have integrated the pRyr2006 
sequences either at random or in the target region in Ryrl exon 17 the neomycin gene 
expression provides resistance to the drug G418. Selection for G418 resistance was 
applied first. 
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Figure 5.7: Insertion of a neo gene - to test efficiency of gene replacement by homologue recombination. 
Replacement vector pRyr2006 targeting constructs 
Knock-out Ryrl allele in Ryr 17+1- cell clone 
Structure of the pRyr2006 targeted Ryrl allele after homologous recombination 
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Figure 5.7: Insertion of a neo gene - to test efficiency of gene replacement by homologous recombination. 
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Where the pRyr2006 sequences integrated at a random location the HPRT mini-gene 
in the knocked-out Ryrl allele should remain active. Such non-targeted cells (Ryrl 
knock-out allele with HPRT mini-gene) should be sensitive to the drug 6-TG. After 
15 days of G418 selection, the medium was replaced with medium containing 6-TG 
and G418 and continued for another 6 days. In theory only cells in which the neo 
cassette had replaced the HPRT mini-gene in the Ryrl gene should survive this 
selection procedure. 
5.2.4.1. 	Targeted replacement of the HPRT mini-gene in the Ryr17' 
cell line with a neo gene 
The construct pRyr2005 was designed to introduce the C1843T mutation into the 
Ryrl gene. In successful homologous recombination with the knocked-out Ryrl 
allele containing the HPRT mini-gene, the HPRT mini-gene would be lost and the 
cells would become resistant to 6—TG. However, through metabolic co-operation 
purine nucleotides could be transferred from cells carrying the HPRT mine-gene to 
targeted cells. Such transfers would lead to the 'kiss of death' in the targeted cells. 
To avoid this process and to determine the efficiency of second gene targeting, a new 
targeting construct carrying a neomycin marker was used to replace the HPRT mini-
gene in the first round targeted ES cell line (Ryrl 7 k" ). 
The pRyr2006 construct was linearised at the NotI site in the plasmid backbone and 
electroporated into the Ryr17 ES cell line at passage 13. The number of random 
integration events was determined after selection for MT-Neomycin expression in 
G418 and the number of homologous recombinants clones was estimated after 
selection against PGK-HPRT mini-gene function in G418, 6-TG selection. 
Duplicate experiments were performed in which 1 x 107  cells were electroporated 
with linearized pRyr2006 and plated in 10 culture dishes (i.e., a total of 2 x 10 7 cells 
and 20 plates). A control electroporation (without DNA) was carried out on 1 x 107  
cells from which two aliquots (1 x 106  cells, each) were plated - one without 
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selection and one with G418 selection. Two of the plates of cells electroporated with 
pRyr2006 were examined before selection and were compared to the control plates. 
After the initial G418 selection the total number of cells successfully transformed 
with pRyr2006 was estimated by counting the number of G418 resistant clones on 
two of the twenty culture dishes. One hundred and forty colonies were observed 
giving a transformation frequency of 0.7 x 10 cells. G418, 6-TG double selection 
was applied to the remaining sixteen culture dishes. The G418, 6-TG double 
selection yielded a total of 15 colonies from 16 x 106  cells. 
Twelve of these 15 colonies showed signs of differentiation when the colonies were 
expanded. These colonies were assumed to have lost their ES cell properties. DNA 
was isolated from the 3 non-differentiated ES cell clones and assayed by PCR for the 
presence of the novel junction between the neo cassette or HPRT mini-gene and Ryrl 
sequences outside the targeting vector (figure 5.8). Genomic DNA from the 129 
mouse, parental Ryr 1 7+/  cell line and the G418 R  , 6TGR  clones were tested for the 
presence/absence of the novel junctional PCR products in order to confirm the 
homologous recombinant nature of the clones. 
The common forward primer 2005plus (table 5.2) was designed from murine Ryrl 
sequences outside the targeting vector. The reverse primer, KHPRT3 (table 5.2) was 
designed from the PGK-HPRT mini-gene and primer MT  (table 5.2) from the MT-
neo promoter region such that they will only amplify the homologous recombinant 
alleles and not either the normal Ryrl endogenous allele or random integration 
events (figure 5.8 A). 
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Primer name Primer sequence (5' - 3') Annealing 
temperature 
(°C)  




2005 PLUS CAG TCA CTA GGC ATC AAA ATG TCC C 60 1.5 1.8 
KHPRT3 ACA TGT TTC AGC AGT GTT GGC TGT A 
2005 PLUS CAG TCA CTA GGC ATC AAA ATG TCC C 60 1.5 1.9 
MT1 GCC TGC CCT CTT TAT AGT CGT TG 





















E H 	R V PGK-IIPRT 
2005 pi 	1.8 kb 	KIIPRT3 f  
(C)  
F H 	* V 	MT - Neo 
2005 plus 	1.9 kb 	MT 1 
I 
(D) 
Figure 5.8: PCR analysis of clones with the neo gene. 
The neomycin expression cassette (construct pRyr2006) was used to 
replace the HPRT mini-gene present in the first targeted Ryrl locus. 
Homologous recombination was analysed by presence or absence of the 
novel junction product (1.8 kb and 1.9 kb) using primers 2005 plus and 
KHPRT3 (A) and 2005 plus and MT-i (B). A Schematic diagram of the 
primer location is showed in (c) and (D). 
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A novel 1.8 kb junction (Ryri-HPRT mini-gene) fragment was amplified from the 
knock-out cell line (Ryrl 7) genomic DNA generated in the first targeting step, 
while using the primers 2005plus and KHPRT3 (figure 5.7). A 1.9 kb junctional 
(Ryrl-MT-Neo cassette) fragment was observed only in the G418, 6-TG resistant cell 
clones while using 2005plus and NIT  primers (figure 5.8 B). These primer pairs are 
specific to the integrated HPRT mini-gene or MT-Neo and do not amplify randomly 
integrated vectors or wild type alleles. These results show that all three G418R,  6-
TGR clones were homologous recombinants. 
The fifteen G418', 6TGR  clones represent the survivors from 16 x 106  cells 
electroporated with pRyr2006. The absolute frequency of homologous 
recombination in this experiment was 0.1875 - 0.9375 x 106  (depending upon 
whether all 15 G418', 6TGR  clones or only the 3 fully characterised clones are 
regarded as homologous recombinants). The frequency of transformation with 
pRyr2006 as estimated above was 0.7 x The effective targeting frequency can 
be defined as the proportion of homologous recombinants in the total number of 
transformed cells (homologous and non-homologous/random integrants). Therefore, 
in this experiment the effective targeting frequency was 2.67 - 13.39 x 10 
(depending upon whether all 15 G418R ,  6TGR clones or only the 3 fully 
characterised clones are regarded as homologous recombinants). 
The effective targeting frequency in the first round gene targeting of the Ryrl locus 
in which the HPRT mini-gene was inserted into exon 17 was 62% (620 x 10-3) 
(Hitchin et al., unpublished). This first round gene targeting used an enrichment 
procedure based on positive (with HAT for HPRT) and negative (with GANC 
against 1K) selection. This effective targeting frequency is very high (40 - 250 
times more successful) compared to the present gene targeting frequency observed in 
the neo replacement experiment. 
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5.2.4.2. 	Attempts to introduce the neo gene into the Ryrl wild type 
allele 
The wild type Ryrl allele can be targeted efficiently as shown by the knock-out 
experiment. In the gene targeting experiments described above, the selection 
procedures used were designed to isolate cells in which the disrupted Ryrl allele has 
been modified by replacing the HPRT mini-gene with either a neo gene or with the 
C  843T mutation. The failure or low success rates with these experiments may be 
the result of changes to the disrupted allele that make it resistant to gene targeting. 
Under G418 and 6-TG selection as described above, only the cells in which the 
neomycin cassette replaced the HPRT mini-gene will survive. If the gene 
replacement construct pRyr2006 integrated into the wild (normal, non-targeted) Ryrl 
allele by homologous recombination, it would experience the same fate as a random 
integrant and be eliminated in 6-TG selection. Therefore in order to determine 
whether the wild type allele in Ryrl7 ES cells can be effectively gene targeted, 
another gene targeting experiment was performed. In this experiment, the targeted 
cells were selected only for neomycin resistance in G4 I 8 medium. 
The pRyr2006 was linearized at the NotI site in the plasmid backbone and 
electroporated into Ryr17 ES cell line at passage 21 (1 x 107  cells). Following 
G4 1 8 selection about 300 clones were isolated and cultured. Twenty of these clones 
failed to survive in G418 medium during clone expansion. DNA was isolated from 
the surviving 280 ES cell clones and assayed for Ryrl alleles with an HPRT mini-
gene in exon 17 and / or a neo cassette in exon 17. 
The primer pairs (1. KHPRTI + KHPTR2; and 2) exon 17 forward + reverse, table 
5.1) used for genotyping the mice lines were used to assay the G418' clones. 
Successful amplification of DNA from a clone with both primer pairs was interpreted 
as indicating that both the wild type Ryrl and HPRT-disrupted alleles remained 
unaltered and that the neomycin expression cassette had integrated somewhere else 
in the genome (wt-Ryrl/Ryrl-HPRT). Amplification with only the Ryrl exon 17 
primers would have suggested that the HPRT mini-gene in the knock-out allele had 
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been replaced with the neo cassette (wt-Ryrl/RyrJ-Neo). Amplification with only 
the HPRT primers would have suggested that the neo cassette had been inserted into 
the wild type allele to create a double knock-out (Ryri-HPRT/RyrF-Neo). Both the 
HPRT mini-gene (KHPRTI + KHPRT2) and the Ryrl exon 17 primers (exon 17 
forward + reverse) produced PCR products from all 280 clones. Therefore, I 
concluded that the neo cassette had been integrated at random in these clones. 
The nature of PCR products generated with exon 17 primers from the parental line 
(HM-1), the knock-out cell lines generated from the first targeting step (Ryr17 
Ryr24 1 ), G418 R  and 6-TG' clones isolated from the first neo gene replacement 
experiment, and 12 randomly selected G418 resistant clones was further analysed by 
Southern hybridisation using the HPRT mini-gene and neomycin cassette as probes. 
Cell clones were PCR amplified using long range PCR amplification protocols, using 
the primer pair exon 17 forward and reverse. This protocol should produce PCR 
products from the normal (wild type Ryrl) allele, the HPRT or neo knock-out alleles 
and randomly integrated neomycin expression constructs (pRyr2006). In PCR 
amplification, 2.8 kb and 0.46 kb PCR products were observed for modified and 
normal alleles respectively (figure 5.9). Blots were probed separately with neomycin 
and HPRT probes (figure 5.9 B, Q. 
The HPRT cDNA probe hybridises to the 2.8 kb PCR product from the control 
samples (lane 2, 6 and 7) and G41 8R  clones (lanes 11-22) (figure 5.8 B). The 
neomycin probe also hybridises to the 2.8 kb PCR products from the positive control 
samples (lane 3), G418' and 6TGR  clones (lane 8,9,10) and all G418 clones except 
two (lanes 17 and 21). These results showed that in the G418 and 6-TG resistance 
clones the neo gene replaced the HPRT mini-gene by homologous recombination but 
resistance to G418 in the clones shown in lanes 11 - 22 was due to random 
integration of the neo gene construct into the genome not by homologous 
replacement of the HPRT mini-gene. 
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Figure 5.9: Analysis of murine Ryrl locus targeted clones. 
The allelic nature of the murine Ryrl locus was analysed by PCR using a long-range 
PCR amplification protocol. Template DNAs from gene replacement vectors and 
gene targeted clones were PCR amplified using exon 17 forward and reverse primers. 
The cycling reaction was preceeded by 5 min denaturation at 95 °C and terminated 
with a final extension at 72 °C for 10 mm. the first 10 cycles consisted of 1 mm 
denaturation at 94 °C, 1 min annealing at 55 °C and 5 min primer extension at 72 °C. 
In the subsequent 25 cycles the primer extension time was increased by 30 sec for 
each cycle. 
Ethidiurn bromide - stained PCR products analysed by agarose gel 
electrophoresis. 
PCR products in (A) hybridised with HPRT mini-gene as probe 
PCR products in (A) hybridised with neo gene as probe 
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Figure 5.9: 	Analysis of murine Ryrl locus targeted clones 
The PCR results were further confirmed by Southern blot analysis performed on 
EcoRV and BstEII digested genomic DNA isolated from the G418 resistant clones, 
G418 and 6-TG resistant clones (Rneo-1, Rneo-2, Rneo-3), the knock-out cell lines 
generated from the first targeting step (Ryrl 7+/  Ryr24) and the parent line (HM-
1), using the HPRT mini-gene and neomycin gene as probes. The HPRT mini-gene 
probe recognised a 9.4 kb BstEII fragment in all the G418   clones and in the Ryrl7 
and Ryr24 cell lines indicating that the HPRT mini-gene in the knock-out allele 
generated in the first targeting step remains intact in these cells. The HPRT-mini-
gene did not hybridise to genomic DNA digests from the G418, 6-TG doubly 
resistant clones indicating the HPRT mini-gene in exon 17 of the Ryrl gene had been 
lost from these doubly resistant clones. The neomycin probe recognised a 9.4 kb 
BstEII fragment in the G418 and 6-TG resistant clones (Rneo-1, Rneo-2, Rneo-3), 
and different sized fragments in G418   clones indicating that the construct pRyr2006 
replaced the HPRT mini-gene in the G418, 6-TG doubly resistant clones but is 
randomly integrated in the G418 R  clones. 
5.2.5. Expression of the HPRT mini-gene in targeted cells 
The second round gene targeting strategy assumes that loss of HPRT activity 
indicates that the HPRT mini-gene has been inactivated preferably by excision by 
homologous recombination with the second round targeting vector. Loss of HPRT 
activity by other mechanisms will create a high background of false positives in the 
second round targeting experiment. Melton et al. (1997) observed different levels of 
HPRT mini-gene expression in different target loci. This study suggests that the 
expression of the introduced marker gene (HPRT mini-gene) could be affected by 
gene methylation (Melton et al., 1997). Therefore gene inactivation by methylation 
is one of the potential disadvantages of using the HPRT gene as the selectable marker 
for gene targeting. Melton et al. (1997) observed that HPRT gene expression could 
be unstable. Instability of HPRT gene expression or loss of HPRT gene expression 
could explain the problems with the second round targeting experiments. In order to 
determine whether the HPRT-mine-gene in exon 17 was stably expressed in Ryr 1 7+1-  
cells,  I examined HPRT mini-gene expression in both the selective culture medium 
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(HAT) and the non-selective culture medium (HT). Total mRNA was isolated from 
the Ryr 17 cells cultured in HAT and HT medium, Northern blotted and hybridised 
with a HPRT cDNA probe (kindly provided by Professor. David Melton). The 
results shows that the HPRT mini-gene in Ryr 17 cells is expressed in the non-
selective medium (HT) as well as in the selective HAT medium. The Northern blot 
analysis would not distinguish between the HPRT mini-gene being expressed in all 
the cells or in only a proportion of the cells. As not all cells will take up DNA when 
exposed to electroporation it is not possible from the Northern blot results to be 
certain if the HPRT mini-gene was expressed in the cells that took up the second 
round construct DNA. 
5.2.6. Genotyping knock-out Ryrl mouse lines 
A PCR test was developed for genotyping the knock-out mouse lines (Ryr]). Two 
primer pairs were designed - one pair to amplify the wild type Ryrl exon 17, the 
other pair to amplify the HPRT mini-gene. The normal / endogenous mouse HPRT 
gene is approximately 33 kb in size gene with 9 exons and maps to the X-
chromosome (Melton et al., 1984). The HPRT forward (KHPRT1) and reverse 
(KHPRT2) primers (table 5.1) were designed to span exon boundaries such that they 
will only function with the HPRT eDNA/mini-gene template DNA and will not 
amplify endogenous normal HPRT genomic sequences. Exon 17 region forward and 
reverse primers (table 5.1) amplify the exon 17 region. The presence/absence of the 
PCR products was used to determine the genotype of mice in the Ryrl knock-out 
lines. Amplification with both primer pairs identified heterozygous knock-out 
animals (wt-Ryrl/RyrF-HPRT), amplification with only the Ryrl exon 17 primers 
identified homozygous normals (wt-Ryrl/ wt-RyrI) and amplification with only the 
HPRT primers indicated homozygous knock-out mice (RyrF-HPRT /Ryri-HPRT). 
Mouse 129 genomic DNA and plasmids containing the HPRT mini-gene and 
genomic DNA from the Ryrl7) knock-out cells were used as controls. 
5.2.7. Phenotyping knock-out Ryrl mouse lines 
In order to examine the effects of the disruption of the Ryrl in exon 17, matings were 
set up to generate mice of all three genotypes ((Ryri-HPRT/Ryri-HPRT, wt-Ryrl/RyrF 
-HPRT, wt-Ryrl/ wt-Ryrl). Crosses between mice hemizygous for the Ryrl (+1-) 
locus were made. Takeshima et al. (1 994a) reported that mice homozygous for the 
knock-out die perinatally and this was confirmed by our experience with previous 
breeding programmes. Therefore, offspring were removed by hysterectomy at 18 
days gestation and tissue samples were collected. DNA from the tail was used for 
genotyping by PCR while hindlimb tissue was used for histological analysis 
(collaboration with Dr. M. McClenaghan). 
After analysis by PCR, several litters were shown to comprise a mixture of 
genotypes. One such litter is shown in figure 5.10. The homozygous pups (figure 
5.10 a, b, c) were easily distinguished by gross appearance from their litter-mates 
and displayed similar abnormalities to those reported by Takeshima ci' al. (1994a). 
These pups exhibited spinal curvature, increased neck thickness and appeared 
swollen and oedematous. In all the litters examined, the hemizygous and the normal 
pups were indistinguishable at gross level. 
Skeletal muscle sections from homozygous pups showed pronounced differences at 
the microscopic level when compare to hemizygous siblings (figure 5.11). Upper 
hindlimb muscle from the homozygous animals was less dense, with fewer cells. At 
low magnification (x4) it was clear that affected pups had substantially less muscle 
tissue when compared to normal pups (data not shown). Examination at higher 
magnification (x20, figure 5.11) revealed that muscle tissue in homozygous knock-
out pups was dispersed and clearly less dense (sections a, c, and e) than the muscle 
formation observed in hemizygous siblings (sections b, d and I) - in addition, muscle 
cells appeared to be much reduced in size in these animals, giving an overall picture 
of degenerative tissue. 
go 
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Figure 5.10: Homozygous, hemizygous and wild-type pups from a single 
litter. Offspring were removed by hysterectomy at 18 days gestation and 
tissue samples were taken for genotyping by PCR. Pups a, b, and c (top 
row) were identified as homozygous for the Ryrl knock-out locus, while 
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Figure 5.11: Skeletal muscle sections from homozygous and hemizygous 
sibling pups stained with haematoxylin and eosin. Upper hindlimbs were 
collected and placed upright in 1% agarose blocks to maintain the vertical 
axis. The samples were snap-frozen in freezing isopentane and stored in 
liquid nitrogen. Frozen transverse sections were cut at a thickness of 11 I.tm 
using a cryostat at — 20 °C. After staining with haematoxylin and eosin, 
sections were examined under x20 magnification. Sections a, c and e came 
from homozygous knock-out (RvrI') pups while sections b, d and f came 
from hemizygous knock-out (Ryrl') siblings. 
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5.3. Discussion 
There are two main issues for discussion - the efficiency of gene targeting and the 
phenotypes of mice with different knock-out Ryrl genotypes. 
The murine Ryrl gene has been disrupted in three independent studies. The Ryrl 
gene has been knocked-out by the insertion of a neomycin gene into exon 2 
(Takashima et al., 1994a) or into exon 10 (Moore et al., 1998) and by inserting an 
HPRT mini-gene into exon 17 (Hitchin et al., unpublished). The results from these 
studies suggest that the mouse Ryrl locus can be efficiently targeted by homologous 
recombination. Takeshima et al. (1994a) used a positive-negative selection strategy 
and found 4 homologous recombinant clones amongst 61 doubly resistant clones (an 
effective targeting frequency of 6.56 x 102).  Moore et al. (1998) also used a 
positive-negative selection strategy but they do not state the targeting frequency data. 
Dr. Ed Hitchin (unpublished) created knock-out Ryrl loci in the HM-1 embryonic 
stem cells by inserting an HPRT mini-gene into exon 17 using a replacement vector 
pRyr1013. The effective targeting frequency in this experiment was 62% (62.0 x 10 
2) - tenfold higher than achieved by Takeshima et al. (1994a). 
I attempted to replace the HPRT mini-gene in exon 17 and introduce the C1 843T 
mutation with the replacement vector pRyr2005 in the knock-out cell line generated 
from the first targeting step (Ryr17). Although the vectors pRyrlO13 and 
pRyr2005 have the same length of sequence homology to the target site, no 
homologous recombinant ES clone with C1843T mutation was observed in second 
step gene replacement. The failure of the second round targeting was surprising as 
the first round targeting using the identical regions of sequence homology had been 
very efficient. Possible reasons for the failure to introduce the C1843T mutation 
include the possibility that the target locus had been changed in a way that made it 
resistant to homologous recombination, or that mutations or rearrangements had been 
introduced during the second round targeting. 
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Five attempts have been made to introduce the C1843T mutation by homologous 
recombination into the knock-out cells (Ryr 1 line) generated in the first targeting 
step. All five attempts were unsuccessful. I examined the targeting construct and the 
knocked-out locus in an attempt to understand the reasons for failure of the second 
round gene replacement. I also made a new targeting construct in order to examine 
whether the Ryrl locus was readily mutated. 
The replacement vector pRyr2005 was analysed using restriction enzymes and 
sequencing. The positions of restriction enzymes used for vector construction were 
in the correct order. Genomic sequence from the insert in the pRyr2005 was 
compared with the murine Ryrl cDNA to confirm that the exons in pRyr2005 are 
arranged in the right order and there was no nucleotide mismatch among the exons 
except the C1 843T mutation. These results confirmed that there was no problem in 
vector construction and its arrangements. 
The replacement vector construct pRyr2005 was shotgun cloned using AluI and 
Sau3A to produce overlapping clones. The restriction enzyme CviJI was also used. 
This enzyme is capable of digesting DNA at a two or three base recognition 
sequence. CviJI normally cleaves RGCY sites between the G and C to leave blunt 
ends (Swaminathan et al., 1994) and generates an overlapping population of psuedo-
randomly fragmented DNA in partial digests (Fitzgerald et al., 1992; Gingrich et al., 
1996). This property was used to generate subclones for shotgun sequencing. About 
40 subclones derived from the CviJI digests provided more than 4.0 kb of 
overlapping sequence information. At the same time, the same length of the 
sequence information was derived from more than 100 AluI and Sau3A subclones. 
Therefore, I found that CviJI based random shotgun sequencing approach was more 
effective and efficient than the two enzyme shotgun approach. 
Ten 6-TG resistant clones were isolated in second round gene targeting with 
pRyr2005. None of these ten clones had the desired C1843T mutation as determined 
by a PCR-RFLP test. Homologous recombination between pRyr2005 and the 
disrupted Ryrl locus (RyrlT allele) could occur in such a way that the point 
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mutation is not introduced to the Ryrl locus but as the point mutation is only 38 bp 
from the location of the HPRT mini-gene such recombinants would be unlikely. 
When the ten 6-TG resistant clones were tested for the presence of the HPRT mini-
gene all ten were found to have the mini-gene. Therefore, these 6-TG resistant 
clones represent false positives. Resistance to 6-TG in these clones could be due to 
spontaneous mutations in the HPRT mine-gene. 
The second round gene targeting efficiency was further analysed with the neo gene 
as a selectable marker in the replacement vector pRyr2006. The frequency of 
transformation with pRyr2006 as estimated above was 0.7 x i0". The absolute 
frequency of homologous recombination with G418 and 6-TG selection was 0.1875 
- 0.9375 x 106  and the effective targeting frequency was 2.67 - 13.39 x 10. 
Although the vectors pRyr1013 and pRyr2006 have the same length of sequence 
homology to the target site, the second round gene targeting efficiency was very low 
(40 - 250 times) compared to the first round gene targeting frequency of the Ryrl 
locus in which the HPRT mini-gene was inserted into exon 17 (62% ie., 620 x 10) 
(Hitchin et al., unpublished). 
The second round gene targeting strategy assumes that loss of HPRT activity 
indicates that the HPRT mini-gene has been inactivated preferably by excision by 
homologous recombination with the second round targeting vector. Loss of HPRT 
activity by other mechanisms will create a high background of false positives in the 
second round targeting experiment. It has been suggested that instability of gene 
expression of HPRT can influence the efficiency of second round gene targeting 
(Melton et al., 1997). However, the HPRT mini-gene in exon 17 of the Ryrl locus in 
Ryr17" ES cells was expressed in both selective (HAT) and non-selective (HT) 
medium. Therefore, there do not appear to be problems with expression of the 
HPRT mini-gene in the target locus. 
During mouse development, expression of the Ryrl gene expression has been 
detected at day 9.5 in the myotome and later at high levels in developing skeletal 
muscles (Rosemblit et al., 1999). As noted below, mice homozygous for Ryrl 
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knock-outs can survive to near term (Takeshima et al., 1994a; this thesis). 
Therefore, Ryrl gene expression is not essential for early development or ES cell 
survival. These observations suggest that absence of Ryrl gene expression in ES 
cells in possible double knock-outs (RyrF-HPRT/RyrF-Neo) would not be lethal and 
therefore would not explain low success rates with pRyr2006. Genotyping of 280 
G418 R  clones carrying the neo gene from the vector pRyr2006 transformed cells 
demonstrated that homologous recombination did not occur either in the knock-out 
allele or in the non targeted Ryrl wild loci. 
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Chapter 6 
6. General Discussion 
6.1. General background 
In pigs the gene responsible for the porcine stress syndrome (PSS) and for halothane-
induced malignant hyperthermia is referred to as the halothane gene (HAL). It can be 
triggered by stress, such as handling the animal, transport, high temperatures and 
disturbance of the animal before slaughter (Archibald, 1991). The halothane reactor 
(homozygous n/n) animals produce poor quality meat, with a higher frequency of 
pale, soft, exudative (PSE) meat or watery pork, compared to halothane non-reactors 
(N/N or N/n). These detrimental effects of the gene on meat quality were first 
reported in 1953. The stress susceptible allele (HAL") could have been eliminated by 
selective breeding using the halothane challenge test and progeny testing. But 
selection for high feed efficiency, superior muscling and low fat content led to most 
genetically superior pig lines and breeds showing increasing frequencies of PSS 
(Louis et al., 1990; Archibald, 1991; MacLennan, 1992). In Pietrain the recessive 
HAL" allele is associated with lean, heavily muscled pigs and low fat meat. Similar 
observations have been made in RYRJ mutation studies with respect to meat quality 
in six different breed groups (Rempel et al., 1995; Murrary and Johnson, 1998). In 
contrast, in other populations no significant effect of the C1843T mutation was found 
on fatness and carcass composition (Garcia-Macias et al., 1996) or slaughter weight 
(Larzul et al., 1997). Hence there are some advantages associated with the HAL 
locus and the MH point mutation in the calcium release channel gene may provide an 
advantage in lean meat production. However, these studies are based on associations 
between the mutant sequences and the disease phenotype. In order to prove that the 
mutant is causal of the disease it is necessary to create the mutant de novo and 
monitor the consequences i.e., a reverse genetic approach. At present such 
experiments are not possible in pigs. Therefore, the present study in mice was 
carried out to understand the phenotypes associated with mutations within the gene 
encoding the skeletal muscle sarcoplasmic reticulum calcium release channel. 
196 
6.2. Transgenic mice 
Gene targeting in the murine embryonic stem cell followed by gene replacement is 
potentially a very powerful technique to generate mouse models of human (and pig) 
genetic diseases. A transgenic mouse line, in which the mouse Ryrl gene has been 
disrupted by inserting an HPRT mini-gene into exon 17 (Hitchin et al., unpublished 
data) was available. The disrupting HPRT mini-gene had been inserted into the exon 
homologous to the porcine containing the point mutation. This disrupted Ryrl gene 
forms the substrate for the second round of gene targeting to reproduce the C1 843T 
point mutation in mice. 
Takeshima et al. (1994a) created knock-out mice in which the Ryrl gene has been 
disrupted in exon 2 by inserting a neomycin marker gene. This mouse model has 
been used to study functions of the Ryrl gene in E-C coupling. Examination of the 
transgenic mice with the Ryrl exon 17 knock-out showed gross phenotypes similar 
to the homozygous (exon 2) knock-out mice created by Takeshima et al. (1994a). 
This observation demonstrates that the gene can be disrupted effectively at several 
sites. 
Malignant hyperthermia (MB) is a pharmacogenetic disease with an autosomal 
dominant pattern of inheritance in humans (McCarthy et al., 1990; Fagerlund et al., 
1997). In pigs the gene responsible for the porcine stress syndrome and for 
halothane-induced malignant hyperthermia is referred to as the halothane gene 
(HAL). In pigs, unlike humans, the allele responsible for susceptibility to halothane-
induced malignant hyperthermia is recessive. In the halothane challenge test, the 
heterozygous carriers (HAL') fail to respond. Homozygous susceptible pigs 
(HAL ) respond to stress or exposure to halothane in the same way as human MH 
carriers (i.e., heterozygotes) respond to anaesthetics (Louis et al., 1990). The 
reaction of a susceptible pig appears to be more rapid than that of a susceptible 
human. 
Hemizygous Ryrl +1-  adult mice exposed to halothane prior being killed showed no 
adverse reaction to halothane (unpublished). 
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6.3. Characterisation of the murine Ryrl gene 
The murine skeletal muscle ryanodine receptor gene was characterised by cloning of 
the coding region by RT-PCR and contig mapping of the genomic clones isolated 
from the larger insert size libraries. 
6.3.1. Murine Ryrl cDNA 
To clone the murine Ryrl cDNA, exon specific primers were used to amplify the 
mouse 129-strain skeletal muscle total RNA. The resulting nine fragments were 
subcloned and sequenced. The sequences were aligned using the STADEN package. 
The resulting DNA sequence and predicted amino acid sequences have been 
examined. The 5 'and 3' cDNA contigs of 12.73 kb and 1.61 kb respectively provide 
almost complete coverage of the Ryrl transcript. The murine Ryrl cDNA sequence 
shared higher (83%) sequence identity with mammalian than other vertebrate (72%) 
Ryrl cDNA sequences. The deduced murine Ryrl amino acid sequence shares 
greater sequence identity with mammalian RYR1 (90%) and shares 75% and 71% 
identity with frog and fish Ryrl amino acid sequences, respectively. Amino acid 
sequence comparison between the human and deduced amino acid sequences from 
the 5' and 3' end contigs revealed that the uncloned region could cover about 891 bp 
cDNA sequence and encode 297 amino acids. 
The Ca2 release channel can be modulated by Ca 2 , Mg2 , ATP and calmodulin 
(Zorzato et el., 1990). Putative Ca 2+'  calmoduhn-dependent protein kinase and 
adenine nucleotides binding sites have been identified in the Ryr protein as 
glutamate-rich regions, RXXS/T regions and GXGXXG regions respectively (Otsu 
et al., 1990; Zorzato et el., 1990; Nakashima et al., 1997; Franck et al., 1998). The 
presence of these putative binding sites was examined in the deduced amino acid 
sequences from murine Ryrl and other published Ryrl amino acid sequences. Most 
of the regions are highly conserved in mammalian sequences. These conserved 
sequences are also found in the murine sequence. These observations suggest that 
studies on the murine Ryrl gene and a mouse model could be used to ask questions 
about human and pig diseases associated with Ryrl mutations. 
63.2. Murine Ryrl genomic clones 
The murine Ryrl genomic locus clones spanning a contiguous length of about 450 kb 
were isolated from the BAC and PAC libraries. The BAC library was screened by 
PCR with murine Ryrl specific primers and 4 BAC clones for the Ryr] locus were 
identified. STS content mapping and Southern analysis revealed the contig produced 
by these clones has a gap. The gap between the BAC contigs in the Ryrl locus was 
bridged with the PAC clones. The PAC library, supplied as high-density filters, was 
screened by probe hybridisation followed by autoradiography. This library screening 
yielded 22 PAC clones. The BAC and PAC clones were contig mapped using STS 
markers present in the Ryrl region. 
I found the one step high-density filter screening method to be much quicker and 
easier than PCR analysis of DNA superpools, plate pools and individual colonies. 
The hybridisation approach requires only one screening step to identify positive 
clones. Filter hybridisation and single film exposure was sufficient to detect the 
positive PACs. In contrast, PCR analysis of DNA pools of clones requires 
successive rounds of screening to identify positive clones. 
6.3.3. Sequencing 
BAC ends sequence information was generated by plasmid end rescue and inverse 
polymerase chain reaction techniques and the also by direct sequencing of BAC 
insert ends. The direct end sequence information suggests that insert end isolation, 
and sequencing is not required to generate end probes. The direct end sequence can 
be successfully used to design new STS markers that can be used for chromosomal 
walking. I found direct sequencing quicker and more effective. 
199 
The replacement vector construct pRyr2005 was shotgun cloned using AluI, and 
Sau3A to produce overlapping clones. Partial digest fragments generated by 
restriction enzyme CviJI were also used. About 40 subclones derived from the CviJI 
digests provided more than 4.0 kb of overlapping sequence information. At the same 
time, the same length of the sequence information was derived from more than 100 
A/uI and Sau3A subclones. Therefore, I found that CviJI based random shotgun 
sequencing approach was more effective and efficient than the two-enzyme shotgun 
approach. 
6.4. Gene targeting in the Ryr17 ES cell line 
Although the second step gene targeting to introduce point mutation in the knock-out 
cell lines generated from the first targeting step (Ryrl cell line) using pRyr2005 
was unsuccessful, possible reasons for failure were examined. Sequence analysis of 
pRyr2005 data revealed that the construct has 4.7 kb murine Ryrl sequence from 
intron 13 to intron 20. The exons were identified by comparison to the pig genomic 
RYR] sequence (EMBL accession number: Z49778, Brening and Brem, 1992; 
Schmoelzl et al., 1996; Wen etal., 1996). The exon sequences of the construct were 
found to be more than 80% identical to those of the pig skeletal muscle ryanodine 
receptor gene and 100% identical to murine Ryrl sequence, except for the C1 843T 
mutation in the exon 17. Sequences homologous to porcine exons 14 - 20 were 
found in the correct order and orientation in the sequence of pRyr2005. The 
sequence analysis confirmed that in exon 17 a thymidine nucleotide had been 
substituted for the wild-type cytosine at the location corresponding to the porcine 
C1 843T mutation. Introduction of the C—T mutation causes the loss of a RsaI site 
and changes Arg—*Cys in amino acid position 616. Loss of the RsaI site provided an 
advantage to aid analysis of the second round targeted clones by the PCR-RFLP 
method. 
200 
A new replacement vector pRyr2006 was constructed to introduce the point mutation 
by homologous recombination in the knock-out cell lines generated from the first 
targeting step (Ryr17 cell line). Although the vectors pRyrl013 (used for first step 
gene targeting) and pRyr2006 have the same length of sequence homology to the 
target site, the second round gene targeting efficiency was very low (40 - 250 times) 
compared to the first round gene targeting frequency of the Ryrl locus in which the 
HPRT mini-gene was inserted into exon 17 (Hitchin et al., unpublished). 
The second step gene targeting experiment using replacement vector pRyr2006 was 
designed to isolate cells in which the disrupted Ryrl allele has been modified by 
replacing the HPRT mini-gene with a neo gene. The low success rates with these 
experiments may be the result of changes to the disrupted allele that make it resistant 
to gene targeting. The wild type Ryrl allele can be target efficiently as shown by the 
knock-out experiment. If the gene replacement construct pRyr2006 integrated into 
the wild (normal, non-targeted) Ryrl allele by homologous recombination, it would 
experience the same fate as a random integrant and be eliminated in 6-TG selection. 
Therefore in order to determine whether the wild type allele in Ryrl 7" ES cells can 
be effectively gene targeted, another gene targeting experiment was performed. In 
this experiment, the targeted cells were selected only for neomycin resistance in 
G418 medium. Genotyping of 280 G418   clones carrying neo gene from the vector 
pRyr2006 transformed cells demonstrated that the homologous recombination did 
not occurr either in the knock-out allele or in the non targeted Ryrl wild loci. 
One interpretation of these results is that some kind of structural rearrangement has 
occurred in the targeted locus, which may also affect the normal allele. 
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6.5. Future work 
I tried to localise the knock-out Ryrl gene in the ES nucleus. The Ryrl7" ES cell 
line and HM-1 nucleus was stained with a monoclonal antibody raised against the 
mouse hetero-chromatin specific protein M31 (Wreggett et al., 1994; kindly provided 
by Dr. Prim B. Singh) and then hybridised with fluorescently labelled murine Ryrl 
BAC 548_1,24. This experiment could address the location of the murine RyrF in 
the nucleus and may allow changes in chromatin structure to be identified. Due to 
insufficient experience in this technique I was unable to localise the Ryrl gene in the 
nucleus. I also attempted to build a new gene-targeting construct with 10 kb 
sequence homology in the target region. For this construct, I isolated a 10 kb EcoRV 
fragment possessing exon 17 region from the BAC 548_1,24. I attempted to 
introduce a 2.5 kb EcoRI fragment with the C--+T mutation in exon 17, isolated from 
the pRyr2005, into the construct using the RecA-assisted restriction endonuclease 
(RARE) cleavage method described by Ferrin (1995). Due to lack of time I was 
unable to finish this construct. It would be useful to complete this construct and use 
it for gene targeting experiments. This construct with its increased regions of 
sequence homology to the target locus might produce the desired C1 843T mutation 
in mice. The phenotypes of such mice as well as mice carrying other Ryrl mutations 
would be interesting. Understanding the reasons for the failure of the second round 
targeting may be of more general interest. Therefore, determining the chromatin 
structure of the Ryrl locus in the ES cell nucleus in the knock-out cells could be 
important. Studies of the nuclear organisation have shown effects of chromosomal 
rearrangements that change the position of a gene with respect to the boundary 
between the euchromatin and heterochromatin (Singh and Huskisson, 1998). In 
general, genes in the heterochromatin are inactive. Experiments to examine 
colocalization of the mouse heterochromatin specific protein M31 and Ryrl gene in 
the Ryrl 7' ES cell line and HM- 1 cells might identify chromosomal rearrangements 
in the Ryr1 allele. I expect one of the three patterns in the Ryr17 ES cell line. 
The RyrT and wt-Ryrl alleles are both located in euchromatic regions or both located 
in heterochromatic regions, or the wt-Ryrl allele is located in a euchromatic region 
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and the RyrT allele in a heterochromatic region. If changes in chromatin at the 
mutated Ryrl allele were detected, then it would be interesting to study both alleles 
in mice developed from the mutated ES cell line and in normal mice. If the altered 
chromatin state found in the disrupted Ryrl allele in the ES cell lines is changed back 
to the normal state in the mice, then this locus could be used as a marker in nuclear 
reprogramming studies. 
Mice carrying various null alleles have been generated by disrupting a variety of 
endogenous genes in ES cells, and valuable information has been obtained by 
analysis of animals carrying these mutations. However, the introduction of point 
mutations into a gene of interest without alteration of the rest of the genome is a very 
difficult task. Recently, a Cre-lox P based method has been used to introduce 
defined chromosomal rearrangements (deletions, duplication, and inversions) into the 
mouse genome (Zheng et al., 2000). This procedure could be useful to introduce 
point mutations into the Ryrl gene but applying this procedure would introduce the 
lox-P sequence into the gene. The 'hit-and-run' procedure has been successfully 
used to introduce point mutations into the Hox-2.6 locus (Hasty et al., 1991c) and the 
Colla-1 gene (Wu et al., 1994). Wu et al. (1994) demonstrated that the 'hit-and-run' 
procedure was very time and labour intensive compared with the double-replacement 
procedure for introducing mutations into genes. However, this procedure could be 
an alternative method for introducing the point mutations into the Ryrl gene. 
If the research project on manipulating the mouse Ryrl gene was to continue my 
priority would be to look for any chromosomal rearrangements due to insertion of the 
HPRT mini-gene into the Ryrl exon 17 in the RyrT' cell lines. I would then try new 
alternative approaches to introduce the point mutation into the exon 17 of the Ryrl 
gene. The alternatives would include constructs with greater lengths of homology to 
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Annex - 1 
Nucleotide and deduced amino acid sequence of the 5' end contig of the murine Ryrl eDNA 
The deduced amino acid sequence is shown in one - letter code below the nucleotide 
sequence in blue letters. Nucleotide and amino acid residue numbers are indicated at 
both sides. 
234 
1 ATGGGTGATGGAGGAGGTGAAGGCGAGGACGAGGTCCATGTTTTTGCGGAGGATGATGP 60 
1 M G 	C G GE CEDE V H V F A ED D E 	20 
61 GTGGTCCTGCAGTGCAGCGCCACGGTGCTCAAGGAACAGCTGAAGTTGTGTCTGGCCGCT 120 
21 V V L 
121 GAGGGGTTCGGCACCGCCTTTGCTTTCTGGAACCCACCAGCAACGCGCAGAATGTACCC 180 
41 E G F' G N R L C F L E P T S N A Q N V 	30 
181 CCTGATCTGGCCATCTGCTGCTTCATCCTGGAGCAGTCTCTGTCAGTTCGAGCCCTGCAG 240 
	
61 P D L A I C C F' I L E Q S L S V R A L Q 	80 
241 GAGATGCTGGCCAATACTGTGGGGGCCGGTGTGGAGTCATCCCAGGGCGGGGGACACAGG 300 
81 EM LA N TV GAG V ES S 	G G G HR 	100 
301 ACACTCTTGTATGGCCACGCCATCCTGCTCCGGCACGCACACAGTCGTATGTACCTGAGT 360 
101 T L L Y G H A I L L F' H A H S R M Y L S 	120 
361 TGCCTCACCACCTCCCGATCCATGAATGACAAGTTGCCCTTTGACGTGGGATTACAGGAA 420 
121 C L T T S R S N N 0 K L P F' D V G L Q E 	i40 
421 CACGCAACAGGGGAGGCCTGTTGGTGGACGATGCACCCAGCCTCAAAGCAGAGGTCTGAA 480 
141 H A T C F' A C W N T N H P A S K Q F' S F' 	160 
481 GGAGAGAAGGTTCGAGTTGGGGATGACCTTATCCTTGTGAGTGTCTCCTCTGAGCGATAC 540 
161 G F' K V R V G D D L I L V S V S S E R Y 	180 
541 CTGCACCTGTCAACCGCAAGTGGGGAGCTCCAGGTTGACGCCTCCTTTATGCAGACTCTG 600 
181 L H L S T A S G F' L Q V D A S F' M Q T L 	200 
601 TGGAACATGAATCCCATCTGCTCTGGCTGTGAAGAAGGCTTTGTGACTGGAGGCCACGTC 660 
V N V V F' I C' S G C E E C F' V T G G H V 	220 
661 CTGCGCCTCTTTCATGGACATATGGATGAATGTTTGACCATCTCCCCTTCTGACAGTGAT 720 
221 L R V F' H C H N 0 E C L T I S P S D S 0 	240 
721 GATCAACGCAGGCTTGTCTACTACGAGGGAGGGCCTGTGTGCACTCATGCCCGCTCCCTA 780 
241 0 Q F' R L V Y Y K C G P V C T H A R S L 	260 
781 TGGAGGCTAGAGCCGCTGAGAATCAGCTGGAGTGGAAGCCATCTCCGCTGGGGCCAGCCA 840 
261 N R L E P L R I S N S G S H L R N G Q P 	280 
841 CTAAAAATCAGACATGTGACCACAGGGAGGTACCTTGGGCTCACTGAGGACCAAGGCCTT 900 
281 L K I R H V T T G R Y L G L T E 0 Q C L 	300 
901 GTGGTGGTTGATGCCAGCAAGGCCCACACCAAGGCTACTTCCTTTTGCTTCCGAATCTCC 960 
301 V V V D A S K A H T K A T S F' C F R I S 	320 
961 AAGGAGAAGCTGGATGTGGCCCCCAAGAAAGATGTGGAGGGCATGGGTCCCCCTGAGATC 1020 
321 K F' K L D V A P K K D V F' C N C p p F' I 	340 
1021 AAGTATGGAGAGTCGCTCTGCTTTGTACAGCATGTGGCCTCAGGCCTGTGGCTCACCTAT 1080 
341 K Y C F' S L C F V Q H V A S C L N L T Y 	360 
235 
1081 GCTGCCCCAGACCCTAAGGCCCTGAGGCTTGGGGTACTCAAGAAGAAGGCCATGCTGCAC 1140 
361 A A P D P K A L R L G V L K K K A K K K 	380 
1141 CAGGAAGGTCACATGGATGATGCGTTGTCACTGACGCGATGCCAGCAGGAGGAGTCCCAG 1200 
381 Q K G H K D D A L S L T R C Q Q K K S Q 	400 
1201 GCTGCCCGGATGATATACAGCACTGCCGGCCTGTACAACCAGTTCATAAAGGGTCTCGAT 1260 
401 A A R K I Y S T A G K Y N Q F I K G L D 	420 
1261 AGCTTCAGCGGGAAGCCACGGGGCTCGGGGCCACCGGCTGGGTCAGCATTGCCCATCGAG 1320 
421 S F S G K P R G S C p P A C S A L P I K 	440 
1321 GGCGTCATCCTGAGCCTACAGCACCTCATTCGCTACTTCGAGCCGCCTTCAGAGGAGCTG 1380 
IlL 	C V 	L K 	 T 	460 
1381 CAGCACGAGGAGAAGCAGACCJ½AGCTGCGCAGCCTGCGCAACCGACAGAGCCTCTTCCAG 1440 
461 Q H K K K Q T K L R S L R N P Q S L F Q 	480 
1441 GAGGAGGGGATGCTCTCCCTGGTCCTGAATTGCATTGACCGCCTCAACGTCTACACCACC 1500 
481 E E C K L S L V K N C I D P L N V Y T T 	500 
1501 GCTGCCCACTTTGCCGAGTTTGCGGGAGAGGAGGCAGCTGAATCTTGGAAAGAGATTGTG 1560 
501 A A H F A K F A C K K A A E S K K K I V 	520 
1561 AACCTGCTCTATGCTTCTAGCCTCTCTGATCCGTGGCPATCGCACCAACTGTGCGCTC 1620 
521 N L L 6 El L L A S L I R C N P T N C A L 	540 
1621 TTCTCCACAAACTTGGATTGGCTGGTCAGCAAGCTGGACCGTCTGGAGGCCTCATCTGGC 1680 
541 F S T N L K W L V S K L D R L E A S S C 	560 
1681 ATCCTGGAGGTGTTGTACTGTGTCCTGATTGAGAGTCCTGAGGTGCTGAACATCATCCAG 1740 
561 I L E V K Y C V L I K S P K V L N I I Q 	580 
1741 GAGAACCACATCAAGTCTATCATCTCCCTCTTAGACAAGCATGGGCGGAATCACAAGGTC 1800 
581 E N H I K S I I S L L D K H C R N H K V 	600 
1801 CTGGATGTGCTGTGTTCACTCTGTGTGTGCAATGGTGTGGCTGTACGCTCCAACCAGGAC 1860 
601 L D V L C S L C V C N G V A V P S N Q 0 	620 
1861 CTCATCACCGAGAACTTGCTCCCGGGCCCAGAACTTCTGCTGCAGACAAACCTCATCAAC 1920 
621 	L 	I 	T K 	1. 	2 	26 	2 	L 	K 	T 	K 	I.. 	IL 	N 	640 
1921 TATGTCACCAGCATCCGCCCCAACATCTTTGTGGGCCGAGCAGAGGGCTCCACGCAGTAT 1980 
641 1 V T S I R P N I F V G R A El G S T Q Y 	660 
1981 GGCAAATGGTACTTTGAGGTGATGGTGGATGAGGTGGCTCCATTTCTGACAGCTCAGGCC 2040 
661 G K K I F K V K V D K V A P F L C A Q A 	680 
2041 ACCCACCTGAGGGTGGGCTGGGCCCTCAGCGAGGGCTACAGCCCCTACCCCGGAGGCGGC 2100 
681 T H L P V G K A L S E G I S P 1 P C G C 	700 
2101 GAGGGCTGGGGCGGCAACGGGGTCGGCGATGATCTCTATTCTTACGGCTTTGATGGGCTG 2160 
701 E C K C C N C V C K D L Y S Y G F D C L 	720 
236 
2161 CATCTTTGGACAGGGCATGTGGCACGCCCAGTGACTTCTCCGGGACAACACCTCTTGGCC 2220 
721 H L W T C H V A P P V I S P G Q H L L A 	740 
2221 CCGGAGGATGTGGTCAGCTGCTGCCTGGACCTCAGCGTCCCGTCCATCTCCTTTCGTATC 2280 
741 P F' D V V S C C L 	3 V P S I S F P I 	760 
2281 AACGGCTGCCCCGTGCAGGGTGTCTTTGAATCCTTCAACCTCGATGGGCTCTTCTTCCCT 2340 
761 N G C P V Q C VP ES F N L DCL F PP 	780 
2341 GTCGTGAGCTTCTCGGCTGGTATCAGTGCGCTTCCTCCTTGGTGGCCGCCATGGTGAA 2400 
781 V V S F S A C I K V P F L L C C R H C E 	800 
2401 TTTPGTTCCTGCCCCCACCTGGCTATGCTCCATGCCATGPGCTGTGCTCCCTCGGGAG 2460 
801 F K F L P P P C Y A P C H F' A V I. P R P 	820 
2461 CGGCTCCATCTCCAACCCATCAAAGAGTATCGCAGGGAGGGGCCTCGGGGGCCCCACCTG 2520 
821 P L H L Q P I K P Y P R E G P R G P H L 	840 
2521 GTGGGCCCCAGTCGCTGCCTCTCACATCTGGACTTTGTACCCTGTCCTGTGGACACCATC 2580 
841 V C P S R C L S H L D F V P C P V D T I 	860 
2581 CAGATCGTCTTGCCCCCCCACCTGGAGCGGATTCGGGAGAAGCTGGCAGAGAACATTCAT 2640 
861 Q I V L P P H L F' R I P F' K L A F' N I H 	880 
2641 GAACTCTGGGCACTGACTCGCATTGAGCAAGGATGGACCTATGGTCCGGTACGGGATGAC 2700 
881 E L W A L T F I E Q C V T Y C P V R D D 	900 
2701 AACAAGAGGCTGCACCCATGTCTTGTGAATTTCCACAGCTTGCCACAACCTGAGCGGAAT 2760 
901 N K R L H P C L V N F H S P 	P 1 3, R N 	920 
2761 TACAACTTGCAGATGTCAGGGGAGACACTCAfiGACTCTGCTGGCCCTGGGCTGCCATGTG 2820 
921 Y N L Q N S C E T L K T L L A L G C H V 	940 
2821 GGCATGGCAGATGAGAAGGCAGAAGACAACCTGAAGAAGACGAAGCTGCCTAAGACGTAT 2880 
941 C N A D K K A E D N L K K T K L P K T Y 	960 
2881 ATGATGAGCTGGATACAAGCCGGCTCCTCTGGACCTGAGCCACGTGAGGCTGACGCCT 2940 
961 M N S N C Y K P A P L D L S H V F L T P 	980 
2941 GCACAGACAACTCTGGTGGACCGGCTGGCAGAGAATGGGCACAATGTCTGGGCGAGAGAC 3000 
981 A Q T T L V D R L A K N C H N V H A R D 	1000 
3001 CGCGTGGCACJAGGCTGGAGCAACAGTGCTGTGCAGGACATCCCTGCACGCAGAAATCCT 3060 
1001 R V A Q C H S N S A V Q D I P A R R N P 	1020 
3061 CGCCTCGTGCCCTACCGCCTGCTGGACGAGGCCACCAAGCGCAGCAATAGGGACAGCCTC 3120 
1021 R L V P 1 R L L 0 K A T K F S N R D S L 	1040 
3121 TGCCAGGCTGTGCGCACCCTGCTGGGCTATGGCTACAACATCGAGCCTCCTGACCAGGAG 3180 
1041 C Q A V F T L L C Y C Y N I K P P D Q K 	1060 
3181 CCCAGTCAGGTGGACAGCCAGTCTCGTGGTGACCGGGCCCGCATCTTCCGGGCAGAGAAG 3240 
1061 P S Q V D S Q S F C D F A F I F R A F' K 	1080 
237 
3241 TCCTATGCAGTCCAGAGCGGCCGCTGGTACTTCGAGTTCGAAGCAGTCACCACAGGAGAG 3300 
1081 S V A V Q S G R W Y F F F E A V T T G F 	1100 
3301 ATGCGAGTGGGCTGGGCAAGGCCTGAGCTGAGACCTGATGTGGAGCTGGGAGCGGACGAT 3360 
1101 M R V G W A F P E L R P D V F L G A D D 	1120 
3361 TTGGCCTATGTCTTCAATGGGCATCGAGGCCAGCGCTGGCACTTGGGCAGTGAGCCATTT 3420 
1121 L A Y V F N G H R G Q R W H L G S E P F 	1140 
3421 GGGCGCCCCTGGCAGTCGGGCGATGTCGTCGGCTGCATGATTGATCTCACAGAGPCACC 3480 
1141 G R P 	 1 	 DL T F 
3481 ATCATCTTCACCCTCAATGGCGAGGTCCTCATGTCTGACTCGGGCTCGGAAACAGCCTTC 3540 
1161 I I F T L N G E V L M S D S G S E T A F 	1140 
3541 CGCGACATTGAGATCGGGGACGGCTTCCTGCCAGTCTGCAGCTTGGGACCTGGTCAGGTG 3600 
1181 F 2 I E I S D G F 2 P V C S 2 5 P G Q V 	1200 
3601 GGCCACCTGAACCTGGGCCAGGATGTGAGCTCCCTGAGGTTTTTTGCCATCTGTGGCCTC 3660 
1201 G H L N L G Q D V S S L F F F A I C G L 	1220 
3661 CAGGGGCTTTGAGCCGTTCGCCATCPCATGCAACGCCCAGTTACCACCTGGTTTAGC 3720 
1221 Q E G F F P F A I N M Q F P V T T W F S 	1240 
3721 AAGAGTCTTCCTCAGTTTGAGCCTGTGCCCCTCGAACACCCCCACTATGAGGTGGCCCGC 3780 
1241 K S L P Q F F P V PEE HP NY F V AR 	1260 
3781 ATGGATGGTACTGTGGATACACCCCCCTGCCTGCGCTTGACCCACCGCACCTGGGGCTCA 3840 
1261 M D G T V D T P P C 2 R L T H R T W G S 	1280 
3841 CAGAACAGTCTGGTGGAGATGCTGTTTCTCCGGCTAAGCCTTCCGGTCCAGTTCCACCAG 3900 
1281 Q N S L V F M L F L F L S 2 P V Q F H Q 	1300 
3901 CACTTCCGCTGCACGGCAGGGGCCACACCCCTGGCATCCCCTGGCCTGCAGCCTCCTGCT 3960 
1301 H F F C T A S A T P L A S P C L Q P P A 	1320 
3961 GAAGATGAGGCCCGGGCAGCAGAACCGGATACGGACTATGAAAACCTGCGCCGCTCCGCT 4020 
1321 E 0 E A R A A E P D T 0 Y F N L F F S A 	1340 
4021 GGAGGCTGGGGAGAGGCTGAGGGGGGCAAGGATGGAACTGCCAAGGAGGGGACACCCGGA 4080 
1341 5 G W G F A E G G K D G T A K E C T P G 	1360 
4081 GGCACTGCCCAGGCTGGGGTAGAGGCTCAGCCTGCGAGGGCGGAGAATGAGAAAGACGCT 4140 
1361 G T A Q A S V E A Q P A R A E N F K D A 	1380 
4141 ACCACCGAGAAGAACAAGAAGAGAGGGTTCTTGTTCAAGGCCAAGPGGTTGCCATGATG 4200 
1381 T T E K N K K R S F L F K A K K V A M N 	1400 
4201 ACCCAACCACCTTCCACTCCGGCTCTTCCCCGACTCCCTCGAGATGTGGTACCTGCTGAC 4260 
1401 T Q P P S T P A L P R 2 P R 0 V V P A D 	1420 
4261 AACCGCGACGACCCTGAGATCATCCTCAACACCACCACGTACTATTACTCTGTGAGGGTC 4320 
1421 N R 0 D P E I I L N T T T Y Y Y S V R V 	1440 
238 
	
4321 TTCGCGGGTCAGGAGCCCAGCTGCGTGTGGGTGGGCTGGGTCACTCCTGACTACCATC 	4380 
1441 P A G Q E P S C V W V G W V T P D Y H Q 1460 
4381 CATGACATGAGCTTCGAGCTCAGCAAAGTCAGGGCGGTGACAGTGACCATGGGAGATGAA 4440 
1461 H P M S F P L S K V R A V T V T M G D 5 	1480 
4441 CAAGGCAATGTCCACAGCAGCCTCAAGTGTAGCAGCTGCTACATGGTGTGGGGTGGAGAT 4500 
1481 Q C N V H S S L K C S S C V M V W G G D 	1500 
4501 TTTGTGAGTCCCGGACAGCAGGGCCGAATCAGCCACACAGACCTTGTCATTGGCTGCCTG 4560 
1501 F V S P G Q Q C H I S H T D L V I G C L 	1520 
4561 GTGGATCTGGCCACCGGCTTGATGACCTTCACAGCCAATGGGAAAGAAAGCAACACCTTC 4620 
1521 V D L A T C L M T F T A N G K P S N T F 	1540 
4621 TTCCAGGTGGAACCCAACACGAAGCTGTTTCCTGCTGTCTTCGTGCTGCCCACCCACCAG 4680 
1541 F Q V P P N T K L F P A V F V L P T H Q 	1560 
4681 AACGTGGTCCAGTTTGAGCTGGGGAAGCAGAAGAACATCATGCCGCTGTCAGCCGCCATG 4740 
1561 N V V Q F E L C K Q K N I M P L S A A M 	1580 
4741 TTCCTGAGCGAGCGCAAGAACCCAGCCCCACAGTGCCCACCAAGGCTGGAGGTGCAGATG 4800 
C P P R L P V Q M 	1600 
4801 CTGATGCCTGTCTCGTGGAGCCGAATGCCCAACCACTTCCTACAGGTGGACACGCGGCGT 4860 
1601 L N P V S N S 1 'V 	N H F L Q V P T H R 	1620 
4861 GCTGGAGAGCGGCTGGGCTGGGCAGTTCAGTGCCAGGAGCCGCTGATGATGATGGCGCTA 4920 
1621 A G E R L C N A V Q C Q P P L M M N A V 	1640 
4921 CACATCCCGGAGGAGAACAGGTGCATGGACATCCTAGAGCTATCTGAGCGGCTGGACCTA 4980 
1641 H I P P 8 N H C N D I L P L S E H L D L 	1660 
4981 CAGCGCTTCCACTCACACACGCTCTCGCTCTACCGCTCGGTGTGTGCCCTGGGCAACAAC 5040 
1661 Q R F H S H T L S L Y H S V C A L C N N 	1680 
5041 CGCGTGGCTCATGCCCTGTGCAGCCACGTGGACCAGGCACAGCTGTTGCATGCGCTGGAG 5100 
1681 H V A H 'V 	 V H V V 	V. 	L L H A L E 	1700 
5101 GATGCGCGCTTGCCAGGTCCTCTGCGAGCAGGCTACTACGACCTCCTCATCAGCATCCAC 5160 
1701 D A H L P G P L R A G V Y D L L I S I H 	1720 
5161 CTCGAAAGCGCCTGCCGCAGCCGTCGCTCCATGCTCTCTGAGTACATTGTGCCACTCACG 5220 
1721 L P S A C R S R R S M L S E V I V P L T 	1740 
5221 CCGGAGACCCGCGCCATCACGCTTTTCCCACCTGGGCGAAGTGCGGAAGATGGCCCOCGC 5280 
1741 P P T R A I T L F P P C H S A P D C P R 	1760 
5281 CGCCATGGCCTGCCTGGCGTTGGGGTCACAACCTCCCTGAGACCTCCACACCATTTCTCA 5340 
1761 R H G L P G V C V Ti T S L R P P H H F S 	1780 
5341 CCCCCGTGTTTTGTGGTCGCCCTGCCAGCTGCTGGGGCCACAGAAGCTCCGGCTCGCCTC 5400 
1781 P P C F V V A L P A A G A T P A P A H L 	1800 
239 
5401 AGCCCTGCCATCCCTCTGGAGGCTCTGCGAGACAAGGCGCTGAGAATGTTGGGGGAAGCC 5460 
	
1801 S P A I P L E A L R 0 K A L R M L G E A 	1820 
5461 GTGCGTGATGGAGGACAGCATGCTCGCGACCCGGTTGGGGGCTCTGTGGAGTTCCAGTTC 5520 
1821 V P D G C Q H A R D P V C G S V E F Q F 	1840 
5521 GTCCCGGTGCTCAAGCTTGTGTCTACCCTCCTGGTGATGGGTGTCTTTAGTGACGAGGAT 5580 
1841 V P V L K L V S T L L V K G V F S D E D 	1860 
5581 GTGAAGCAGATCCTGAAGATGATTGAGCCTGAAGTCTTCAGGGAGGAAGAAGAGGTGGAG 5640 
1861 V K Q I L K K I E P F V F P E F F E V E 	1880 
5641 GAGGAGGGAGAGGAGGAAGAGGAAGATGAGGAGGAGAAAGAGGAGGATGAAGAAGAAGAG 5700 
F. F F E D E E E K F F P F F F F 	10fl 
5701 GCACACGAGAAGGAAGATGAGGAAAAAGAAGAGGCAGAGGATGCTGCAGAAGAGGAGPG 5760 
1901 A H E K F D E F K E F A F 0 A A E F E K 	120 
5761 GAAGAGCTTGAGGAGGGGCTGCTGCAGATGAAGCTGCCCGAGTCTGTGAAATTACAGATG 5820 
1921 F F L F F C L L Q K K L P F S V K L Q K 	1940 
5821 TGCCACCTCCTGGAGTATTTCTGTGACCAAGAGCTGCAGCACCGGGTGGAGTCCTTGGCG 5880 
1941 C H L 1 F Y F C 9 Q F C Q H P V F S L A 	1960 
5881 GCCTTTGCAGAGTGTTATGTGGACAAGATGCAGGGCAACCAGCGGGGTCGCTACGGCCTC 5940 
1961 A F A SC IV 9KM Q G N Q R G RIG L 	1980 
5941 CTCATGAAAGCCTTCACCATGAGCGCAGCCGAGACCGCAAGGCGCACCCGAGAGTTCCGT 6000 
1981 L N K A F TM S A A ETA R R T RE FR 
6001 TCTCCACCCCAGGAGCAGATCAACATGCTATTGCACTTCAAAAATGGTGCTGATGAGGAA 6060 
2001 S P P Q F Q I N M L L H F K N C A D E E 	2020 
6061 GAGTGTCCTCTCCCTGAAGAGATCCAACAGGAGTTAGTCAACTTTCACCAAGACCTGCTG 6120 
2021 E C P L P E F I Q Q E L V N F H Q 0 L L 	2040 
6121 GCACATTGTGGAGTCCAGTTGGAGGGAGAGGAGGAGGAGCCAGAGGAGGAGAGCACTCTG 6180 
2041 A H C G V Q L K G E E E E P E E E S T L 	2060 
6181 GGAAGCCGCCTCATGAGCTTGTTGGAAAAAGTAAAGCTGGTGAAGAAGACAGAGGAGAAG 6240 
2061 G S R 9 9 	1 1 F. 1< V K L V K K T F K K 	2080 
6241 CCTGAGGAGGAGCCGGCACCTGAGGAGCACAAGCCTCAGTCCTTGCAGGAGCTGGTGTCC 6300 
2081 P E E E P A P F F H K P Q S L Q K L V 5 	2100 
6301 CACACAGTGGTGCGCTGGGCCCAGGAGGACTTCGTTCAGAGCCCGGAGCTGGTCCGTGCC 6360 
2101 H T V V R K A Q K D F V Q S P F C V R A 	2120 
6361 ATGTTCAGCCTCCTGCATCGGCPIGTATGACGGGCTCGGCGAGCTGCTGCGTGCCCTGCCC 6420 
2121 N F S L L H R Q Y D G L C F L L R A L P 	2140 
6421 CGGGCCTACACAATCTCTGTGTCCTCGGTGGAGGATACCATGAGCCTGCTGGAGTGCCTG 6480 
2141 R A Y T I S V S S V E D T N S L L E C L 	2160 
240 
6481 GGCCAGATCCGCTCACTGCTCATTGTGCAGATGGGTCCCAGGAGGAGAACTATGATCCAG 6540 
2161 G Q I R S L L I V Q M C P R R R T N I Q 	2180 
6541 AGCATTGGGAACATCATGAATAACWGTCTTCTACCAACACCCAAACCTGATGAGAGCG 6600 
2181 S I C N I N N N K V F Y Q H P N L N R A 	2200 
6601 CTGGGTATGCATGAAACAGTCATGGAGGTTATGGTGAACGTCCTTGGGGGCGGCGAGTCA 6660 
2201 L C N H F T V N F V N V N V L G G G E S 	2220 
6661 AAGGAGATCCGCTTCCCCAAGATGGTGACPAGCTGCTGCCGCTTCCTCTGCTACTTCTGC 6720 
2221 K E I R F P K N V T S C C R F L C Y F C 	2240 
6721 CGAATCAGCCGGCAGAACCAGCGCTCCATGTTTGACCACCTCACCTACCTGCTGGAGAAC 6780 
2241 R I S R Q N Q R S M F D H L S S S L F N 	2260 
6781 AGCGGCATTGGCCTGGGCATGCAGGGCTCCACACCCTTGGATGTAGCTGCTGCTTCTGTC 6840 
2261 S C I C S C N Q C S T P L D V A A A S V 	2280 
6841 ATTGACAACCGAGCTAGCCTTGGCATTACAAGAGCAAGACCTGGAAAAGGTTGTGTCA 6900 
2281 I D N N E L A L A L Q F Q D L F K V V S 	2300 
6901 TACCTGGCAGGGTGTGGCTTACAAAGCTGCCCCATGCTTCTGGCCAAAGGGTATCCTGAC 6960 
2301 Y L A C C C L Q S C P N L L A K C Y P D 	2320 
6961 ATCGGATGGAATCCCTGTGGGGGCGAACGCTACCTCGACTTCCTGCGTTTTGCTGTCTTT 7020 
2321 I G W N P C C G F R S L D F L R F A V F 	2340 
7021 GTCAACGGTGAGAGCGTGGAAGAGAACGCTAACGTGGTCGTGCGGCTGTTGATCCGCAAA 7080 
2341 V N C E S V F F N A N V V V R L L I R K 	2360 
7081 CCCGAGTGCTTTGGACCTGCCCTGAGGGGTGAGGGTGGCTCAGGGCTGCTGGCTGCCATC 7140 
2361 P F C F G P A L R C F C G S G L L A A I 	2380 
7141 GAAGAGGCCATCCGAATCTCTGAGGATCCCGCACGGGATGGGCCGGGTGTCCGCAGGGAC 7200 
2381 F E A I R I S F D P A R D G P G V R R D 	2400 
7201 CGGCGACGTGAGCACTTTGGTGAGGAGCCCCCTGAAGAAAACCGGGTACACCTGGGACAT 7260 
2401 R R R E H F C F E P P F E N F V H L G H 	2420 
7261 GCCATCATGTCCTTCTATGCTGCCTTGATTGACCTGCTAGGACGCTGTGCACCTGAGACG 7320 
2421 A I N S F Y A A S I 5 1 5 1 51 5 	FT 
7321 CATTTGATTCAAGCCGGTAAGGGTGAGGCCCTGAGGATCCGTGCCATCCTTCGGTCCCTC 7380 
2441 H L I Q A C K C F A L F I F A I L F S L 	
1I460 
7381 GTGCCCTTGGATGACCTCGTGGGCATCATCAGCCTCCCACTGCAGATCCCCACCCTGGGC 7440 
2461 V P L S 2) 5 V G I I S S F L Q I P T S C 	2480 
7441 AAAGATGGCGCACTGGTTCAGCCGAAGGTGTCTGCATCCTTCGTGCCTGACCACAAGGCA 7500 
2481 K D G A L V Q P K V S A S F V P D H K A 	2500 
7501 TCCATGGTGCTTTTCCTGGACCGAGTGTATGGCATTGAGAACCAGGACTTCTTGCTGCAT 7560 
2501 S N V L F S D R V Y C I F N Q D F L L H 	2520 
241 
7561 GTGCTGGATGTGGGGTTCCTTCCTGACATGAGGGCGGCTGCTTCACTGGACACGGCTACT 7620 
2521 V L D V G F L P D M R A A A S L D T A T 	2540 
7621 TTCAGCACCACGGAGATGGCGCTGGCACTGAACCGCTACCTCTGTCTGGCTGTGCTGCCG 7680 
2541 F S T T F N A L A L N R Y L C L A V L P 	2560 
7681 CTCATCACCPGTGCGCGCCACTCTTTGCGGGCACCGAGCACCGCGCCATCATGGTGGAC 7740 
2561 L I T K C A P L F A G T K H R A I N V D 	2580 
7741 TCCATGCTACACACAGTGTACCGGCTGTCGCGGGGCCGCTCGCTCACCAAAGCACAGCGC 7800 
2581 S N L H T V V R L S R C R S L T K A Q R 	2600 
7801 GACGTCATCGAGGACTGCCTCATGGCGCTGTGCAGGTATATCCGCCCCTCCATGCTGCAG 7860 
2601 D V I F 	 r 	N 2 	2620 
7861 CACCTGCTTCGACGCCTGGTGTTCGATGTGCCCATCCTCAATGAGTTCGCCAAGATGCCA 7920 
2621 H L L R F L V F D V P I L N F F A K M P 	2640 
7921 CTCAAGCTCCTTACCAACCACTATGAGCGTTGCTGGAAGTACTACTGCCTCCCCACAGGC 7980 
2641 L K L L T N H Y F R C W K Y Y C L P T G 	2660 
7981 TGGGCCAACTTCGGGGTCACCTCTGAGGAAGAGCTGCACCTCACACGCPGCTCTTCTGG 8040 
2661 N A N F G V T S F F E L H L T R K L F N 	2680 
8041 GGCATCTTTGATTCTCTGGCGCATAAGAAATACGACCAGGAGCTTTACCGAATAGCCATG 8100 
2681 G I F D S L A H K K V D Q E L Y R I A N 	2700 
8101 CCTTGCCTGTGTGCCATCGCGGGCGCACTGCCCCCTGACTACGTGGACGCCTCATACTCA 8160 
2701 P C L C A I A C A L P P D Y V D A S Y S 	2720 
8161 TCCAAGACGGAGAAAAAAGCCACAGTGGACGCTGAAGGCAACTTTGATCCCCGGCCTGTG 8220 
2721 S K T K K K A T V D A F C N F D P R P V 	2740 
8221 GAGACCCTCAACGTCATCATCCCCGAGAAGCTGGACTCCTTCATTAACAAGTTCGCAGAG 8280 
2741 E T L N V I I P F K L 0 S F I N K F A E 	2760 
8281 TACACCCATGAGAAGTGGGCCTTCGACAAGATTCAGAACPATTGGTCCTATGGTGAGAAC 8340 
2761 Y T H K K N A F 0 K I Q N N N S V C K N 	2780 
8341 ATTGATGAAGPTTGAAGACCCACCCCATGCTGAGACCCTACAAGACCTTCTCAGAGAAG 8400 
2781 I D K E L K T H P N L R P Y K T F 3 F K 	2800 
8401 GACAAAGAGATTTACCGTTGGCCCATCAAGGAGTCTTTGAAGGCCATGATTGCCTGGGAA 8460 
2801 0 K E I Y R N P I K E S L K A M I A N E 	2820 
8461 TGGACAGTAGAGAAGGCCAGGGAAGGCGAGGAGGGGAAGACGGAA?AGAAAAAAACAAGA 8520 
2821 W T V E K A R K C F F G K T K K K K T F 	2840 
8521 AAGATATCCCAPACCGCCCAGACATATGACCCCCGAGAAGGCTACAATCCCCAGCCACCA 8580 
2841 K I S Q T A Q T V N P F K C Y N P Q P P 	2860 
8581 GACCTCAGCGTGGTTACGTTGTCCCGGGAGCTGCAGGCCATGGCCGAACAACTGGCAGAA 8640 
2861 D L S V V T L S R K L Q A N A E Q L A K 	2880 
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8641 AATTACCACAACACTTGGGGGCGAAAGAAGGAGCAAGAGCTGGAGGCTAAAGGAGGTGGG 8700 
2881 N V H N T W C P K K P Q P L P A K C C G 	29u 
8701 TCTCATCCTCTACTGGTTCCCTACGACACGCTCACGGCCAAGGAGAAGGCACGGGATCGA 8760 
2901 S H P L L V P Y D T L T A K E K A H D H 	2920 
8761 GAGGGCCCAGGAGTTGCTGAAGTTTCTGCAGATGAATGGCTATGCTGTCACCAGGGGT 8820 
2921 P K A Q EL L K FL Q MN G VA VT R G 	2940 
8821 CTTAAGGACATGGAACTGGACACATCCTCCATTGAGAAGCGATTTGCCTTCGGCTTCCTG 8880 
2941 L K D 	1 	 G F L 	2960 
8881 CAGCAGCTGCTTCGCTGGATGGACATCTCCCAGGAGTTCATCGCCCACCTGGAGGCTGTG 8940 
2961 Q Q L L R W K 0 I S Q P F I A H L E A V 	2980 
8941 GTTAGCAGTGGACGGGTGGAGAA.ATCCCCACATGAACAGGAGATTAAATTCTTTGCTAAG 9000 
2981 V S S G R V K K S P H E Q E I K F F A K 	3000 
9001 ATTCTGCTGCCTTTGATCAACCAATACTTCACCAACCACTGTCTCTACTTCCTATCCACA 9060 
3001 I L L P L I N Q V F T N H C L V F L S T 	3020 
9061 CCAGCCAAAGTGCTGGGCAGTGGTGGCCATGCCTCCAACAAGGAGAAGGAAATGATCACC 9120 
3021 P A K V L N S G C H A S N K E K E M I T 	3040 
9121 AGCCTCTTCTGTAAACTTGCTGCCCTTGTCCGCCACCGAGTCTCCCTCTTTGGGACGGAT 9180 
3041 S L F C K L A A L V R H R V S L F N T V 	3CwCi 
9181 GCCCCAGCTGTGGTCAACTGTCTTCACATATTGGCACGCTCTCTAGATGCCAGAACGGTC 9240 
3061 A P A V V N C L H I L A H S L V A R 1 	D8O 
9241 ATGAAATCGGGCCCTGAGATCGTAAAGGCGGGTCTGCGCTCCTTCTTCGAGAGTGCCTCC 9300 
3081 M K S C P P I V K A C L R S F F E S A S 	3100 
9301 GAGGACATTGAGAAGATGGTGGAGAACCTGCGGCTAGGAAAGGTGTCGCAGGCGCGCACG 9360 
3101 P D I P K M V P N L R L C K V S Q A H T 	3120 
9361 CAGGTGAAGGGCGTGGGCCAGAACCTCACCTACACCACGGTGGCTCTGCTGCCCGTCCTC 9420 
3121 Q V KG V N Q N V T IT TV ALL P V L 	3140 
9421 ACCACCCTCTTCCAGCACATCGCCCAGCAOCAGTTCGGAGACGATGTCATCCTGGATGAC 9480 
3141 T T L F Q H I A Q H Q F G 0 0 V I L D D 	3160 
9481 GTACAAGTGTCTTGCTACCGAACGCTCTGCAGTATCTACTCTCTGGGAACCACCAGGAAC 9540 
3161 V Q V S C V R T L C S I V S L G T T H N 	3180 
9541 CCCTATGTGGAAAAACTGCGGCCAGCCCTGGGGGAATGCCTGGCCCGCCTGGCCGCAGCC 9600 
3181 P Y V E K L R P A L G P C L A R L A A A 	3200 
9601 ATGCCAGTGGCATTCCTGGAGCCTGAGCTGAATGAATACAACGCCTGCTCTGTCTACACC 9660 
3201 K P V A F L P P E L N P Y N A C S V Y T 	3220 
9661 ACCCAATCTCCTCGAGAGCGGGCCATCCTGGGGCTTCCCAACAGCGTGGAGGAGATGTGT 9720 
3221 T Q S P H E R A I L G L P N S V E E N C 	3240 
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9721 CCTGACATCCCAGTGCTAGAAAGGCTCATGCCAGAAATCGCGCGGCTGGCCGAGTCCGGA 9780 
3241 P D I T V L K R L N V:. 	 V K P V3260 
9781 GCACGCTACACAGAGATGCCGCATGTCATCGAGATTACGTTGCCTATGCTGTGCAGCTAC 9840 
3261 A R Y T E N P H V I F' I T L P N L C S Y 	3280 
9841 CTGCCCCGCTGGTGGGAGCGAGGGCCTGAGGCGCCCCCACCAGCCCTGCCTGCGGGCGCC 9900 
3281 C P R W W F' R G P K A P P P A L P A G A 	3300 
9901 CCGCCACCCTGTACAGCGGTCACCTCCGACCACCTCAATTCCCTCCTGGGGAACATCCTC 9960 
3301 P P P C T A V T S D H L N S L L G N I L 	3320 
9961 CGAATCATCGTGAACAACCTGGGCATCGATGAGGCCTCGTGGATGAAGCGGCTGGCCGTG 10020 
3321 R I I V N N L G I D F' A S W N K R L A V 	3340 
10021 TTTGCCCAGCCCATTGTGAGCCGTGCCAGGCCGGAGCTCCTACGCTCCCACTTCATCCCT 10080 
3341 F A Q P I V S R A R P F' L L R S H F I P 	3360 
10081 ACCATCGGGCGATTGCGTAAGCGGGCAGGGPGGTGGTGGCAGAGGAGGAGCAGCTGCGC 10140 
3361 T I C F' L R K R A C K V V A F' £ K Q L R 	3380 
10141 CTGGAAGCCAAGGCAGAAGCTGAGGAGGGTGAGCTCCTGGTCCGGGACGAGTTCTCCGTG 10200 
3381 L E A K A F' A E E G F' L L V R D F' F S V 	3400 
10201 CTCTGCCGCGACCTGTATGCCCTCTACCCACTGCTCATCCGCTACGTAGACAACAACAGG 10260 
3401 L C 	DL Y AL Y P L L 	R Y V 2 N N R 	3420 
10261 GCACACTGGCTGACAGAGCCCAACCCCAATGCAGAGGAGCTGTTCAGGATGGTGGGAGAA 10320 
3421 A H W L T E P N P N A £ F' L F R M V C F' 	3440 
10321 ATCTTCATCTACTGGTCCAAGTCCCACCTTTAAGCGTGAAGPCAGAACTTCGTGGTC 10380 
3441 I F I Y K S K S H N F K F' F' K Q N F V V 	3460 
10381 CAGAATGAAATCAACAACATGTCCTTTTTGACAGCTGACAATAAGAGCAAAATGGCCAAG 10440 
3461 Q N El N N MS FL TAD N KS K MA K 	3480 
10441 GCAGGAGACGTACAGTCAGGTGGCTCAGATCAGGAACGCACCAAGAAGAAGCGCCGGGGG 10500 
3481 A G D V Q S C C S D Q E R T K K K R R G 	3500 
10501 GACCGCTACTCCGTGCAGACATCCTTGATCGTGACCACACTCAAGAAGATGTTGCCGATC 10560 
3501 0 R Y S V Q T S L I V T T L K K N L P I 	3520 
10561 GGACT1AAACATGTGTGCTCCCACCGACCAGGACCTCATTGTACTGGCCPJAGCCCGCTAT 10620 
3521 G L N N C A P T D Q D L I V L A K A R Y 	3540 
10621 GCCCTGAIAAGATACAGATGAGGAGGTCCGTGAATTCCTTCAAAACAACCTTAACCTTCAG 10680 
3541 A L K 2 T D E F' V F' E F L Q N N L N L Q 	3560 
10681 GGAAAGGTGGAAGGCTCACCATCTCTTCGCTGGCAAATGGCACTGTACCGCGGCGTCCCA 10740 
3561 G K V £ G S P S L F' K Q N A L Y F' C V P 	3580 
10741 GGCCGCGAGGPAGATGCCGATGATCCGGAGAAAATCGTGTGCAGAGTCCAGGAAGTGTCC 10800 
3581 G F' F' F' D A D D P E K I V C R V Q E V S 	3600 
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10801 GCAGTGCTCTATCACCTGGACCAGACGGAGCATCCTTACAAGTCCAAGAAGGCGGTGTGG 10860 
	
3601 A V L I H L D Q T E H P 1 K S K K A V K 	620 
10861 CATWCTTCTGTCCAAGCAGCGCCGGAGGGCTGTGGTGGCCTGTTTCCGCATGACGCCC 10920 
3621 H K L L S K Q R R R A V V A C F P M T P 	3640 
10921 CTGTACAACTTGCCCACGCACCGAGCGTGTCATGTTCTTGGAGAGCTACAAAGCCTCC 10980 
3641 L 1 N L P T I-i R A C N N F L E S I K A S 	3660 
10981 TGGATCCTGACTGAGGACCACAGTTTCGAGGACCGCATGATAGATGACCTATCGPGCT 11040 
3661 W 	I I S I H S F E D R M I D D L S K A 	3680 
11041 GGAGAGCAGGAAGAAGAGGAGGAAGAGGTGGAGGAGAAGAAGCCAGACCCCTTACACCAG 11100 
3681 G E Q S E E E E E V S P K K P 0 P L H Q 	3700 
11101 TTGGTCCTACACTTCAGCCGCACAGCTCTPACTGAAAAGAGCAAACTGGACGAAGACTAC 11160 
3701 L 	L H F SR TA L T S K SE L D ED Y 	3720 
11161 CTATACATGGCTTACGCTGACATCATGGCWGAGCTGCCACCAGGAGGAGGGCGGGGAA 11220 
3721 L I N A I A D I N A K S C H Q E S G G E 	3740 
11221 AATGGCGAAGAAGGAGGCGAAGAAGAGGAAGTGGAGGTGTCCTTTGAGGAGAAGGAGATG 11280 
3741 N C P 5 C G K P E E V E V S F P 5 K E N 	3760 
11281 GAGAAACAGAGGCTCCTGTACCAGCAGTCAAGGCTGCACAACCGGGGTGCTGCTGAGATG 11340 
3761 E K Q R L L I Q 	1 	1 1 P G A A E M 	3780 
11341 GTACTGCAGATGATCAGTGCCTGCAAAGGAGAAACGGGTGCCATGGTGTCTTCCACCCTG 11400 
3781 V L Q M I S A C K G P T G A N V S S T L 	3800 
11401 AAGCTGGGTATCTCCATCCTTAACGGAGGGAACGCTGAATTGCAGCAGAAAATGCTGGAT 11460 
3801 K L C I S I L N G G N A P L Q Q K N L D 	3820 
11461 TACCTGAAGGACAAGAPIGAAAGTGGGCTTCTTCCAGAGTATCCAGGCGCTGATGCAAACG 11520 
3821 1 L K D K K K V C F F Q S I Q A L N Q T 	3840 
11521 TGCAGCGTCCTGCACCTCAATGCCTTCGAGAGGCAGAACAPGGCAGAGGGGCTGGGCATG 11580 
I R Q N K A E C L G M 	3860 
11581 GTGAACGAGGACGGAACTGTCATCAATCGCCAAAACGGAGAGAAAGTCATGGCGGATGAC 11640 
3861 V N E D G T V I N R Q N G P K V M A D D 	3880 
11641 GAGTTCACACAGGACCTGTTCCGCTTCCTGCAGCTGCTCTGCGAGGGGCACAACAATGAT 11700 
3881 E F T Q D L F R F L Q L L C P G H N N D 	3900 
11701 TTCCAAAACTACCTACGGACACAGACTGGGAACACGACCACCATCAATATCATTATCTGC 11760 
3901 F Q N I L P T Q T C N T T T I N I I I C 	3920 
11761 ACAGTGGACTACCTCCTGCGGCTGCAGGAATCCATCAGTGACTTCTACTGGTATTACTCG 11820 
3921 T V D I L L R L Q E S I S D F Y K I I S 	3940 
11821 GGCAAGGATGTCATCGAGGAACAGGGAAAGAGAAACTTCTCCPAAGCCATGTCGGTAGCT 11880 
3941 G K D V I 5 5 Q G K R N F S K A M S V A 	3960 
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11881 AACAAGTGTTCAACAGCCTCACCGAGTACATCCAGGGACCCTGCACCGGAAACCAGCAG 11940 
3961 K Q V F N S L T F I 	Q C PC T G N Q Q 	3980 
11941 AGTCTGGCGCACAGTCGCCTCTGGGATGCCGTGGTGGGCTTCCTGCACGTGTTCGCGCAC 12000 
3981 S L A H S R L K D A V V G F L H V F A H 	4000 
12001 ATGATGATGAAGCTGGCTCAGGACTCCAGCCAGATAGAGCTGCTGAAGGAGCTGCTGGAC 12060 
4001 M M M K L A Q D S S Q I K L L K K L L D 	4020 
12061 CTACAGAAGGACATGGTGGTGATGCTGCTGTCCCTCCTGGAAGGAAACGTGGTGAACGGT 12120 
4021 L Q K D M V V M L L S L L E G N V V N G 	4040 
12121 ATGATCGCGCGGCAGATGGTGGACATGCTCGTGGAGTCTTCGTCCAATGTGGAGATGATT 12180 
4041 M I A R Q N V D N L V K S S S N V K N I 	4060 
12181 CTCAAGTTCTTCGACATGTTTCTGAPCTCAAGGACATCGTAGGCTCTGAGGCCTTCCAG 12240 
4061 L K F F D N F L K L K D I V G S K A F Q 	4080 
12241 GACTATGTCACAGACCCCCGTGGCCTCATCTCCAAGAAGGACTTCCAGAAGGCCATGGAC 12300 
4081 D I V T D P R G L I S K K C F Q K A N C 	4100 
12301 AGCCAGAAGCAGTTCACTGGCCCAGAJATCCAGTTCCTGCTCTCGTGTTCCGAAGCAGAT 12360 
4101 S Q K Q F T C P K I Q F L L S C S E A D 	4120 
12361 GACAATGAGATGATCAACTGCGAAGAGTTTGCGAACCGCTTCCAGGAACCAGCGCGGGAC 12420 
	
F H F N IH' K K F F H F F Q K P A R C 	4140 
12421 ATTGGCTTCAACGTGGCGGTACTGCTTACCAACCTGTCAGAGCATGTGCCCCACGACCCG 12480 
4141 I GE N V A V L L TN L SE H V PH D P 	4160 
12481 CGCCTGCGCAACTTCCTGGAGCTGGCTGAGAGCATCCTGGAGTACTTCCGGCCTTACC'rG 12540 
4161 R L R N F L K L A K S I L K I F R P 1 L 	4180 
12541 GGCCGCATCGMATCATGGGCGCATCGCGTCGCATAGAACGGATCTATTTTGAGATCTCA 12600 
4181 C R I K I N G A S R R I K R I Y F K I S 	4200 
12601 GAGACCAACCGTGCCCAGTGGGAGATGCCCCAGGTGAAGGAGTCCAAGCGCCAGTTCATC 12660 
4201 E T N R A Q K K N P Q V K K S K R Q F I 	4220 
12661 TTCGACGTGGTGAACGAGGGCGGCGAGTCCGAGAAGATGGAGATGTTCGTGAGTTTCTGC 12720 
4221 F D V V N K G C E S K K N K N F V S F C 	4240 
12721 GAGGACACGATCTTTGAGATGCAGATCGCAGCTCAGATCTCCGAGCCTGA 	 12770 
4241 K D T I F K N Q I A A Q I S K P 	 4256 
246 
Nucleotide and deduced amino acid sequence of the 3' end contig of the murine Ryrl 
cDNA 
The deduced amino acid sequence is shown in one - letter code below the nucleotide 
sequence in blue letters. Nucleotide and amino acid residue numbers are indicated 
at both sides. Putative polyadenylation signals in the nucleotide sequence are in 
red letters and underlined. The 3' end untranslated region is indicated in pink 
letters. The stop codon is indicated by asterisk mark. 
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1 AGAGTGAAATTCTTGAACTACTTGTCGAGGAATTTCTACACACTGCGGTTCCTGGCCCTC 60 
	
1 R V K F L N V L S R N F V T L R F 	A El 
61 TTCCTGGCCTTTGCCATCAACTTCATCTTACTGTTTTATAAGGTCTCAGACTCTCCACCA 120 
21 F L A F A I N F I L L F Y K V S D S P P 	40 
121 GGGGAGGATGACATAGP3AGGTTCCGGTGCTGGGGACATGTCAGGGGCAGGGTCTGGTGAT 180 
41 G E P D I E G S G A C D M S G A G S G D 	60 
181 GGCTCTGGCTGGGGCTCCAGGGCCGGCGAGGAGGTAGAGGGTGATGAAGATGAGAACATG 240 
61 G S G W G SR AGE EVE G 	ED E NM 	80 
241 GTGTACTACTTCCTGGAGGAGAGCACCGGCTACATGGAGCCTGCCCTGAGGTGCTTGAGC 300 
81 	V V Y 	FL El 	El lIT ElY MEL OF 	 100 
301 CTGCTGCACACGCTGGTGGCCTTTCTCTGCATCATTGGCTACAACTGTCTCAAGGTGCCC 360 
101 L L H T L 	A FL CI I G Y N CL EL F 	120 
361 CTTGTCATCTTCAAACGGGAGAAGGAGCTGGCCCGGAAGCTGGAGTTTGATGGCCTCTAC 420 
121 L V I F K RE K EL AR K L FED G L 	140 
421 ATTACAGAGCAGCCCGAGGATGATGACGTGAAGGGACAGTGGGACCGCCTGGTGCTCAAC 480 
141 I T F Q P F D D D V K G Q N D R L V L N 	160 
481 ACGCCGTCTTTCCCTAGCAACTACTGGGACAAGTTTGTCAAGCGGAAGGTTCTGGACAAA 540 
161 T P S F P 5 N Y N D K F V K R K V L D K 	180 
541 CACGGGGACATCTTTGGGCGGGAGCGGATTGCGGAGCTGCTGGGCATGGATCTGGCCTCT 600 
181 H G D I F C R E R I A F L El El 	F El A 3 	200 
601 CTGGAGATCACAGCCCACAATGAGCGCAAACCTGACCCTCCACCGGGCCTGCTGACATGG 660 
201 L F I T A H N F R K P D P P P C L L T N 	220 
661 ATCATGTCTATCGATGTCAAATACCAGATCTGGAAGTTTGGAGTCATCTTCACAGACAAC 720 
221 I N S I 0 V K Y Q I N K F G V I F T D N 	240 
721 TCTTTCCTGTATCTGGGCTGGTACATGGTGATGTCCCTCCTGGGGCACTACAATCTTC 780 
241 S F L Y L C N V N V M S L L C H V N N F 	260 
781 TTCTTTGCTGCCCACCTCCTGGACATCGCCATGGGAGTCAAGACGCTCCGCACCATCCTT 840 
261 F F A A H A L DI A MG VET L R TI L 	280 
841 TCATCTGTCACTCACAATGGAAAGCAGCTGGTGATGACCGTAGGGCTCCTGGCCGTAGTG 900 
281 S S V T H N C K Q L V M T V G L L A V V 	300 
901 GTCTACTTGTATACAGTGGTGGCCTTCAACTTCTTCCGCAAATTCTACAACAAGAGCGAA 960 
301 V V L V T V V A F N F F R K F Y N K S F 	320 
961 GATGAGGACGAGCCTGACATGAAGTGTGATGACATGATGACGTGCTACCTGTTCCACATG 1020 
321 D F D F P 0 M K C D D N N T C V L F H N 	340 
1021 TATGTGGGCGTCCGGGCCGGTGGAGGGATCGGGGACGAGATCGAGGACCCGGCCGGCGAT 1080 
341 V V C V R A G G C I G D E I F D P A G D 	360 
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1081 GAATATGAACTTTACCGGGTCGTCTTCGACATCACCTTTTTCTTCTTCGTTATCGTCATT 1140 
361 E Y E L Y R V V F D I V F 1- 	F F': V 1 	380 
1141 CTGCTGGCTATCATTCAGGGTCTGATTATTGATGCTTTTGGGGAGCTCCGAGACCAACAA 1200 
381 L L A I I Q G L I I V A 	1 L R D Q Q 	400 
1201 GAGCAAGTGAAGGAAGACATGGAGACCAAGTGCTTCATCTGTGGAATAGGCAGTGACTAC 1260 
401 F Q V K F D M K T K C F I C G I C S D Y 	420 
1261 TTCGACACA1CCCCACATGGGTTTGAGACCCACACTCTAGAAGAGCACAACCTAGCCAAT 1320 
421 F D T V P H G F F T H T L F. E H N L A N 	440 
1321 TACATGTTTTTCCTGATGTATTTGATAAATAAGGATGAGACAGAGCACACTGGTCAGGAG 1380 
441 Y M F F L M Y L I N K D F T E H T G Q E 	460 
1381 TCGTATGTCTGGAAGATGTACCAGGAAAGGTGCTGGGATTTCTTCCCTGCTGGAGACTGT 1440 
461 S Y V W K M Y Q E R C W D F F P A G D C 	180 
1441 TTCCGCAAGCAGTATGAGGACCAGCTTAGCTGA:'l"!' 	V 	 Cfl' 	1500 
481 	F P K 	V F 1) (3 L S 	* 	 490 
1501 	 1560 
1561 	.TV\F3I,A1'i'V 	 V.' 	 1610 
249 
Annex —3 
Multiple alignment of the murine Ryrl amino acid sequence to the published Ryr isoform. 
The murine deduced amino acid sequence was aligned to the Ryrl isoform sequence from Human (P21817); Pig (Q29104); Rabbit 
(P11716); Frog (Q91313) and Fish (013054), Ryr2 isoform sequence from Human (Q92736); Rabbit (P30957), Ryr3 isoform sequence 
from Human (Q15413); Rabbit (X68650); Mink (Q95201); Chicken (Q90985) and Frog (Q91319) and invertebrate Ryr sequence from 
C. elegan (P91905) and Drosophila (Q24321). The deduced amino acid sequence for the Rabbit Ryr2 isoform was determined by 
translating the published nucleotide sequence EMBL: X68650. Amino acid positions that are identical in the alignment among all isoforms 
are shown in four colours. Primary conserved positions in green, secondary conserved positions in blue, tertiary conserved positions in 
pink and others in black. Duplicate copy of the human Ryrl amino acid sequence is showed in gary colour, in which substituted amino 
acid identified in human MH /CCD pedigree families are indicated in bold letters in red box. The putative modulatory sites for gluamate-
rich region is in pin colour box. RXXS/T regions and GXGXXG regions are highlighted in yellow and gary colours respectively. The 
transmenbrane region homologous to rabbit Ryrl isoform amino acid sequence (Takeshima et al., 1989) is in black boxes. Gaps have been 
introduced to permit alignment. Amino acid residue numbers are indicated at the right side. The deduced amino acid sequences used in 
multiple alignment and their respective EMBL accession numbers are given above. 
1 MGD GGEG...EDEVHVFAED.VVLQCSA VLEKE .... QLIKLT 	£GGNRLCFLETSN QN PPDLA.CCFILEQSLSVRALQ 	: 81 
HumanRyrl : 	MGD. .AEfl. . .EDEVQFLRTLDEVVLQCSA VL}EI. .. . 	 L 	L GEGNRLCFLE TSN QN PPDLA . CCFLEQSLSVR\LQL: 79 
. R 	FGNRLCFLE EQSLSEDE1ç)LRTDDELQCZ . V 	 I 	: 
PigRyrl GD .GE. . .EDEVQFLRTIDDEVVLQCNP. VLF 	.L L GEGNRLCFLE TSN QN PPDLACCF'7LEQSLSVRALQ 	: 80 
RabbitRyrl : 	GD .GEG ... EDEVQFLRT1DVVLQCSA VLV....QLL:1. 	EGGNRLCFLETSN QN I-PDLA CCFTLEQSLSVRALQH : 80 
FrogRyrl E .GEJ. . .EDEIQFLRTEDVVVLQCSA IRKE .... NLKMCMGVEG GNRLCYLESTSN QNAPPDLA.CCFILEQSLSVRALQL : 80 
FishRyrl : 	 IT 	K ADG ... EEEIQFLRT: DHVVLQCTASILYI.... 	.IIKLCLSCEGEGNRLCFLETTSN QN PPDLACCE'ILEQSLSVRALQE : 80 
0 GE.G ... EDEIQFLRTIDVVLQCTA IHi ... ......QKLCLAEGFGNRLCFLESTSNSKN FDLSCTF:LEQSLSVRALQE : 80 
M D GE.G...EDEIQFLRT D:VVLQCTA . IHE ....)QKLCLAEGGNRLCFLESTSNSKN PPDLS  CTFLEQSLLVLQE  80 
HumanRyr3 : 	N E GEGG... EDEIQFLRTEDPVVLQCIA IHI.. . 	)RKFCL.AEGLGNRLCFLE TSE KYIPPDLCVCNF:LEQSLSVRALQE : 81 
RabbitRyr3 N E GEGG ... EDEIQFLRTED::VVLQCIA  VHI 	.......RKFCLAEGLGNRLCFLE TSE KFIPPDLCVCNF LEQSLSVRALQE 81 
MinkRyr3 N E GEGG... EDEIQFLRTEDI:VVLQCIANIHVH.. 	RKFCLAEGLGNRLCFLE TI'E KY PPDLCVCNF LEQSLSVRALQE : 81 
ChickeriRyr3 : 	ME GEGG...EDEIQFLRT.D.VVLQCVSSIHI ........RKFCLEGLGNRLCFLE TSE KY PHDLC CNF LEQSLSVRALQE : 81 
FrogRyr3 : 	N E GE.V.. . EDEIQFLRT ft VVLQCIA IHE ......;RKFCL 	EGLGNRLCFLE TIlE KY PTITLC CNE LEOISVRALQE 	: 80 
C.eleganRyr : M DKEEQGGGEQDDVSFLRTGDIVCLSCVASHNRDGVLGSERV 1 ' CTL 	HJM TT 	NV.TD.KDIT 	IAMCMLYIDNA 87 
- 
ML 	NT ..... VGA V ............SSQ(IGGHRTLLYGHAILLRHAHSRMYLSCL TST-IlMNDKLPFDVGLEH GEACWWTMH 152 
HumanRyrl 	: ML 	NT ..... V A V ............SSQIlGGHRTLLYGHAILLRHAHSRMYLSCL TSRSMTDKLAFDVGL ED GEACWWTMH 150 
THRTLLYGHAILLHII. .t'SCT 	liNT I KTEDVGL. TGEACWWTMH 
PigRyrl MLANT ..... ...A V ............SSQGGGHRTLLYGHAILLRHAHSGMYLSCL 	I.'RSMTDI<LAFDVGLED GEACWWTTH : 151 
RabbitRyrl MLANT ..... VA 	V ............. SSQGGGHRTLLYGHAILLRHAHSRMYLSCL TRSMTDKLAFDVGL.FID GEACWWTMH : 151 
FrogRyrl 	: MLINT ..... V M 	S . .  ............ SSQGGGHRTLLYGHAILLRHCHSDMYLCCL 	'RSLTDKLAFDVGL.EID SGEACWWT H : 151 
FishRyrl : MLSNTSVDEAVDLDKW ............SSQGGGHRTLLYGHAILLKHTHSSMYLSCL TSRSLTDKLAFDVGL.EDS GEACWWTH : 156 
MLINT ..... V KSEGQVDVEKWKFMMKTAQGGGHRTLLYGHAILLRHSYSGMYLCCLSTSRSSTDKLAFDVGL.EDT IlEACWWT.H 	: 163 
ML.NT ..... V KSEGQVDVEKWKFMMKTAQGGGHRTLLYGHAILLRHSYSGMYLCCLSTSRSSTDKLAFDVGL.EDT IIEACWWT H 	: 163 
HumanRyr3 	: MLANT ..... G N G ...........GAAQGGGHRTLLYGHAVLLRHSFSGMYLTCLFTSRSQTDKLAFDVGLREH IlEACWWT 153 
RabbitRyr3 : ML -,.NT ..... G N G ...........GAAQGGGHRTLLYGHAILLRHSFSGMYLTCLITSRSQTDKLAFDVGLREH IEACWNT H : 153 
MinkRyr3 ML 	NT ..... G N G ...........GAAQGGGHRTLLYGHAILLRHSFSGMYLTCLI'TSRSQTDKLAFDVGLREN GEACWWTH : 153 
ChickenRyr3 MLTNT ..... GDNAS ...........GAAQGG.HRTLLYGHAILLRHSFSEMYLTCLSSRSQTDKLAFDVGLREN AGEACWWT H : 152 
FrogRyr3 ML-'-.NT ..... IAN N ...........GASQGGGHRTLLYGHAILLRHSFSGMYLTCLTSRSLTDKLAFDVGLDT GEACWWT H : 152 
C.eleganRyr 	: MMSAD ..... SDHKS ............. ASGAGGHKTLLYGHAVQLKHVQSEMYLACLSSCSS.NDKLAFDVGV.ETNEGEACWWT H 156 
[)rosphi1aRy ......................................................................................... : - 
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PASKQRSEGEKVRVGDDiILVSVSSERYLHLSTAS..(7,EL.V0ASFQT 	MNPI S CE.... L4FVTGGVIRLFHGHMDECLTI 	: 234 
HumanRyrl 	: SRCE.... GFVTGGVRLFHGHMDECLTI : 232 
3sKQRSEGEKvjvSDDIILVSvSSERYLL::.1: . . 	 DASFMQ 	 3 .... 7T3GS7LRLFHGHDECLT1 S 
PigRyrl 	: rASKQRSEGEKVRVGDDIILVSVSSERYLHLSTAS..GEL.VDASFMQTLWMNPI S CE.... VTGGVRLFHGHMDECLTI : 233 
RabbitRyrl 3ASKQRSEGEKVRVGDDLILVSVSSERYLsTA55ELsQTMI SCCE.... VTGG V!RLFHGHMDECLTI 	: 233 
FrogRyrl SKQRSEGEKVRIGDDSILVSVSSERYLHLSTAS..GDL:VDASFQTLW MNPITS CEIA.. 3 VTGGDVRLFHGHMDECLTI 	: 235 
FishRyrl 	: SASKQRSEGEKVRVGDDLILVSVSSERYLHLSYAS. .GDLMVDASFIQTLWTMTPVMS CELA.. GFLIGGYVRLFHGHMDECLAI 240 
PASKQRSEGEKVRVGDDLILVSVSSERYLHLSYGN. .GSLHVDAAFQQTLWSVAPISS SEAP. .QG:LIGGDV RLLHGHMDECLTV : 247 
PASKQRSEGEKVRVGDDUILVSVSSERYLHLSYGN. . GSLHVDAAFQQTLWSVAPISS SEAA. .QG LIGGDV. RLLHGHMDECLTV : 247 
HumanRyr3 PASKQRSEGEKVRIGDDLILVSVSSERYLHLSVSN. .CNIVDASFQTLW VHPT S SSIE.. S LLGGUVVRLFHGH.DECLTI 236 
RabbitRyr3 	: PASKQRSEGEKVRIGDDUILVSVSSERYLHLSISN..GNIVDASFMQTLW VHPT S SSIE.. 3 LLGGVVRLFHGH.DECLTI 	: 236 
MinkRyr3 : PASKQRSEGEKVRIGDDUILVSVSSERYLHLSVSN..GNV.VDASFQTiPT S SSIE.. 3 LLGGVVRLFHGH.DECLTI 	: 236 
ChickenRyr3 : S 	SNIT.. 3 LLCG VVRLFHGH.DEYLTI 	: 235 
FrogRyr3 	: PASKQRSEGEKVRIGDD ILVSVSSERYLHLSISNGM3N1.VDASFUQTLWUVHPT S SSVE.. S LLCG VVRFFHGH.DECLTI 	: 237 
C.e1eqnRyr PASKQRSEGEKVRVGDDVILVSVATERYLHMAYSKG ... YMVIASFHQTLWIQSVSS SMRTRNMGFLFGNDV RLFHGN.DECLT{ 240 
U r )soph 	. iaR 	.......................................................................................... - 
DQRRLYYE GPVCTHARSLWRLE. LR ,WSGS1LRWGQPLKIRHVTTCRYLGLTE Q LVVVDASK.HKA SE'CFRIS 	: 320 
HumanRyrl 	: SPA S. DQRRL Y1H 	AVCTHARSLWRLELRISWSGSSLRWGQPLRVRHVTTGQYL:.LTE Q LVVVDASK.HIKASFCFRIS. 318 
1. SARSLWRLEPLRISWS 3SL3. S. : .RURHVTTI 3y333.1TE HLVVV 	$KPHTK'-SF'CI'R 	: IS 
PigRyrl 	: SPA S. DQRRL YSSVCTHARSLWRLEULR3SWSGS LRWGQPLPIRHVTTGRYLS  LIE Q LVVVDASKSHIKA SFCFRIS : 319 
RabbitRyrl 	: SAA S. DQRRL YlU SAVCTHARSLWRLEULRISWSGS:LRWGQPLUIRHVTTGRI'L LTE Q LVVVDACK.HKA SFCFRV.'. 319 
FrogRyrl : SST QGEEQRRIPHYE GAVCSHARSLWRSELRISWSGSHMRWGMP RARHVTTGRYLSREEER LVLVDAEKSNA 	FCFRIS. 322 
FishRyrl 	: PGA QG DQRRVAHYE GAVCSHARSLWRLEILRANSGG IKWGQS RRHEITTGRYLCLEFIEK LLLVDPEK VSKNS FCFRIS 	: 327 
PSGEHGEEQRRTHYE CAVSVHARSLWRLETLRVAWSGSIRWGQP RLRHVTTGKYLSLME KNLLLMDKEKDVKS 	FTFRSS : 334 
PSGEHGEEQRRT.HYE GAVSVHARSLWRLETLRVAWSGSSIRWGQPIRLRHVTTGKYLSLME KNLLLMDKEKDVKS FTFRSI 	: 334 
HumanRyr3 	: PST QN SQHRRIFYEAGGAGTRASSLWRVEiLRISWSGSNIRWGQARLRHLTTGHYL LTE Q LILQDRAKSDKS:FSFRASK 324 
RabbitRyr3 : PST QN SQHRRIFYEAGGAGTRARSLWRVEULRf.3WSGSNIRWGQA RLRHLTTGHYL.LTE Q LLLQDRGK D:KS:FSFRPSK 324 
MinkRyr3 PST QN AQHRRIFYEAGGAGTRARSLWRVDULRISWSGSNIRWGQA RLRHITTGHYL.LTE Q LLLQDRAFKSD KS 	F'SFRASK : 324 
ChickenRyr3 	: PST QN SQQKK LYETGGAGVRARSLWRVE3LRSWSGSNIRWGQP RLRHITTGMYL1LND E LVNLDREKSDTSS E'CFRASK : 323 
FrogRyr3 PST PAEAQHRK NYEAGGAGIRARSLWRVELRJSWSGSUIRWGQT RLRHITTGQYLLTE Q LVLQDRAKSD KSS FCFRAS. 324 
C.eleqanRyr PENWSEHPHNM lYE GAAVTQARSLUPVSLIRNKWHGALVGWEQV:RIKHITSSRYLGVLDN.5VQLYHKEr< DFDL 	FVMCQNK : 327 
UrjsnrhI1 .. ........................................................................................  
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..KEK DVAP K VGMGP ' 7 ETLCFQH A GLWTYA PDPKALRLGV K. M H EGHMDDA SLTR QQEES. •ARMJ 	: 405 
HumanRyrl . KEK DVAP V GMGP E LCFQH A GL 	TYA PDPKALRLGV .KN M H EGHMDDA SLTR QQEESARMI 	: 403 
R . ;:i.; 	KA:::::: :::: EGH:.:,. SQPR 
PigRyrl 	: ..KEKDTAP V GMGP 1 	ELCFQH A GLWITYAPDPKALRLGV .KK..HEGHMDDA SLTR QQEES.ARM 	: 404 
RabbitRyrl 	: ..KEKDTAP V GMGP EIE16EJLCF'QH A GLW:TYA PDPKALRLGV .KK HEGHMDDA FLTR OQEES 	ARM 	: 404 
FrogRyrl : ..KEK DVAP I GMGPADIKYGESMCFQH N LWLTYA.ADSKVARLGP .RK H.EGHMDDASLSF.Sc:REES ARM: 	: 407 
FishRyrl 	: . .KEKIEVTQ V GMGT EIKYGESMCF QHAS 'GLW.TYAVDAKSARLGP .RK HKEGHMDDA TVARSQTEEA 	ARM 	: 412 
• 	KEN tDvGvRKEvDGMGTSEJKYGDSVCYIQH DTGLW: TYQSVDVKSVRMGSIQ.RK MHHEGHMDDGISLSRSQHEESRTARV 419 
KEK, DGGVRKEVDGMGTSEIKYGDSICYIQH DTGLW TYQSVDVKSVRNGSIQ.RK MHHEGHMDDG NLSRSQHEESRTARVI 	: 419 
HumanRyr3 	: ELKEKDSSH I GM.GV EIKYGDSVCFQHIA SLWVTYKQDAKTSRLGP .RKV HEGHMDDGTLQR QREES 	ARII 	: 411 
RabbitRyr3 	: ETKEK DSSH I GMGV EIKYGDSVCF.QHIA LWVTYK QDAKTSRLGP •RKV HEGHMDDGTLQR QREES 	ARIL 	: 411 
MinkRyr3 : EIKEK DSSH I GMGV EIKYGDSVCF.QHIA GLWVTYK QDAKTSRLGP •RKV .HEGHMDDGTLQR QREES.ARII 	: 411 
ChickenRy3 	: ELKEKQDSTL IDGMGV EIKYGDSVCFIQH A ALWTYK PDAKSARIGL •RKV H EGHMDDGTLQR QHEES. 	ARII 	: 410 
FrogRyr3 	•...KEK DSVP IDTVAEIKYGDSICFIQH D -'LW TIK QOANTAPLOP .RR H FHMPPGVTLQK QHFNS 	ARIT 	: 409 
C.e1eoanRy •.DPKKQMLDEKEE 	:::.NAT :Ri ETNAFIcH KTQL; 	s:QTTEvTKKG:. KVEEKP' VALKD 	': 	cyTFFMALEt:KsAv: 	: 413 
YSTAGLY • F KGLDSFS KP GSGP AGSALP 	GVILSLQDLIGYFEPPSEE QHEEKQT LR LRflRQSLF EEGM S VL 	iIE) 	: 493 
HurnanRyrl HSTNGLY 	F KSLDSFS KP GSGP AGTALPEGVILSLQDLIIYFEPPSED QHEEKQSLR. LRNRQSLFEEGM SMVLLCID : 491 
LIIYFEPLE . 	 QSKLPRQSLFQEELLNCID : 
PigRyrl 	: YSTAGLY HF KGLDSFS KP GSGA AGTAI 	L GVILSLQDLIGYFEPPSEE QHEEKQSLR LRNRQSLFEEGM S \'LHCID 	: 492 
RabbitRyrl 	: HSTAGLY 	P KGLDSFS KP GSGP AGPAI AVILSLQDLIGYFEPPSEE QHEEKQS'LRLRNRQSLF.EEGM S VLLCID 	: 492 
FrogRyrl : YSTAGLFIF KGLDSLN KNKPSKPIS..JELDMVVLTLQDLIGYFQHPEEE QHEEKQT LR LKNRQNLF,EEGIISQVLDCID : 492 
FishRyrl 	: YSTTGLF. F KGLDTLS KNKSANP S.. .LPMDTVVLSLQDLIFYFRPPGHE EHEDKQF LP LKNRQNLF.EEGMIT VLDCVD 497 
RSTVFLFRP RG..LDALSKKAKASTVD..l.,il 	SVSLSLQDLIGYFHPPDEH EHEDKQNRLRALKNRQNLFEEGMIN VLECID 503 
RSTVFLFRF RG..LDALSKKAKASSVD..LP 	SVSLSLQDLIGYFHPPDEH EHEDKQNRLRALKNRQNLF'.EEGMINVLECID 503 
HurnanRyr3 	: RNTTALFSFVS .•.... NN •TAA IT..LP 	EVLQTLQDLIAYE'QPPEEEMRHEDKQNLR. LKNRQNLE'KEEGMA VL.CID 	: 490 
RabbitRyr3 	: RNTTALFSFVS ••.•.. NN •TAA VT..LP 	EVLQTLHDLTAYFQPPEEEMQHEDKQNLR LKNRQNLFKEEGM A VLLCID : 490 
NinkRyr3 : RNTTALFS. FVS ..••.. NN •AAA VT.. i 	QEVLQTLQDLIAYFQPPEEEMQHEDKQN:LRLKNRQNLEKEELM A VLCID 	: 490 
ChickenRyr3 	: RNTTSLFS.F S...... NN 	•TLS IA. .LFV EMAQTLQDLIKYFQPPGED EHEDKQNHLR. LKNRQNLFKDECM A VLLCI[' 	: 489 
FrogRyr3 	: RNTTGLFS,F SDLDSLT NN TVTA VA..LP 	EVVQTLQDLIAYFQPPEED EHEDKQNLR LKNRQNLFKEEGM A VLCIL 	: 495 
C.e1egar.Fr 	: RKCSSVLKFLKGIDALQLEGNQSTDWTR..VDLNEVLKLMEDLIEYFAQPNDEQDFFEKQNHLRALRSPQDF EFTV NMILDTID : 499 
flrosoph . 	:P 	.......................................................................................... : - 
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RL 	YTTAHFAEF E AESWK IVN 	L 	 . 	 I7 	 ..   579 
HumanRyrl : 	RL 	ITT.AHF'AEF E AESWK IVN .SLIRGNRSNCALFS..TLDWLV. ASSGILEVLYCLESPEVLN 	1. 577 
RL I. S 	 W 	SGILE1LYCVLIESPEVLH 
PigRyrl RL 	YTT AHFAEF E AESWK IVfl 	I I.SLIRGNRANCALFS. .N.LDWLV 	ASSGILEVLYC LESPEVLN 	f 	: 578 
RabbitRyrl : 	RL YTT 1HFAEY E AESVK IVN LY.LLASLIRGNRANCALFS. .T LDWVVS L RbiASSGILEVLYC LESPEVLN : 578 
FrogRyrl : 	 RL'. 	YST AHEPEF F AESWK IVNLYFLLASLIRGNRSNCALFS. .N LDWVVS L RLEASSGILEVLYC •L ESPEVLN 	: 578 
FishRyrl : 	RL YNT AHFSEY E AESWE' IVNLYFLLASLIRGNRANCALFC. .D LDWLVSKLRLEASSGILEVLYC L ESPEVLN : 583 
RLH YSS: AHFADV RE GESWKSILNSLY: LLAALIRGNRKNCAQFS. .GSLDWLISRLERLEASSGILEVLHC LVESPEALN 	: 589 
RU-I YSS AHFADV RE GESKSILNSLYLLAALIRGNRKNCAQFS. .GSIDWLISRLERLEASSGILEVLHC LVESPEALN 589 
HumanRyr3 : 	 RL' IYNSVAHE'AGI R ESGMAWK ILN LYKLLAALIRGNRNNCAQFS. .N LDWLISKLRLESSSGILEVLHCILTESPEALNLI 	: 576 
RabbitRyr3 : RL'JYNSVAHFAGI R ESGMPWF VLS LYKLLAALIRGNRNTCAQFS. .N 	LWLISLDRLESSSGILEVLHCIL ESPEALNL : 576 
MinkRyr3 : 	 RLjIYNSVAHFAGI R ESGMAWF ILN LYKLLAALIRGNRNNCAQF. .N TDWLISFLERLESSSGILEVLHCILESPEALNLI 	: 576 
ChickenRyr3 : RLDYNSPJiFAEISRVENGTAWK ILNLY LLAALIRGNRNNCTQFS..S :.DwLISLRLESSSGILEVLHCILESPEALN.I 	: 575 
FrogRyr3 RL 	YSS AHFAEII K GPAWK ILN FY LLAALIRGNRSNCAQFS. .Y LDWLIS-LERLESSSGILEVLHSILESPEALNLI 	: 581 
C.eleganRyr : 	 KFSQMEALPDi'/GLI ETHVKWEQISTYLYLLVAAr"iKGNHY 	;AQFASAQRYLFGRLSNPQSAEGILDVLY 	LTESPEAI:;M1 	: 587 
QENHIKsIrsLLDKHGRN KVLDVLCSLC CNGVAVR NQDLITENLLPGRELLLQTN NYVSIRPNIFVCREGTQYGKWYFEV : 667 
HumanRyrl QENHIKSIISLLDKHGRN:KVLDVLCSLCCNGT 	:DLITENLLPGRELLLQTN NYVISIRPNIFVGR.EGTTQYSKWYFEV : 665 
.F.HIKSI ISLLDKI-IGRNHKVLDVLCSLCVCN C 	LiNLLpGRELLLQTLINyvTSIRpNIFvRAFGTTQYsKwyF: : 
PigRyrl 	: QENHIKSIISLLDKHGRN-iKVLDVLCSLCVCNC 	C DLITENLLPGRELLLQTN NYVSIRPNIFVGRIEGTTQYSKWYFEV : 666 
RabbitRyrl 	: QENHIKSIISLLDKHCRNiKVLDVLCSLCCNG. ...DLITENLLPGRELLLQTN NYV. SIRPNIFVGR EGTQYGKWYFEV : 666 
FrogRyrl : KKNHIKSIISLLDKHGRNHKVLDVLCSLCYCNGVAVRNQNLITENLLPRRDLLLQTRNVNYV SMRPNIYFGTCEC 'TQFKKWYFEV : 666 
FishRyrl 	: QFNHIKSIISLLDKHGRNHKVLDVLCSLC'CNGVAVRNQNLITENLLPGRDLLLQTNI NYV SMRPNIFLGTCEG TQYKKWYFEV : 671 
KEGHIKSIISLLDKHGRNKVLDVLCSLCCHGVAVRNQHLICDNLLPGRDLLLQTR. VNHVSSMRPNIFLGVSEG AQYKKWYYEL : 677 
KEGHIKSIISLLDKHGRNr:KVLDVLCSLC CHGVAVRNQHLICDNLLPGRDLLLQTR VNHVSSMRPNIFLGVSEC AQYKKWYYEL : 677 
HumanRyr3 	: AEGHIKSIISLLDKHGRNrKVLDILCSLCLCNGVAVRANQNLICDNLLPRRNLLLQTR NDVISIRPNIFLGV•EG. AQYKKWYFEL : 664 
RabbitRyr3 : AEGHIKSIISLLDKHGRNiKVLDVLCSLCLCNGVAVRANQNLICDNLLPRRNLLLQTR NDV SIRPNIFLGV EG AQYKKWYFEL : 664 
MinkRyr3 	: AEGHIKSIISLLDKHCRNHKVLDVLCSLCLCNGVAVRANQNLICDNLLPRRNLLLQTR NDV SIRPNIFLGV .EG AQYKKWYFEL : 664 
ChickenRyr3 AEEHIKSIISLLDKHGRNYKVLDVLCSLCCNGVAVRANQNLICDNLLPRRDLLLQTR NDVSIRPNIFLGV. EG  AQYKKWYFEL 663 
FrogRyr3 EKRHIRSVISLLDKHGRNYKVLDVLCSLCVCNGVAVRTNQNLICDNLLPRRDLLLQTR VNDV SMRPNIFLGVDG AQYKKWYFF.M 669 
C.eleganRyr: NEGHI RVIGTLEKVGRDPKVI DVLSSLCEGNGMAVR SçNI 	TQYLIPGKDLLLQTSMRDHVSSMMPNVMLGVVI1 ALFRWYFIA 675 
DrcsophJRv.. ........................................................................................ : - 
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M DE APFTAQATHLRVGWALSEGYSPYP 	GE WGGNG 	DL":'SYGFDGLHLWTGHVARPVTSPGQHLLAPEDV SCCLDLS P3 : 755 
HumanRyrl 	: M DE TPE TAQATHLRVGWAL EGYTPYP 'AGE WGGNG 
-)DL''"SYGFDGLHLWTGHVARPVT"Z"PGQHLLAPEDVISCCLDLS PS : 753 
I '': 	'JT 	'TiR1GWAP'YTPf 	": 	 " 	 DLYSYGFDGLHLW3 	' ','.•.RPVT. 	31 	
3DvIscc:;3.';:,'  
PigRyrl 	: M DE VPF TAQPTHLRVGWAL EGYSPYP 	GE WGGNG 	1,DLYSYGFDGLHLWTGHVPRLVTSPGQH:..LAPEDV'SCCLS PS 
754 
RabbitRyrl M DE VPF TAQATHLRVGWALEGYSPYE' 	GE WCGNG DL' : SYGFDGLHLWTGHVARPVTSPGQHLLAPEDV';SCCTNS PS : 754 
FrogRyrl 	: I DQ EPE'VTAEATHLRVGWAL'EGYSPYPA 
WGANGA 'JDL'SFAFDGLHLWSGRVCRAVASHNQHLLTADDV:SCCLD1T PS : 754 
FishRyrl : M DQ EPFVTAQPYHLRVGWAL1EGYSPYPG'G' WG.GVGDDLiSYGFDGLHLWSGRVPRHVATPSQNILEDVSC 
	IJLS PS : 759 
M DHTEPFVTAEATHLRVGWASEGYSPYPG GEEY2 	jVGDDLFSYGFDGLHLWSGCIARTVSSPNQlLLRTDDVISCCLSAP 5 : 765 
M DHTEPFVTAEATHLRVGWAS EGYSPYPG GEEWS 	j3VGDDLFSYGFDGLHLWS(-CIARTVSSPNQH 	RTDDVISCCLDLSAP 	: 765 
HurnanRyr3 IIDQ DPFI TAEPTHLRVGWASSSGYAPCPG 'GE ;WGGNGVGDDLYSYGFDGLHLWSGRIPPAVASVNQHLLRSDDV\;SCCLDLG 
	: : 752 
RabbitRyr3 	: IIDQ DPF TAEPTHLRVGWASSSGYAPYPGGGEWGGNGVGDDL1SYGFDGLHLWSGRIPVASINQHLLKSDDV.SCCLDLG l 
: 752 
MinkRyr3 IIDQ DPF1TAEPTHLRVGWASSSGYAPYPG IGE 	GGNGVGDDL:'SYGFDGLHLWSGRIPRAVASI 	
LRSDDV SCCLDLG 	.' 752 
ChickenRyr3 	: IIDQ DPFI TAEPTHLRVGWAS SGYAPYPG3GE'3WGGNGVGDDL':SFGFDGLHLWSGRVPVASVNQHLLSSDDVSCCLDLG D.' 
	: 751 
FrogRyr3 	: IIDQ DPY' TPEPTHLPVGWAS . SGYAPYPGIGE .IWGGNGVGDDLFSYGFDGLHLWSGRVPVASSNQHLLASDDV SCCLDLG 
[ 	 : 757 
C.eleganRyr E EHIET.MTKQTPYI.I'I 	,T.NSVGFKPFPGSGDKMGCUVGDDF 3iFT 
	KSMYFGGKSPR''G. 	.HKLLEKGDVIGCSIP[TIE 	: 759 
I 
ISFRINGCPVQGVFESFNL GLFFPV'.SFSAGIK'.'RFLLGGRHGEFKFLPPPGYAPCHEAVLPR RLHLQ I EYREGPRGPHLVGP : 843 
HumanRyrl 	: : SFRINGCPVQGVFESFNL' GLFFPV:SFSAG:K;RFLLGGRHGEFKFLFPPGYAPCHEAVPR RLHLE I EYR EGPRGPHLV P 
: 841 
RINGCP.JQCVFP S . 	 ':1 	133  
PigRyrl 	: .,GGRHGEFKFLPPPGYAPCHEAVLPR RLRLE I1EYR EGPRGPHLVIP : ISFRINGCPVQGVFEAFNLNGLFFPVVSFSAG;7K','RFL 
T 842 
RabbitRyrl 	: ISFRINGCPVQGVFEAFNL GLFFPV'SFSAG"K"RFLLGGRHGEFKFLPPPGYAPCHE 7 L 	RLRLE I'EYR EGPRGPHLVIT : 
842 
FrogRyrl : ISFRFNGHPVQGMFENFNL GLFFPVSSFSPGIKIRFLiGGRHGEFKFLPPFGYAPAY 	LPRDRNRVE IEYKHDVGDIRNLLGP 
842 
FishRyrl 	: ISFRINGHPVQGMFENFNL GLFFPV 'SFSAG . KLRFL GGRHGDFKFLPPPGyAPCYEAVLPRDRLRIE' IEYKHDFDGIRNLLGP 
847 
ISFRINGQPVQGMFENFNL GLFFPV' SFSAGIK,'RFLI GGRHGEFKFLPPPGYAPCYEAVLPK KLKVEHSREYKQERTYTRDLLGP : 853 
ISFRINGQPVQGMFENFNI :GLFFPV' SFSAGIK :RFL' GGRHGEFKFLPPPGYAPCYEAV3FK KLKVEHSREYKQERTYTRDLLGP : 853 
l-iumanRyr3 	: ISFRINGQPVQGMFENENT1GLFFPVMSFSAGKRFLMGGRHGEFLSGYEALL 	KMRLEV EYK DADGIRDLLGT 
840 
RabbitRyr3 : ISFRINGQPVQGMFENFNTGLFFPVMSFSAGKRFLMGGRKSCL< KMRLE Vi'EYK DAEGVRDLLGT 840 
MinkRyr3 ISFRINGQPVQGMFENFNT7GLFFPVISFSAG K RFLTGGRHGEFKFLPPSGYAPCYEALLPK KMRLEIV 5 EYK DAEGIRDLLGT : 840 
ChickenRyr3 : ISFRINGQPVQGMPENFCTEGFFFPV'SLSAG KARFL: GGRHGEFKFLPPTGYAPCYEALLPK KMKLE: V"EYK DSDGVRDLLGT : 
839 
FrogRyr3 	: ISFRINGQPVQGMFENPNTEGLFFPA'SFSAG K RFLI.GGRHGEFKFLPPAGYAPCYEALLPK KMRVE V'EYK DCEGVRDLLGT : 845 
C. eleganRyr 	: IKFSVNGTYMSGSFKKF'NII GYFFPVMSLSAK SCRFI' GGNQGRLRYGPPTGFSAVVEAVN. .GELQITDCLSFG. DLGKNIFSGPQ : 
: 
844 
[r',s:pri1aRy ......................................................................................... - 
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SRCL 'HLDF'VP P'DTIQ 	LPPHLERIRELAENIHELWALTRIEQGW 	GPVRDDNKRLHPCLVNF'HSLPEPERNYNLJ1SGETLK : 931 
HumanRyrl 	: SRCL HTDF'VPP'DTVQ 	LPPHLERIRE LAENIHELALTRIEQGW 	GPVRDDNKRLHPCLVDF'HSLPEPERNYNLMSGETLK : 
929 
:11 	:PVDT.icIVLPHLI 	AENIHEL1 	- 	 RDDNiRLHPCL.'L 	ENYNLQM.ET 
PigRyrl 	: SRCLHTDFVPTVDTVQ. 	LPPHLERIREHILAENIHELWALTRIEQGW 	GPVRDDNKRLHPCLVDFHSLPEPERNYNLMSGETLK : 930 
RabbitRyrl SRCLHTDFVPPDTVQ LPPHLERIRELAENIHELWALTRIEQGW 	GPVRDDNKRLHPCLVNFHSLPEPERNYNLMSGETLK : 930 
FrogRyrl 	: KSL HTSEVPTPVDTVQI :LPPHLERIRELAENIHELWALTRIEQGW GPIRDDNKRLHPCLLDFHSLPEPERNYNLLMSGETLK 930 
FishRyrl QSL HTAFTPPDTIQ 	LPPHLERIRE:LAENSHELWAVTRIEQGW ;GPFRDDNKKLHPCLVDFQSLPEPEKtYNLAMSGETLK : 935 
VSLTQAAE'TPIPDTSQ 	LPPHLERIRELAENIHELWVMNKIELGWQ GPVRDDNKRQHPCLVEFSKLPEQERNYNLMSLETLK 941 
vSLTQFTPIP DTSQ: 	LPPHLERIRE.LAENIHELNKIELGWQ GPVRDDNKRQHPCLVEFSKLPHQERNYNLMSLETL 	: 941 
HumanRyr3 QFL QASFIP . PDTSQVILPPHLEKIRDRLENIHELWGNNKIELGwFGKI 	DNKRQ 	VEt F(LPETNMSTETL\ : 928 
RabbitRyr3 	: QFL QASFIP PIDTSQV . LPPHLEKIRDRLAENIHELWGMNKIHLGWFGKMRDDNKRQHPCLVEFSKLPETEKNYNLMSTETLK : 928 
MinkRyr3 : QSL QASFIP PIDTSQV .LPPHLEKIRDRLAENIHELWGMNKIELGW FGKIRDDNKRQHPCLVEFSKLPETEKNYNLMSTETLK : 928 
ChickenRyr3 QFL QASFIP PIDTSQALPFHLEKIRDLAENIHELWGMNKIELGW 	GKIRDDNKRHHPCLVEFSKLPETEKNYNL)MSTSTLK : 927 
FrogRyr3 	: HFL QASFIP PIDTSQ 	LPPHLEKIRDLAFNTHELWGMNKIELGWI CKVRDDNKRQHPCLVEESKPFTFKNYNLMSTETLK : 933 
C.eleganRyr 	: IFNNLEPFfl-'T;IDVSATQLNHHATEMHQ Y/L{EiANRKIELGWS GETRSETSRKHPCLTKF'EY::THKK':NILLALTTMI 	: 932 
• TLLALGCHVGMA EKAEDNLKTKLPKTY 	GYKPAPLDLSH RLTPAQTTLVRLAENGHNVWARDRVAQGWSNSAVQDIPA..R : 1017 
HumanRyrl TLbALGCHVGMA EKTEDNLK:-TKLPKTYNGyKPAPLDLSH RLTPAQTTLV RLAENGHNVWARDRVGQGWS'{SAVQDIPA. .R 1015 
- •ALGCH'. --H: :KTKLPKTYMNSNGYKFAPLDLS:TPAQr 	L:DRLENGHNVPD 	•. •. 	 . 
PigRyrl 	: TLLALGCHVGMA EKAEDNLRTKLPKTY'1SMGYKPAPLDLSH RLTPAQTTLV RLAENGHNVWARDRVAQGWSYSAVQDIPA..R : 1016 
RabbitRyrl 	: iLLALGCHVGMA EKTEDNLKTKLPKTY 	HC-YKPAPLDLSH RLTPAQTTLV RLAENGHNVWARDRVAQGWSYSAVQDIPA. .R : 1016 
FrogRyrl : TLLALGCHVGMA EKAEENLKIKLPKT1 •GYKPAPLDLSH KLTPAQNTLV• KLAENGHNVWARDRVQQGW YSIIQDIKN..K : 1016 
FishRyrl ILLALGCHVGMG EKAEENLKRTKLPKTY Q SGYKPAPLDLNH KLTPNQNTLVERLAENGHNVWARDRVRQGW YSIVQDILN. .K : 1021 
:LLALGCHVGIS EHAEDKVKMKLPKNYQLTSGYKPAPMDLSFIKLTPSQEANV KLAENAHNVWARDRIRQGW YGIQQDVKN. . R : 1027 
TLLALGCHVGIS EHAEEKVKMKLPKNYQLTSGYKPAPNDLSFIKLTPSQEAMV KLAENAHNVWARDRIRQGWYGIQQDVKN..R : 1027 
HumanRyr3 	: TLLALGCHIAHVNPAAEEDLKVKLPKNY 	GYKPAPLDLSD KLLPPQEILV KLAENAHNVWAKDRIKQGW YGIQQDLKN. . K : 1014 
RabbitRyr3 : TLLALGCHIAHVNPAAEEDLK:VKLPKNY .GYKPAPLDLSD KLLPPQEILVKLAENAHNVWAKDRIKQGW YGIQQDLKN. .K : 1014 
MinkRyr3 	: TLLALGCHIAHVNPAAEEDLKVKLPKNYH.GYKPAFLDLSD KLLPPQEVLV KLAENAHNVWAKDRIKQGW YGIQQDLKN..K : 1014 
ChickenRyr3 : TLLALGCHIVHANPAAEEDLKXVKLPKNYI."GYKPAPLDLSE KLLPSQEFLVNKLAENAHNVWAKDRIKQGW YGIQQDLKN..K 1013 
FrogRyr3 	: TLLALGCLIVHSNQTAEENLKVKLPKNY 	GYKPAPLDLSD KLLPAQEVLVKLAENAHNVWAKDRIKQGW YGIQQDLKN. .K : 1019 
C.eleganRyr TIEALGYHLITE P..PCRLRAVRLGPNFQQQGYKPGPLDTHEIQLPAELQPLTEALARNTRNIWAKEKIKRGW FGLSEHVDATQK : 1018 
Drosophi1aR' .. ........................................................................................ 	 : - 
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RNPRLVPYRLLDEATKR NRDSLCQAVRTLGYGYNI EP. DQEPSQVD.. .SQSRG RARIER EK Y. VQ GRWYFEFEAVTTGEMR : 1102 
RumanRyrl 	: RNPRLVPYRLLDEATKR NRDSLCQAVRTLGYGYNEPFDQEPSQVE ... NQSRC RVRIPR EKYTVQ GRWYFEEEAVTTGEMR 1100 
RNPRL'P-b 	tJP 	LLGGYNIEPPD 
PigRyrl 	: RNPRLVPYRLLDEATKR NRDSLCQAVRT LGYGYNIEPEDQEPSQVE. . .SQSRW RVRIFREK.Y.VQ GRWYE'EFEAVTTCEMR : 1101 
RabbitRyrl 	: RNPRLVPYRLLDEATKR NR[3LCQAVRTILCYGYNJEPDQEPSQVE ... NQSRW RVRIFR EK YTVQ GRWYFEFEAVTTGEMR 1101 
FrogRyrl : RNPRLVPYVLLDEKTKKTNRDSLCEAVRTIMGYGYNiEPDQESSAQGG 	TK 	RNRIF'R EK Y VK GKWYFEFEAVTTGEMR : 1103 
FishRyrl RNPRLVPYNLbDEKTKKTNRDTVCAAVRT-IGYGYNiEPDQESSGHG. .PGSARENKIRLFRI.EK Y ITQGKWYFEFEAVTVGEMR : 1107 
RNPRLVPYTPLDDRTKK JKDSLREAVRT LGYGYNLEA DQDHAARAE.VCSGTGERFRIFREKTY VKAGRWYE'EFETVTAGDMR 1114 
RNPRLVPYTLLDDRTKK NKDSLREAVRT LGYGYNLEA DQDHRAE.VCSGTGERFRIFR.EKTY VKAGRWYFEFEAVTSGDMR : 1114 
HumanRyr3 	: RNPRLVPYALLDERTKK NRDSLREAVRTFVGYGYNEPSDQ.ELADSA.VEKVSI KIRFFRVER Y yR GKWYFEFEVVTGGDMR 1100 
RabbitRyr3 RNPRLVPYALLDERTKK NRDSLREAVRTFVGYGYN] EPSDQ.ELADPA.VEKVSI KIRFERVER Y VR GKWYFEFEVVTGGDMR 1100 
MinkRyr3 	: RNPRLVPYALLDERTKK.NRDSLREAVRTFVGYGYN EPSDQ.ELADPA.VEKVSI KIRFERVEW YVR CKWYFEFEVVTGGDMR : 1100 
ChickenRy:3 	: RNPRLVPYDLLDERTKKNRDSLREAVRTFAGYGYNVEPI DQ.EIADQT.VEKVSI KIRFYRVEQ Y VK GKWYE'EE'EAVTGGDMR : 1099 
FrogRyr3 RNPRLVPYALLDERTKK NRDSLREAVRTFIGYGYN EP DQ.EITDQM.TSRVSI KIRFFRVEQTY VKTGKWYFEFEVVTGGDMR : 1105 
C.eleganRyr RSPHIVPYEQVDERIKQANRESAAENIPA QLFIFLI ....: 	 AHEHDEVAEKELRARK NTRTY 	ATI 	CGK1PPHILTAGYMK : 1106 
............................................................................................. : - 
VGW RPEL:PDVELG.DDLAY FNGHR Q WHLG 	PGRPWQSGDVVGCM.D TENTI FTLNGEVLMSD 	SETAFR I 	DGFL : 1190 
I-iumanRyrl 	: VCW.RPELPDVELG.DELAY ENGHR Q WI-ILG 	PIGRPWQPGDVVGCMD TENTI FTLNGEVLMSD SETAFREI DGFL : 1188 
:IARPELRPDVELGADELAYI 	: 	 . 	 .L.EGRPWQPGDVVCZii 	I I ... - 	 biIIIEL 
PigRyrl 	: VGWRPEL'PDVELG.DELAY FNGHR Q WHLG.LIGRPWQSGDVVGCM D TENTIIFTLNGEVLMSD CSETAFR 1V DGFL : 1189 
RabbitRyrl 	: 'GW•RPELIPDVELGDELAY FNGHR Q WHLG 	PGRPWQSGDVVGCMIDTENTIFTLNGEVLMSD GSETFREI 	. 	DGFL : 1189 
FrogRyrl : VCW.RPEVPDVELGDELAY FNGHR Q WHIG.PIGRNWQPGDVVGCMD TEMNIMFTLNGEMLIGD GSDVAFK I EGFI : 1191 
FishRyrl VGW.RPSVRADTELV DELAY FNGFKAQ WHVGNPGRQWQSGDVGGCMAHRGMNIMFTLNGDMLISD.VSEMVYR I 	IEGFI 1195 
VGWSRPGCQPDQELGSDERAFAFDGFKAQ WHQGN HYGRSWQAGDVVGCMVDMNEHTMMFTLNGEILLDD GSELAFK FDV DGFI : 1202 
VGWSRPGCQPDQELGSDERAFAFDGFKAQWHQGN HYGRSWQAGDVVGCMVDMNEHTMNFTLNGEILLDD GSELAFK FDV DGFI : 1202 
HumanRyr3 VGW.RPGCPDVELGDDQAF FEGNR QWHQG GYGRTWQPGDVVGCM N DDASMFTLNGELLITNKGSELAFA Y 	ENGFV : 1188 
RahbitRyr3 	: VGWIRPGC.PDIELGPMTKPLCLKAAGASVGTKVVGILGVPWQPGDVVGCM N DDASM FTLNGELLITNKGSELAFA Y ENGFV : 1188 
MinkRyr3 1'GW.RPGCI-PDIELG.DDQAF FEGSR QWHQG.GYGRTWQPGDVVGCMN DDASMFTLNGELLITNKGSELAE'AY 	ENGFV : 1188 
ChickenRyr3 VCWARPGCRPDIELGADDQAF EEGSK QWHQG GFGRSWQPGDVVGCMNDDKSIIFTLNGELLITSKGSELAFA FG ESIWV : 1187 
FrogRyr3 v'GWRPTCPDLELG.DDRAFFEGSR QCWNMG SF GRNWQPGDVVGSM N DDKSMFT[NGELLITNQGSELAE'A F 	ENGFV : 1193 
C. eleganRyr IGWMDIGSTPEIQLGDDRSYAFDGYL RKWHQGA - TYGKEWKIGDVVGCFLD NDRTISESLIILL.LDP GSEMAFDNVVC DCLV : 1194 
DrcscphLIaRy: ........................................................................................: - 
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P 	:pG'VGHLN GQDVSS RF AICGLQEG:'EPFINMQRP 'TTWE'SKSLPQE'EPVP. .LEH. HYEVARMIDGTV T PCLRLTR : 1276 
HumanRyrl 	: P GPGUVGHLN GQDVSS RE' AICGLQEG'EPF.INMQRP TTWFSKGLPQE'EPVP. .LEH HYEVSRVD(TV T PCLRLT R : 1274 
PV 	. GQDVWLK:A:CGLQEGFEPFAlNK,R  
PigRyrl 	: P IPQVGHLJ GQDVSS RE' AICGLQEGEPFMNMQRP TTWFSKSLPQE'EAVP. .LEH [-IYEVSRVDGTV T PCLRLT R : 1275 
RabbitRyrl P 	CPGcVGHLN GQDVSS RE' AICGLQEG.EPFAINMQRP TTWFSKSLPQFEPVP. .PEH HYEVARNDTV T PCLRLA R : 1275 
FrogRyrl 	: P GMSQVq LNGQDVGS RY PICGLQEGFEFFAINMKREITTWFSKSLPQFANVS..ADHGHIEVSRIDGTV N PCLVT 1277 
FishRyrl P 	GLSQVG IN GQNVSS RY iICGLQEGPEPFAINMKRDITMWFSKSLPQE'ITAP..TDH HMEVSRVDGTVETAPCLVT 	: 1281 
P VA V 	MNFGKDVST KY 	ICGLQEGYEPE'AVNTNPDITMWLSKRLPQE'LQVP. .SNHE}{IEVTRIDGTI SSPCL VTQ : 1288 
hatunhyr P C.3LVAVJ MNFGKDVST KY.ICGLQEGYEPFAVNTNRDITMWLSKRLPQE'LQP..SNHEHIEVTRIDI SSE'CLVTQ 	: 1288 
HumanRyr3 	: PICCLGLSQIG MN GTDASTFKFY MCGLQEG;EPFAVNMNRD AMWFSKRLPTFVNVE..KDH HIEVMRIDATM S PCL;VT : 1274 
RabbitRyr3 : PICSLGLSQIG MNGTDASTFKFY MCGLQEGEPFAVNMNRD AMJFSKRLPTE'VNVP..KDHHIEVVRIDTM SPCLVVT 	: 1274 
MinkRyr3 	: PICSLGLSQIG MNIGMDASTFKFY MC(LQEGVEPFAVNMNRD ANWFSKRLPTE'VNVP. .KDH HIEVVRIDLTM S PCLVT : 1274 
ChickenRyr3 	: PICSLGLSQIG.MN GMDASTFKYY MCGLQEGIEPFAVNMNRD ANWFSKRLPTFVNVP..KNH HIEIWRIDTFIES PRLVT 	: 1273 
FrogRyr3 	: P CSLGLSQIG MN CKDASTFKYY MCGLQEGQPYAVNNNRE AMWFSKRLPTFVNVP. .KDH HIEVTRK[VTVEI PCLVT : 1279 
C.eleganRyr 	: PAMTLGSGQR; LNFGQQSNS KF 	T 	LQEGYEPFCV.'YTMPMWFAKHFPRFEDISTLKSGSILE'S 1 IPAGNS PCL ILQ 1282 
: 	
............................................................................................ - 
WG Q ... N LVE LFLRLSLP QF QHFRCTAGATPLASPGLQPPAEDE ...........ARAAEPDTDYENLRRSAGGWGEAEGGK : 1350 
HumanRyrl 	: WV Q... N LVE LFLRLSLP QF QHFRCTAGATPLAPPGLQPPAEDE ...........ARAAEPDPDYENLRRSAGGWSEAENGK 1348 
.....................................................................................  ........... ....PAAN. 	. 	::-..AL 	.•.... 
PigRyrl 	: WG Q. . . N LVE LFLRLSLP QF QHFRCTAGATPLAPPGLQPPAEDE ...........ARAAEPDPDYENLRRSAGRWGEAEGGK : 1349 
RabbitRyrl WG. Q. . . N LVE LFLRLSLP QF QHFRCTAGATPLAPPGLQPPAEDE ...........ARAAEPDPDYENLRRSAGGWGEAEGGK 1349 
FrogRyrl 	: FG Q... N NTD LFFRLSMP EFYETFKCTPGATPLTR. . SFTIVEEE ...........VQDVDMDSEFEVLKKSPRKEIEATNE 	: 1349 
FishRyrl : FS Q... NANTDLLFLRLSMP EF ETFKVPAGTTLLTR. .VLTIPEDE ...........VLEVDPDSDYEILKKSASRKEQEEEKK : 1353 
SFG Q... N NTDIMFYRLSMPIECAEVFSKTVAGGLPGA. . GLFGPKND ...........LEDYDADSDFEVLMKTAHGHLVPDRVD 	: 1360 
SFG Q... N NTDIMFYRLSMPIECAEVE'SKTVPGGLPGA. . GLFGPKND ...........LEDYDADSDFEVLMKTAHGHLVPDRVD 	: 1360 
HumanRyr3 	: FGTQ... N NAD IYCRLSMP 	EC 	SSFSHSPC ......................................................: 1305 
RabbitRyr3 : FGTQ ... N NAN IYCRLSMP 	EC 	SSESHSPC ......................................................: 1305 
MinkRyr3 	: FGTQ... N NAS IYCRLSMP 	EC 	SSE'SHSPC ....................................................... 1305 
ChickenRyr3 : LGTQ... N NSD IYCRLSMPIEFRSSFNFGVG ......................................................: 1304 
FrogRyr3 	: FGTQ... N NED IYCRLSMP 	EF 	SAFIN .........................................................: 1307 
C.eleqanRyr 	: VTI EGGPSEKAK EYIKLSLP KCNDTE'VKNKDKETIRRQLQEYKPRSQSVVSQIRAPGIPKEFDDNKEKKGFLRSMLGSKDSHESD : 1370 
fl r:scphi1aR ........................................................................................ : - 
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KAKKVAMMTQPPSTPALPRLPRD VPA ........................................................ NRDD 
KAKKVAMY1TQPPATPTLPRLPHD VPA ........................................................ NRDD 
KAKKAAMMTQPPATPTLPRLPHE VPA ........................................................ DRDD 
KAKKAAMMTQPPATPALPRLPHD VPA ........................................................ NRDD 
KPKKPAFISTTPVVPTMPRLMKE VPD ......................................................... ROD 
KAKKPALITPPPVVPTMPRLVED VPD ........................................................ .RDD 
RRTKPDYSTSHS ..... ARLTED LAD ........................................................ .RDD 




























DGTA ............................................ K GTPGGTAQAGVEAQPARAE EK ATT NKKRG. . FLF 
HumanRyrl 	: EGTA ............................................ K GAPGGTPQAGRGA.PARAE EK ATT NKKRG. .FLF 
PigRyrl 	: EGTA ............................................ K GAPGGTAQAGVEAQPPRAE EK ATT NKKRG. . FLF 
RabbitRyrl EGTA ............................................ K GTPGGTPQPGVEAQPVRAE EK ATT NKKRG. . FLF 
FrogRyrl 	: KDLA ............................................ K TPK ... E ....... PPKPE 	EK 	TTT TKKRG. . FLF 
FishRyrl : EPSV ............................................ PKDIP ... A ....... TKNGE 	EK 	PQQR QEER.. . FLF 
KD .............................................. K ATK ............ PEE'N 	1-1K 	YAQ PSRLKQRFLL 
KD .............................................. K TTK ............ AEFN 	HK 	YAQ PSRLKQRFLL 
HurnanRyr3 ................................................ LD ............... SEAFQKRKQMQ ILS ........ 
RabbitRyr ................................................ LD ............... SEAFQKRKQMQ ILS ........ 
MinkRyr3 	................................................. LD ............... SEAFQKRKQMQ ILS ......... 
ChickenRyr3 	................................................. V NAS ............ SDALQKRKHSQ FP .......... 
FrogRyr3 ................................................................. EENFQKRNQLQDASS ........ 











PEIILNT 	YYSRVF.GQEP.CVW GW.T DYHQHDMSFE S 	AVTVTMGD QN HSSLKCSSCYMV 	G FVSPGQQGRI 1511 
HumanRyrl 	: PEIILNT YY;RVF;.GQEP CVWAGWTDYHQHDMSFD S VVT'MGD QGN HSSLKCSNCYMV-v, G FVSPGQQGRI 	: 1508 
CsNCYM' 	.' 
PigRyrl 	: PDIILNT 	YY..RVF-GQEPCVWGW.T.DYRQHDMNFDT 	AVT7MGD QGNIHSSLKCSNCYMVI. G FVSPGQQGRI 	: 1510 
RabbitRyrl PEIILNT YYRVE'.GQEPCVWGW'TDYHQHDMNED S AVT1'4GD QGN HSSLKCSNCYMV' 	G FVSPGQQGRI : 1510 
FrogRyrl PEIIRNT. 	YY.RVFGQEETGVWIGWT DYHL DMNFDN 	NATII'MGDDKGNIFNSINRSNCYMV GEFSNNTQQARVR 1499 
FishRyrl 	: VDIILNT :YY 	RVE' .GQEP.GVWGWIT DYHQDPHFDIS NVTVTVGDDKGNIHDSIKRSNCYMV. GEFSS.SQQTRV 	: 1501 
• 	 : YDFLMQTS :YY 	RIFPGQEPANVW GWITSDFHQ DTGFD DR 	TVTVTLGD KK HESIKRSNCYMVCAGESMSPGQ. .GRN 1501 
YDFLMQTS 	YY. 	RIFPGQEPANVW.GWITSDFHQ DTGFD DR TVTVTLGD KGK HESIKRSNCYMVCAGESMSPGQ. .GRN : 1501 
HumanRyr3 	. .... HTT QCYYAIRIF. ,GQDP CVW1GW.TDYHL SEK1D N .NCTVTVTLGD RGR HESVKRSNCYMV;; G IVASSQRSNR 	: 1405 
RabbitRyr3 . .... HTT QCFY IRIFGQDP . CVW .IGW .:TPDYHL:SEKPD N .NCTVTVTLGD RGR HESVKRSNCYMV 	G VVASSQRSSR : 1405 
MinkRyr3 	. .... HTT QcyyAIRIF:oQDp,cvw;Gw;TDYHL SEKE'DN .NCTVTVTLGDRGR RESVKRSNCYV. G IVATSQRSSR 	: 1405 
ChickenRyr3 	. .... ASS 	CFY.LRIFGQDP SVWcGWT DYHF SENETIN .NCTVTVTLGD RGR HESVKRSNCYMV.. C IAANSQRSGR : 1406 
FrogRyr3 	. .... HTT L YY 	RIF GQDP SVW:GW T DYHF SENEL S .NCTVTVTLGD RGR HESVKRSNCYMV. 	C LSTGSQRSGR 	: 1405 
C.eleganRyr 	: VHHKDKVDE YYGIPIFPGQDP QVW 	W TTQYHY NVNE 	GSQG 	KCRFSEADHHGTTVDSVQSQNCYMVNVSELLATTPDVANT : 1634 
- 	 1 	................................................................................................ 
- 
HT . VIGCL''DIATG MTFTANG<ESNTFFQVEP:.TKFPAVEVLPTHQ VVQFELG QKNIMPLSAAI'4FLSERKNPAPQCPPRLE 1598 
HumanRyrl 	: HT . VTGCLVDLATG MTE'TANGKESNTFFQVEP'JTKFPAVFVLTHQ VIQFELG QKNIMPLSAAMF'QSERKNPAPQCPPRLEM 1595 
CLVDIA1 	:-:e 	ANGKE:1 	.pQVEPNTKLFPA;: 	 PAPQCPPRLE: 
PigRyrl 	: HT . VIGC I .D1ATGIMTFTANGKESNTFFQVEPTKTFPAVFVLPTHQ VIQFELGQKNIMPLSAAMFLSERKNPAPQCPPRLEM : 1597 
RabbitRyrl 	: HT . V 	CLVDATG1MTFTANGKESNTFFQVEPTKiFPAVFVLETHQ VIQFELGQKNIt1PLSAAMFLSERKNPAPQCPPRLE 	: 1597 
FrogRyrl : KS . VVGC IDI ATG MTFTANGKEVNTFFQVEPTKCFPAVFVTPLSQTLFQFELC LKNIMPISAAMFRSESKNP FQCPPRLD : 1586 
FishRyrl 	: QE .FVIGC IDDTG MTFTANGKEINTFYQVAPITKFPAVFVLPSSQ MIQFELG LKNIMPISAANFRSERKNPPQCPPRLD : 	 1588 
NNG. EIGCV. - DAASG.LTFIANGKELSTYYQVEPSTKT,FPAVFAQATSP VFQFELGRIKNVMPLSAGLFKSEHKNP.PQCPPRLH : 	 1588 
NNG. ECV;DAASGLTFIANGKELSTYYQVEPSTK:FPAVFAQATSP VFQFELGRIKNVMPLSAGLFKSEHKNP PQCPPRLH : 	 1588 
HumanRyr3 	: NV . EiGCI 	D AMGMLSFSANCKELGTCYQVEPHTKVFPAVFLQPTSTSLFQFELGLKNAMPLSMIFRSEEKNPPQCD : 	 1492 
RabbitRyr3 : NV . EGCH F) AMGMLSFSANGKELGTCYQVEPCTKVFPAVFLQPTSTSLFQFELG LKNANPLSAAIFKSEEKNP PQCPPRLD' : 	 1492 
MinkRyr3 	: NV . 51CC 	D AMGMLSFSANCRELGTCYQVEP1TKVFPAVFLQPTSTALFQFELGLKNAMPLSIFK5EE 	PQCPPRLD : 	1492 
ChickenRyr3 NV . EIGCF D ATGMLSFTANGKELGTCYQVEP TK F'PAAFVQPTST LIQFELG LKNTMPLSPIFKSEERNP PQCPPRLD : 	 1493 
FrogRyr3 NV .IDIGC .D.ATG LSFTANGKDLGTCYQVEP TK F'PAVFLQPTST LFQFELG LKNTMPLSAAIFKSSEKNP SQCPPRLD : 	 1492 
C.ele:lanRvl 	: KVSGTLIGCIIDTSIGELSFQVGSTDTGIKFKLEPGAN FPAAFVTPTATEILQFELGRIKYTFPLSAAMFKSCEKSL PFCflHIT : 	1722 
11 	........................................................................................................... : 	 - 
260 
MLM VSWSRMNHFLQVD R AGERLGWAV CQ PLM 	LHIPEENR MDILEISERLLQRFRSHTLSLYRSVCALGNNRVA A : 1686 
HumanRyrl 	: MLM VSWSRMPNHFLQV 	R AGERLGWAVrQ P -'T MLHIPEENR MDILELSERLDLQRFHSHTLRLYRVCALGNNRVAiAL : 1683 
I 	HS: 	-1I 7 CALGHNRVAHAI. 
- 	 LSRMPNH.. ILG' 1:ALHIPEEN 	I 	 PA 
PigRyrl 	: QMLM VSWSRMPNHFLRV 	R AGERLGNAV.CQ PLTHWLHI PEEN R M[ILELsERLDLQQHsHTLRLyRvcALGNNRvAi:AL : 1685 
RabbitRyrl 	: QMLM VSWSRMPNHFLQV 	R AGERLCWAVCQDPLTM.LHIPEENR MDILELSERLDLQRFHSHTLRLYRVCALGNNRVAAL : 1685 
FrogRyrl : QVLK WWSRt"IPNDFLKV SSKVSDRRGWMVECTDELM M LHIPEEDR 
I IDILELSERLDLLKFHYHTLKLYCSVCALGNNRVAAL : 1674 
FishRyrl 	: MT VIWSRNPNHFLTPD G ITERLGWVVECQ PLT M .LHIPEENR IDILELSERMDLLKFHYHTLKLYGSVCALGNNRVAHAL 1676 
QFLSHVLWSRMPNQFLKVDVS ISERQGWLV, CLDPLQFMSLHIPEENRSVDILELTEQEELLKFHYHTLRLS VOALGNHRVAHAL : 1676 
QFLSHVLWSRMPNQFLKVDVS ISERQGWLV. CLDPLQFMSLHIPEENRSVDTLELTEQEELLKFHYHTLRLYS VCALGNHRVA Al, : 1676 
HurnanRyr3 QTIQ VLWSRMPNSFLKV 	E VSERHGWVV.CL PLQM.LHIPEENR VDILELCEQEDLMRFHYHTLRLYS- - VCALGNSRVAYA 7, 1580 
RabbitRyr3 	: QTIQ VLWSRMPNSFLKV 	E VSERI-IGWVVCL PLQ 'M.LHIPEENR VDILELCEQEDLMQFHYHTLRLYS VCALGNSRVAYAL : 1580 
MinkRyr3 : QTIQ VLWSRMPSSFLKV 	EGVSERHGWAVCL: PLQ:MI-LHIPEENR VDILELCEQEDLMQFHYHTLRLYS VCALGNSRVAYAL : 1580 
ChickenRyr3 : QTIT VLWSRMPNSFLKV 	E VSERHGWVVCL PLQMILHIPEENR VDILELCEQEDLMKFHYHTLKLYSSVCALGNTRVAYAL : 1581 
FrogRyr3 QTITVLWSRMPNMFLKV 	F VSERHGNVCL PLQ'LLLHIPEENR IDILELSEQEDLMKFHYHTLKLYCVCALGNNRVA AL : 1580 
C.eleganRyr 	: EQIESVYWARVPNETLRTTALKLSEVRGWSVLCNDPVRIMSVYI 	KDQSUT.ITMIEMPDMLE 	RQTLN1CKLASH 	JHKL T 	: 1810 
.............................................................................................. 
CSHVDQAQLLHLEDARLPGPLRAGYYDLLI.IIHLE 	CRS RSMLSE IVPLTP TRAIT 	PPGRSAEDGPRRHGLPG GVTTSLR 1774 
HumariRyrl CSHVDQAQLLFL LEDAHLPGPLRAGYYDLLISIHLE 	CRS RSMLSE IVPLTP I AIT 	PPGRSTENGHPRHGLPG GVTTSLR : 1771 
I, 	 I 	LGYYDLLISIHLE : 	 I,: 	 HGLPI ::i 	-.11. 
PigRyrl 	: CSHVDQAQLLH LEDAHLPGPLRAGYYDLLI.IIHLE 	CRS RSMLSE IVPLTP TRAITL PPGKRTENGPRRHGLPG 	VTTSLR : 1773 
RabbitRyrl 	: CSHVDQAQLLH LEDAHLPGPLRAGYYDLLI3IHLE 	CRS RSLSE IVPLTP TAIT 	PPGRKGGN.ARRHGLPC GVTTSLR : 1772 
FrogRyrl : TSRVDESQLLYT ESNNLSGLLRSGFYDLLI.IHI.E 	KRG MTV1NSEFIVPMTDQTKSiTI 	PNEN ...... KKHGLPG GMSTCLR : 1756 
FishRyrl 	: CSHVDESQLFY 	ENTYLPGPMRSGFYDLLIMHLE 	KRN LGTNKEFIVPMTD 	ITITLYSD ........ RSI-[ALPG GLTTCLR : 1756 
CSHVDEPQLLY 	ENKYMPGLLRAGYYDLLIDIHLS YATA LMNINNE IVPMTE TKSITL PDEN ...... KKHGLPGIGLSTSLR : 1758 
CSHVDEPQLLY 	ENKYMPGLLRTGYYDLLIDIHLS YATA LMMNNEFIVPMTE TKSITL PDEN ...... KKHGLPGIGLSTSLR : 1758 
HumanRyr3 	: CSHVDLSQLFY 	DNKYLPGLLRSGFYDLLI. IHLA 	KERKLMMKNE IIPITSTT NICL PDES ...... KRHGLPG GLRTCLK : 1662 
RabbitRyr3 CSHVDLSQLFH 	DNKYLPGLLRSGFYDLLI.IHLAN KERKLMMKNE.IIPITSTT NIRLYLDES ...... KKHGLPG CPRTCLK : 1662 
MinkRyr3 CGHVDLSQLFY 	DNKYLPGLLRSGFYDLLISIHLAN KERKLMMKNEIIPITSAT KIRLYPDES ...... KRHGLPG GLRTCLK : 1662 
ChickenRyr3 CSHVDISQLFYT DNQYLPGLLRSGFYDLLISIHLDH KQAKLMMNNEFIIPVTE TTIKLYPDET ...... KKHGLPG GLSTCLK : 1663 
FrogRyr3 	: CSHVDQSQLLYT DNQYLPGLLRSGFFNLLIIYLE 	KEGKLMMNNEFIIPITD T KIRL PDES ...... KRHGLPG GRSTCLK : 1662 
C.elecianRyr CQHIDEDQIMY 	KSHYLSGPMRQGFHDLLIGLHLM HTAA NSMAKE VIPLVPQLQIKNVLDPDS ....... ESRYPQITGESVSM : 1891 
EisophiLaR .......................................................................................... : - 
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PHHESPP FVVALPAAGATEAPARLSPAPLEALRDKLRMLGEAVRDG QHARDPVGGI EE'.FVP. KLVSTLL7MGVESD. D K 	1862 
HumanRyrl PHHFSPP 'E'VAALPMGAAEAPARLSPA PLEAJRDK LRMLGEAVRDG QHARDPVGA ,EFQFVP.1KLVSTLL.'MGIF'GD 0 K : 1859 
- PTA: PLEAVDVA , •. 	CEAVPD77QHARDE77REVEFQFVPVIX 	IVMGIFGDEPVK 18 
PigRyrl 	: PPHHE'SAP FVAALPAVGAAEAPARLSPSPLEALRDK LRMLGEAVRDG QHARDPVGG..EF)FVP..KLVSTbL MGIFGD D K 1861 
RabbitRyrl PPHHFSPE FVAALPAAGVAEAPARLSPA PLEALRD< LRMGEAVRDG QHARDpvGG.:'.'EF.Fvp.IKLvSTLL:MGIFGD D K : 1860 
FrogRyrl 	: PELHFSHT 	FVSTISEL. .YQH. . . . SPY PLDILKTK INPILTESVQDG QHTRDPVGG.iEFFVP 	KLISTLLIMGVFQDDD R 1838 
FishRyrl : PKLHFSSTGFVGTDPDI..YTL ..... PV PLQVLKTK LNMLTEAVQDG QAMRD9VGG..EFHFVPI.KLISTLLIMGVFDD D T : 1838 
PRMQFSSPSFVSISNEC. . YQY .... .....:EFPLDILKSKTIQMLTEAVKEGSLHARDPvGGTTEFLFVPL1 	FYTLMIFHN DLK : 1840 
PRNQFSSPSFVSINNEC. .YQY... .SPEFPLDILKATIQMLTEAVKEGSLHGRDPVGGTTEFLFVPLIKLFYTLLIMGIFHN DLR : 1840 
HumanRyr3 	: PGFRFSTPFVVTGEDH..QKQ .... SPE PLESLRTK LSiTEAVQCS AHIRDPVGG:EF.FVP'KLIGTLLMGVF'DDDD R : 1744 
RabbitRyr3 	: PGFKE'STP EVVTNEER. .QKQ. . . .SPEIPLEILKMK LS1LTEAVQCS AHIRDPVGGSEF.FVP 	KLVGTLL.'MGVFCDDD R : 1744 
MinkRyr3 : PGFRFSTP FVVTGEEH. .QKQ. . . .SPEPLEILKTK LSMLTEAVQHS AHIRDPVGGEF2FVP 	KLIGTLL7MGVFDDDDIR : 1744 
ChickenRyr3 : PSFNFSTP 	FIVTSEEH. .QTS ..... 7D PLDTLKSK ISMLTEAVQCS SHIRDPVGGHIAF.FVP 	KLIATLL.MGVFDDDD K : 1745 
FrogRyr3 SDLHE'TAP 	PVLTGEER. .QQH ...... E PVDILKSK ISMLTEAVQSS DHIRDPVGGFCAEIF.FVP 	KLIATLLIMGVFED P R : 1744 
C.eleqanRyr LSQMASEPVKKHVSREDEMKLLP .... SVDFEALKKHVMESLQSATHHAVNNCPLLISDNTNHFEPLFKLFDQLL.IGLIN0 ELE 1975 
- I.................................................................................................. 
• 	
- IPKMIEPEVFR EEEV E GEE.E DREEK 	E ..... DEE.EEAHEKIIDEE 	EEAEDAAEEEKEE ..................... : 	 1922 
HumanRyrl 	: • ILKMIEPEVPT EEEE D EEEGE DEEEK 	E ..... DEE.ETAQEKFDEE 	EEEEAAEGEKEEG ..................... : 	 1920 
.. . ... 
-:•-7 	 • 
. 	 ••• 	 - 	 ...................... TO 
PigRyrl • ILKMIEPEVFT EEEE H EEEEE DEEEK 	H ..... DEE.EEAREKEDEE 	EEEETAEGEKEEY ..................... : 	 1922 
RabbitRyrl 	: ILKMIEPEVFT EEEE E EEEEE EEEDE 	E ..... KEEDEEEEEKPDAE 	EEEEAPEGEKED ...................... : 	 1921 
FrogRyrl : HKMIEPNVFS EEPA EGGEEGE KEATEKGG. .EEGEVEGEGQEKTEIDGEEKTVEDGEAEAKEE. .. .E .............. E. : 	 1905 
FishRyrl 	: HI LKNIEPTVFSGKKAE PAEENTKLKEEKEQKGPPKVGPVKEEQQEAVHDEEEEYEDDGLGEEEEEEEEMEEEEELEE1ESIIPDED 1926 
HILQLIEPSVFK AATP 	H 	SDTLEK 	LSVDDAK ............. LQGAGEEEAK. .GGKRPKE ......................: 1891 
- HILQLIEPSVFKDAATP H GDTLE PSVEDTK ............. LEGAGEEEAK. .VGKRPKE ....................... 1891 
HumanRyr3 zILLLIDPSVFG HS.AGT EGAEK VTQVE 	K ............. AVEAGE 	AG... .KEAPVK ...................... : 	1792 
RabbitRyr3 	: ILLLIDPSVFG HS.ADT EGAEK VSQVE 	K ............. AVEAGETSKEARKEAPVR ...................... : 	1796 
MinkRyr3 : .ILLLIDPSVFG HS.V T DGAEK VTQVE 	K ............. AVEAGEAG .... KEAPVK ...................... : 	1792 
ChickenRyr3 : • VLILIDPNVFGDHK.E A EKTEK VTQVE 	K ............. AVEAGE 	AVK. .ETKAPTK ...................... : 	1795 
FrogRyr3 	: ILLLIDPNVEGDHKEE A ENGEK DVAQIE 	K ............. AVEAGE 	PTR. .DAKAPAK ...................... : 	 1795 
C.eleganRyr CLLRLIHPQAED 	N .................................. YETGTTQKG ............................... : 	1998 
DrosophiiaR 	........................................................................................... - 
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LEEGLLQMKLPEVKLQMCHLLEYFCDQ 	R ESLAPAEC VD MQGNQRG : 	1976 
HumanRyrl .................................. LEEGLLQMKLPESVKLQMCHLLEYFCDQ 	L R 	ESLAAERVD LQANQRS : 	1974 
Hunari 	................................................... LPESVKLQMCHLLE 1RT. I 
PigRyrl .................................. LEECLLQMKLPESVKLQMCNLLEYFCDQ 	L 	R.ESLAAFAERVDLQANQRD : 	1976 
RabbitRyrl 	................................... LEEL3ILQMKLPE.3VKLQMCNLLEYFCDQ. L. iRESLAAFAERVD LQANQRS : 	 1975 
FrogRyrl • ................................. ALEECLLQMKLPESVKLQMCNLLQYFODR L.HR EAIIAFSERHMDSLQTNQRH 1960 
FishRyrl 	: TGNKTEPPHGEKGAEETEKEIKPVETTGEAKEEHLEQGFQMKLPE.VKLQMCTLLQiFCDC LRHREAITAFSDEFVSQIQSNQRQ : 2014 
...................................... LLQMKLPEPVKLQMCLLLQYLCDCQVRHRIEAIVFSDDFVA LQDNQRF : 1942 
...................................... 
LLQMKLFEPVKLQMCLLLQYLCDCQVRHRIEAIVAFSDDFVALQDNQRF : 1942 
RumanRyr3 	...................................... GLLQTRLPE3VKLQMCELLSYLCDC LHR EAIVAFGDI VS LQANQKF : 1843 
RabbitRyr3 ..................................... GLLQTRLPE5VKLQMCELLSYLCDCHLHR 	EAIVAFGDIVSLQANQKF : 1847 
MinkRyr3 	...................................... GLLQTRLPEVKLQMCELLSYLCDCL:JHRTEAIVFGDIVSLQANQKS : 1843 
ChickenRyr3 	...................................... (LLQTRLPE.VKLQMCHLLNYFCDCi L, HR EAIVSFADH VS LQYNQKY 1846 
FrogRyr3 ..................................... GLLQTRLPE.VKLQMCELLHYFCDC 	LKI-iR 	ESIVAFSDK 	VS LQYNQKF : 	1846 
C.e1ega::r 	- ...................................... LTQLELAEPVKIQLVSILDHLCDIQLRYRIESLVI\FTEGFVGELQSDQCK : 	2048 
Drosoph:li.R: ........................................................................................ : 	 - 
RYGL 	KAFTM.AAETA RTPEFRSPPQEQINMLLHFNGADE ........... EECPLPEEIQQELVNFHQDL AHCVQ. G 	E. : 	2052 
HumanRyrl 	: RYGL IKAFSMTAAETARTEFRSPPQEQINMLLQFDGTDE ........... EDCPLPEEIRQDLL FHQDLAHCGIQ DG 	E. : 	2050 
.... ....................:'LPEi 1 
PigRyrl 	: RYGI 	KAFTMTAAETA RT. EFRSPPQEQINMLLHFDGEDE ........... EDCPLPDEIRQDLLEFHQDL THCcIQ G 	E : 	2052 
RabbitRyrl 	: RYAL 	RAFTNAAETA RTEFRSPPQEQINMLLHF DEADE ........... EDCPLPEDTRQDLQ FHQDLAHC(IQ G 	E : 	2051 
FrogRyrl RYK QAFTM AAETART EFRPPPQEQINMLVNF NIPE ............ EEYPVPEEIRDEHI 	FHADL. AHCGVHM GQ E. : 	2035 
FishRyrl RYN 	LAFTM .ETAKT..EFRSPPQEQVNMLMNL NCSED ........... EECPIPDEVRESLLAFHNAL AHSGVHIVE Q. : 	2090 
RYN V QALNM AALTJ\ KTKEFRSPPQEQINMLLNF DDKS ............. ECPCPEEIRDQLL FHEDLMTI-iCGIE DEDGSL : 	2017 
RYN V QALNMLTAKTKEFRSPPQEQINLLNF DDKS ............. ECPCPEEIRDQLL FHEDLMTHCGIE DEDGSL : 	 2017 
HumanRyr3 	: RYN 	QALNM PALTAKTKEFRSPPQEQINMLLNFQLGE .............. NCPCPEEIREELY FHEDL.LHCCVP E 	.. : 	1915 
RabbitRyr3 : RYN QALNM AALTA-KT EFRSPPQEQINMLLNFQLGE .............. NCPCPEEIREELY FHEDL VHC(VP F .. 	: 1919 
MinkRyr3 	: RYN 	QALNN AALTAKT EFRSPPQEQINMLLNE'QLGE .............. NCPCPEEIREELY FHEDL IHVP E 	. . : 	1915 
ChickenRyr3 RYN QALNNL AALTAKKTKEFRSPPQEQINMLLNFQLGE .............. DCPCPEEIRDELY FHDDL IHCGIP F . . : 	1918 
FrogRyr3 	: RYN 	LALNM AALTAKKTEFRSPPQEQINMLLNFQMQE .............. ESPCPEEIRDELYEFHEDL IHCGIP F 	. 	. 	 : 1918 
C.eleganRyr 	: RYM IKQT.DMPPAEAAKKTKEFRCPPKEQMFRLLMC VKEERDPELMFEDADVDQCPMAEGLQQQLR. FCELLVGKIGNVK GDSDD : 	2135 
9rosohilR'y.. ........................................................................................ : 	 - 
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P ESTLGS LM 	LEKVKLVK T EKPEEEPA.P HK QSLQELVSH V WAQE FV S ELVRANIFSLLHRQYD LGEL : 2135 
HumanRyrl P ETTLGS LM .LEKVRLVK K EKPEEERS.A SK RSLQELVSHMV WAQE FV S ELVRAMFSLLHRQYDLGEL : 2133 
. 	 C : : '.'..,'.7A1r P PPEiVPA1iPSLLHRQYDGLGF 1 
PigRyrl 	..... P EATLGS LM 	.LEKVRLVK K EKSEEEPP.A SK QSLQELVSH V WPQE FV S.ELVRAMFSLLHRQYDLGEL : 2135 
RabbitRyrl 	. ....P ETSLSS LR bLETVRLVK K EKPEEELP.A KK QSLQELVSHMV WAQE YV S ELVRAMFSLLHRQYDLGEL : 2134 
FrogRyrl . .... EQ DTSLARLL LVEKIKNLRGKKQEPEPEPEEQ PK TTLQEL SH N HWAQESF N ELVRVNF'SLLHRQYDLGEL : 2119 
FishRyrl 	. .... GE VDNSVRG LLRLLEKVKKFREKKVEVEPEP. .Q DKK STLQELSH MIHWAQESF .N ELVRMMLSLLHRQYDLGEL : 2172 
DGNSDLTIRGLL LVEKVTYLK KQAEKPVES ... DSKKSSTLQQL SE N WAQESV ED ELVRAMFVLLHRQYD IGGL : 2098 
Rau.jit. . . . . DGNSDLTIRG LL. LVEKVTYLK KQTEKPVES ... DSRKSSTLQQL SE N WAQESV ED ELVRAMFVLLHRQYD IGGL : 2098 
HurnanRv ....... E DTSWTGKLCALVYKIKGPP P KEQPTEE... RC TTLKEL SQ MICWAQE Q DSELVRNMFNLLRRQYDSIGEL : 1996 
RabbitR 	. .... E DTSWTGKLRTLVYKIKGPP P KEQPTEE... RC TTLKEL SQ MI WAQE Q .DAELVRMMFNLLRRQYDSIGEE 2000 
MinkRyr3 E DTSWAGKLRALVYKIKGPPP KEQPTEE... RC TTLKEL SQ MI WAQE Q .DAELVRNMFSLLQRQYDSIGEI 1996 
ChickenRyr3 	. .... E DSSLTGKLR LIYKIKGPP P KIEPRFE... DKS TTLKEL SQ N WSQE Q .DELVRIMYTLLRRQYDSIGEI. : 	1999 
FrogRyr3 	. .... QE DTSWTG LR LVYKIKGRP A EQAPQE... KS TTLKEL SQ N WAQE H D ELVRIMFSLLRLQYDSIGE1 : 	1999 
C.eleganRyr 	: QLALIES EGSWVDSFARIVVKVPPPVLE GNEMQKK ...... GTQNFREI VTMLREWAA F ESKSIRNMFRLLLRQYS IRF.I 	: 2217 
................................................................................................ 
A PRAYTT VSSVEDTMSLLECLGQIRSLLIVQMGPRR.RTMIQSIGNIMNNKVFYQHPNLNRALGMHETVMEVMVNVLG GE... : 2219 
HumanRyrl A PRAYT 	PSSVEDTMSLLECLGQIRSLLIVQM :pQPPNLMIQSIGNIMNNKVFYQHPNLNRALGMH ..................VNVLG GE 	: 2218 
.':DTI:,ECL1::. 	11Ltp:QsI:NNNKvFYQHpNLMRALc-: 	M 	MVNVLG 	- 	 :. 
PigRyrl 	: A PRAYTI PSSVEDTMSLLECLGQIRSLLIVQNIGPQEENLMIQSIGNIMNNKVFYQHPNLMRALGM} VNVLG GE : 2220 
RabbitRyrl 	: A PRAYT. 	PSSVEDTMSLLECLGQIRSLLIVQMGPQEENLMIQSIGNIMNNKVFYQHPNLNRALGNI.......... 	WVNVLG GE 	: 2219 
FrogRyrl : I AMPKA 	. NAVSVEDTMNLLESLGQIRSLLIVQMGPEEENLMIQSIGNIMNNKVFYQHPNLMRALGNHETVMEVMVNVLG GE : 2204 
FishRyrl N A PKAHI.NAVSIQDTMDLLECLGQIRSLLIVLMGPEEERLMIQSIGNIMSNKVFYQNPNLMRALGNHETVMEVMVNVLG GD 	: 2257 
V A PKTYTNGVSVEDTINLLASLGQIRSLLSVRMTKEEEKLMIRGLGDIMNNKVFYQHPNLNRALGMHETVMEVMVNVLG GE : 2183 
VIA. PKTYTINGVSVEDTINLLASLGQIRSLLSVRMGKEEEKLMIRGLGDINNNKVFYQHPNLMRALGNHETVMEVNVNVLG GE 	: 2183 
HurnanRyr3 . QAI RKTYTI HTSVSDTINLLMLGQIRSLLSVRMGKEEELLMINGLGDIMNNKVFYQHPNLMRVLGNHETVMEVNVNVLGTEK : 2081 
RabbitRyr3 QA RKTYTI HAPVSDTINLLAALGQIRSLLSVRMGREEELLMINGLGDIMNNKVFYQHPNLMRVLGNHETVMEVNVNVI.PTEK 	: 2085 
MinkRyr3 	: QA RKTYTT QAPVSDTINLLAALGQIRCLLSVRMGKEEELLMINGLGDINNNKVFYQHPNLMRVLGNHETVMEVMVDVLTAEK : 2081 
ChickenRyr3 	: QA RKAYTI AASVKDTINLLAALGQIRSLLSVRMGKEEELLMINGLGDINNNKVFYQHPNLMRVLGNHETVMDVMVNVLG DK 	: 2084 
FrogRyr 3 	: AMRKTYT I AASVEDTINLLASLGQIRSLLSVRMGKEEEMLMIDGLGDIMNNKVFYQHPNLMRVLGNHETVMEVMVDVLG NK : 2084 
C.e1egarRr 	: RDAMSQTYVFHERNEKDVTDFLVYLIQIRELLTVQFEHTEEAILKRGLWKLWNNRIFTQHPDT 	LLSVE1EN"MSIMMNILTAQQGTV : 2305 
Drosophil3P .......................................................................................... : - 
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............ SKEIRFPEVTCCRFLCYFCRISRQNQRSMFDHLSYLLENGIGLG ... MQG 	bDVSVIDNNELALLQEQD : 2294 
HumanRyrl 	............ KEIRFPKMVT CCRFLCYFCRISRQNQRSMFDHLSYLLENSGIGLG ...MQG LDVAAASVIDNNELAL LQEQD : 2293 
REP 	;' 	CCRFLCYFCRISRQNQRREiLSYLLENR 	..., 	J)VAAASVI DNELALAL EQD 	: 
PigRyrl 	........... SKEIRFPKMVTCCRFLCYFCRISRQNQRSMFDHLSYLLEN.GIGLG ... MQG LDVAAISVIDNNELAL LQEQD : 2295 
RabbitRyrl 	........... TKEIRFPNMVT CCRFLCYFCRISRQNQRSMDHLSYLLEN.GIGLG ... MQG 	LDVAkSVIDNNELALLQEQD : 2294 
FrogRyrl .......... SKEIRPP<MJTNCCRFLCYFCRISRQNQRAMEDHLSYLLEN.GIGLG ... M GSTLDVAA:SVIDNNELAL  LQEQD : 2279 
FishRyrl 	........... sKEIRTPRvVTNCCRFLCYFCRISRQNQRSt4FDHLSYLLQNSGILG ... M TSTPLDVMSCIDNNELAL LQFQD : 2332 
........... SKEITE[iANCCRFLCYFCRISRQNQKNffDHLSYLLENSSVflI 	 TPLDVAA-SVMDNNELAL IREPD : 2261 
............ KEITEPKMVANCCRFLCYFCRISRQNQKMFDHLSYLLENSSVASPAR iSTPLDVAAASVMDNNELAL, LREPD : 2261 
HumanRyr. 	............. Q.IAFPKMVA CCRFLCYECRISRQNQKANFEHLSYLLENSSVWASPSMGSTPLDVATSSVMDNNELALSLEEPD : 2158 
RabbitRyr3 ............ Q. IAFPKMVA CCRFLCYFCRISRQNQKAMFEHLSYLLENSSVCLASPSM GSTPLDVAASSVMDNNELALGLEEPD 2162 
MinkRyr3 ........... Q.IAFPKMVACCRFLCYFCRISRQNQKAMFEHLSYLLENSSVGLASPSM GSTPLDVAASSVMDNNELALGLEEPD 2158 
ChickenRyr3 ........... Q. IAEPKMVA CCRFLCYFCRISRQNQKAHFEHLSYLLENSSVGLAFPSM GSTPLDVAASVMDNNELAL LEEPfl 2161 
FrogRyr3 	. ............ QQIAF'PKMVA CCRFLCYFCRTSRQNQKAMFEHLAYLLENSSVGLASPSM CSTPLDVP.A SVMDNNELAL LQEP[) : 2162 
C.eleganRyr EHEGDELKEKAPIKDASEMVVACSRFLCYE.T:H.:cKANEH3FLLDNATMLLARPSL 	vT::YSFMDNNELALLKEEE : 2393 
................................................................................................ : - 
LEKvvs.YLAGCGLQSCMLL;KGYPDGW:PCGGERYLDFLRFAVF.NESVEENANVWRLLIRKPECFGPi. 	GEGCSC 	AAIE : 2381 
HumanRyrl 	: LEKVVS.YLAGCGLQSCPMLVKGYPDGWKPCGGERYLDFLRFAVF'NESVEENANVVVRLLIRKPE0FGP. 	GEGGSG 	ME : 2380 
diI1LLY: 
PigRyrl 	: LEKVVS.YLAGCGLQSC 	LLKGYPDGWtPCGGERYLEFLRFAVF.NESVEENANVVVRLLIRKPECFGPA. 	GEGGSG 	ATIE : 2382 
RabbitRyrl 	: LEKVVS.YLAGCGLQSCPMLLKGYPDiGWiPCGGERYLDFLRFAVF1N3ESVEENANVVVRLLIRKPECFGP1 GEGCSG lAME : 2381 
FrogRyrl : LEKVVS. YLAGCGLQSCIMLL KGypDjGwNpvGGERyLFLRFAvE,NEsvEENANvvvRLLIRPpEcFcpi; 	GEG(N3t14AIE : 2366 
FishRyrl 	: LEMVVK. YLAGCGLQSCMLLSKGYPDIGWPCGGEKYLFLRFAVF.N ESVEENANVVVPLLIRRPECFGPA 	GEG(NGI.AAIE : 2419 
LEKVVR.YLAGOGLQSCQMLVSKGYPDGWIJPVEGERYLNFLRFAVFCNESVEENANVVVFLLIRRPECFGP.I ; 	 N 	MME : 2348 
LEKVVVRYLAGCGLQSCQMLVSKGYPDfGWPVEGERYLlFLRFAVFCNESVEENANVVVRLLIRFPECFGPALRGEGGNLAAME 2349 
HumanRyr3 	: LEKVVT. YLPGCGLQSCMLL KGYPDVGWlPIEGERYLSELRFAVFNSESVEENASVVVKLLIRRPECFGPALRGEGGNGLLTAMQ : 2245 
RabbitRyr3 	: LEKVVT. YLAGCGLQSCRMLL KGYPDVGW PIEGERYLSELRFAVF' NSESVEENASVVVKLLIRPECFGPALRGEGGNGLLJAJMQ : 2249 
MinkRyr3 : LEKVVT.YLAGCGLQSCFMLL KGYPDVGW PIEGERYLSFLRFAVF NSESVEENASVVVKLLIRRPECFGPALRGEGGNGLLAAMQ 2245 
ChickenRyr3 	: LDKVVT.YLAGCGLQSCI VLL KGYPDIGW PIEGERYLsFLRFAVF:NSESVEENASVVVKLLIRRPECFGPELRGEGGNGLLAA1'4Q : 2248 
FrogRyr3 LEKVVT. YLAGCGLQSCLMLITKGYPDTGW.PIEGERYLSFLRFAVF NCESVEENASVVVKLLIRPECFGPSLRGEGGNGLLAJ\NQ : 2249 
C.eleganRyr 	: LDKVAV.YLSRCGLQPNSELITKGYPDGWDPVEGERYI ELRFCVWIN ENVEENALVI LLIRPECLGVALKGEG.QGLFSAFK : 2479 
















AIRISE 	P.  ....... ..GFGVRRD RREHFG. PPEFNR NLGHAIM FYAALJ. 1: 	HTHLIQ GKGEALRIRA 
AIRISE 	P. ....... ...GPGIRRD RREHFG. PPEENR HLGHAIMFYAALJI HLIQ..GKGEALRIRA 
.• LLA:MsFiAA 	RH 	:HHLIQAGKGEALRIP 	C 
AIRISE. P ........ DGPGVRRD RREHFG. PPFLPNR HLGHAIM.:FYAALT I . HLIQ/.GKGEALRIRA 
AIRISE. 	P. ....... IGPGVRRD RREHFG. PPFF.NR NL(HATM PYAALIDLLGRCAPE HLIQ:.GKGEALRIRAiLRJ. 
DAIKISE 	P ....... ..GPTVKKD RRELYGG PHLEINR I1LLNAIM.FYAALIDLLGRCAPE:HLIQIGKGEALRIRAILRSL 
•P .......  AIKISE RFPMFGG QHPNR HLGNAIM. E'YSALIDLLGRCAPEPIHLIQI.GKGEALRIRAILRSL 
.AIKIAE 	. ........... GPSPNSGSSKTLD. .T EEEDDTIPMGNAIMTFYSALIDLLGRCAPEIHLIHGKGEAIRIRSRSL1 
1AIKIAE 	F. ....... S DGPSPTSGSSKTLD. .T EEEDDTIHMGNAIMTFYALIDLLGRCAPELHLIHIGKCEAIRIRSILRSLI 
GAIKISENP ....... LDLPSQGYK EVSTE. .DDEEEEEI HMGNAIM.FYSALIDLLGRCAPELHLIQTGKGEAIRIRSILRSL 
GAIKISESE ....... LDLPSQGYK EVP.E. .DGEEEEEI HMGNAIM. FYSALIDLLGRCAPEHLIQTGKGEAIRIRSILRSL 
GAIKISENP ....... LDLPSQGYK EVM.... DGEDEEI HMGNAIMJFYSALIDLLGRCAPE HLIQTGKGEAIRIRSTLRSL 
AIRISENP ....... T DLPSQGYK EGD.E.. EEEEEI HMGNAIM FYSALIDLLGRCAPE HLIQSGKGEAIRIRSILLRSL 
.AINISENE ........ LDLPSQGYQ EVV.E.. DEEEEEI HMNAIM PYSALIDLLGRCAPEPHLIQ GKCEAIRTRAITRSL 








































LDDLVG ISL QIPTLGKDGALVQPKV ASE'VPDHKASMVLFLDRVYGIENQ FLLHVLDVGFLPDMRAGASLDTATFS T ALA 
LEDLVGISL1 . QIPTLGKDGALVQPKM. ASFVPDHKASMVLFLDRVYGIENQ FLLHVLDVGFLPDMRAIASLDTATFS TG ALA 
1 DLVGIT:I P I PTLIYI .G • EPSASF'LPLHKA.HMVLFLDRVIG EI9FLLHVLDVIFL 7 DRAAASLDTATE'STTEMALA 
LDDLVGIISL. QIPTLGKDGALVQPKM.ASFVPDHKASMVLFLDRVYG]IENQ FLLHVLDVGFLPDMRAASLDTATFSTTEPiALA 
PLDDLVG1ISL QIPTLGKDGALVQPKM. ASFVPDHKASMVLFLDRVYGIENQ FLLHVLDVGFLPDMRAAASLDTATFSITEMALA 
-IEDLVGVISL QIPAFGKDGNTIEPKM ASFVPDHKAPMVLFLDRVYGIDNQ ELLQVLPVGFLPDMPA.GASLDTAAFSFTEMALA 
PIEDLVGVISL VQIPSFGKDNSIIEPKM ASFVPDHKAPMVLFLDRVYGIDNQ FLLHVLIVGFLPDMRkIASLDTVAFSTE:ALA 
PLGDLVGVISIAFQMPTIAKDGNVVEPDM. AGFCPDHKAAMVLFLDRVYG IEVQ FLLHLLPVGFLPDLRAGASLDTAALSATD' ALA 
PLGDLVGVISIAFQMPTIAKD'NVVEPDM AGFCPDHKAAMVLFLDRVYGIEVQ FLLHLLVGFLPDLRA?.ASLDTAALSATDALA 
PTEDLVGI ISI. KLPSLNKDCSVSEPDMAANFCPDHKAPMVLFLDRVYGIKDQTFLLHLL VGFLPDLRASASLDTVSLS T .AALA 
PTEDLVGIISI KLPSLNKDGSVSEPDNIAANFCPDHKAPMVLFLDRVYGIKDQTFLLHLL VGFLPDLRASASLDTVALS T SALA 
PTEDLVGI ISI KLPSLNKDGSISEPDPIAANFCPDHKAPMVLFLDRVYGIKDQTFLLHLL VGFLPDLRASASLDTVSLS T AALA 
PTEDLVG:ISI. KLSTVNKDGTVNEPDM ANFCPDHKAPMVLFLDRVYG[KDQSFLLHLL VGFLPDLR.A.SASLDTVSLS T AALA 
PTEDLVGf ISI KLPAFNKDGTVFEPDPIAASFCPDHKAPMVLFLDRVYGIKDQSFLLHLL VAFLPDLRASASLDTASLSVT ALA 
SLDDLGQ LALRFTIPNLAAP.SIEDTGPLPGLLPNHKGSVLLFLDRVYGIDQQ. MLFHVL QSFLPDLPA TMMDSPRALESDTALA 
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NRY CLAVLPLITKCAPLFAGTEHR IMVDSML TVYPI'RGRSLTKAQRDVIEDCLMALCRYIRPSM QHLLRRLVFDVPILNEF. 	2636 
HumanRyrl VRY CLAVLPLITKCAPLFAGTEHR IMVDSMLTVYI 	.'RG SLTKAQRDVIEDCLMSLCRYIRPSWQHLLRRLVFDVPILNEF. : 	2635 
T:1RiL':AvL:1::.PLFAGTEb:.: :*LTKQP1I 	H YRPSMLQHLLRRLVFDVPILNEF. 
P±gRyrl : 	 'JRYICLAVLPLITKCAPLFAGTEHR IMVDSML TVY 	.RG SLTKAQRDVIEECLMALCRYIRPSM.QHLLRRLVFDVPILtJEF. : 	 2637 
RabbitRyrl : 	 CLAVLPLITKCAPLF:.GTEHR IMVDSML TVY.: :RG SLTKAQRDVIEDCLMALCRYIRPSMQHLLRRLVFDVPILNEF. 	: 2636 
FrogRyri : MNRY CSAVLPLITKCAPLFSGTEHR IMVDSML TIYFtRG SLTKAQRDVIEECLMGLCRFLRPSMI QHLLRRLVFDVPILNEF. 	: 2622 
FishRyri 'RYCSAVLFLITKCAPLFAGSDHR IMIDSML TIYRI 	R 	AFTKAQRDIIEECLMALCKHLRPSM' QHLLRRLVFDVPILNEY. 	: 2675 
RY CTAVLPLLTRCAPLFGTEHH SLIDSLL: TVYRLSKGCLTKAQRDSIEVCLLSICGQLRPSMMCHLLRRLVFDVPLLNEH. 	: 2602 
NRYCTAVLPLLTRCAPLFAGTEHH SLIDSLL TVYRLSKGCSLTKAQRDSIEVCLLSICGQLRPSMMQHLLRRLVFDVPLLNEH. 	: 2603 
HumanRyr3 : 	LNRYICSAVLPLLTRCAPLFAGTEHCTSLIDSTLQTIYRLSKGSLTKAQRDTIEECLLAICNHLRPSM QQLLRRLVFDVPQLNLY. 	: 2499 
RabbitRyr3 LNRYICSAVLPLLTRCAPLFHGTEHYTSLIDSTLQTIYRLSKGSLTKAQRDTIEECLLAICNHLRPSMJ QQLLRRLVFDVPQLNDY. 2502 
MinkRyr3 : 	 LNRYI CSAVLPLLTRCAPLF13.GTEHYTSLIDSTLQTIYRLSKGSLTKAQRDTIEECLLAICNHLRPSMI QQLLRRLVFDVPQLNEY. 	: 2497 
ChickenRyr3 : 	 NRYICSAVFPLLKRCAPLFSGTEHH SLVDSML TIYRLSKG SLTKAQRDTIEECLLAICHHLRPSM QQLLRRLVFDVPLLNEY. 	: 2501 
FrogRyr3 NRYICSAVLPLLTRCAPLFSGTF13•Y ALIDSTLYTIYRLSKGSLTKAQRDTIEECLLSICHHMRPSM QQLLRRLVF[VLLSEY. 	: 2502 
C.eleganRyr NRY CNSVLPLLTNHSHFF DA3HSALLAT13 'TV 13HMNRLKSLTKNQRDAVSDFLVAITRELPPAMNIKYKKVITDILTMNDMN : 2742 
............................................................................................. 
AKMPLKLLTNHYERCWKYYCLPTILVANFGVT EEELHL RKLFWGIFD, LA KKYDQ LY I MPLCAIAGA1 FPDYV ASYS KT1 : 2724 
HurnanRyrl 	: AKMPLKLLTNHYERCWKYYCLPTGLANFGVTEEELHL RKLE'WGIFD LAHKKYDP LY M MP7LCAIAGA1PPDYV ASYS KA1 2723 
PLKLLTNHYERCWK1113LP1 	;13SEEEL. Hi7JGi 	.1 AHKLi H-ALP313' 
PigRyrl 	: AKMPLKLLTNHYERCWKYYCLPTGWANFGVT 1 EEELHL RKLFWGIF'D LA[KKYDPLY M MPI1CAIAGALPPDYV ASYS KAE : 2725 
RabbitRyrl 	: AKMPLKLLTNHYEPCWKYYCLPTIWANFGVTEEELHLRKLFWGIFD LA KKYDQ LY M 4PJLCAIAGA1PPDYV ASYS KAE : 2724 
FrogRyrl : Sr1N1PLKLLTNHYEPCWKYYCLPTGWANYGVS EEELHLRKLFWGIFE. LA.KRFDA LYKITMPCLCAIAGAIPPDYV ASYS KTD : 2710 
FishRyrl 	: AQMPLKLLTNHYERCWKYYCLPNGWANFGVA EEELYL RKLFWGIFE. LA KKFDA IFKISMPCICAIAGAIPPDYV ASYS KTET 2763 
AKMPLKLLTNHYERCWKYYCLPGGWGNFGAAEEELHLSRKLFWGIFDALSQKKYEQ LFKL LPCLSAVAGAIPPDYMESNYV MME : 2690 
RabbitRyr7 AKMPLKLLTNHYECWKYYCLPGGWGNFCAA.EEELHLSRKLFWGIFDALSQKKYEQ LFKL LPCLSAVAGAI PPDYMESNYV MME : 2691 
HumanRyr3 	: CKMPLKLLTNHYEQCWKYYCLPSGWGSYGLAVEEELHL EKLFWGIFDLSKKYDPDLF M LP(LSAIAGAI PPDYL TRITATLI3I 	: 2587 
RabbitRyr3 	: CKMPLKLLTNHFEQCWKYYCLPSGWGSYGLAVEEELHL EKLFWGIFD.LSKKYDFDLF MSL13LSAIAGA PPDYL TRITATLE : 2590 
MinkRyr3 CKMPLKLLTNHYEQCWKYYCLPSGWGSYGLAVEEELHLTEKLFWGIFDLSKKYDPDLFM LLLSAIAGA1PPDYL TRISATLE : 2585 
ChickenRyr3 	: CKMPLKLLTNHYEQCWKYYCLPSGMGSYGIAAEDELHL EKLFWGIFD. LSHKKYDP LF N LP1LSAIAGA PPDYL TRIR TLE 2589 
FrogRyr3 	: CKMPLKLLTNHYEQCWKYYCLPSGWGSYLLA EEELHL EKLFWGIFD. LS KKYDA LF MCMLLSAIAGAPPflYV TRIKATPE 2590 
C.eleganRyr 	: VLVPLRLITLHYECGKYYGSGN ... HYGVA EQEKRLSNLLFDAIFC)TLGSRPYDP LFGK L13 'MTAIGSAISH. 	TLTSGLEDVR 	: 2827 
rscçr,ti 	.......................................................................................... : - 
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KKAT D 	GNF PRP ETLNVI PEKLDSFI KFAEYTHEKWAFKLNWSYGENI 	ELK HPML PYK FSEKDKEIYRWP KES 2812 
HumanRyrl KKAT D 	GNF PRP ETLNVI PEKLDSFI'.KFAEYTHEKWAF KI.:NWSYGENI 	ELK HPMLPYK FSEKDKEIYRWP KE[ : 	2811 
H 	.GNFI'PJ 	: 	 .1 . KU:: 	1.HHDKUJY 	LI: 	..: 	 HI'HL9.PYKI KKEIYH;  
PigRyrl 	: HKAT D 	GNF. PRP ETLNVI 	PEKLDSFI KFAEYTI-iEKWAF..KI. 	NWSYGENI 	ELK HPt4L1 PYK FSEKDKEIYRWP KES : 	2813 
RabbitRyrl 	: HKAT D 	GNF PRP ETLNVI F'KLDSFI KFAEYTHEKWPF [<I 	NWSYGENV 	ELK HPML PYK FSEKDKEIYRWP KES : 	2812 
FrogRyri : EKAS r 	GNE'. PKP ETLNVI PEKLDGFIKYAEHTH KWAFEKI. 	NWSYGETI 	EAK HPML PYK FSEKDKEIYRWP KES 2798 
FishRyrl 	: KKAS D 	GNFIPKP ETTNTIPERLDPFIRFAEYTH KWAFEKI.'NWSYGEVL 	NAK HPML PIE FSEKDKEIYRWPKES : 	2851 
KQSSMDSGNFNPQP DTSNIT PEELEYFI KYAEHSH KWSM KLA GWIYGEIYSDSSKVQPLMKPYKLLSEKEKEIYRWP KES : 	 2778 
KQSSMDS GNFNPQP DTSNII PEKLEYFI KYAEHSII KWSM ELA GWIYGEIYSDSSKIQPLMKPYKLLSEKEKEIYRWP KES 2779 
HumanRyr3 	: EQIS D DGNF PKPINTMNFSLPEKLEYIVTKYAEHSH KWAC KS.SGWKYGISL 	NVK HPLIPFK LTEKEKEIYRWPAREL 2675 
RabbitRyr3 KQVS P DGNF PKPINTINFSLPEKLEYIVTKYAEHSR KWACEKS SGWKYGISL 	NVK RPLI PFK LTEKEKEIYRWPARE. 2678 
MinkRyr3 	: KQIS P DGNF. PKPINTMNFSLPEKWEYIVTKYAEHSH KWACI KS. GWKYGISL 	NVK HPLI:,pFK LTEKEKEIYRWPARES : 	2673 
ChickenRyr3 	: KQTS Pp GNF PKP NTANLVLPEKLEYIVSKYAEHSP EWAF KTN GWKYGVSL 	NTK HPLILPFK LTEKEKEIYRWPVRES : 	2677 
FrogRyr3 	: KQMS P 	GNF PKP NTANLTLFEKLEYIV KF.EHSR EWAY KLHSGWKYGTTL 	NTKSHPLL PFK LAEKEKETYRWP REP : 	2678 
C.eleganRyr NK.RREE GAWIPRT DVSRCE NRDLEKMTELFAIHFH SWASRKLEKGWVHPDLYSRANF HPRLKPFALLKDFESFKERCSEC 2914 
LKAMIAWEWTVEKAREUE GKTEKK.KTRLI QTAQ.TYDPRE .YNPQPPDSVVTLSRL,AM. EQLAENYHNTWGRKKEQELEAK 2897 
HumanRyrl 	: LKAMIAWEWTIEKARECE EKTEKK.KTA I QSAQ. TYDPRE .INPQPPD SAVTLSR:.LAMHEQLENYHNTWGRKKKQELEAK : 	2896 
imUPç 	HLH. 	VTLSRELQAI4AE 	AENYHN.'K.KKKQELEU .1 
PigRyrl 	: LKAMIAWEWTIEKAREGE EKTEKK.KTR I QSAQ.TYDARE .YNPQPPD SGVTLSREL.AMEQLAENYHNTWGRKKKQELEAK : 	2898 
RabbitRyrl 	: LKAMIAWEWTIEKARECE ERTEKK.KTRI QTAQ.TYDPRE .INPQPPD SGVTLSR.L.AMEQLAENYHNTWGRKKKQELEAK : 	2897 
FrogRyrl : i.KAMIAWEWLVEKARECE DRTEKKTKTR I QTAQQTYDPMVQTFSE'TPID TGLTLSRL.SM .EQLAENYHNTWGRKKKVELETK : 	2886 
FishRyrl IKAMLAWEWNIEKARE.E ESEKKKATSR I QTAQATYDPSH . YSPQPIDISHVALSRDL. SM EQLAENYHNTWGRKKKLELQAK : 	2937 
LKTMLARTMRTERTREG.DSMALYN.RTRRI QTSQVSVDAAH . YSPRAIDMSNVTLSRDLHAM EMMAENYHNIWAKKKKMEPESK : 	2863 
LKTMLAWGWRIERTREG.DSMALYN.RTRRI QTSQVSVDAAH .YSPRAIDMSNVTLSRDLHAM EMMAENYHNIWAKKKKLELESK : 	2864 
HumanRyr3 	: LKTMLAVGWTVERTKES. ALVQQR.ENE LRSVSQANQ..GNS.YSPAPLD.SNVVLSR:L.GMVEVVAENYHNIWAKKKKLELESK : 	2758 
RabbitRyr3 LKTMLAVGWTVERTKEP. ALVQLR.ENE LRSVSQTSQ. .GNS.YNPAPLD SNVVLSR UGMVEVVAENYHNIWAKKKKLELESK : 	2761 
MinkRyr3 	: LKTMLAVGWSVERTKK.. ALVQQR.ENE LRSVSQASQ. .GNS.YSPAPLD SNVVLSR LGMVEWAENYHNIWAKKKKLELESK : 	2756 
ChickenRyr3 	: LKTMLAMGWSLERTKEGG GMLHQR.ENELRSISQSSQ. .GN .YSPAPLD TNVVLSR L.GMVEVMAENYHNIWAKKKKMELESK 2761 
FrogRyr3 	: VKTMLAIGWSVERTKEP. ALALHR.ENE MRSISQTSQ. .GN .YTPVPID SNVVLSR L GMVEVMAENYHNIWAKKKKMDLETK : 	2761 
C.eleganRyr 	: LKALMAWNYSFEMMDR ... DANDRASAARTL GTSISN ....... FAPKPID SSMTLEKDMVNA EKMAEHSHLIWAKKVMNDLNTK : 	2992 
DrosophilaRy ......................................................................................... : 	 - 
268 
ISHPLLVPYDTLTAKEK ,:DREKAH 	.J<FLQMNG . VTRGLKD ELE ........ T. SIEKRFAFGFLQQ 	RWMDIS. 	I 	: 2977 
HumanRyrl 	: THPLLVPYDTLTAKEK1JDREKAQELLKFLQt4NG 	.VTRGLKD'ELL. ........ SSIEKRF'AFGFIQQ 	RWMDIS. IA : 2976 
THPLLVPYDTLTAKENARDREKAQELLKFLOYNGYAVTRGLKLYELD 	 .1 	.1.,IAHL 
PigRyrl 	: THPLLVPYDTLTAKEKt1DREKA, 	KFLQMNG 	VTRGLKDEI r ...T SIEKRF'AFGE'LQQ 	RWM[IS 	IAP. 2978 
RabbitRyrl 	: THPLLVPYDTLTAKEKt.DREKTi. KFLQMNG 	VTRGLKD ELD ........ T $IEKREAFGFLQQ 	RWMDIS. lAD. 	: 2977 
FrogRyri : .1THPLLVPYDTLTAKEKDREKAH 	KFLQLQGVTRGLKD.ELD ........ T SIEKRFAYGFLQK 	KLMDS 	IA : 2966 
FishRyrl 	: GTHPLLVPYDTLTAKEK 	DREKAY KFLQLNGiDVTRGLKD1ESD ........ I SIEKRFAYGF'LQK 	KWMEI I 	> 3017 
;DNHPLLVPYDTLTAKEK.KDREIDI KFLQING.VSRGFKDLELI .. ........ TPSIEKRFAYSFLQQ IRYVLE HQYILEF : 2943 
GGGNHPLLVPYDTLTAKEKWDREKXDI KELQINGD.vsRGFKDLEL .. ........ TPSIEKPFAYSELQQ IRYVDE HQYILEF 2944 
HumanRyr3 GGGSHPLLVPYDTLTAKEKFKDREKA.D FKFLQVNGIIVSRGMKD[IELL . ........ A SMEKREAYKFLKKI KYVDS 	I 	: 2838 
RabbitRyr3 	: GGGSHPLLVPYDTLTAKEKFI'DREKA,D FKFLQVNGVIVSRGMKDDEL .... ........ AFSMEKRFAYKFLKKI KYVDS I : 2841 
MinkRyr3 GGGSHPLLVPYDTLTAKEKFDREKAD FKFLQVNGIVVSRGVKDIELD ........ A SMEKREAYKFLKKI KYVDS 	IDI 	: 2836 
ChickenRyr3 	: CGGSHPLLVPYDTLTAKEKSDREKA, 	FKFLQVNGIIISRGLND'DLD ........ A. SMEKRFAFKKI.KKI KYVDS : 2841 
FrogRyr3 GAGSHPLLVPYDTLTAKEK •DREKA. 	,FKFLQVNG 	ISRGLKD ELI. ........A. St4EKRFAFKEIKKV HYVPS 	I . 2841 
C.eleganRyr 	: GGFMPIPI 	WL,.FDFERRKDRFRAS I KFLQYHG HVNCPKDEQSQNDRLKSEGERTSVEKRFAYNLIEK ITYLEQ SLKMKSV 3080 - 
M..S RyE 	P 	.QEIKFFAKI.LPLINQYFNH.LYELST A VLGSGGHAS:.KEKEMITSLFCKL ALVRHRVSLFGTD PAV 3064 
HumanRyrl 	: .vD.S RyE .PD..QEIKFFAKILLPLINQYFTNHLYFLST A VLGSGGHASDKEKEMITSLFCKLALVRHRVSLFGTD PAV : 	3063 
i!,: 	:.11::.I A;y55p:...D:PHE.QEIKFEAKILLpLINQyFTNNCLyFL5IDi 	.1 	JGHA5NKEKEMITSLECKLAALVRHRVSLF'GTI.;! . 
PigRyrl 	: ........... S RVE . PRE.QEIKFFAKITLPLINQYFTNHLYFLST A VLGSGGHASDKEKEMITSLFCKLALVRHRVSLFGTDPAV : 	3065 
RabbitRyrl •V 	S RVEY.PKD,QEIKFFAKII LPLINQYF NH LYFLST A VLGSGGHASDKEKEMITSLE'CKLT ,.ALVRHRVSLFGTD PAV 3064 
FrogRyrl 	: V 	S RyE 	P 	.REIKFFAKI LPLINQYF.NH LYFLST A VLGSGGHAS'KEKEMIASLFCKIALVRHRVSLFGND PAV : 	3053 
FishRyrl IV 	S RyE 	P 	.QEIKFFAKI MPLINQYFKNH LYFLST A VLGSGGHSS'.KEKEMIASIFCKMSALVRHRVSLFGTD PAl : 	3104 
DGGSRG.KGEHFPY .QEIKFFAKVVLPLIDQYFKNHRLYFLSAASRPICSGGHAS .KEKEMVTSLFCKLGVLVRHRISLFGND TSI : 	3029 
DGGSRS.KGEI-iFPY .QEIKFFAKVVLPLIDQYFKNHRLYFLSAASRPLCSGGHASKEKEMVTSLFCKLGVLVRRRISLFGND TSI 3030 
HumanRyr3 	: I 	S WE 	PRD.QEIKFFAKVLPLVDQYF SH LYFLSS L PLSSSGYASHKEKEMVAGLFCKL:DALVRHRISLFGSDSTTM : 	2925 
RabbitRyr3 	: I 	S KTE 	P D.QEIKFFAKV LPLVDQYF NHRLYFISS L PLSSSGYASHKEKEMVASLFCKLAALVRHRISLFGSDSTTM : 	2928 
MinkRyr3 : I 	S KTE 	PD.QEIKFFAKVLPLVDQYF NHHLYFLSS L PLSSSGYASHKEKEMVASLFCKLAALVRHRISLE'GSDSTTM : 	2923 
ChickenRyr3 : I TS WE 	P D.QEIKFFAK\TLPLVDQYF NHLYFLSS T TLsssoyAs':KEKEMvASLFCKLAALvRHRISIFGSDSTTM : 	2928 
FrogRyr3 	: V GS KSE . QEIKFFAKV LPLVDQYFKNH LYFLSS I TLSSSGYASDKEKEMVASLFCKLAALVRHRISLFGSDSTTM : 	2928 
C.eleganRyr 	: KPSQELTRRNSFKK GQDVKFFEKVVLPLMHAYFNAHKNYFLEGSS. . IVQTGTASDKEKEMVANLFCRLALLRIKNRAFGSV KIT : 	3166 
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VNCLFiIJ. RS..: ARTVMK. GPEIVK LRSEF SASDIEKMVINI.R G. VSQAR VKVGQ LT1TTVLLVLITLQii 	: 3151 
HumanRyrl 	: VNCLHII. RSLDARTVMK.GPEIVK. LRSF'F SASEDIEKMVENLR G. VSQAR QVKGVGQ .LTYTTVALLPVLTTLFQH' •QHQ : 3150 
: !NCLHli 	 .TE im:EDIE1;.: 	... S 	 ..,.S- 1T7ALL 	IAQ1-i : 	 1 
PigRyrl 	: VNCLHIL. RSLDARTVMK GPEIVK 	LRSFF. SASEDIEKMVENLR G. VSQAR.QVKGVGQ'LTYTTVALLPVLTTLFQHSQHQ 3152 
RabbitRyrl 	: VNCLH1I 	RSLDARTVMK.GPEIVK LRSFFSASEDIEEKNVENLR G. VSQAR QVKGVGQLTYTTVALLPVLTTLFQH :..QHQ : 3151 
FrogRyrl : VNCLHIL RSLDARTVMK.'GPEIVK. LRSFF GSEDIEKMVENL 	C. VSQSR QVKGVQ INYTTVALLPVLTSLFEU. .QHQ : 3140 
FishRyrl VNCLHIL RSLDARTVMK: 7GPEIVK 	LRSFF SAADDIEKMVENL 	C. VSKGNQQVKCVSQINYTTIALLPVLTSLFDH .QHQ : 3191 
VNCLHILGQTLDARTVMKTGLESVKSALRAFLDNAAEDLEKTMENL QG.QFTHTRNQPKGVTQIINYTTVALLPMLSSLF'EH GQHQ 3116 
VNCLHILGQTLDARTVMKTGLESVKSALRAFLDNAAEDLEKTMENL QG.QFTHTRNQPRGVTQIINYTTVALLPMLSSLFEH GQHQ : 3117 
HumanRyr3 	: VSCLHIL QTTDTRTVMK GSELVK 	LRAFF NAAEDLEKTSESCL 	C. 	FTHSR QIKGVSQ'.INYTTVALLPILTSIE'ERVTQHQ : 3012 
RabbitRyr3 : VSOLHIL QTLDTRTVMK CSELVEK LRAFF SAAEDLEKTSENL 	C. 	FTHSR QIKGVSQSINYTTVALLPILTSIFEHVQHQ : 3015 
MinkRyr3 	: VSCLHIL QTLDTRTVMK GSELVK 	LRAFF. NPAEDLEKTSENL: G. FTHSR QIKGVSQ INYTTVALLPILTSIFEHV QHQ 3010 
ChickenRyr3 : VSCLHIL QSLDTRTVMK GSELVK.T LRAFF NAAEDLEKTSENL 	C. FTHSR QIKGVSQ INYTTVALLPVLTSIFEH SQYH : 	 3015 
FrogRyr3 	: VSIHIL QTLDTRTVMK GSELVK 	VRAFF NAAEDLEKTLENL 	C. FTHSR QMKGVSQ INYTTVALLPILTSIFEHV RHQ : 	 3015 
C.eleganRyr .K SQGLTQALDLRTLVKVNSDIVRTSLLT 	NNCADDLYASVNEL DGGQYSLIRGQALKSWNSFEFANQMIVPVLTTMF'AHL RNH 3254 
I II................................................................................................ . 	 - 
FCDDVILDDVQ SCY. TL SlY IC ......... TTR SPYVEKLRPALGECLAR 	 NACSVYTTQS RER 	L : 	 3230 
HumanRyrl 	: FGDDVILDDVQ.SCYTL:SIY LT ......... TT 	TYVEKLRPALGECLAR..TAI.ANPVAFLEPQLNE.NACSVYTTKS RER. L : 	 3229 
L,L1QVSCYRTLCSIi,.................................PALGECLARLAkIPVAFLEPc2LNEYAcJYTHHi+ERA 1 : 	 22 
PigRyrl f 	 .............. TRPYVEKLRPALGECLARA.AMPVAFLEPQLNENACSVYTTKS 5 RER.T L FGDDVILDDVQTSCY:TL 'SlY .    3231 
RabbitRyrl 	: FCDDVILDDVQ'.'SCY TL SlY I 	....... TT 	TYVEKLRPALGECLARSPAMPVAFLEPQLNE NACSVYTTKSSRER.L 	L : 	 3230 
FrogRyrl FGDDVILDDVQ'. STY TL SlY. H . ...........:T PYVEKQRPALGECLAR A AMPVAFLEPHLNE NIYSVYTTKTS RER : 	 3219 
FishRyrl 	: FGDDVILDDLQMSCY IM SlY H H ......... TV 	PHVERQRPALGECLAH A AMPVAYLEPLLNEFNAFSVYTTKTRER 	L : 	 3270 
FGEDLILEDVQ SCY ILTSLYAf ..............IS SIYVERQRSALGECLAAFAGAFPVAFLETHLDKHNIYSIYNTKSSRERTAL : 	 3195 
FGEDLILEDVQ  SCY ILTSLYAI .......... ...S SIYVERQRSALGECLAAFAGAFPVAFLETHLNKHNIYSIYNTKSSRERAL : 	 3196 
HumanRyr3 	: E'GMDLLLGDVQISCYHIL SLY S . ..........SC 	IYVERQRPALGECLASI ATAIPVAFLEPTLNR NPLSVFNTKT RERS H 3091 
RabbitRyr3 : FCVDLLLGDVQISCY IL SLY. LH ......... TG IYVERQRPALGECLAS.A AIPVAFLEPTLNR NALSVFNTKT RERS I : 	 3094 
MinkRyr3 	: FGVDLLLGDVQISCYHIL SLY LC ......... CC 	IYVERQRPALGECLAS A AIPVAFLEPTLNR NPLSVFNTKT RERS I 3089 
ChickenRyr3 FGVDLLLGDVQSCY IL SLY. LG ......... TG IYVERQRPALGECLAS A AIPVAFLEPSLNH NPLSVFNTKSAREPJ 	I : 	 3094 
FrogRyr3 FGVDLLLDDVQYSCYIL SLY LG ..........G 	IYVERQRPALGECLAA AGAIPVAFLEPSLNHNNPLSVFNTKSHRER I : 	 3094 
C. eleganRyr 	: FHT[ LLLDDIQAACYKI LDSLYMVTGLSSSISHRKSISGESEKHRPGLGQCLAAFASCFPVAFLEPEFNKSNKFSVLAKSQDQS. . . V 3339 
DrosophilaR\ ......................................................................................... . 	 - 
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LPNSVE1CP IPVLRL A IGGLAESGRYTMPHVEITLPMLCSY PRWWE GPEAP.PPALPAGAP PCTA SDH SLLG : 3317 
HumanRyrl 	: LPNSVEMCPEIPVL RL ADIGGLAESGRYTEMPHVTEITLPMLCSY PRWWE GPEAP.PSALPAGAP PCTA 	SDH SLLG : 3316 
.VEEMCPDIE:.::. 
PigRyrl 	: LPNSVEENCPLIPVL RL .ADIGGLAESGRYTEMPf{V EITLPMLCSY PRWWEGPEAP.PPALPAGAP P([A 	SDH SLLG 	: 3318 
RabbitRyrl LNSVEL1CPLIPVLDRL ADIGGLAESG;RYTFMPHV EITLPMLCSY PRWWEGPEAP.PPALPAGAP PCTA 	SDH SLLG 3317 
FrogRyrl LINSVE1CPIPDLYTLTK ISLLAESGRYT:MPHV EVTLPMLCNY PRWWE GPEN ..... MPDETT C('TT 	SEH ALLG 3302 
FishRyrl 	: LrNEVQLCPIPELDALLK IGDLAESGARYTMPHVEITLPMLCNY PRWWE GPEN ..... SPEMDGQLTFE 	SEH QLLG : 3353 
SLPTNVEDVCPNIPSLKL.E IVELAESGIRYTQMPHVMEVILPMLCSYMSRWWEHGPEN ..... NPERAEMC 'ALNSEHM TLLC 	: 3278 
SLPANVEDVCPNIPSL KL E IVELAESGIRYTQMPHVMEVILPMLCSYMSRWWHGPS ..... NPGEMC(TALNSEHMTLLG : 3279 
HumariRyr3 	: MPDTVED OP IPQL GL K INDLAESGARYTMPHV EVILPMLCNY SYWWE GP;-, N ..... LPPSTG C.TK 	SEN SLILG 	: 3174 
RabbitRyr3 MPDTVE 	CP IPQLGL K INDLAESGARYTMPHV EVILPMLCNY SYWWEGPEN ..... LSPSTG CCSK 	.SEH SLILG 	: 3177 
MinkRyr3 	: IVIPDTVEEMCP IPQLGL K ISDLAESGTRYT,MPHV EVILPMLCNY SYWWEGPEH ..... LPPSTG WrTK EH SVILG : 3172 
ChickenRyr3 	: MPDTVE 	CPEIPQLDGLIK INNLAESG1RYTFMPHV.EVILPMLCNY SYWWEGSES ..... VPESAG C'TMI SEH SIILG 	: 3177 
FrogRyr3 	: MDTVE CSEMPHLDGL K INDLAESGRYTMPHVEVVLPIVSNY SYWEGTEN .......rENAR CTQ 	SEN SVILG 	: 3177 
C. elegartRyr 
.............................................................................................. 
QVQEMLQNLSTHI PHL KLLTDLETVNNNTMYSDVPNVYDVDLPLMCSYMAHWFSVGPDGKRDKEDQRASVVQTTS SCDI RIFN 3427 
NILRIIVNNLGIDEA WMKRLAV 	QPIV R RPELLRHF P IGRLRKRAGKVVAEE .LRLEA AEAEEGE LVRDEFS •L R[)L : 	3405 
HumanRyrl 	: NILRIIVNNLGIDEA:WI1KRLAV 	.QPIV R RPELLQHF P IGRLRKRAGKVVSEE .LALEA AEAQEGE LVRDEFs;L RDL : 	3404 
1VNNLGIDEASWMKRLVFQPI 	I.; 	QSHPI. I 	IGKVV 	ES 	AIS 	1 	...:LGESSIPDEFSVLCRDL 
PigRyrl 	: NILRIIVNNLGIDEAWNKRLAV 	QPIV R RPELLHHFIP IGRLRKRAGKVVAEE LRLEA AEAEEGE LVRDEFSL'RDL : 	3406 
RabbitRyrl NILRIIVNNLGIDEATWMKRLAV 	QPIV R RPELLH.'HE P IGRLRKRAGKVVAEE 	LRLEA AEAEEGE LVRDEFS LIRDL : 	3405 
FrogRyrl 	: NILRIVVNNLGIDEAWMKRLAV.QPIV K KPELLRTHF P M KLKKRAGKVVAEE LRLEA SESEDSESLIRDEFS L'RDL : 	 3390 
FishRyrl SIMKIVVNNLGIDEA WMKRLAV SQPIV R KPEMLK HF P M KVKKRTSKVVAEEDHLRNEG SEGDEEDGTIRDEEA L RDL : 	 3441 
NILKIIYNNLGIDEGAWMKRLAV SQPIINKVKPQLLKTHFLPLM KLKKKAATVVSEEDHLKAEARGDMSEAE LILDEFTTLARDL : 	 3366 
NILKIIyNNLGIDEGAw?KRLAVSQPIINKVKPQLLKTHFLPLM KLKKKAAMVVSEEDHLKAEARGDMSEAE LILDEFTTLPRDL : 	3367 
HumanRyr3 	: NILKII[NNNLGIDEA."WMKRIAVY QPII K RPDLLRHF P L KLKKAVKTVQEE 	LKADG GDTQEAE LILDEFA L RDL : 	3262 
RabbitRyr3 : NILKIINNNLGIDEAWMKRIAVYQPII K RPDLLRHF P L KLKKKAVKTVQEE.LKADG GDTQEAE LILDEFAIL'RDL 3265 
MinkRyr3 	: NILKIINNNLGIDEA'WMKRIAVY QPII K RPDLLK:HF P L KLKKKAVKTVQEE ,LKADT GDTQEAE LILDEFAL:RDL : 	 3260 
ChickenRyr3 : NILKIINNNLGIDEAWMKRIAVYQPII K RPDLLKTHF P L KLKKKAIKIVMEE ,LRADS SDTQEAE.LILDEFA L'RDL : 	3265 
FrogRyr3 	: NILKIINNNLGIDEA,WMKRIAVY QPII K QPDLLK HE' P L KLKKKAIKIVQEE 	SKADS SDTQEAE LILDEF'A LRDL 3265 
C.eleganRyr ALLKMIRNHVGIENAPWLCRVNF 	VQIIQNVTSDPVREFVLPIA RLRRMSEKAYKEE HMRTHP... DDADEGTVAEDNARLVRDT : 	3512 
Drosophi1aRy ........................................................................................ : 	 - 
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rI YALYPLLIRYVD.NR HWLTEPNPNAE IFRMVGEIEIYWKSHNFKREEQNEVVQNEINNMSFL ADNKSKMA AGDVQS SL)QER 	: 3493 
HumanRyrl : 	yALypLLIRyvD:NR• QWLTEPNPSAE LRMVGEIEIYW'KSHNFKREEQNFVVQNEINNNSFL ADNKSKMA S ..... SDQER : 3487 
YALYPLIRYVDI.iLI" RMVG 	I1;KSHNFKREEQNFV!cIN 	I. 
PigRyrl : 	 IALYPLLIRYVDHNRHWLTEPNPSAE LFRMVGEIFIIYWKSHNFKREEQNFVVQNEINNMSFL ADNKSKMA S ..... SDQER : 3489 
RabbitRyrl LYPLLIRYVDNR HWLTEPNANAE LFRMVGEIE'IYW KSHNFKREEQNFVVQNENNMSFi ADSKSKMA AGDAQS SDQER : 3493 
FrogRyrl : 	 1ILYPLLIRYVDNR NLTVPNCDAE LFRMVGEVFIFW KSHNFKREEQNFVVQNEINNMSFL ADSKSKMS SGDSQS SDQGR 3478 
FishRyrl : 	 Y.LYPLLIRYVDNR RWLTCPDPDAE I FRMVGEVFIFW KSHNFMREEQNFVVMNEINNMSFLADSKSKMS GGDSEG SDTER : 3529 
YAFYPLLIRFVDYNR KWLKEPNPEAE LFRMVAEVFIYW'KSHNFKREEQNFVVQNEINNMSFLITDTKSKMS .....KAAVSDQER 3449 
YAFYPLLIRFVDYNR KWIKEPTPEAE LFRMVAEVIYW KSHNE'KREEQNFVVQNEINNMSE'LITDTKSKMS .....KAAVSDQER 	: 3450 
HumanRyr3 YAFYPMLIRYVDNRSNWLKSPDADSDQIF'RMVAEVFILWCKSHNFKREEQNFVIQNEINNLAFL GDSKSKMS AMQVKS QDQER 3350 
RabbitRyr3 YAFYPMLIRYVDNRSNWLKSPDGDSDQLERMVAEVFILWCKSHNFKREEQNFVIQNEINNLAFL GDSKSKMS AMQVKS QDQER : 3353 
MinkRyr3 : YAFYPMLIRYVDNRSNWLKSPSADSDQLFRMVAEVFILWCKSHNFKREEQNFVIQNEINNFL GDSKSKMS .....KS QDQER : 3343 
ChickenRyr3 : 	 YAFYPMLIRYVDNR NWLKKPDADSD LFRMVAEVE'ILWCKSHNFKREEQFVIQNEINNLAFL GDTKSKMS ANQVKS QDQER 3353 
FrogRyr3 YPFYPMLIRYVD NRSNWLKKPDADSDDLFRMVAEVFILWCKSHNFKREFQ'1FVIQNEINNLAE'L GNNKSKMS PIQVKS QDQER : 3353 
C.eleganRyr IFFPILMKYTDLHP QWLKTrTWETDGVYENVAVIRI/ Q,QHFtFLNYVAQFEEDAAATGGGDMKTGKA ....... AIAERKK : 3593 
TKKKR GDRYSVQTSLIVTTLK LPIGLN CAPTDQDLIVLAKAR A DT 5EV EF Q. NLNLQGKVEGSPSLRWQMALYRGVPG : 3581 
HumanRyrl TKKKR GDRYSVQTSLIVATLKL::1LPIGLN:CAPTDQDLITLAKTR A 	DT EEVEF H.NLHLQGKVEGSPSLRWQMALYRGVPG : 3575 
S'QT SLIVATLEKLPIGLNNI' 	TQDL1TLAK9:'A TDEEVRE!U!NLHLc'V :i;IVLY 	1 	: 5 
PigRyrl 	: TKKKRGDRYSVQTSLIVATLK5LPIGLNCAPTDQELITLAKTR A 	DTEEVIEF Q NLHLQGKVEGSPSLRWQMALYRGLPG : 3577 
RabbitRyrl 	: TKKKRGDRYSVQTSLIVATLK1LPIGLNCAPTDQDLIMLAKTR A 	DTDEEV SF Q NLHLQGKVEGS?SLRWQMALYRGLPG : 3581 
FrogRyrl : TKKKR-GDRYSVQTSLIVPTLKKMLPIGLNICSPTDQbLITLAMTR S. iDTEEV.'EF N NLHLQGKVE.NSSMRWQMALYNRMSG : 3565 
FishRyrl 	: TKKKRGDRYSVQTSLIVAALKY'LPIGLN CSPADQLINLAKIR S RDTEEVEF Q NLHLQGKVD.NPSMRWQMALYKEMAG : 3616 
KKNKRKGDRYSMQTSLIVAALKRLLPIGLNICAPGDQ' LIALAKNRFS 	DTEDEV DIIRSNIHLQGKLE.DPAIRWQMALYKDLPN 3536 
KKRKGDRYSMQTSLIVAALFLLPIGLNICAPGDQ.'.LIALAERFS 	ATEDEVDIIR NIHLQGKLE.DPAIRWQMALYKDLPN : 3537 
HumanRyr3 	: KKTKRGDLYSIQTSLIVJALKNLPIGLNCTPGDQELISLAKSR SHRT SEVER R NLHLQEKSD.DPAVKWQLNLYKDVLK : 3437 
RabbitRyr3 KKTKR. GDLYSIQTSLIVAALKKMLPIGLNCTPGDQLISLAKSR SYRT EEVKEH R NLHLQEKSD.DPAVKWQLNLYKDVLK 3440 
MinkRyr3 	: KKTKRGDLYSIQTSLIVAALKKMLPIGLNCTPGDQLISLAKSR SYRDT EEVKEH R NLHLQEKSD.DPAVKWQLNLYKDVLK : 3430 
ChickenPyr3 	: KKSKRGDLYSIQTSLIVAALKKMLPIGLNYCTPGDQLISLAKTR SHRDT EEVKEHIR NLHLQEKSD.DPAVKWQLNLYKDILK : 3440 
FrogRyr3 KRTKRGDLYSIQTSLIVAALKKMLPIGLN'CTPGDQ LISLAKTR S 	LIT EEVKEH SSNLHLQEKSE.DPAVKWQLNLYKDILK : 3440 
C.eleganRyr 	: KRREGQIKKDKHAASIVIACLKRLLPV (ThNVFGGRELDIVQQSKEKFIQ ETEEKI EFIKGLLEIPVKTDPTDKNAWQLSLYRKIGK : 3681 
Drcsophi1aP\ .. ........................................................................................ . - 
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R ... E 	DADD-HNI 	CR'; EV Y LD . TEHIYKSKKAVWHKLL5K 	RRAVV 	RHT1TiACHME 3654 
HumanRyrl 	: R... E DADDPEKI RRV EV YYLD ............ TEHPYKSKKAVWHKLLSKQRRRAVVACFRMTPLYNLPTHRACNMF'L 3648 
:AVHKLLSKQRHRAVVACFRI'JLP1H. 
PigRyrl 	: R ... E DADDHEKI RRVEV Y 	... ............ MEHPYKSKKAVWHKLLSKQRRRAVVACFRMTPLYNLE'THRACNMFL : 3650 
RabbitRyrl 	: R ... E DADDFI RRV.EV Y 	... ............ TEHPYKSKKAVWHKLLSKQRRRAVVACFRMTPLYNLPTHRACNMFL 	: 3654 
FrogRyrl : K ... A DANNPEKI KRV EV F 	IL, 	L ............ TEHPFKSKKAVWHKLLSKQRRRAVVACFRMTPLYNLPRHRACNML 3638 
FishRyrl K ... A DADAPVKV KRV.EV Y H V ............ TEHPFKSKKNVWHKLLSKQRRRAVVACFRMTPLYNIPRHRASNMFL 	: 3689 
R... TDDTSDPHKT ERVLDIAN 	F L 	KSKRVGRRHYCLVEHPQRSKKAVWHKLLSKQRKRAVVACFRMAPLYNLPRHRAVNLFL : 3621 
R... T ETSDPHFKT ERVLDIAN F L 	KSKFIGRRYYNLVEHPQRSKKAVWHKLLSKQRKRAVVACFRMAPLYNLPRHRAVNLFL : 3622 
HumanRyr3 	. .... S EPFNIEKT ERV.RI AVF L ............ VEQPLRSKKAVWHKLLSKQRKRAVVACFRMAPLYNLPRHRSINLF 1 	: 3509 
RabbitRyr3 . .... S EPSNPEKT ERV RI AVF 	L 	. ............ VEQPLRSKKAVWHKLLSKQRKRAVVACFRMAPLYNLPRHRSINLFL : 3512 
MinkRyr3 S EPFNAEKTIERV.RI AVF 	H 	............. VEQPLRSKKAVWHKLLSKQRKRAVVACFRMAPLYNLPRHKINNFFL : 3502 
ChickenRyr3 .... SDEPPDPEKN ERV.RI A Y LD ............ VEQPLRSKKAVWHKLLSKQRKRAVVACFRMAPLYNLPRHRSINLFL : 3512 
FrogRyr3 .... S E.TDPEKAIERV.KI  AVF L ............ VHQPLRSKKAVWHKLLSKQRKRPVVACFRMAPLYNLFRHRCINLFL : 3511 
C.eleq3nPHr: SQMRGKDEMSQDAVIEKIFNMGQ SAILHT ............. MTSRMEKEDIWKKLTLQRKRMAISLITASHI IKTELHRGINFFL 3756 
ESYKASW LTE.DHSFH RN DDLSKAGEQE .................. H 	H 	V 	EKKPDPLHQ 	VL..FSRTALTEK... 	KLDEDY 	: 3720 
HumanRyrl 	: ESYKAAW LTE.DHSIHH RN DDLSKAGEQ H .................. ..E V EKKPDPLHQVLHFSRTALTEK... 	KLDEDY 3714 
WILi1.. ......................................  ................... ..EH:1 	PLHQL'JLHFSRTALTEH... HLY 3714 
PigRyrl 	: ESYKAAWLTE.DHSFH RM DDLSKAGEQ E'................... E 	H 	V 	EKKFDPLHQVLHFSRTALTEK ........DEDY 	: 3716 
RabbitRyrl 	: ESYKAAW LTE.DHSHH RN DDLSKAGEQ H. .................. .H 	V 	EKKPDPLHQIVLFSRTALTEK... 	'HDEDY 	: 3720 
FrogRyrl EGYKHNW MTE.EHAFH RN DDLAKSGETGE .................. H 	H 	E EKKPDPLHQI .L 	FSRTALTEK ... THLEEDY 	: 3704 
FishRyrl 	: EGYKRNWLHTH.GYAFH RN DDLSKANEQ HG ................. D 	H 	EQETKPDPLHQ 	IL .FSRTALTEK... 	HLDTDH 	: 3756 
QGYEKSWETE.EHYFH KL EDLAKPGAEPPE ................. EDFGTKR. .VDPLHQ LLFSRTALTEK.. .CKLEEDF 3686 
QGYEKSW ETE.EHYFE KL EDLAKPGAEPPE ................. EDEVTKR. .VDPLHQI ILLFSRTALTEK ... CKLEEDF 	: 3687 
HumanRyr3 	: HGYQRFW ETE.EYSFEEKLVQDLAKSPKV HE ................. E 	H 	T 	K.QPDPLHQIILYFSRNALTER... 	KLEDDP 	: 3575 
RabbitRyr3 HGYQRFW ETE.EYSFEEKLVQDLAKSPKV HE ................. H 	H 	N K.QPDPLHQI 	L 	FSRNALTER... 	KLEDDP 	: 3578 
MinkRyr3 	: STFQRVWLEKVNEKTQY RL PILMKSPKV HE ................. ... N 	K.QPDPLHQI 	LIIFSRNALTER... 	KLEDDP 	: 3569 
ChickenRyr3 	: HGYQNYW ETE.EYSFEEKLVQDLATSPKK HE ................. ..HDT 	KEQPDPLHQI 	LYFSRNALTER ... 	KLEDDP 	: 3579 
FrogRyr3 	: HGYQRFW ETE.ENSFEETL QDLAKPKKKDEE .................E 	H T 	K.KPDPLHQI.LI FSRNTLTER... 	KLEDDP 	: 3577 
C.eleganRyr 	: PAFSRLWMEEH. .DAGQ QL ADICSGVEE HGPRIEIIMEEGVPIVASSHDTKEKETNPDPLKQ. 	RCFQRAATSEETAA.AIHEDS 3842 
Drosophi1aR .. ......................................................................................... - 
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LYM I IMAKSCL EGG NGEEGGEEE VEVSFEEKEMEKQR LYQQSRLHNFGAAEMVLQ ISACKGET AMVSSTLKLGISILN 3808 
HumanRyrl 	: LIM I IMAKSC:L:EGG NGEA. 	.EE VEVSFEEKQMEKLR LIQQ RLHTRGAAEMVLQ.ISACKLET AMYSSTLKLGISI.LN : 3799 
1tAKSCHL:: .• 
	
. QI.L 	RLHTAEMVLQMILA' 	... 
PigRyrl 	: :fM I IMAKSCIL EGG NGEA...QE VEVSFEEKEMEKQR LYQQ.RLHNRGAAEMVLQ:IISACK 1 ET AMVSSTLKLGISIL 	: 3801 
RabbitRyrl L.YM Y IMAKSC L EGG NGEAE .EE VEVSFEEKEMEKQR LYQQSRLHTRGAAEMVLQISACK4LT AMVSSTLKLGISILN 3806 
FrogRyrl 	: LIM I IMAKSC M EEG APE 	.GE.E DEIPF'EEKEMEKQK LIQQSRLHNRGAAEMVLQISACKGLP AMVSSTLKLGISIL: 3789 
FishRyrl : LIM I IMAKSC IGEEE GGEEMVENA DEMSFEEKEMEKQR LYQQSRLHNRGAAEMVLQIISACKGDT PMVSTTLKLGISIL, 3844 
LYM Y IMAKSCHDEDDDG. E ...... EVKSFEEKEMEKQK' LYQQARLHDRGAAEMVLQTISASKGET PMVAATLKLGIAILL 3767 
LIM I IMAKSCD EDDDG.E.. ...... EVKSEEEKEMEKQK LYQQRLHDRGAEMVLQTISASKLLT P!F:AATLKLGIAILJ 3768 
HumanRyr3 	: LYTSYSSMMAKSCQSGEDE EDF. ...... DKEKTE'EEKEMEKQKTLYQQRLHERGAAEMVLQ ISASKLEMSPMLVETLKLGIAIIN : 3657 
RabbitRyr : LYTSYSSMMAKSCQSGEDE E.E. ...... DKEKTFEEKEMEKQKTLYQQL.RLHERGAAEMVLQISASKLMSPM7VETLKLGIAILti 3659 
MinkRyr 	: LYTSYSSMMAKSCQSGEDE EEL. ...... DKEKTFEEKEMEKQKTLYQQ.LRLHERGAAEMVLQ.ISASKLMSPM1VETLKLGIAiLN : 3651 
Chicken - ,` 	: LYI Y AMMAKSCQE LEE E.F. ...... DKEKTFEEKEMEKQRTLYQQL.RLHDRGAAEMVLQISASKHT PfIVVETLKLGIAILN : 3660 
FrogRyr3 : 	LYT I AMNAL.CQN LED E ......... KLKTFEEKEMEKQKTLYQQ RLHEP.GAAEMVLQ I SAS K C : LMSPMLVETLKLG TAI Lfl : 3656 
C.eleqanR 	: LYIRF' V'L.L:i 	I LEDGEDG ..... E GEIDQAAKEEQSQA RGE) V.AS. AIMCLMYLSASGLLPNEMVAQTIQ1 	HLLS : 3925 
r 	 .. . - 
LGNAELQQKMLDYLKDKKK GFFQSIQALMQTCSVLDLNAFERQNKAEGLGMVNEDC V N QN EKVMA LLFTQDLFRFLQLLCEG 3896 
HumanRyri 	: NAEVQQKMLDYLKDKKE.GFFQSIQALMQTCSVLDLNAFERQNKAEGLGMVNEDL V N QN EKVMA DEFTQDLFRFLQLLCEG 3887 
.. ... AEVQQKMLDYLELL'LVGFFQLTC5VLDLLAEERQNKAEGLGMVLI ..LI,DEFTQDLFRFLQLLCF 	: 
PigRyrl 	: HNADVQQKMLDYLKDKKE.'GFFQSIQALMQTCSVLDLNAFERQNKAEGLGMVNEDG V N QN EKVMA DEFTQDLE'RFLQLLCE : 3889 
RabbitRyrl :UAEVQQKMLDYLKDKKE GFFQSIQALMQTCSVLDLNAFERQNKAEGLGMVNEDG V N QN EKVMA DEFTQDLFRFLQLLCEL : 3894 
FrogRyrl 	: NVEVQQKMLDYLKDKRE CFFQSVQALMQTCSVLDLNAFERQNKAEGLGMVTLDG I N EQ EKVMA DQFTQDLFRFLQLLCE 	: 3877 
FishRyrl : LLNSEVQRKMLEYLKDKRD GFFLSVQALMQTCCVLDLNAFERQNKAEGLGMVSLEG ...... TNEKVMS 	DEE'TCDLFRFLQLLCE : 3926 
GGNSTVQQKMLDYLKEKKD.GFFQSLAGLMQSCSVLDLNAFERQNKAEGLGMVTEE ...... S EKVLQ LEFTCDLFRFLQLLCEL 3849 
H 	. GGNSTVQQKMLDYLKEKKD GFFQSLAGLMQSCSVLDLNAFERQNKAEGLGMVTEE . 	. 	. 	- 	- 	.S EKVLQ PEETCDLFRFLQLLCEG : 3850 
HumanRyr3 	: GGNAGVQQKMLDYLKEKKDAGFFQSLSGLMQSCSVLDLNAFERQNKAEGLGMVTLE L V ER LKVLQNDEE'TRDLFRFLQLLCEG : 3745 
RabbitRyr3 : GGNAGVQQKMLDYLKVKKDAGFFQSLSGLMQSCSVLDLNAFERQNKAEGLGMVTEE L V ER EKVLQN:.LETRDLFRFLQLLCEG : 3747 
MinkRyr3 	: GGNAGVQQKMLDYLKEKKDAGFFQSLSGLMQSCSVLDLNAFERQNKAEGLGMVTEEG ...... TREKVLQNHLFTRDLFRFLQLLCEG : 3733 
ChickeriRyr3 	: GGNTIVQQKMLDYLKEKKDAGFFQSLSGLMQSCSVLDLNAFERQSKAEGLGMVTEEE L V ER EKVLQHDLFTRDLFRFLQLLCEL 3748 
FrogRyr3 	: GGNTVVQQKMLDYLKEKKDAGFFQSLSGLMMSflSVLDLNAFERQNKAEGLGMVTLEG L V ER EKVLQNDEFTRDLFRFLQLLCL 	: 3744 
C.eleganRyr GGNVEIQKMLIEYLQLKKD RFETSMAGLMNKCSVLNLEMFERQIKAEGLGMGAELAS ..... GDNQNLN ADETCSLFRFLQLTCL3 : 4008 
Drosophi1 1 : ......................................................................................... - 
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HNN[)FQN LRTQTLNTTTIN. I ICTVDYLLRLQESISDFYWIYSGKL) iEQ KRNFSL.LMSvAKQVVN LI YiQGPCTIINLLAt1 	3984 
HumanRyrl HNNDFQNLLRTQTGNTTTIN IICTVDYLLRLQESISDFYWYYSGKD IEIQ:KRNFSfLSVAKQVE'N LTEYIQGPCTGNQQSLAH : 	 3975 
LNDFQi : 
PigRyrl 	: RNNDE'QN LRTQTGNTTTINI IICTVDYLLRLQESISDFYWYYSGKD IEEQGKRNFSKJAMSVAKQVFN.LTEYIQGPCTGNQQSLAH : 	 3977 
RabbitRyrl 	: NNNDFQN LRTQTGNTTTIN. IICTVDYLLRLQESISDFYWYYSGKDIEEQGKRNFSLAMSVAKQVFNLTEYIQGPCTGNQQSLAH : 	 3982 
FrogRyrl : LNNDFQN LRTQTGNTTTINT IICTVDYLLRLQESISDFYWYYSGKDIIDEQGKRNFSMSVAKQVFN'LTEYIQGPCTGNQQSLAH : 	 3965 
FishRyrl NDFQN'LRTQTGSTTTIWIICTVDYLLRLQESISDFYWYYSGKD7IDEPGKKLMTVAKQIFN LTEYIQGPCTGNQQSLAR : 4014 
INSDFQN I . FTITLNNTTVN:IISTVDYLLRVQESISDFYWYYSGKD:IDEQGQRNLSKAIQVAKQ'NTLTEQCT 	QQSLAH 3937 
HNSDFQN LRTQTGNNTTVNI IISTVDYLLRVQESISDFYWYYSGKDIDEQGQRNSKAIQVAKQVF'NTLTEYIQGPCTGNQQSLAH 3938 
HumanRyr3 	: HNSDFQNFLRTQMGNTTTVNVIISTVDYLLRLQESISDFYWYYSGKDIIDESGQHNESKALAVTKQIFN LTIQ 	GNQQSLAH : 	 3833 
RabbitRyr3 : HNSDFQNFLRTQMGNTTTVNVIISTVDYLLRLQESISDFYWYYSGKDIIDESGQHNSKALAVTKQIFNLTEYIQGPCIGNQQSLAH : 	 3835 
MinkRyr3 	: : 	 3821 
ChickenRyr3 	: HNNDFQNILRTQMGNTTTVN IISTVDYLLRLQESISDFYWYYSGKDIDESGQRNFSKALAVTKQIFNLTEYIQGPCIGNQQSLAH : 	 3836 
FrogRyr3 	: HNNDFçNFLPTQMGNTTTVN IISTVDYLLRLQESIDFYJYYSGKD IEESGQHNFSKSLAVTKQIFNLTEYIQGPCIGNQQSLAH : 	 3832 
C. eleganRyr HLEL'..I 	.iPCHTTSVNLINCTVDYLLPL 	.:VM 	IH(SSKE IDEGGKEYILR/\IQ CS1VFNTLTV S TQGPCVGNQMTLAN 4096 
SRLWDAVVGFLHVFA. MMMKLQ .......... DSSQIELLKELLDL 	DMVVMLLS LEGNVVNGMIARQMVDMLVESSSNVEMILK : 	 4062 
HumanRyrl 	: SRLWDAVVGFLHVFAHMMMKLAQ .......... DSSQIELLKELLDLDVVMLLSLLEGNVVNGMIARQMVDMLVESSSNVEt'4ILK : 	 4053 
SRLWDAVVGFLRVFAHMtMK.: .......... DSSQIELLELLDLQKDMVVMLLSLLEGNVVNGIAL-IVDMLVESSSNVEML 
PigRyrl 	: SRLWDAVVGFLHVFAHMMMKLA(.I. ..........DSSQIELLKELLDLQ[DMVVMLLSL,LEGNVVNGMIARQMVDMLVESSSNVEMIL : 	 4055 
RabbitRyrl 	: SRLWDAVVGFLHVFAHMMMKLAQ .......... DSSQIELLKELLDLQKDMVVMLLSLLEGNVVNGMIARQMVDMLVESSSNVEMILL 4060 
FrogRyrl : SRLWDAVVGFLHVFA 	MMKLAQMPQNGGLRNGDSSQIGLLKELLDLLKDMVVMLLS LEGNVVNGTIARQMVDMLVESSSNVEMIIL : 	 4053 
FishRyrl 	: SRLWDAIVGFLHVFGLMMMKLAQGK ........ DSSQIGLLKELLDLQKDMVVMLLS LEGNVVNGTIARQMVDMLVESSSNVEMILL : 	 4094 
SRLWDAVVGFLHVFAHMQMKLSQ .......... DSSQIELLKELMDLKDMVVMLLSMLEGNVVNGTIGKQMVDMLVESSNNVEMILK 4015 
SRLWDAVVGFLHVFAMQMKLSQ .......... DSSQIELLKELMDLDMVVMLLSMLEGNVVNGTIGKQMVDMLVESSNNVEMI 1 : 	 4016 
HumanRyr3 	: SRLWDAVVGFLHVFANMQMKLSQ .......... DSSQIELLKELLDLLQDMVVLLSI.LSGNVVNGTIGKQMVDTLVESSTNVEMIL< : 	 3911 
RabbitRyr3 : SRLWDAVVGFLHVFANMQMKLSQ .......... DSSQIELLKELLDLLQDMVVMLLSiLEGNVVNGTIGKQMVDTLVESSTNVEMII : 	 3913 
MinkRyr3 	: SRLWDAVVGFLHVFANMQMKLSQ .......... DSSQIELLKELLDLLQDMVVMLLSLLEGNVVNGTIGKQMVDTLVESSTNVEMILK : 	 3899 
ChickenRyr3 	: SRLWDAVVGFLHVFANMQMKLSQ .......... DSAQIELLKELLDLLDMVVMLLS1LEGNVVNGTIGKQMVDTLVESPSNVELILK 3914 
FrogRyr3 	: SRIWDAVVGFLHVE'PNMQMKLSQ .......... DSSQIELLKQLLDLLQDMVVMLLS LEGNVVNGTIGKQMVDTLVESSSNVEMILK : 	 3910 
C.eleganRyr 	: SPLWfl\INGFFFLE'A MMEKLYK .......... NSTQLELLREFLNL. 	DMIVLMLSMLEGNVLNGSIGKQMVDALVESQPSVEKIIK : 	 4174 
Drosophi1aRy ........................................................................................ : 	 - 
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FFDMFLKLKDIVGE. .FQDYVTDPRGLISKK. FQKAMD 	K F GPEIQLLSCS 	NE I CE FAN 	ARD1GNVAVLL1 4150 
HumanRyrl 	: FFDMFLKLKDIVGSEI'.FQDYVTDPRGLISKKLFQKAMD. QK.FSGPEIQFLLSCSEtDENE I CE FANRFQEPARDIGFNVAVLLT : 4141 
DMFLKLKDIVGSEAFQDY 	LISKKDFQKAM':< 	bIQFLLSCSEADENE.I 	 ZRDIGFNVAVLL I 	- 
PigRyrl 	: FDMFLKLKDIVGSE.FQDYVTDPRGLISKKFQKAMDQK. FGPEIQFLLSCSE.DENE IDCE FANRFQEPARDIGFNVAVLLT : 4143 
RabbitRyrl FFDMFLKLKDIvGsE:•.FQDYvTDPRGLIsKKDFQKAMD:QrK. F CPEIQFLLSCSE DENE 1 FE E'ANRFQEPPtRDIGFNVAVLLT : 4148 
FrogRyrl 	: FFDMFLKLKDIVASDT.FRDYVTDPRGLISKKTQKAMDQK. 	TSEIQFLLSCSE..DENE I FE FADRFQEPAKDIGFNVAVLLT : 4141 
FishRyrl : FFDMFLKLKDIVASD FSDYVTDPRGLISKKFQKAMDQK 	SPSEIQFLLSCSE.DEND I YE FANRFQEPAKDIGFNIAVLLT : 4182 
P FFDMFLKLKDLTSSDTFKEYDPDGKGVISKR FHKANE HKH QSETEFLLSCAETDENETLDYE FVKRFHEPAKDIGFNVAVLLT 4103 
FFDMFLKLKDLTSSDTFKEYDPDGKGIISKR FHKAME HKH 	QSETEFLLSCAETDENETLDYEKRFHEPAKDIGFNVAVLLT : 4104 
HurnanRyr3 	: FFDMFLKLKDLTSSDTFKEYDPDGKGIISKKEFQKAMEGQK, QSE:IDFLLSCAErDEND F YVDEVDRFHEPAKDIGFNVAVLLT : 3999 
RabbitRyr3 : FFDMFLKLKDLTSSDTFKEYDPDGKGIISKKEFQKAMEGQK 	QSEIDFLLSCAEDEND F YIDFVDRFHEPAKDIGFNVAVLLT : 4001 
MinkRyr3 FFDMFLKLKDLSSSDTFKEYDPDGKGIISKKEFQKAMEGQK, I QSEIDFLLSCAE DEND F YVDFVDRFHEPAKDIGFNVAVLLT 3987 
ChickenRy3 	: FFDMFLKLKDLTNSD FKEHDPDGKGIISKKLFQKSMEAQK, 	IQSEIEFLLSCAE. DEND F YIDFVERE'HEPAKDIGFNVAVLLT : 4002 
FrogRyr3 	: FFDMFLKLKDLTSSD FKEYDPEGKGIISKKEFQKAMEGQK, AQSEIEFLLSCAE DEND F YV FVDFHEPKDIGFNVAVLLT : 3998 
C.e1eganP: FSDMFLKLKDLTTSQFQDFDTNQDGWISPKEFQRAME QKN 	VEDITYLMNCTDVNNDGKVDYM 	TEFENRDIGFNLAVLLV 4262 
D.:scph 1 	1 - P.............................................................................................. - 
NLSEHVPHDPRLRNFL LA 	. ILEYFRPLGRIEIMCASRRIERIYFEISETNRAQWEMPQVKESKRQFIFDVV.NEGCESEKMEMF : 4236 
HurnanRyrl 	: NLSEHVPHDPRLHNFL LA - 	.ILEYFRPILGRIEIMGASRRIERIYFEISETNRAQWEMPQVKESKRQFIFDVV.NEGGEAEKME F : 	 4227 
: 
PigRyrl 	: NLSEHVPHDPRLRNFL LA N.ILEYFRPiLGRIEIMGASGRIERIYFEISETNRAQWEHPQVKESKRQFIFDVV.NEGGESEKME F : 4229 
RabbitRyrl 	: NLSEHVPHDPRLRNFL LA 	. ILEYFRPLGRIEIMGASRRIERIYFEISETNRAQWEMPQVKESKRQFIFDVV.NEGGEAEKME F : 4234 
FrogRyrl : .ISEHVPHDTRLHNFL LADC.IINYFKP:LGKIEIMGAGKKIERIYFEISEANKTQNEMPQVKESKRQFIFDVV.NEGGESEKMEF : 	4227 
FishRyrl LSEHVPHDTRLQNFL QA 	.VLNYFRPFLGRIEIMGASRKIERIYFEISEVNRRQWEMPQVRESKRQFIFDVV.NEGGESEKMEMF : 4268 
::SEHMPNDTRLQTFL LA: .VLNYFQPFLGRIEIMGSAKRIERVYFEISESSRTQWEKPQVKESKRQFIFDVV.NEGGEKEKME F : 	4189 
NLSEHMPNDTRLQTFL LA 	.VLNYFQPFLGRIEIMGSAKRIERVYFEISESSRTQWEKPQVKESKRQFIFDVV.NEGGEKEKME F : 4190 
HumanRyr3 	: NLSEHMPNDSRLKCLLDPA .VLNYFEP1LGRIEIMCGAKKIERVYFEISESSRTQWEKPQVKESKRQFIFDVV.NEGGEQEKME F : 	 4085 
RabbitRyr3 : NLSEHMPNDSR[KCLLDPA 	.VLNYFEP:LGRIEIMCGAKKIERVYFEISESSRTQWEKPQVKESKRQFIFDVV.NEGGEQEKMEI F : 4087 
MinkRyr3 	: NLSEHMPNDSRLKCLLDPAG .VLNYFEP:LGRIEIMGGAKKIERVYFEISESSRTQWEKPQVKESKRQFIFDVV.NEGGEQEKME F 4073 
ChickenRyr3 	: NLSEHMPNDSRLQSLL PA ESVLNYFEP:LGRIEIMIGAKKIERVYFEISESSRNQWEKPQVKESKRQFIFGIV.NEGGEEEKME F 4089 
FrogRyr3 	: NLSEHMPNDSRLQCLLDPAN 
I .VLNYFSP:LGRIEIMGGAKRIERVYFEISESSRTQWEKPQVKESKRQFIFDVV.NEGGEQEKME F 4084 
C.eleganRyr NLKEHITNrPRIEKIIKAQT.LLEYFDPFLGRIEIISSKRVEKIYEIQESWLEQWGKQQIRDSKNSFLFNVLQDDGGDQGKLEA. 4349 
Drosophi1aR 	.......................................................... PQETEAVH ....... Q ............... I : 	 10 
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VSFCEDTIFEMQIAAQISEP 	 . 	: 4256 
HumanRyrl VSFCEDTIFEMQIAAQISEPEGE.PE ... TDEDEGA.GPJ AGA G .AEEGAAGLEGT.AATAAAGTARVVAAAGRALRGLSYRS : 4307 
VSCEDTIFEMQiAQISP 	. ..........- 	 . 	 .: 	 I 	.I...s..:1I.I:.::: ............... II 	.1LSiI.IL I 
PigRyrl 	: VSFCEDTIFEMQIAAQISEPEGE.PE . . .EDEDEGA.GLA AGA G .AEEGAVGPEGA.AGTAAAGLTARLAAATSRALRGLSYRS. 4309 
RabbitRyrl VSFCEDTIFEQIAAQISEPEGE.PE .. .ADEDE. . .GMG TJIA C .AEEGAAGAEGA.AGTVAAG TARLAPJAARALRGLSYRS 	: 4312 
FrogRyrl 	: VFCEDTIFEMQIASQISEPEEE.KA ... EDEDEDD ..... GGEG ... AGEGEEAENGS.APPEASS FVEFMNNVINFFKMFTYKN 4302 
FishRyrl VFCEDTIFEMNIASQISEQEEEEKG... EEDDEIDEGGG.IGPGGGANGGGDEDSNGEEGQPESSS FADFINSMLSFFSIFTFRN 	: 4353 
ViFCEDTIFEMQLAAQISESDLNERS .... ANKEES. .EK RPE 	..... Q. .GPRMAFFSILTVRS LFALRYNILTLMRNLSLKS. 	: 4264 
V;FCEDTIFEMQLQISESDLNERS .... ANKEES..EK.RPE ..... Q..GPKMGFFSVLTVRS LFALRYNILTLMLSLKS : 4265 
HurnanRyr3 VFCEDTIFEMQLASQISESDSADRP.EEEEEDF'DSSYVL lAG ...... E. .EEDGSLEPASAFAM CASVKRNVTDFLKRATLKN 	: 4165 
RabbitRyr3 	: VFCEDTIFEMQLASQISESDSADRP.EEEEGDVESSYVL ING ...... E. .EEDKSFESASAFAN CASLKRNITNLLRKATLKN : 4167 
MinkRyr3 VjFCEDTIFEMQLASQISETDSAERPDEEEEEDEDSSYVL lEG .  ..... E. . EDDKSFESASAFAN CASVKRNVANFLKKATLKN. 	: 4154 
ChickenRyr3 	: VFCEDTIFETQLASQISESDSRERL .... RKIEEPCYVVDIGDD ..... E. .EEKKSLESPSAFAL CAAVKKNVANFFKMVTVKN : 4166 
FrogRyr3 	: V FCEDTIFEMQLASQISESDTADRP. . EEEEEEEPHHLL VGE ..... D. .EEEKSLESSSAFIV CTALRKNTSDFLKNLTLKNI 4163 
C.lqriRvr I 	FCEDTIFEMQFIAAAISSGDSD ....... TK ....... M RAIK ......... QRDYFLQQTSADHISETFKSGYNYGISAASALSP 	: 4414 
DrcrhI1 - F 	......... D ........ FSQD ................................................. 	....... 	....... T.... 	: 16 
HumanRyrl RRV RLRRLTAR AATAVAALLWAAVTRAGAAGAGA.AAGALGLL GSL CC LVV II. KVTV ELAGMPDPTSDEV GEQPAGPG 4394 
lIlT .-. 	 ..•.... 	 . . ........ I. 	.......... 	 .-.....• 	 : I 
PigRyrl 	: •RRV RLRRLTAR AATALAALLWAALAHAGAAGAGA.PAGALRLL GSL.GGlLVEGAIKVTVELLAGMPDPTGDEV GEQPAGPG : 4396 
RabbitRyrl 	: RRV RLRRLTAR AATALAALLWAVVARAGAAGAGA.AAGALRLL GSL GGLVEGAKVTV ELLAGMPDPTSDEV.GEQPAGPG : 4399 
FrogRyrl : RQY KIKKMTIK MVMAIASFLWTLFIGTLHFIYSV.CKGIFFLI HTL TGSLVEGAQKLTV ELLASMPDPT.DEV GD ... GLP : 4386 
FishRyrl 	: RQY RVRKMTFK IAVALTTFFWTILMSILHFIYNV.CKGFFMII QTL CC LVEGANITV EILASMPDPT,DDV GD ... GPG : 4437 
; KKQMKKVKKMTVKDMVTAFFSSYWSIFMTLLHFVASV. FRGFFRIICSLLLGGSLVEGAKIKVAELLANMPDPT. DEVRGD. . .GEE : 4348 
. .GEE 	: 4349 
HumanRyr3 	: KQY NVKKMTAK LVKVLFSFFWMLFVGLFQLLFTI.LGGIFQIL STV GGLVEGANIRV KILGDMPDPT.FGI DD. . .TME : 4249 
RabbitRyr3 KQY NVKKMTAK LVKVFFSFFWMLFVGLFQLFFTI.VGGIFQIL STV GGTLVEGANIRV KILGDMPDPT,FGI DD.. .AME : 	 4251 
MinkRyr3 KQY KVKKMTVK LVKVFFSFFWNLFVGLFRLFFTI.LGGIFQIL NTV GGTLVEGA NIRV KILGDMPDPT FGI DD. . .ALD : 	4238 
ChickenRyr3 	: KQY KVRKMTVK MVKCFSLFFILFVGVFQLFFTI.VWCIFQIL STV GGILVEGANIKV KILGDMPDPT.FGIDD ... VTE : 	 4250 
FrogRyr3 	: SKQF KVKKMTIK LVKVFFSFFWTLFVGLFQFVFTI.VWGIFQIL STVGG LVECANIKV KITGDVHPT,FGIDD ... VLE : 	4247 
C.eleganRyr 	: QNISTTMRNVSSSVRQMSWTQLLYAVIILFIRAGLAIGWACYLLLMTIFR GYFLTTSSEEEEAAR ..... QEKE.AKMNN ........ 4490 
Drcsohi1aRy ......................................................................................... : 	 - 
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HurnanRyrl 	: GDADG GASH AGDAAEGAGDE EAVHEAGPGGAD AVAVTD 	... PFRPEGAG 	MGPTTPAEP TPEGSPILKRKLGVDGVEE : 4479 
.. 	. 	 .......... 
PigRyrl 	: GEADG GAGE AGEALEGAGDE VAVQEAGPGGAD AVAVAE 	.. .PERPEGAG 	MGTPAEP TPEGSPIIKRKLGVDGEEE : 4481 
RabbitRyrl 	: GDADGAGEGE EGDPAEGDGDE VAGHEAGPGGAE VVAVAD . . . PFRPEGAG MG 	TPAEP TPEGSPILKRKLGVDGEEE 4484 
FrogRyrl : VVVSD LPEA DAMDFTDAGKE VQEEGAEIFGLE. .L.KKDG HYRLSAPDAEC 	MG FPVEP TPEGSPILKRKFGDDEIQH 4471 
FishRyrl 	: EPRTG EQDT GVTDTGETGSG EEEEDTQ ......... EKEG . . RIPGIDAG MG1'APVEP TPEGTPITKRKMQPEETDA : 4514 
GER..KPLEAALPSEDLTDLKELTEESDLLS.DIF LDLKREG Q...YKLIPHY:/. 	I,MSN.. 	VPMPEVQEKFQEQKAKEEE 	: 4428 
GER. .KPMETTLPSEDLTDLKELTEESDLLS.DIF LDLKREG Q ... YKLIPHNPNAGLSDLMSN.. VLIPEEQENFQEQKTKEEE : 4429 
HumanRyr3 	: AERA. VMEP ITTELVHFIKG KGDTDIMS.DLF LHPKKEGSL .... KHGPEV 	LSEIIGKDE PTLESTVQKKRKAQAAEMK : 4331 
RabbitRyr3 : AERA. VAEA ITTELVHFVKG RGDTELMS.DLF LHPKKEI V .... KHGPEV LSEIIGKDE PTLESTVRKKRKAQAAETK : 4333 
MinkRyr3 AERA. VTEP VPPELIHFVKG KGDADIMS.DLF FHPKKEG L .... KFIGPEG 	LSEIIGKDE PTLESTVRNKRKAQAAEMK : 4320 
ChickenRyr3 AEKT. GAEH IRDELVQFVKG KGETDIIS.DIF IPSKKEG S .... KHGHDA IAEILGSDIQSSLENNAR<KKGLQIPETA : 4332 
FrogRyr3 	: NEKA.DAPEFiTSSSELAHLVKG KGEIDMP. .DIF LQTKKEGS ..... KHGPEI 	YSENVGTENTTSLESAVHKQRKALEAEIA : 4327 
C.e1e3anPv ....... HPSFN.PPIIQEFHHSHVGVTAFG ........... V.; ...... MNADHLNVNSLPDFVPPER ETPETVLEEEKPLNQETSP 4555 
RV 	: 4258 
HumanRyrl 	: .ELPP PEPEPE .... PELEPEK 	AEN 	PEE ......... VP PTPEP... PKK. .QAPPSPPP KEEAGG ... E WGE 	VQ.RV 	: 4544 
. 
.. ................. . 	 : 
PigRyrl .ELPP PEPEPE .... P.. EPEK 	AENGEKEE ......... VPKPPPEP... PKK. .TAPPPPPP KEEGGSGGLE WGE 	VQ.RV : 4547 
RabbitRyrl 	: .ELVP PEPEPE .... P. . EPEK 	EENGEKEE ......... VP APPEP... PKK ... APPSPPA KEEAGGAGME WGE 	VQ.RV : 4549 
FrogRyrl : LDGSDQPQPAAEEEPEPEPEPEK 	LENGEKGETAVEEEATPAP EPEEP.. . PVKAPKKKTPQKE KAEAGEGGFE WNE IQ.RI 	: 4555 
FishRyrl 	: SQKPP PVPVEE.... PPQEPEK 	VETGEKAE ... KESQSKEK EPEEP ........ KKSATKKE KLKK.EGGFQIWTE 	TQ.RN 	: 4585 
KEEKE TKS .......... EPEK 	EGEDGEKEE ........ KAK D ........ KGKQKLRQLHTHRYGEPEVPESA WKKIIAY.QQ 	: 4489 
KEEKE TKS .......... EPEK..EGEDGEKEE ........ KVK D ........ KGKQKLRQLHTHRYGEPEVPESA WKKIIAY.QQ 	: 4490 
HumanRyr3 AANEAGKV .......... ESEK. 	MEDGEKED ........ KDK EEQAEYLWTEVTKKKKRRCGQ VEKPEAFTAN FKG 	IY.QT : 4400 
RabbitRyr3 	: AEHEA GKV .......... ESEK. 	LEDGEKED ........ KAK EERAEYLWAEVTKKKKRRRGQ VEKPEAFMAN FKG IY.QT : 4402 
MinkRyr3 : AAHEA GKV .......... EPEKT 	LEDGEKED ........ TAK EEQAEALWADVTKKKKRRRGQ VEKPEAFMAN FKG 	IY.QT : 4389 
ChickenRyr3 KEAEA RKV ...........AEK 	MEDGEKQD ........ KAK E.QSEQPEEGKMKKKKRRHGQ IEKPEAVMAN FKA IY.QT : 4400 
FrogRyr3 	: KEFiEDNSKA .......... .SEE 	MEDGEKKD ........ KAKTEEQSEFLESKAEPRKKRRRGQ KEKPEAFMAN LAG 	IY.QT : 4396 
C.eleganRyr PTSPTSPAS .......... KAPSIYESIG ............. AP .............. QMVQLQSEADFQQGQYEPKIAESNSTKSRG 	: 4606 









[Al 	CLSL NFLVA LCI GYNCLI 
{ACLSLNTLVA LCIGYNCLI 
lEA 	CLSL LVA LCI GYNCLI 
IPAiWCLSL EITLVA LCI G.NCLI 
(PTLYFLSIVRTLI LCI G{NCLI 
















KVS ....... PG DDIEGSG .... AGDMSGAGSGDGS ... GWGSRAGEEV GDED 
KVS ...... D PG DDMEGSA .... AGDVSAGSGSS. . .GWGLGAGEEA GDED 
.H I.I:l 	............. . 	 .. 	.... 
KVS ...... D PG DDMEGSA .... AGDLSGAGSGGGS ... GWGSGAGEEV GDED 
KVS ...... D PG DDMEGSA .... AGDLAGACSGGGS. . .GWGSCTGEEi\ GDED 
KVS ...... D .KGEED ........... FEGSGMEEELSILDEGSGAG.GD  EDED 
VS ...... DT PEGEEMEGSGLFEGSGMFEGSGLF'EDLGEEAEGSC;MDEGGDEDEE 
KLL YFARt]E' 	MRMLALFVAFAINFILLFYK7S ...... T SW GKELPTR ....... SSSENAKVTS ........... LDSSSHR 
KLL'.YLARN'P'Y MRMLALFVAFAINFILLFYK1S ...... T SVV GKELPSR ....... STSENAKVTTS .......... LDSSSHR 
KLLHYLARNEY LR LALEVAFAINFILLFYKVT ...... ES LE. ETEDV ............ ANLWNSFN .......... DE. 	E. .E 
KLLHYLARNFY:LRLALFVAFAINFILLE'YKVT ...... EE LE ETEDV ............ ANLWNSLN .......... DE 	E. .E 
KLLHYLARNFY';LRLALFVAFAINFILLFYKVT ...... EE VS ETEDV ............ ANLWNSFT .......... DE 	S. .E 
KILHYLARNFYLRLALFVAE'AINFILLFYKVT ...... ES LD VEED ............. SNLWNSFE .......... EE 	E. .5 
KML yLAR:EY LR L1.LFVAFAINFILLFYKVT ...... SE ASDDTDNE ............ PNLWNTYQ .......... ED 	SEAS 
SILl MLAP.NKTIEKITLYLAFFINVILLFHRVD ...... I HAENAEAAS ............ EGDDDED ......... ALESIFITG 
RAVSFLARNFY LKYVALVLAFSINFMLLFYKVTSFTEEAD SAE ELILGSG ........ SGGGADTTGSGFGGSGDGGSGDGEMED 
KF'L' YLSRNFYTLR I LALF'LA FA! NF'1 rLFYI 
KFLYLSRFYTLR I LALFLAFAINFILLFYI 
KFLNYLSRNFYTL i 
KFL' :YLSRNFYTLR LALFLTFAINFILLFYI 
KFL :YLSRNFYTLR I LALELP.FAINEILLPYI 
KFL YLSRNFYLR f LALF'LJEAINEILLYI 
KFMY LSRNE'Y::L.R I LALFLAFALNFILLFY 
HurnanRyrl 
PigRyrl 






















KvpLv: FKREKELARKLEFDGLYITEQPED ...... DVKGQWDRLVLN 
KVPLVI FKREKELARKLEFDGLYITEQPED ..... DDVKGQWDRLVLN 
;L7EiVIFKREKELARKLEFDGLYITEQPEI ..... LVEGQWDRLVLN 
KVPLV: FKREKELARKLEFDGLYITEQPED ........ VKGQWDRLVLN 
KVPLV FKREKELARKLEFDGLYITEQPGD ..... DDVKGQWDRLVLN 
KVPLVI FKREKELARKLEFDGFYITEQPED ..... DDIKGQWDRLVLN 
KIPLVI FKREKELARKLEFDGLYITEQPED ..... DDIKGQWDRLVLN 
IIAVHYVL ESSGYMEPT ILAI RTVI FCI I GYYCLKVPLVFKREKEVARKLEFDGLYITEQPSE ..... DDIKGQWDRLVIN 
IIAvHyvLEssGYMEpTL ILAI 	H 7VI FCI GYYCLKVPLVIFKREKEVARKLEFDGLYITEQPSE ..... DDIKGQWDRLVIN 
AMVFFVLQESGYMAPTL ALAIII-ITII LVCVVGYYCLKVPLVVFMREKEIARKLEFDGLYITEQPSE ..... DDIKGQWDRLVIN 
AMVFFVLQES'FGYMAPTL ALAVVRTII LVCVVGYYCLKVPLVVFKREKEIARKLEFDGLYITEQPSE ..... DDIKGQWDRLVIN 
ANVFFVLQESTGYMAPAL ALAIIHTVI LVCVVCYYCLKVPLVVFKREKEIARKLEFDGLYITEQPSE ..... DDIKGQWDRLVIN 
GMVFFVLI ES GYMAPAL ALALFIPII VCVI GYYCLKVPLVVFKREKEVARKLEFDGLYITEQPSE ..... DDIKGQWDRLVIN 
GAVYFVLQES GYMAPTL ILAVIHTII LCV CYYCLKVPLVVFKREKEIARNVEFDGLYITEQPSD ..... DDIKGQWDRLVIN 
MQFPYVEY ITGWMLAQI LYWISV HLST ALLVSFYQLKIPLITFKREKEIARKLMFDGCWITEEDSEELGIVDTFMWYLDRIVVS 
































TSFPSNYWDKFVKRKVLDKHGDIFGRRI..,.ELLGMDLASLEITAHN R PD. PPPG LT IMSIDVKY, WK. FGVIFTDNSFLYLG 
TSFPSNYWDKFVKRKVLDKHGDIYGR:iRIAELLGMDLATLEITAHN R PN.PPPG LT 	SIDVKYIWK. FGVIFTDNSFLYLG 
FPSNYWDKFVKRKVLDKHCDIYGRERIAELLGt::I1 LI::Hi . I•;LI:3iDvKYQIWK. FVIFTDNSFLYLC 
T. SFPSNYWDKFVKRKVLDKHGDIYGRLRIAELLGMDLATLEITAHN R FE. PPPG LT MSIDVKY. WK. FGVIFTDNSFLYLG 
T SFPSNYWDKFVKRKVLDKHGDIFGRRIAELLGMDLASLEITAHN R PD. PPPG. LT MSIDVKY, WK. FGVIFTDNSFLYLG 
T SFPGNYWDKFVKRKVLDK 'GDIYCRRI.ELLGMDLASIEITSQNGK FE. PDKSMLA ITSIDIKY WK. FGVVFTNNSFLYLV 
T SFPNNCWDKFVKRKVLDK.GDIYGR. RIrELLGVDLASLDVSQQH K QEEPDNSVFA VTSIDIKY, WK.FGVVFTDGTE'LYLC 
TQSFPNNYWDKFVKRKVMDK GEFYGRDRISELLGMDKAALDFSDAR K KPKKDSS SAV NS IDVKY. MWK.LGVVFTDNSFLYLA 
TQSE'PNNYWDKFVKRKVMDK GEFYGRDRISELLGMDKAALDFSDAR K KPKKDSS SAV NSTDVKY. MWK.LGVVFTDNSFLYLA 
T SFPNNYWDKFVKRKVINKGDLYGA.RIELLGLDKNALDFSPVE T A. .EAAS VS SSIDMKIH WK.LGVVFTDNSFLYLA 
T SFPHNYDKFVKRKVINK GDLYGAIRIIELLGLDKNALDFSPVE TTA. .EAPkS VS SSIDMKYH WK..LGVVFTDNSFLYLA 
T SFPNNYWDKFVKRKVINK SDLYGARILELLGLDKNALDFSPVEAS A. .EAASI Vs: .SSIDMKIH lolK.LIGVVFTDNSFLYLA 
T SFPNNYWDKFVKRKVINK GDLYGA RI ELL.ILDKNARHFCPVE SEP. .EAASIVS SSIDTKYH WK.LGVVFTDNSFLYLA 
T SEPNNYWDKFVKRKVINK.GDLYGADRI ELLXILDKNALDFSPVEKT I..EEGS VS SSIDMKYH WK.LGVVFTDNSFLYLA 
AKSR?MMYWDKFVRRKTRSKFKDQVDE TLTSIL-EEKMSTDS ...................S.YDYRYSCWLWIGVILTNGQFLYRV 
AKSFPVNYJDKFVKKKVRQK SETYDFDSISNLLIMEKSTFAAQESE ....... TGIFKYIMNIDWRY. VWK.AGVTFTDNAFLYSL 
WYMVMSLLGHYNN. FFFAAI-ILLDIANGVKTLRTILSSVTHNGK IQ VMT VGL LA V VVY LYT V VA FN F El RKFYNKS. EDEDEPDMKCDDt'4 
WYMVMSLLGHYNN. FFFAAHLLDIAMGVKTLRTILSSVTHN(E v'MT VS LAVV VYLY \'VA EN F' El RKFYNKS. EDRDEPDMKCDDM 
J;:.;.LLGHYNN.FFFHLLDIAMGVKTLRTILSSVTH I .i;'.::.. ............:...':FEl KFYNKS. EDEDEPDMKCD 
WYMVMSLLGHYNN. FFFAAHLLDIAMGVKTLRTILSSVTHN: IMTVGLLAVVVYLYTVVJENFEl RKFYNKS. EDEDEPDMKCDD:•: 
WYMVMSLLGHYNN. FFFAAHLLDIAMGvKTLRTILSSVTH: L '.'MTVGLLAVVVYLYTVVAFNFEl RKFYNKS. EDEDEPDMKCDDIN 
WILVNISMLGHYNN. FFFAAHLLDIAMGVKTLRTILSSVTHN .MMI' VS LLA V VVY LYT V VA EN F £1 RKFYNKS. EDEDEPDMKCDDN 
YLIMSLLGHYNN. FFFACHLLDIAMGVKTLRTILSSVTHNGK IQLMMTVGLLAVvVYL'TAEN FF1 RKFYNKS. EDRDEPDMKCDDS 
WYMTMSVLGHYNN. FFFAAHLLDIAMGFKTLRTILSSVTHNCKcLVLTVGLLAVVVYLYTVVAFNFERKFYNKS. EDGDTPDMKCDDM 
WYMTMSILGHYNN. FFFAAHLLDIANGFKTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRKFYNKS. EDGDTPDMKCDDM 
WYTTMSVLGHYNN. FFFAAHLLDIAMGFKTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRKFYNKS. EDDDEPDMKCDDM 
WYTTMSVLGHYNN. FFFAAHLLDIAMGFKTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRKFYNKS. EDDDEPDMKCDDM 
WYTTMSVLGHYNN. FFFAAHLLDIAMGFKTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRKFYNKS. EDDDEPDMKCDDt'! 
WYTTMSILGHYNN. FFFAAHLLDIAMGFKTLRTILSSVTHNGKQLVLTVGLLAVVVYLYTVVAFNFFRKFYNKS. ED DEPDMKCDDV 
WYTTMSILGHYNN. FFFAAHLLDIAMGFKTLRTILSSVTHNGKQLVLTVCLLAVVVYLYTVVAFNFFRKFYNKS. ED DDPDMKCDDN 
GYLLCSACGVFLSPFFYAFHLI DVVLSFPMLKAI LQSVTHNLQQLILTIMMTLVVVYLYTVIAFNFFRKEYVQEGEEGEEPDRKCHNM 



























































TCY FHMYVGVRAGGGIGDEIEDE'AGDEYELYRV FE) IITFFFFV1VILLAI IQGLI II DAFGELRDQQEQVKE DMETKCFI CDI GS DY 
TCYI FHMYVGVRAGGGIGDEIEDPAGDEYELYRV FE) IITFEFEVIVILLAI IQGLIII DAFGELRDQQEQVKE DMETKCFI CG I GS DY 
CYLFHMYVGVRAGGGIGDEI EDPAGDEY ELY RV V F/IVI TC I IAFGELRDQQEQ.FEE)FETKCFICGIGSD 
TCYJFHMYVGVRAGGGIGDEIEDPAGDEYELYRV ED ITFE'FFVIVILLAI IQGLI I DAFGELRDQQEQVREDMETKC El CG I GS DY 
TCYL FHMYVGVRAGGGIGDEIEDE'AGDEYELYRV ID TFFFEVIVI LIA: Ici.III LRFGELRDQQEQVKEDMETKCFI CGI GS DY 
TCYE FHMYVGVRAGGGIGDEIEDPAGDEYELYRV ED (ITFEFEvIVILLAI IQGLI II DAFGELRDQQEQVKEDMETKCFICGI GS DY 




TCYLFHt1YVGVRAGGGIGDEIEDPAGDPYEMYRI.FDITFFFFVIVILLAI IQGLI IDAFGELRDQQEQVREDMETKCFICGIGNDY 
TCY FHMYVGVRAGGGIGDEIEDPAGDPYEMYRI TDITE'FFFVIVILLAIIQGLIIDAFGELRDQQEQVREDMETKCFICGIGNDY 
'MCYI EHMYVGVRAGGGIGDEIEDPAGDPYEMYRI EDITFFFFVIVILLAIIQGLIIDAFGELRDQQEQVREDMETKCFICGIGNDY 
TCYI FHMYVGVRAGGGIGDEIEDPAGDPYEMYRI FDITFFFFVIVILLAIIQGLIIDAFGELRDQQEQVREDMETKCFICGIGNDY 





























DT:PHGFETHTLEEHNLANYMFFLYLINKDETEHTGQESYVWFYQER ..... CWDFFPAGDCFRKQYEDQLS ............. 
HurnanRyrl 	: E)TTPHGFETHTLEHNLANYMFFLYLINKDETEHTGQESYVWKMYQER ..... CWDFFPAGDCFRKQYEDQLS ............. 
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MinkRyr3 	: FDTTPHGFETHTLQEHNLANYLFFLMYLINKDETEHTGQESYVWKMYQFI. ..... CWDFFPAGDCFRKQYEDQLG ............. 
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